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MOTIVATED BEHAVIOUR – THE ROLE OF GABA 
RECEPTOR SUBTYPES IN THE NUCLEUS ACCUMBENS 
 
SUMMARY 
 
The role of γ-aminobutyric acid (GABA) in modulating nucleus accumbens (Acb) 
function was investigated using feeding in rats as a model of motivation. Feeding 
encompasses processes associated with ‘appetite’, ‘satiety’ and ‘reward’. Distinct 
neurotransmitter systems in the Acb have been demonstrated to control specific 
behavioural mechanisms subserving these motivational processes. 
 
The Acb has been described as an interface between ‘motivation’ and ‘action’. It is 
involved in the modulation of feeding, sexual behaviour, defensive behaviours and drug 
seeking. Over 97% of Acb neurons are GABAergic and GABA mimetics robustly 
increase food intake in satiated animals. One current hypothesis suggests that GABAA 
and GABAB receptors gate control of ingestive motor responses via the same circuit but 
this circuit cannot control more complex goal-directed behaviours (Kelley et al., 2005). 
 
Temporal changes in the feeding related ‘behavioural satiety sequence’ (BSS) correlate 
with mechanisms that override satiety. The BSS is sensitive to effects on consummatory 
behaviour. Satiated rats given chow following intra-Acb infusions of a GABAB receptor 
agonist fed voraciously and the BSS was delayed but all other behaviours were still 
present. The pattern was similar with fasting and a systemically administered 
benzodiazepine but, with a µ-opioid agonist (postulated to increase the incentive value 
of food), the peak in feeding was delayed. A GABAA receptor agonist induced feeding 
but all other behaviours were significantly reduced at all effective doses.  
 
In a second order operant schedule that independently measured appetitive and 
consummatory behaviour, the GABAA and opioid receptor agonists had no effect on 
responding but the GABAB receptor agonist increased reinforced responding in a dose 
dependent manner. Several other behavioural indices of motivation also increased, 
suggesting behaviourally selective effects. These results are inconsistent with the 
hypothesis described above. 
 
Intra-Acb GABA receptor subtype stimulation led to significant differences in the 
location and magnitude of activity in motivation related brain structures, particularly the 
lateral hypothalamus and amygdala, which were revealed using Fos-like 
immunoreactivity as a marker. The differential modulation of feeding behaviour via 
GABA receptor subtypes in the Acb is used to construct a modified model to explain 
endogenous inhibitory motivational control. 
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Chapter 1 
 
Introduction 
 
Overview  
The nucleus accumbens (Acb) is a critical locus for the control of motivated behaviours. 
It is anatomically well placed to serve as an interface between circuits subserving 
motivational processes and motor behaviours (Mogenson et al., 1980). The majority of 
neurons in the Acb are GABAergic (Meredith, 1999) and activation of GABA receptors 
in the shell (AcbSh) stimulates feeding in satiated rats (Stratford and Kelley, 1997b). 
However, activation of GABAA receptors does not stimulate instrumental responding 
for food (Zhang et al., 2003) or potentiate acquisition of Pavlovian associations (Hanlon 
et al., 2004). The underlying mechanisms for the contrasting effects of activating 
GABAA receptors on feeding and on food seeking have not been explored although 
there is evidence that the lateral hypothalamus is critically involved (Stratford and 
Kelley, 1999). Thus there are limitations in our understanding of the role of inhibitory 
neurotransmission in the Acb in the context of feeding, and by extension, in motivation. 
In particular, it is not known yet whether stimulation of AcbSh GABA receptors affects 
processes subserving appetite or satiety or indeed if the results of inhibitory 
neurotransmission could be GABAA or GABAB receptor specific.  
 
In attempting to distinguish appetite and satiety, we need to bear in mind that appetitive 
motor behaviours precede the initiation of consummatory responses. It is possible that 
the behavioural transitions between appetitive to consummatory responses and from 
consummatory responses to non-motivated behaviours either depends on fluctuations in 
a single variable or on multiple processes at the level of the Acb. These questions will 
be addressed by investigating further the contribution of inhibitory neurotransmission in 
the Acb to the phasic expression of food motivated behaviours and the consequent 
activation of associated neural circuitry. Understanding the role of the Acb in motivated 
behavioural output is particularly important given evidence that obesity, drug addiction 
and affective disorders all involve pathological over-expression of goal orientated 
actions and consummatory behaviours. 
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Structure of this chapter 
First of all, in this chapter, I will introduce a theoretical framework for investigating 
different phases of food motivated behaviour. Initially this will involve a discussion of 
the development of motivational theories to explain the contribution of internal and 
external factors and associative learning to the initiation and termination of feeding. I 
will then review evidence for the contribution of a variety of regions of the brain in food 
motivated behaviours including the Acb. To some extent an historical approach will be 
taken to illustrate how some of the ideas and arguments that will crop up throughout 
this thesis have developed and to provide context for those concepts that remain 
dominant in understanding food motivated behaviour. Next I will describe the internal 
organisation of the Acb and both the afferents to this region and the efferents that 
project from it. I will focus in particular on the evidence for subdividing the Acb into 
core (AcbC) and shell (AcbSh) regions.  
 
The next part of the chapter will cover in more detail the functional and behavioural 
evidence for the contribution of the AcbSh to the control of feeding and food motivated 
behaviours. This will focus in particular on the role of GABA and hence I will consider 
in brief the different subtypes of receptors for this transmitter in the central nervous 
system. I will then review the behavioural evidence for a specific role for endogenous 
GABA in the AcbSh in controlling ingestive behavioural output in terms of food intake 
and appetitive responses. I will also consider briefly evidence for the contribution of 
other local neurotransmitters and neuromodulators in the AcbSh that may act 
synergistically or compete with GABAergic signalling to control ingestive behaviour. 
Next I will look at the evidence for additional behavioural effects of modulating AcbSh 
GABA neuronal activity. 
 
Finally I will review the effects of modulating AcbSh GABA neuron activity on activity 
in other functionally linked brain regions. This chapter will conclude with a discussion 
of one current theory to explain the role of GABA sensitive neurons in the Acb in 
feeding and the relevance of this mechanism to understanding broader control over 
motivated behaviours. I will highlight questions that this theory raises, particularly with 
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reference to the role of GABA receptor subtypes in the AcbSh, and describe the aims of 
the studies undertaken in this thesis. 
Motivation 
The term motivation has been applied to behaviour elicited by a variety of natural goals 
that can initiate motor output in animals and humans including feeding, drinking, sexual 
behaviour, exploration, fear and aggression/defence, sodium appetite and temperature 
control. In addition it is possible to identify numerous categories of species-specific 
motivated behaviours such as territory acquisition and defence, nest building, parental 
behaviours towards offspring, defensive burying etc. Humans are also motivated to self-
administer drugs and alcohol although animals do show a natural affinity for stimulants 
and opiates (Weeks, 1962, Thompson and Schuster, 1964, Headlee et al., 1955, Spragg, 
1940, Deneau and Seevers, 1964, Pickens and Harris, 1968). Many difficulties have 
arisen in attempting to formulate a single motivational theory that adequately explains 
the complex behavioural output for such varied goals (Toates, 1986). In this thesis 
feeding will be used as a model system because it has been demonstrated that 
stimulation of GABA receptors in the Acb increases feeding but not drinking (e.g. Ward 
et al., 2000).  
 
Motivated behaviour can be described as following three sequential phases 1) initiation, 
2) procurement and 3) consummatory (Swanson and Mogenson, 1981). Furthermore 
animal and human behaviour has historically been discussed in terms of appetite, when 
a particular goal is actively sought, and satiety following consummation which is 
characterised by eventual termination of behaviour. To understand how motivated 
behaviour is controlled in the CNS we need to understand what processes contribute to 
each of these phases.  
 
At the start of the 20th century it was believed that complex innate or voluntary 
behaviours consisted of a series of individual reflex components; the reflex chain 
hypothesis (for a review of the multiple origins of this hypothesis see (Clower, 1998). 
Of course this was in part due to the huge impact of the work of Pavlov on conditioned 
reflexes (e.g. see Pavlov and Anrep, 1927). However animals would need an extensive 
repertoire of reflexes controlled by a multitude of dedicated synaptic pathways for each 
stimulus type. These synaptic pathways would be in constant competition and would be 
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poorly suited to adapt to a changing environment or producing new behaviours on 
encountering novel stimuli. 
A strict behaviourist view (Thorndike, 1933b, Thorndike, 1933a, Skinner, 1938) was 
that an animal’s behaviour could be explained by the acquisition of fixed reflexive 
connections between specific external stimuli (S) and the response (R) without higher 
order cognitive processing (S-R association). The problem with this, pointed out as 
early as 1917 by Craig, (Craig, 1917, Craig, 1918, Craig, 1919, Craig, 1920) is that 
many active behaviours in motivated animals appear before there is any clear stimulus 
i.e. they are not stimulus bound reflexes and, apart from during the eventual congress 
with an incentive goal, do not take the form of stereotypical chained reflexes.  
 
Homeostatic theories of motivation 
For decades motivation has been considered almost exclusively in terms of drives and 
often in terms of homeostatic drives. However the conceptual framework that grew up 
out of a homeostatic approach is inadequate in explaining much of what can be 
observed and measured about behaviour in reality. Modern motivational theory also 
takes into account processes governing affective responses, associative learning and 
cognitive inputs to voluntary behaviour as well as innate goal directed responses. Some 
of the evidence that has accumulated for the multiple processes that subserve motivated 
behaviour will be (necessarily) briefly considered here. 
 
Walter Cannon proposed an explanation for motivation whereby behavioural output was 
dependent on the influence of physical signals from the peripheral nervous system (e.g. 
gastric contractions) on the central modulation of autonomic and reflex responses 
(Cannon, 1932). These reflex responses were necessary to maintain a constant internal 
state that he termed ‘homeostasis’(Cannon, 1926, Cannon, 1932).  His student Curt 
Richter suggested that animals could express organised motor behaviours not just 
reflexes, to maintain a constant internal state (e.g. Richter, 1941). 
 
Cannon and Richter did not consider learned behaviours to be conducive to homeostatic 
regulation and thus the integration of information about the consequences of expressing 
homeostaticaly driven behaviours was not considered important (Smith, 2007, Smith, 
2008). In contrast, Hull (1943) believed that associative learning was intrinsically 
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involved in the expression of a specific hierarchy of different habits depending on 
stimulus strength. Homeostatic imbalance or deficit was a driving force for learning 
which habits to express. Drive reduction was believed to be rewarding and physical 
drive reducers such as food and water could initiate and reinforce the expression of 
motivated behaviours.  
 
Central to homeostatic models of motivation and drive reduction theory is that 
deprivation is intrinsic to motivation and animals cease to be motivated once they are 
replete or in a state of ‘satiety’ (Moran, 1975). It was later hypothesised that such a 
model requires a ‘set point’ or optimum physiological parameter, detectors to compare 
deviations in current physiological state from the goal value and a mechanism such as 
motivational drive to trigger behavioural responses (Toates, 1986(Berridge, 2004). The 
model predicts that an animal will engage in an appropriate category of motivated 
behaviour until a set point has been reached. For example a rat injected with salt to 
induce dehydration will drink exactly the right amount of water to return body fluid 
concentration to normal (Fitzsimons, 1963). 
 
The termination of homeostatic behaviour driven by internal deficits is an example of 
negative feedback whereby motivational drive is eliminated when consummatory 
behaviour returns the internal state to the set point. At a basic level ingestive behaviour 
is an example of unambiguously homeostatic mechanisms that maintains body fluid 
levels and energy balance and it is possible to experimentally induce behaviours that are 
terminated by negative feedback. There is a vast body of literature exploring the 
neurophysiological mechanisms that subserve this feedback. Beyond circulating levels 
of nutrients many candidate ‘satiety’ signals have been identified including 
cholecystokinin (CCK) (Harper and Raper, 1943), melanocyte-stimulating hormones 
(α-, β-, and γ-MSH) (Bittencourt et al., 1992), leptin (Rowland et al., 1996), cocaine 
and amphetamine regulated transcript (CART) (Thim et al., 1998, Kristensen et al., 
1998). The search for satiety factors also resulted in the discovery of hormones and 
peptides that can apparently increase ingestive behaviours including neuropeptide Y 
(Rudski et al., 1996, Dhillo et al., 2002), agouti gene related transcript (AgRP) (Fan et 
al., 1997, Dhillo et al., 2002) and ghrelin (Kojima et al., 1999, Wren et al., 2000, Date et 
al., 2000). The homeostatic model of motivation has led to the identification of areas of 
the brain that process information about deviations from optimal conditions and signals 
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that can initiate and terminate autonomic responses particularly in relation to feeding 
and drinking (Berridge, 2004). These will be discussed in detail later in this chapter. 
The problem with a homeostatic view of motivated behaviours is that, although it 
explains goal-direction it does not adequately explain all the conditions that precede the 
initiation of consummatory responses or shifts in the magnitude, speed and persistence 
of behavioural output in response to external and internal stimuli. Equally homeostatic 
explanations do not take into account the fact that non-human animals and humans will 
vigorously pursue a multitude of specific goals when there is no apparent internal 
imbalance or need for homeostaticaly driven behaviours. For example, animals will 
overfeed when the normal sensory experience associated with ingestion is bypassed 
(Rowland and Nicolaidis, 1976) or eat even when satiated if presented with conditioned 
cues that predict reward (Weingarten, 1983), highly palatable meals (Wirtshafter and 
Davis, 1977, Gilbert and Sherman, 1970, Carper and Polliard, 1953, Carper, 1953, 
Guttman, 1953) or novel / varied diets (Kushner and Mook, 1984, Clifton et al., 1987, 
Treit et al., 1983). Conversely they fail to consume enough to meet physiological needs 
if the flavour is aversive (Nicolaidis and Rowland, 1975). 
 
Furthermore, outside of a laboratory setting feeding and drinking is often anticipatory, 
initiated prior to any homeostatic deficit (Bindra, 1968), but controlled via the same 
cues from detector systems that would trigger motivation if a deficit were present 
(Berridge, 2004). It has been suggested that rather than motivation being driven by a set 
point it is the result of an ever shifting balance between a multitude of opposing 
endocrine and neuronal processes and innate behaviours (Bolles, 1980, Wirtshafter and 
Davis, 1977, Pinel et al., 2000).  
 
Drive reduction theory also suffered following the discovery that stimulation of neurons 
in the brain that could elicit feeding was rewarding in and of itself i.e. drive and reward 
appeared to be the same process subserved by the same local circuits in the CNS (e.g. 
see Valenstein et al., 1970, Valenstein, 1975). It was demonstrated that high levels of 
electrical stimulation in various regions of the brain could be rewarding, there was a 
clear anatomical dissociation between rewarding and punishing mechanisms and 
stimulation that increased consummatory responses to natural rewards was most 
effective in the same regions where self stimulation was rewarding (Olds, 1958b, Olds, 
1958a, Olds et al., 1960, Margules and Olds, 1962).  
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Section summary 
To summarise, regardless of whether behaviours are subserved by drive to reach a set 
point or fluctuations in drive engendered by competing systems, homeostatic models 
only really explain the expression of basic goal-specific behaviours like ingestion, and 
then only under specific sets of circumstances. These processes do not explain more 
complex strategies to procure access to a goal in anticipation of needs, the flexibility of 
behavioural selection in the face of changing or novel environments or the persistence 
of behaviours beyond satisfying physiological needs. A major advance in the approach 
to studying motivation was the assertion that motivation systems must encompass 
processes that allow the acquisition of new, flexible operant responses that can be 
changed appropriately in light of changing circumstances (Berridge, 2004). A 
conceptual framework that contributed to this more inclusive theory of motivation was 
based on the idea of appetitive and consummatory phases in behaviour (Craig, 1917). 
 
Appetitive and consummatory behaviour 
On the basis of extensive observation of natural behavioural patterns Craig (1918) 
described motivated behaviours as occurring in a series of phases that appeared in 
cycles. He described two key phases as consisting of “appetitive” and “consummatory” 
behaviours. An appetite described a state of agitation and restlessness in the absence of 
the “appeted” stimulus that was characterised by a “readiness to act” and included 
“incipient consummatory action” (Craig, 1918). The strategy that the animal would 
employ during the appetitive phase to gain access to the stimulus depended on its 
success in using the strategy previously to make consummation of the act possible. 
 
Craig noted that appetitive behaviours became quicker and more efficient over time and 
thus must be learnt by trial and error. Importantly Craig (1918) suggested that 
“readiness” to perform some actions excluded the performance of others because 1) 
activity in some neurons would inhibit activity in others, 2) the “condition of the 
internal secretions” meant the animals was unready for alternatives and 3) some 
instincts were mutually exclusive due to “incompatibility of motor components” (Craig, 
1918). In particular condition two suggests a similar level of insight into the underlying 
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neural mechanisms as Hebb more than 30 years later (Hebb, 1949). Craig (1918) also 
suggested that while he believed appetite was the outward expression of internal causes 
and physiological states a stimulus from the environment could be an “immediate 
excitant of an appetite”. 
 
The consummatory phase was initiated by congress with appeted stimuli and activity at 
this stage often took the form of chained reflexes to consummate the appetitive act. 
Consummation of the appetitive act would usually rapidly “discharge” the appetite. 
Consummation could lead to further appetite and these first two phases (appetitive and 
consummatory) could alternate for some time. Nevertheless consummatory behaviour 
would eventually terminate the appetitive phase. Craig also suggested that once the 
animal reached a state of “satisfaction” the appetitive stimuli might actually become 
aversive and actively avoided (phase 3).  The final phase (4) was a state of rest in the 
absence of the activities expressed in the preceding phases. 
 
Taking into account the importance of the appetitive phase in Craig’s model it was not 
enough to explain motivation in terms of drives subserving consummatory behaviour 
via homeostatic mechanisms. However it was many years before theorists attempted to 
construct a parsimonious model that included factors that could subserve the appetitive 
phase. Epstein (1980) suggested that motivation included (1) flexible goal directedness 
or means – end readiness, (2) goal expectation, and (3) affect (Berridge, 2004). The 
important shift on emphasis was that motivated behaviour must be subserved by 
processes that that could initiate appetitive behaviours before the goal object initiated 
consummatory responses. In Epstein’s criteria this would require more than simple S-R 
type learning to organise flexible procurement strategies to gain access to the goal under 
different circumstances. This learning component was further important to confer 
expectation whether this was in the form of simple conditioned anticipatory responses 
or a more cognitive declarative process. Finally it would also include an affective 
component expressed as a result of interactions with a hedonically potent goal.  
 
The suggestion of such criteria to define a motivated behaviour lead to a new model – 
incentive motivation. The premise of this new conceptual framework was that reward 
was not due to drive reduction but related to the positive value of the goals and 
appetitive-consummatory behaviours would not always be satisfied and terminated 
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simply by physiological drive reduction. Models of motivation needed to take into 
account learning, expectation and affective (emotional) components. 
Hedonic reward, affective processes and learning 
One possible explanation for non-homeostatic motivation is that animal behaviour can 
be driven by the hedonic properties of rewards, cues predicting hedonically rewarding 
goal stimuli and learning about the value of external cues. The parallel development of 
motivational theory and learning theory has been inextricably linked for decades and it 
is beyond the scope of this introduction to discuss the vast literature. The early 
controversies surrounding the conflict between single process theories (Hull, 1943, 
Guthrie, 1935, Tolman, 1932, Pavlov and Anrep, 1927) and two process learning theory 
first suggested by Miller and Konorski (1928, in (Rescorla and Solomon, 1967) were 
discussed in detail by Rescorla and Solomon (1967) over 30 years ago. The legacy of 
these arguments however was evidence that reinforcement of behaviours was 
fundamental to learning and that affective components of the learning process 
contributed to an animal’s experience and consequent behaviour. 
 
Alcaro et el., (2007) suggest that a clear distinction between motivational systems that 
determine future behaviour and learning systems that retroactively strengthen 
associations between preceding events is often made. Thus approach to incentive 
stimuli is considered an expression of motivation whereas the attribution of value to 
previously neutral stimuli is considered an expression of learning. However, although 
this serves a useful purpose when attempting to measure the magnitude and persistence 
of innate behaviours it sidesteps the issue that animals are continually adapting their 
behavioural responses to their environment on the basis of experience. Little behaviour 
expressed even by non-human animals will be purely innate reflexes, instincts and 
unconditioned actions. 
 
Tolman proposed an incentive learning theory whereby the motivational effects of 
physiological drive states were indirect due to the incentive value that an animal assigns 
to an instrumental reinforcer or outcome(Tolman and Gleitman, 1949a, Tolman and 
Gleitman, 1949b). The animals learnt through consummatory interactions with the goal 
to assign a higher value when in a state of homeostatic deficit and hence will work 
harder to attain that goal when in the same state. This incentive value constitutes a non-
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homeostatic form of motivation. Many incentive motivation theories have built upon the 
concept of incentive value associated with reward but I will consider the contribution of 
some key authors who, in the 1970s and 1980s attempted to bring some of the old 
learning theory into perspective to form a more parsimonious motivation theory. 
 
A shift away from drive reduction theories and the strict behaviourism of researchers 
such as Skinner began as alternative incentive concepts of motivation were proposed. In 
particular the concepts developed by Bolles, Bindra and Toates (e.g. Bolles, 1958, 
Bolles, 1972, Bolles, 1979, Bindra, 1969, Bindra, 1974a, Lajoie and Bindra, 1978, 
Toates, 1981, Toates, 1986) were critical to the development of incentive motivation 
theory. 
 
Bolles (1972) suggested that behaviour was motivated by incentive expectancies rather 
than by homeostatic drives (or a need for drive reduction). He asserted that previously 
neutral cues that had been associated with hedonically potent goals could induce a state 
of expectation and would be perceived as predictors of future reward (Bolles, 1972). 
However Berridge (2004) pointed out that it is not clear why expectation would 
necessarily be motivating enough to induce active behaviour when an animal could 
passively wait for the reward the cue lead them to expect.  
 
Bindra (1979) suggested that stimuli in the environment could be “affectively” 
(hedonically) potent or neutral and that those stimuli that were hedonic could be 
positive or negative. It is probably important to note that, at the time this theory was 
developed, it did not explicitly describe the neurobiological representations of internal 
‘motivation’ but simply referred to internal ‘homeostatic’ status (Nader et al., 1997). A 
“central motive state” (c.m.s.) (Morgan, 1943) was produced by the interaction between 
the central representation of incentive stimuli (such as food) with internal, physiological 
states (such as hunger) (Bindra, 1974a, Bindra, 1978). This idea was not new (e.g. for a 
review of Kornorski’s ideas that shaped such theories see Zielinski, 2006) but Bindra 
went further in suggesting that if an animal experienced a neutral stimulus followed by 
a rewarding incentive such as food the former could take on some of the incentive 
properties of the reward and motivate behaviour itself (Bindra, 1974b, Lajoie and 
Bindra, 1978). 
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Bindra (1979) talked of “organismic variables” determining how excitable motivation 
related brain circuits were and neural activity due to affective or hedonic stimuli 
determining which circuits would be excited. The problem with this explanation is that 
it might predict that once a neutral stimulus acquired incentive value it would always 
elicit the response whether the animal was internally motivated or not. Neither does it 
explain how incentive stimuli such as food encountered when an animal is not in an 
appropriate state of deprivation can have hedonic value, particularly if not consumed. 
 
Toates (1981, 1986) added the caveat that the incentive value of a neutral stimulus, 
gained via association with a rewarding stimulus, was subject to modulation by the 
current internal state of the animal, thus hungry animals might lick a cue light but treat 
it as a neutral signal when satiated. Toates (1986) also suggested that the animal may 
not encounter the stimuli in a state that will confer positive hedonic value to it (e.g. 
water is not particularly arousing when an animal is not thirsty) but they assimilate 
information about the original incentive stimuli that can become hedonically arousing at 
a later date. Finally Toates (1986) suggested that, although novel objects may appear to 
have hedonic properties because they arouse exploration or avoidance, these responses 
are short lived (animals habituate to them) whereas animals do not become permanently 
habituated to food and transfer of incentive to neutral stimuli increases rather than 
decreases with experience (Toates, 1986). The c.m.s cannot be generated by internal 
variables alone but determines how effective an external incentive will be in arousing a 
c.m.s. which in turn will lead to behavioural output (Toates, 1986). 
 
Incentive learning theory  
Dickinson and Balleine (1994) condensed many of these concepts into an incentive 
learning theory to explain the motivational control of goal directed actions. This was 
based on concepts originally discussed by Tolman. The basic premise of the incentive 
learning theory is that the motivational effect of states of deprivation is indirect because 
state determines the incentive value of a reinforcer or action outcome. The assignment 
of such value occurs once an animal has learnt the value of a particular outcome in a 
given motivational state only by experiencing it in that state. This process of learning 
was referred to as incentive learning by Dickinson and Balleine (1994) who suggested 
that animals learnt both the value of reinforcers under states of deficit (“motivational 
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determination”) and that the high value in this state was dependent on being in that state 
(“motivational control”)(Dickinson and Balleine, 1994, Dickinson and Balleine, 1995, 
Dickinson et al., 1996). These two types of learning represented the basic incentive 
motivation associated with hedonic goals and the cognitive aspects of expectancy and 
prediction that were discussed by Toates (1986). Central to the understanding of 
incentive learning theory is the demonstration that different neuronal substrates 
subserve the assignment of incentive value and the cognitive processes of expectancy 
and prediction (Balleine and Dickinson, 1998, Belin et al., 2009). 
 
Saliency attribution - Wanting versus liking 
Researchers such as Young (Young, 1952, Young, 1966) and Sheffield (Sheffield et al., 
1951, Sheffield et al., 1954) consistently demonstrated that pleasure and positive 
affective experience, hedonic processes, were important instigators and modulators of 
behaviour when other investigators were concentrating exclusively with concepts of 
drive reduction and associative learning (Berridge, 2007a).  Berridge and colleagues 
suggested an important dichotomy between these important hedonic processes which 
they termed ‘liking’ and non-hedonic saliency attributed to reward which they termed 
‘wanting’ (Berridge and Valenstein, 1991). This was termed the incentive salience 
model (Berridge, 1996). In this model liking and wanting, affective states that human 
subjects can articulate but that can only be measured indirectly in rats, are taken as two 
dissociable components of reward, mediated by separate brain systems (Berridge et al., 
1989, Berridge, 1996).  
 
Liking was defined as the immediate evaluation of how ‘pleasurable’ a stimulus is, 
whereas wanting was defined as a process that underlies our attraction toward stimuli in 
the environment (Berridge et al 1989, Berridge 1996). It is the approach to a stimulus 
(and instrumental responses to it) that constitutes a measure of ‘wanting’ (Berridge 
1996). Berridge and Valenstein (1991) hypothesised, for example, that electrical 
stimulation of the lateral hypothalamus (ESLH) specifically increases incentive salience 
attribution (wanting) via associative learning but without directly activating circuits 
involved in affective responding. Liking and wanting often occur together but can be 
dissociated under certain circumstances and are subserved by different neuronal 
circuitry (Berridge, 1996, Berridge, 2001, Berridge, 2004, Berridge et al., 2009). 
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Section summary 
While early homeostatic models of motivation have contributed to our understanding of 
the role of internal signals to both initiate and terminate some classes of behaviour the 
importance of external influences must be accounted for. Although a motivated animal 
does not always express obvious goal directed behaviours, given the appropriate 
external stimuli it will actively seek congress with or avoid an incentive object e.g. 
positive food reward or aversive prey animal. Increases in motivation support increases 
in the speed and strength of both the acquisition and expression of operant responses. 
Motivated behaviours are flexible and although they may become habitual, strategies 
can be consciously adapted. Motivation during learning can result in an increase in the 
ability of external factors to influence the active expression of motivated behaviours at 
lower thresholds of internal drive or even when internal drive is lacking. Any model of 
motivation must thus take into account complex interactions between the impact of 
signals associated with internal state and arousal levels, external stimuli and the 
saliency attributed to them through learning and affective, emotional and cognitive 
processing. A schematic summary of this integration is shown in Fig. 1.1. 
 
Figure 1.1. “A basic schematic for nervous system functional organization. This 
model assumes that the motor system controls behaviour and bodily vital 
functions, and that there are three classes of inputs to the motor system—
cognitive, which is responsible for voluntary (v) control; sensory, which is 
responsible for reflex(r) control; and behavioural state, which is responsible for 
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state(s) control. Note that the sensory, state, and cognitive systems share 
bidirectional connections, and that the results of internal (1) and external (2) 
behaviours feed back through the sensory system to influence future behaviours”. 
(Figure and legend copied from (Swanson, 2000) 
Regions of the brain subserving motivated behaviour  
While early research into the control of motivated behaviours focused on peripheral 
mechanisms controlling homeostatic drives, authors such as Lashley (1938) took a 
centralist view that an excitatory state had to be aroused in a hypothetical neural system 
in the brain to cause a switch from non-motivated to motivated behaviour. This switch 
must involve the integration of a variety of inputs including endocrine signals, 
physiological state, internal and external stimuli and that the central nervous system 
could organise specific goal directed outputs (Lashley, 1938). The challenge was to find 
where in the brain the appropriate information was integrated and such a switch 
occurred. I will focus here particularly on areas of the brain identified as being 
necessary for the expression of food ingestion and behavioural responses that food and 
food related stimuli engender. 
 
Hypothalamus and food intake 
Since the 19th century it has been recognised that damage (e.g. tumours) in the region of 
the hypothalamus-pituitary complex in humans can lead to overeating and obesity 
(Mogenson and Huang, 1973). However diseases such as Babinski-Frölich Syndrome 
encompass a variety of other symptoms because tumours are rarely restricted to a single 
structure. With the development of neurosurgical techniques to target lesions to discrete 
regions of the brain in non-human animals it was possible to explore this phenomenon 
further. Electrolytic lesions of the medial and particularly ventromedial hypothalamus 
(VMH) caused hyperphagia, increased fat deposition and weight gain in rats (Brobeck 
et al., 1943, Brobeck, 1946, Hetherington and Ranson, 1939, Hetherington and Ranson, 
1940, Hetherington and Ranson, 1942b, Hetherington and Ranson, 1942a). VMH 
lesioned animals would not work to gain access to food (Miller et al., 1950). 
 
In contrast electrolytic destruction of the extreme lateral portion of the lateral 
hypothalamus (LH) caused total abolition of spontaneous intake of food and water, the 
effect was so extreme that animals would starve to death and the lesions blocked the 
hyperphagia induced by VMH lesions (Anand and Brobeck, 1951a, Anand and 
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Brobeck, 1951b). These authors suggested that the LH constituted a “feeding centre” 
and the VMH a ‘satiety centre’ in the brain (Anand and Brobeck, 1951a, Anand and 
Brobeck, 1951b, Brobeck, 1955).  
Stellar (1954) took the idea of feeding centres further suggesting that the hypothalamus 
could be the seat of the central motive state that had been described over a decade 
before (Morgan, 1943). He theorised that “the amount of motivated behaviour is a direct 
function of the amount of activity in certain excitatory centres of the hypothalamus” 
(Stellar, 1954). He postulated that excitatory centres (in the LH) were modulated by 
activity in inhibitory centres (in the VMH). The inhibitory centres could control neural 
mechanisms for the satiation of motivation. Furthermore different classes of behaviour 
could be subserved by anatomically discrete areas within these centres. 
 
Around this time it was also reported that electrical stimulation in the LH directly 
evoked feeding responses and increased food intake (Hess, 1954 in (Miller, 1957, 
Anand and Dua, 1955, Smith, 1956). The use of electrode implantation also revealed 
that animals found stimulation of some regions of the hypothalamus intrinsically 
rewarding and would press a lever for this stimulation (Olds, 1956a). More precise 
topographical studies revealed that stimulation in the region of the LH elicited approach 
whereas in the VMH only escape could be produced (Travis and Olds, 1959, Olds et al., 
1960, Olds, 1960).  
 
Despite the compelling evidence from both lesion and electrical stimulation studies 
problems with the dual centres hypothesis of hypothalamic modulation of motivated 
behaviour soon became evident. It was clear from the start that lesions in the VMH 
caused a number of metabolic and behavioural effects collectively known as the Ventral 
Hypothalamic Syndrome. This included reduced drinking, increased blood insulin 
levels, decreased oxygen consumption, decreased utilisation of amino acids, heightened 
reactivity to stimuli, “finickiness” in diet selection, reluctance to work for food and 
inhibition of self stimulation in the lateral hypothalamus (Hoebel and Teitelbaum, 1962, 
Hoebel, 1965) (Miller et al., 1950).  
 
Likewise, lesions of the LH did not cause permanent aphagia or adipsia but did cause 
profound reductions in general motor functions and arousal (Teitelbaum and Stellar, 
1954). Rats did not respond appropriately to physiological challenges such as injection 
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of saline or to food or water deprivation and only consumed food if it was particularly 
palatable and presented with water (Teitelbaum and Epstein, 1962). Electrical 
stimulation of the lateral hypothalamus, as well as producing hyperphagia, causes 
licking, chewing, swallowing described as ‘eating automisms’, which suggests that the 
hypothalamus is linked to other brain regions such as the posterior brain stem (Bell, 
1971). This combination of multiple responses following destruction or stimulation of 
the LH was referred to as the Lateral Hypothalamic Syndrome. 
 
Some authors suggested that the profound effects on feeding and drinking that followed 
lesions or electrical stimulation of the hypothalamus could actually be due damage or 
stimulation of the medial forebrain bundle (MFB) that courses through this region of the 
brain (Morrison and Mayer, 1957, Morrison et al., 1958). Positive responses to 
electrical stimulation coincided with stimulation in the MFB rather than in discrete 
centres in the hypothalamus and Hess’s “parasympathetic” regions (Hess, 1957 in (Olds 
et al., 1960) fell within an extended continuum from the telencephalon to tegmentum 
rather than specifically within the hypothalamus (Olds et al., 1960, Olds, 1960). 
Morgane (1961)(Morgane, 1961e) noted that the MFB connected the hypothalamus to 
other areas of the brain for which evidence was emerging for their role in the control of 
feeding including the amygdaloid complex and regions of the cortex. 
 
Stimulation of the MFB in the region of the hypothalamus both elicited food seeking 
and consummatory responses and was intrinsically rewarding (Olds et al., 1960, Olds, 
1960, Margules and Olds, 1962). Lesions, knife cuts or stimulation of the MFB anterior 
or posterior to the ‘feeding’ and ‘satiety’ centres did not alter basic consummatory 
ingestive responses or intake (Morgane, 1960, Morgane, 1961b, Paxinos and Bindra, 
1972, Paxinos and Bindra, 1973, DiCara and Wolf, 1968). In addition, lesions of the 
MFB anterior to the hypothalamus did not reduce the rewarding effects of self 
stimulation in the hypothalamus (Olds and Hogberg, 1964). 
 
Nevertheless the MFB did appear to be necessary for the expression of motivational 
aspects of ingestion (Morgane, 1961b, Morgane, 1961d). It was acknowledged that 
despite the lack of effects of MFB lesions immediately adjacent to the hypothalamus 
damage to other structures along the pallidofugal extent of the MFB e.g. in the globus 
pallidus (GP) did produce some aspects of hypothalamic syndromes (Morgane and 
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Kosman, 1960, Morgane, 1961c, Morgane, 1961a, Morgane, 1961d, Morgane, 1961e, 
Morgane, 1961b). Although Morgane (1961e) thought the MFB was not essential for 
the control of feeding he acknowledged that the lateral hypothalamic nucleus was “so 
firmly imbedded in this bundle at the level of the ‘feeding center” that it cannot be 
separated from it by any method of destruction”.  
 
In the 1960s a method was developed to visualise catelcholamine expression in neurons 
(Carlsson et al., 1961, Carlsson et al., 1962, Bjorklund et al., 1968) and dopamine 
containing pathways through the MFB were identified and characterised (Dahlstroem 
and Fuxe, 1964, Anden et al., 1965, Fuxe et al., 1965, Fuxe, 1965a, Fuxe, 1965b, Anden 
et al., 1966c, Anden et al., 1966a, Hillarp et al., 1966, Anden et al., 1966b, Fuxe et al., 
1966, Anden et al., 1967, Bjorklund and Nobin, 1973, Lindvall et al., 1974). With the 
development of techniques to selectively destroy these dopaminergic fibres of passage it 
became possible to study their involvement in feeding and food motivated behaviour. 
 
In the 1970s it was suggested by many investigators that the importance of the LH in 
feeding was minimal because effects could be due instead to the incidental destruction 
of the dopaminergic fibres of the nigrostriatal or mesolimbic pathways since many of 
the characteristics of the LH syndrome could be mimicked by DA fibre destruction 
(Ungerstedt, 1970, Ungerstedt, 1971, Ungerstedt et al., 1974, Marshall and Teitelbaum, 
1973, Marshall et al., 1974) (Fibiger et al., 1973a, Fibiger et al., 1973b, Oltmans and 
Harvey, 1972, Oltmans and Harvey, 1976). At the same time Grossman and colleagues 
showed that knife cuts to fibres entering or leaving the hypothalamus laterally (that 
connected the brainstem and basal ganglia) also mimicked the hypothalamic syndromes 
(Grossman and Grossman, 1971, Grossman, 1972, Grossman and Grossman, 1973). 
 
The problem with the assertion that many of the effects of lesioning the hypothalamus 
could be reproduced by damaging fibres of passage was that while it was possible, for 
example, to destroy dopaminergic fibres selectively, it was not possible to destroy cell 
bodies and spare fibres in the hypothalamus and hence test the unique contribution of 
this region to any of the effects demonstrated by electrolytic lesions. With the discovery 
of excitotoxins such as ibotinic acid the importance of the LH in feeding was 
reconfirmed because excitotoxin induced fibre sparing lesions still resulted in 
hypophagia (Grossman et al., 1978, Stricker et al., 1978). 
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Animals with excitotoxic lesions of the LH showed less drastic deficits in feeding, 
drinking and in the maintenance of body weight but were unable to respond 
appropriately to experimentally induced physiological challenges (Winn, 1984, Clark, 
1990, Winn, 1990). Nevertheless animals with excitotoxic lesions of the LH were 
capable of regulating ingestion when food or water deprived, responded appropriately to 
adulteration of their diet and showed no deficits in locomotion, sensorimotor responses, 
or in willingness to perform an operant response for food (Winn et al., 1984, Dunnett et 
al., 1985, Clark et al., 1990, Winn et al., 1990, Clark et al., 1991, Winn, 1995) 
 
The re-assertion of the role for the lateral hypothalamus in feeding and drinking was 
supported by electrophysiological studies that showed activity in the hypothalamus in 
direct response to the sight and taste of food (Burton et al., 1976, Rolls et al., 1976, 
Rolls et al., 1977, Rolls et al., 1979). Furthermore on a purely anatomical basis the 
direct connections to the cortex and to the autonomic systems of brainstem of spinal 
chord suggested the hypothalamus as a point of integration (Saper et al., 1979, Tucker 
and Saper, 1985, Saper, 1985, Saper et al., 1986). Since the 1980s specific regions of 
the hypothalamus e.g. the paraventricular nucleus (PVN) have been shown to be the 
primary sites where metabolic hormones exert their effect (Gao and Horvath, 2007) 
 
Section summary 
The evidence discussed in this section demonstrates that multiple regions in the 
hypothalamus play a fundamental role in the control of food intake and that, contrary to 
beliefs of the first half of the 20th century, activity in feeding related brain regions is 
intrinsically rewarding. The recognition that damage or stimulation of the MFB might 
be responsible at least in part for some of the symptoms associated with hypothalamic 
syndromes suggests that other areas of the brain that are connected via these fibres of 
passage may be critical to the control of food motivated behaviour. In particular, in the 
1970s it was demonstrated that the integrity of the dopaminergic fibres that pass 
through the LH is critical in the organisation of multiple aspects of behavioural control. 
 
The role of other areas of the brain in feeding 
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Despite the predominance of a hypothalamocentric approach to understanding food 
motivated behaviours for over 40 years (from the mid 1940s to mid 1980s) there was 
ample evidence for the involvement of multiple brain regions in ingestion. The 
acknowledgment that the integrity of the MFB could be important in the regulation of 
motivation and, more specifically the nigrostriatal and mesolimbic dopamine pathways, 
also suggested that regions that were either the sources of ascending or descending 
fibres or the site of termination of these neurons might in turn be necessary and or 
adequate for the expression of motivated behaviours. These included the amygdala, 
accumbens (Acb), septum and prefrontal cortex (PFC) anterior to the hypothalamus and 
the ventral tegmental area (VTA), substantia nigra (SN), periaqueductal grey (PAG) and 
reticular formation (RF) posterior to the hypothalamus (Nauta, 1961, Morgane and 
Stern, 1972).  
 
Before Olds and colleagues explored the effects of electrical stimulation in the LH they 
had shown that stimulation in the subthalamic nucleus (STh), cingulate gyrus (CG) in 
the cortex and (most robustly) in the septum was rewarding and facilitated acquisition 
of lever pressing as effectively as a primary reinforcer such as food (Olds and Milner, 
1954, Olds, 1956b). Conversely in some locations the stimulation appeared to be 
aversive, was vigorously avoided and reinforced learning of avoidance responses 
(Delgado et al., 1954, Miller, 1957). Stimulation in the basomedial forebrain facilitated 
learning of a maze and runway behaviour more robustly than giving food reward (Olds, 
1956b). Animals were more willing to overcome aversive events to self stimulate than 
to gain access to food but response rates varied with fluctuations in natural drive states 
e.g. hunger, suggesting that areas that were intrinsically involved in mediating the 
effects of primary rewards were being stimulated (Olds, 1958b, Olds, 1958a).  
 
Robust decreases in ingestion but with varying degrees of persistence were also 
demonstrated following electrolytic lesions of the GP (Morgane, 1961a), midbrain 
tegmentum (Blatt and Lyon, 1968), SN (Ungerstedt, 1971), septum and amygdaloid 
complex (Pubols, 1966), the brainstem (Parker and Feldman, 1967, Zeigler and Karten, 
1974) or thalamic regions (Zeigler and Karten, 1974). Increased ingestion was reported 
following lesions of, for example, the mamillary nuclei (Graff and Stellar, 1962), 
septum (Harvey and Hunt, 1965) and PAG in the brainstem (Skultety and Gary, 1962). 
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The fundamental role for the brainstem in many aspects of the basic control of feeding 
was demonstrated by the finding that decerebrate rats could ingest food and fluid placed 
in the mouth and stop ingestion if the taste was aversive, when gastrointestinal signals 
suggest satiety had been reached or if the food was noxious or toxic (Grill and Kaplan, 
2002, Norgren and Leonard, 1971, Grill and Norgren, 1978a, Grill and Norgren, 1978b, 
Grill and Norgren, 1978d, Grill and Norgren, 1978c). Nuclei in the brainstem are 
connected to peripheral nerves involved in ingestion, digestion, nutrient absorption and 
parasympathetic and sympathetic responses but, while the brainstem can mediate acute 
food responses it cannot respond to long term homeostatic challenges (Berthoud et al., 
2001, Berthoud, 2002, Berthoud, 2004). Electrical stimulation in ‘higher’ regions of the 
brain such as the VTA, MFB and areas of the cortex can initiate stereotypical, 
coordinated movements that are activated by direct stimulation of “pattern generators” 
in the spinal chord and brainstem (Stein, 1978, Dubner, 1970, Sessle et al., 1976) 
 
One group of structures that was particularly well investigated by the 1970s was those 
constituting the limbic system and particularly the amygdaloid complex (Mogenson and 
Huang, 1973). Following lesioning of the amygdala, investigators reported profound 
induction of hyperphagia and obesity (Morgane and Kosman, 1959, Morgane and 
Kosman, 1957, Morgane and Kosman, 1960) or conversely aphagia and adipsia 
(Brutkowski et al., 1962, Fonberg, 1966, Collier and Gault, 1969) or transient effects 
(Crow and Whitaker, 1970). The amygdaloid complex consists of multiple distinct 
nuclei and lesions in dorsomedial sites appeared to be responsible for aphagia (Fonberg, 
1966) whilst destruction of basolateral sites caused hyperphagia (Fonberg, 1968, 
Fonberg, 1971).   Early investigations indicated that lesions might exert their effects due 
to decreased sensitivity to stimuli and to reinforcement contingencies (White, 1971, 
Schwartzbaum, 1960) and to increased sensitivity to the context (Sclafani et al., 1970) 
and deprivation state of the animal (Cole, 1974). Electrical stimulation in the amygdala, 
other forebrain limbic regions and the VTA were shown to elicit ingestive responses 
(Mogenson and Huang, 1973) and influenced the behaviour elicited by stimulating the 
hypothalamus (Sibole et al., 1971, Siegel and Flynn, 1968, Siegel and Skog, 1970). 
 
By the 1970s it was acknowledged that feeding and drinking was probably subserved by 
complex circuits (e.g. Mogenson and Huang, 1973) but there was little direct evidence 
for how these circuits might be organised. There was much focus on the inter-
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relationship between activity in limbic structures and the hypothalamus and between the 
hypothalamus and the midbrain (for a review see (Mogenson and Huang, 1973). There 
was a general consensus that hypothalamic nuclei were well placed to serve an 
integratory role, limbic structures modulated hypothalamic output and this output 
signalled to midbrain and brainstem regions that subserved the motor execution of 
behavioural responses (Mogenson and Huang, 1973). 
 
However there was no satisfactory evidence to show how all these regions were 
connected or related “anatomically or physiologically to neural, humoral and other 
signals to which they apparently respond(ed), nor to the autonomic, endocrine and 
somatic efferent systems that they influenced” (Mogenson and Huang, 1973). While the 
hypothalamus was shown to influence downstream regions in the midbrain and 
brainstem it also caused changes in activity in rostral regions of the brain suggesting a 
more complex level of integration (Mogenson and Huang, 1973). Additionally while the 
hypothalamus clearly served as a point of integration within circuits that controlled 
biologically relevant behaviours this did not mean that it subserved all motivated 
behaviour. Mogenson et al (1980) pointed out that, while stimulation or lesioning of 
brain regions could suggest a role in the execution of specific classes of motor 
responses, these experiments did not elucidate how movements were planned and 
initiated or how the ‘cognitive’ or ‘emotive’ areas of the brain affect these processes. 
 
An interface between limbic and motor regions of the brain 
In 1980 Mogenson and colleagues published a seminal paper in which they proposed 
that the nucleus accumbens, part of the ventral striatum, could be the point of 
integration between neurons of the limbic and motor regions of the brain on the basis of 
newly identified anatomical connections reported by Graybiel at a meeting in 1976.  In 
fact prior to this Ungerstedt had already suggested “the anatomical connections of the 
striatum makes it well suited to be concerned with the final sensory-motor integration, 
i.e. the efferent organization of behaviour” (Ungerstedt and Ljungberg, 1974). 
 
At the time only a small proportion of the afferents and efferents of the Acb were 
known. The model of Mogenson and colleagues was based on the evidence that it 
received direct inputs from the amygdala, hippocampus and other limbic structures and 
indirect inputs from limbic regions via the VTA and that it projected directly and 
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indirectly (via the SN) to the GP (Mogenson et al., 1980). The advance in tracing 
techniques over the following decades has shown that the Acb is even better placed 
anatomically to act as an interface than these authors originally thought. The additional 
afferent and efferents since identified will be discussed later in this chapter.  
Mogenson and colleagues (1980) provide anatomical, electrophysiological and 
behavioural evidence for the interconnectivity of key components of their model. They 
also pointed out that while the “emotive” brain i.e. regions of the limbic system 
innervated the Acb, the “cognitive” brain (regions of the frontal lobes) was connected to 
the dorsal striatum and the two regions could filter or gate converging signals to 
determine their influence over downstream regions such as the GP. While Mogenson 
and colleagues demonstrated that the Acb was involved in the control of locomotor 
responses via its connections to the GP, and pointed out that locomotion is a 
prerequisite to more complex behaviours, there was no functional evidence for the role 
of the Acb in motivated behaviours e.g. feeding, agonistic responses etc (Mogenson et 
al., 1980). These authors noted that Judson Herrick (1926) had suggested that the Acb 
could be involved in both locomotor and “facial reflexes involved in feeding” (Herrick, 
1926 in Mogenson et al., 1980).  
 
Section summary 
A large number of regions in the brain from cortical structures to the brainstem have 
been implicated in the control of food motivated behaviour. Advances in techniques in 
the 1970s to identify anatomical connections between regions of the brain lead 
Mogenson and colleagues to propose a model that included the Acb as an interface 
between motivation and action because of its connectivity with limbic and motor 
regions. While evidence for the role of the Acb in mediating reward and reward related 
actions was emerging it was becoming increasingly obvious that it was not a 
homogenous structure (see below) and that its position within circuits that might 
modulate motivation was determined by regional variations in afferents and efferents. 
Before the role of the Acb in motivation is further discussed, using feeding as a model, 
the anatomy and position of the Acb in distributed macrocircuits will first be described. 
 
Anatomy of the Acb 
The striatum was first suggested to be a unified complex consisting of dorsal and 
ventral divisions by Heimer and Wilson (1975). The term “ventral striatum” was put 
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forward by these authors to denote the area encompassing the Acb and olfactory 
tubercles (Heimer and Wilson, 1975). Broadly speaking the Acb resembles the rest of 
the striatum in terms of cytoarchitecture, subcortical connections and local 
neurotransmitters (Meredith et al., 1992) but a unique combination of afferents and 
efferents of this ventral portion distinguish it from the rest of the striatum. Furthermore, 
although the Acb was originally viewed as a unitary structure both anatomically and 
functionally, it became evident that there were distinct regional differences in neuronal 
connections of the Acb, particularly in their relationship to the extended amygdala and 
LH (Groenewegen and Russchen, 1984).  
 
Core and shell subdivisions 
With advances in neuroanatomical methodology it was suggested that the Acb can be 
divided into at least two distinct subregions, the “core” (AcbC) and “shell” (AcbSh) 
(Zaborszky et al., 1985). The AcbC and AcbSh differ in terms of their histochemistry 
(Voorn et al., 1989, Jongen-Relo et al., 1993, Jongen-Relo et al., 1994), cytoarchitecture 
(Meredith et al., 1989, Meredith et al., 1992, Meredith et al., 1993, Wright et al., 1996) 
and differences in the hodology of projections to and from these regions (Zaborszky et 
al., 1985, Heimer et al., 1991b, Wright and Groenewegen, 1995, Wright and 
Groenewegen, 1996, Groenewegen et al., 1999b, Brog et al., 1993). The AcbC and 
AcbSh can also be dissociated on the basis of metabolic responses (Pontieri et al., 1994, 
Orzi et al., 1996, Pontieri et al., 1998), patterns of neurotransmitter release (Deutch and 
Cameron, 1992, Pontieri et al., 1995, Jones et al., 1996, Ladurelle et al., 1994, Sorg et 
al., 1995) and gene expression (Beck and Fibiger, 1995, Dilts et al., 1993) (Chergui et 
al., 1996) following a range of stimuli. 
 
The AcbC consists of the tissue that surrounds the anterior commissure that is, in turn, 
enveloped in an L-shaped band of tissue, the AcbSh, along its ventral and medial 
aspects and laterally in caudal regions. There are transitional zones of organisation 
between the alleged subregions and no clearly defined boundaries exist (Zahm, 1999). 
A third region where AcbC and AcbSh cannot be clearly distinguished, termed the 
‘rostral pole’, has also been proposed (Zahm and Brog, 1992, Zahm and Heimer, 1993) 
but has only been identified in rats (Meredith et al., 1996). In contrast homologous 
divisions between AcbC and AcbSh subregions have been clearly identified in non-
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human primates and in humans (Meredith et al., 1996, Voorn et al., 1994, Voorn et al., 
1996, Haber and McFarland, 1999, Prensa et al., 2003). In addition to the gross 
distinguishable subregions, complex patterns of compartmentalisation exist within each 
region (Meredith et al., 1989). 
Structural characteristics of the AcbSh 
Evidence has accumulated that the AcbSh is the most heterogeneous area of the 
striatum in terms of its neurochemistry (Voorn 2004), synaptic wiring and morphology 
of its neurons (Meredith et al., 1992) and complexity of compartmental organisation 
(Hiroi, 1995, Herkenham et al., 1984). Some authors suggest that this region can be 
further split into at least three subterritories or domains: the caudal dorsomedial shell 
(sometimes referred to as the “septal pole” or “cone” region ), the rostral shell and the 
lateral shell (Zahm and Brog, 1992). It has also been suggested that the AcbSh is not a 
unitary region of the Acb but rather a collection of segregated neuronal “ensembles” 
(Pennartz et al., 1994, O'Donnell et al., 1999, O'Donnell, 2003). Some authors believe 
that the caudal medial portion of the shell is a transitional division of the extended 
amygdala while the core is an integral part of the basal ganglia (Meredith, 1999, Alheid 
and Heimer, 1988, Heimer et al., 1991a, Meredith and Totterdell, 1999). 
 
Although the way in which the Acb is placed within the networks of neurons and 
circuits that can control behavioural output is critical to understanding its role it is also 
important to take into account the internal workings of this structure. It is has been 
recognised for over a decade that “segregated territories” within the Acb receive 
multiple converging inputs and could differentially activate output neurons depending 
on which subset of neuronal substrates and transmitters are in play (Meredith, 1999). 
This is particularly important given the focus on GABA receptors because their function 
in the Acb may depend on their local interaction with other neurotransmitter systems. 
 
Medium spiny projection neurons 
The large majority of Acb neurons, up to 98% in the rodent brain, (Rymar et al., 2004) 
are GABAergic and >90% of these are medium spiny neurons (MSNs) that constitute 
the projections to extrinsic targets (Meredith et al., 1993, Meredith, 1999). The MSNs in 
the AcbSh are morphologically distinct from those in the dorsal striatum being smaller 
and, in the medial portion of the AcbSh, significantly less spiny (Meredith et al., 1992). 
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These projection neurons (MSNs) are GABAergic and immunoreactive for the calcium 
binding protein calbindin D28K (CaBP) and predominantly fall into two classes 
(Meredith et al., 1993, Zahm and Heimer, 1993, Hussain and Totterdell, 1994, Zahm 
and Brog, 1992) (See Table 1.1). 
The first group are immunoreactive for enkephalin (Groenewegen and Russchen, 1984, 
Graybiel, 1984, Graybiel and Chesselet, 1984) and the second a combination of 
dynorphin and substance P (Christensson-Nylander et al., 1986, Fallon and Leslie, 
1986, Gerfen and Young, 1988, Van Bockstaele et al., 1994, Zahm and Heimer, 1988, 
Pickel et al., 1988). Cocaine- and amphetamine-regulated transcript (CART) peptide 
immunoreactivity is also localised to GABAergic, substance P/dynorphin containing 
MSNs and these subtypes are denser in the rostral shell than the caudal region (Smith et 
al., 1997, Smith et al., 1999, Dallvechia-Adams et al., 2002, Hubert and Kuhar, 2006). 
 
Both types of projection neurons are immunoreactive for neurokinin and neurotensin 
(Zahm and Heimer, 1988, Martin et al., 1991, Ikemoto et al., 1995, Delle Donne et al., 
1996). MSNs in the Acb are organized in clusters (Berendse et al., 1992b, Heimer et al., 
1997). Axon collaterals from MSNs repeatedly synapse onto neighbouring MSNs 
within the AcbSh and these connections are mediated by GABAA receptors (Chang and 
Kitai, 1985, O'Donnell and Grace, 1993, Taverna et al., 2004). It has been hypothesised 
that “lateral inhibition” between MSNs may provide a fast mechanism for selecting 
neuronal ensembles competitively involved in processing the heterogeneous flows of 
information” from brain regions that converge in the Acb (Taverna et al., 2004). 
 
GABAergic interneurons 
2-3% of all GABAergic neurons are interneurons (Rymar et al., 2004). GABAergic 
interneurons can be further divided into at least 3 subtypes; 1) parvalbumin positive 2) 
calretinin positive and 3) somatostatin (SS) / neuropeptide Y (NPY) / nitrous oxide 
(NO) positive populations (Hussain et al., 1996, Meredith, 1999) (Hidaka and 
Totterdell, 2001, French et al., 2005). Calretinin interneurons are densest in the medial 
AcbSh (Hiroi, 1995, Sadikot et al., 1996). Regionally parvalbumin interneurons are less 
dense in the medial and particularly caudal medial shell (Sadikot et al., 1996, Bennett 
and Bolam, 1994). Some axonal processes from interneurons synapse onto other 
interneurons and MSNs but SS/NPY/NOS positive interneurons rarely synapse onto 
MSNs or other interneurons but they do innervate each other (Meredith, 1999). 
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Cholinergic interneurons 
The cholinergic interneurons account for 1-2% of all neurons in the Acb (Phelps and 
Vaughn, 1986). Cholinergic interneurons are immunoreactive for a combination of 
choline acetyltransferase (ChaT), acetylcholine (Ach) and acetylcholinesterase (ACHE) 
(Graybiel and Ragsdale, 1978, Herkenham and Pert, 1981, Herkenham et al., 1984, 
Gerfen, 1988, Phelps and Vaughn, 1986). Cholinergic interneurons are densest in the 
caudal medial shell, three times less so in core and five times less in the rostral pole 
region (Meredith et al., 1989). Cholinergic interneurons synapse onto GABAergic 
interneurons and extend axon collaterals to innervate other cholinergic interneurons and 
they rarely receive inputs from MSN axon collaterals (Meredith and Chang, 1994). 
 
Table 1.1. Principal neurochemical and receptor phenotypes of projection and 
local circuit neurons in the nucleus accumbens (after Meredith, 1999). 
Abbreviations: ChaT, choline acetyltransferase; D1/D2/D3, dopamine receptor 
subtypes 1, 2 and 3; GABA, γ-aminobutyric acid; GAD, glutamate decarboxylase; 
NADPH, nicotinamide adenine dinucleotide phosphate; NMDA, N-methyl-D-
aspartate; NOS, nitrous oxide synthase, 5-HT2a, serotonin 2a receptor. 
GABA receptors in the AcbSh 
GABAA receptors containing the subunits α2, α4, β3 and δ are located postsynaptically 
on the dendrites of the MSNs while receptors containing the α1, β2 and γ2 subunits are 
mostly restricted to the interneurons (Schwarzer et al., 2001). GABAB receptors are 
found presynaptically either as auto- or heterorecptors, they are sparse postsynaptically 
but most common extrasynaptically (Galvan et al., 2006, Bettler and Tiao, 2006). 
Projection neurons Local circuit neurons 
Medium spiny neurons ChAT Parvalbumin Calretinin NOS 
GABA GABA Acteylcholine GABA GABA NADPH diaphorase 
Enkephalin Dynorphin Acetylcholinesterase GAD GAD GABA 
Preproenkephalin Substance P D1 receptor   GAD 
D1 receptor Preprotachykinin D2 receptor   Somatostatin 
D2 receptor D1 receptor    Neuropeptide Y 
D3 receptor  D2 receptor    Acetylcholinesterase 
5-HT2a D3 receptor    NMDA subunit R1 
 5-HT2a    Calbindin D28k 
Not specific to MSN type     
Calbindin D28k     
NeurokininB     
Neurotensin     
Adenosine 2A receptor     
NMDA receptor subunit R1     
-opioid receptor     
-opioid receptor     
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Broadly speaking the postsynaptic location of GABAA receptors is consistent with the 
current view that they mediate fast phasic inhibition and because the GABAB receptors 
are mostly extrasynaptic they are thought to mediate slow long term inhibition, while 
presynaptic GABAB receptors inhibit neurotransmitter release (Otis and Mody, 1992, 
Bettler and Tiao, 2006, Bowery and Enna, 2000, Mody et al., 1994, Mody, 2001). It has 
been suggested that connections between MSN axon collaterals are mediated by 
GABAA receptors (Taverna et al., 2004). The location of GABAA and GABAB 
receptors is depicted in Fig. 1.2. 
 
 
Figure 1.2. Summary figure of the localisation of GABA receptors (and 
transporters) in the striatum. The schematic shows exemplary glutamate and 
GABA terminals that form axo-dendritic synapses. ?GABAA receptors, 
?GABAB receptors, ➀GABA transporter 1, ➂GABA transporter 3. (copied from 
(Galvan et al., 2006) 
 
Characteristics of GABAA and GABAB receptors  
Separate A and B GABA receptors were originally classified on the basis of sensitivity 
to bicuculline and baclofen (Hill and Bowery, 1981). The ionotropic GABAA receptors 
are ligand gated chloride channels formed by five subunits (Nayeem et al., 1994, 
Macdonald and Olsen, 1994). The subunits α1-6, β1-4, γ1-3, ρ1-3, δ, ε, θ, π have so far 
been identified (Galvan et al., 2006) and the most common stoichiometry is two α, two 
β and one γ subunit (Sieghart, 1995, Barnard et al., 1998, Sieghart and Sperk, 2002) 
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(See fig 1.3). The different combinations of subunits confer different pharmacology and 
physiology and there is regional heterogeneity in their distribution throughout the brain 
(Sieghart, 1992, Pirker et al., 2000, Martin and Olsen, 2000, Johnston, 1996). GABAA 
receptors mediate the fast hyperpolarising actions of GABA (Martin and Olsen, 2000). 
GABAA receptors in the Acb are found postsynaptically on MSNs and on GABAergic 
interneurons at both GABAergic and non-GABAergic synapses (Fujiyama et al., 2000, 
Galvan et al., 2006). 
 
Figure 1.3. Schematic drawing of the GABAA ligand-gated ion channel complex. 
The receptor molecule is formed by five subunit proteins. In this case, two subunits 
are of the α type, two β, and one γ. Globular regions of the protein stick out from 
the membrane on the extracellular side, and the interfaces between these are 
targets for GABA, benzodiazepines and related drugs. Protein domains that span 
the cell membrane are depicted as cylinders. These regions are thought to be 
targets for anaesthetics, neurosteroids, and alcohol. In the middle of the subunits is 
the ion channel pore. (Figure and legend copied from (Lovinger, 2008). 
 
GABAB receptors are G-protein linked metabatropic receptors consisting of two 
subunits, GABABR1 and GABABR2 (Bowery, 1993, Bowery and Enna, 2000). The 
subunits each have seven transmembrane domains and must be co-expressed as 
heteromeric complexes for the formation of a functional receptor (Kaupmann et al., 
1998, Marshall et al., 1999). The heteromeric receptors are associated with both 
potassium and calcium channels (Jones et al., 1998). The GABAB receptor has a unique 
“Venus Fly Trap” mode of activation whereby activation requires conformational 
changes (Calver et al., 2002, Galvez et al., 1999) (See Fig. 1.4). These receptors are 
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found in abundance pre- and extra-synaptically but are less prevalent postsynaptically 
(Galvan et al., 2006). Presynaptically they function as autoreceptors on GABAergic 
neurons and as heteroreceptors on glutamatergic afferents (Galvan et al., 2006). 
 
Figure 1.4. Schematic drawing of the heteromeric GABAB G-protein coupled 
receptor. Lobes 1 (LB1) and 2 (LB2) make up a single protomer in GABAB1 
(orange) and GABAB2 subunits (green). In the inactivated ‘open’ state, the ligand-
binding pocket situated in the GABAB1 extracellular binding domain is open and 
the extracellular and transmembrane domains of subunits are apart. Agonist 
binding to GABAB1 induces ‘closing’ of the ligand-binding pocket and an 
‘activated’ receptor state. This conformational change results in the extracellular 
and transmembrane domains of the subunits coming closer together (yellow 
arrows) and is key in the inception of downstream signalling cascades. (Figure 
copied, and legend modified from (Calver et al., 2002). 
 
 
Other classes of receptors in the AcbSh  
Glutamate AMPA receptors are predominantly located postsynaptically on MSNs 
whereas a higher proportion of NMDA and kainate receptors are located on presynaptic 
axon terminals of hippocampal and cortical afferents as well as on postsynaptic sites 
(Tarazi, 1998). Some NMDA receptors are presynaptic on dopaminergic terminals 
which could provide a site for modulation of DA release by glutamatergic afferents 
(Gracy and Pickel, 1996). D2 receptors are present in enkephalinergic neurons (Le 
Moine and Bloch, 1995), half of the cholinergic interneurons (MacLennan et al., 1994) 
but not in the somatostatin interneurons (Jongen-Relo et al., 1995). D1 receptors are 
more abundant in dynorphinergic neurons and cholinergic interneurons (Jongen-Relo et 
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al., 1995, Le Moine et al., 1991). µ-opioid receptors are the most abundant opioid 
receptor subtype in the Acb and are found postsynaptically in the Acb (Churchill et al., 
1991). A small number of µ-opioid receptors are co-localised with the NMDA receptor 
R1 subunit (Gracy et al., 1997). δ-opioid and κ-opioid receptors are predominantly 
found presynaptically (Svingos, 2001, Svingos et al., 1999b, Svingos et al., 1999a). A 
number of other receptor types in the AcbSh have been identified including cannabinoid 
receptors (Herkenham et al., 1991a, Herkenham et al., 1991b, Herkenham, 1991, 
Herkenham, 1992, Hohmann and Herkenham, 2000, Pickel et al., 2004, Pickel et al., 
2006, Matyas et al., 2007), NPY receptors (Goldberg et al., 1975) (Meredith, 1999, 
Migita et al., 2001), adrenergic receptors (Rommelfanger et al., 2009) and CCK 
receptors (Kombian et al., 2004). 
 
Section summary 
The majority of neurons in the AcbSh are GABAergic and can be split into 2 classes of 
MSNs and three classes of interneurons. In addition there are a small number of 
cholinergic interneurons. Receptors for GABA, glutamate, dopamine, opioids and 
variety of other neurotransmitters are distributed both pre- and postsynaptically on 
MSNs and interneurons. The functional implications of the location and co-localisation 
of the various receptor subtypes both pre and postsynaptically in the AcbSh is discussed 
in detail in a number of reviews (e.g. Meredith, 1999, Meredith and Totterdell, 1999). 
 
Inputs to and outputs from the AcbSh 
As Stratford (2007) points out the AcbSh receives a particularly wide variety of inputs 
from afferent connections originating in cortical and subcortical areas of the brain but 
none of these afferents are exclusively related to the AcbSh (Groenewegen et al., 
1999b). Nevertheless some regions that project to the AcbSh may in reality send only a 
very small number of afferents to the AcbC if any (Brog et al., 1993, Zahm, 1999). In 
some cases the information that reaches the Acb does so via indirect pathways including 
other brain regions that may or may not themselves project directly to this region. In the 
following section I will review what is known about both direct and indirect pathways 
by which the AcbSh is innervated. Characterising the indirect pathways is important 
because it shows the sort of information that reaches the Acb and the level of processing 
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that occurs before it gets there. I will also consider the degree to which afferents to the 
AcbSh overlap and converge, particularly where they do so on the same neurons.  
 
Afferents to AcbSh 
Excitatory amino acid inputs – direct pathways 
The majority of inputs to the AcbSh are coded by excitatory amino acids (EAAs) 
(McGeer et al., 1977, Lopes da Silva et al., 1984, Fuller et al., 1987, Robinson and 
Beart, 1988, Walaas and Fonnum, 1979, Fonnum et al., 1981, Pennartz and Kitai, 1991, 
Albin et al., 1992, Finch et al., 1995). Glutamatergic inputs synapse primarily onto the 
spines of MSNs (Tallaksen-Greene et al., 1992, Sesack and Pickel, 1990, Meredith et 
al., 1990). In other words they bypass local circuit neurons (interneurons). However 
these interneurons are found postsynaptic to the terminal boutons of neurons that may 
also be extrinsic glutamatergic inputs (French and Totterdell, 2004). Although there is 
some evidence that glutamatergic afferents synapse onto interneurons in the dorsal 
striatum (Vuillet et al., 1989, Dimova et al., 1993, Lapper and Bolam, 1992, Lapper et 
al., 1992) very little is known about this relationship in the Acb. In the caudomedial 
shell afferent and intrinsic synapses are mixed from distal to proximal locations 
(Meredith and Totterdell, 1999) and proximal inputs can selectively gate distal signals 
(Mogenson et al., 1980, Pennartz et al., 1994). 
 
The AcbSh receives glutamatergic afferents from the prefrontal cortex (PFC) (Berendse 
et al., 1992a, Sesack et al., 1989), entorhinal cortex (Finch et al., 1995, Krayniak et al., 
1981), CA1 region and subiculum of the hippocampus (Groenewegen et al., 1987, 
Kelley and Domesick, 1982, Brog et al., 1993), basal amygdaloid complex (Wright et 
al., 1996), midline, intralaminar and paratenial nucleus of the thalamus (Brog et al., 
1993, Berendse et al., 1988, Berendse and Groenewegen, 1990, Robinson and Beart, 
1988, Vertes and Hoover, 2008). 
 
Projections from regions within the PFC are topographically arranged with respect to 
specific compartments within the AcbSh and this arrangement appears to be determined 
by layer of the PFC from which the projections originate (Berendse et al., 1992a, 
Wright and Groenewegen, 1995). The medial entorhinal cortex projects to the AcbSh 
and the lateral region to the AcbC although there is some cross over (Totterdell and 
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Meredith, 1997). The projections of the hippocampus target predominantly the medial 
ventral and rostral regions of the AcbSh (Brog et al., 1993, Groenewegen et al., 1987). 
Different nuclei of the basal amygdaloid complex project to specific regions of the 
AcbSh (Wright et al., 1996). For example the caudal basolateral amygdala (BLA) 
projects to caudal regions of the AcbSh but there do not appear to be direct projections 
from the central nucleus of the amygdala (CeA) (Brog et al., 1993, Phillipson and 
Griffiths, 1985, Wright et al., 1996). Projections that arise from either midline or 
intralaminar thalamic nuclei terminate in distinct regions of the AcbSh (details in 
Groenewegen 1999)(Brog et al., 1993, Berendse and Groenewegen, 1990) 
 
Excitatory amino acid inputs – indirect pathways 
There are many interconnections between cortical, thalamic, and limbic inputs of the 
Acb which are often reciprocal (Groenewegen et al., 1999b). Taste and visceral 
information can reach the AcbSh via indirect pathways that terminate in glutamatergic 
inputs to this region (Kelley et al., 2005b). The agranular insular cortex, which receives 
gustatory and visceral sensory input from brainstem regions, has dense projections to 
the infralimbic and prelimbic portions of the PFC and hence influences the AcbSh 
(Berendse et al., 1992a, Hurley et al., 1991, Shi and Cassell, 1998, Vertes, 2004). The 
gustatory cortex also connects via the parabrachial nucleus (PB) of the pons to the 
ventroposterior thalamus which projects to the AcbSh (Ricardo and Koh, 1978, Saper, 
1982) and via the BLA to the AcbSh (McDonald and Jackson, 1987). However the BLA 
also projects to the LH and hence influences LH connections back to the AcbSh 
(Petrovich et al., 2001). Homeostatic signalling between the LH and the arcuate nucleus 
(Arc) reaches the AcbSh via a link between the LH and midline thalamic nuclei (Wright 
and Groenewegen, 1996, Berendse et al., 1988, Berendse and Groenewegen, 1990). 
 
The dorsal region of the paraventricular thalamic nucleus  (PVT) from which the 
majority of projections to the AcbSh emanate is heavily innervated by neurons from the 
LH, dorsomedial hypothalamus (DMH), Arc and dorsal raphe nucleus (Guy et al., 1981, 
Parsons et al., 2006, Kirouac et al., 2005, Otake, 2005, Freedman and Cassell, 1994). 
This part of the PVT is also innervated by projections from infralimbic and prelimbic 
cortices, amygdala, suprachiasmatic nucleus, median raphe nucleus, PB, LC, PAG and 
nucleus of the solitary tract (NTS) (Krout and Loewy, 2000a, Krout and Loewy, 2000b, 
Krout et al., 2001, Krout et al., 2002, Risold et al., 1997, Chen and Su, 1990). Thus the 
33 
PVT acts as a relay to the AcbSh for unprocessed and highly processed information 
about energy balance, visceral signals, arousal and circadian status (Stratford, 2007). 
 
Inhibitory amino acid inputs 
While the majority of GABAergic inputs to Acb MSNs are from interneurons and local 
axon collaterals (Meredith, 1999, Taverna et al., 2004) the VP sends reciprocal 
GABAergic afferents to both the AcbC and AcbSh (Churchill and Kalivas, 1994). There 
are also GABAergic projections from the VTA to Acb (Van Bockstaele and Pickel, 
1995) but these authors do not indicate where in the Acb these neurons terminate. The 
regions of the VP and VTA that innervate the Acb are themselves reciprocally 
connected (Haber et al., 1985). GABAergic inputs from axon collaterals of MSNs at 
proximal sites is responsible for lateral inhibition within the AcbSh (Meredith, 1999). 
 
Dopaminergic and cholecystokinin containing inputs 
VTA (A10) dopaminergic neurons project to the entire striatum but primarily to the 
medial and ventral AcbSh however cell clusters receive hardly any dopaminergic fibres 
whereas the ‘cone-shaped’ area is densely innervated (Voorn et al., 1986). Another 
cluster of A10 dopaminergic neurons from the raphe nucleus in the brainstem also 
reaches the AcbSh (Ikemoto, 2007) The A8 group of dopaminergic neurons from the 
retrorubral field (RRF) project to lateral regions of the AcbSh but, in contrast to the 
AcbC region, the AcbSh does not receive dopaminergic inputs from the SN (A9) (Brog 
et al., 1993, Beckstead et al., 1979, Jimenez-Castellanos and Graybiel, 1987, Gerfen et 
al., 1987, Zahm, 1992). CCK is co-expressed in some VTA dopaminergic neurons 
(Lanca et al., 1998) which terminate in the medial AcbSh (Zaborszky et al., 1983, 
Zaborszky et al., 1985) (Lanca et al., 1998). CCK immunoreactive neurons from the 
SNc may also terminate in the AcbSh (Zaborszky et al., 1983, Zaborszky et al., 1985) 
although these neurons primarily innervate the AcbC (Lanca et al., 1998). Indirect 
pathways that terminate in dopaminergic inputs to the AcbSh include a connection from 
the NTS via a pathway between the PB to the CeA then to the VTA which innervates 
the AcbSh (McDonald, 1991). The CeA sends GABAergic afferents to the VTA, SN, 
RRF and hence may influence dopamine efflux in the AcbSh via the projections from 
these regions (Wallace et al., 1992, Phillipson and Griffiths, 1985, Fudge and Haber, 
2000, Kim et al., 2004, Ahn and Phillips, 2002, Will et al., 2004). 
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Peptidergic inputs 
Direct projections from the LH to the AcbSh have been identified (Baldo et al., 2003, 
Peyron et al., 1998). More than 50% of CART immunoreactive neurons from the 
arcuate and perifornical lateral hypothalamus project directly to the AcbSh (Yang et al., 
2005) as do melanin-concentrating hormone (MCH) containing fibres from the LH 
(Peyron et al., 1998).  Orexin is exclusively synthesised by neurons in the LH and the 
AcbSh has orexin neurons suggesting that there are orexinergic projections from the LH 
to the Acb (Sakurai et al., 1998, Nambu et al., 1999, Trivedi et al., 1998, Marcus et al., 
2001, Cluderay et al., 2002). There are a small number of projections from the VMH to 
the Acb (Canteras et al., 1994). The PAG sends enkephalin immunoreactive fibres to 
AcbSh (Li et al., 1990). The majority of opioid input to the AcbSh is from local axon 
collaterals of enkephalin and dynorphin immunoreactive MSNs (Herkenham et al., 
1984). 
 
Noradrenergic inputs 
The AcbSh receives a very small number of noradrenergic inputs from the LC and the 
A1 region of the caudal ventrolateral medulla (CVLM) but robust innervation from the 
noradrenergic cell group (A2) in the NTS (Ricardo and Koh, 1978, Brog et al., 1993, 
Berridge et al., 1997, Delfs et al., 1998). There are however other projections from the 
LC that are not immunoreactive for noradrenaline that innervate the AcbSh (Brog et al., 
1993, Delfs et al., 1998).  The rostral NTS also influences the AcbSh via the PB nucleus 
(Brog et al., 1993). Cell groups in the NTS and CVLM process gustatory signals and 
input from chemo and baroreceptors in the nervous system (Delfs et al., 1998). 
 
Serotonergic inputs 
The AcbSh receives dense serotonergic inputs from the median raphe nucleus 
(Rodriguez et al., 1999, Van Bockstaele and Pickel, 1993, Moore et al., 1978, Azmitia 
and Segal, 1978, Hensler et al., 1994, Vertes, 1991, Brog et al., 1993, Stratford and 
Wirtshafter, 1990, Compan et al., 1996). The rostral raphe nucleus receives inputs from 
the LH (Date et al., 1999) and thus may represent an indirect pathway via which LH 
mediates arousal and behavioural state signals to the AcbSh (Stratford, 2007). 
 
Convergence of inputs  
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Afferents from the ventromedial PFC and BLA overlap and often synapse onto the 
same neurons but those from the PVT terminate on a different group of cells (Johnson 
et al., 1994, Wright and Groenewegen, 1995). Afferents from the ventral subiculum of 
the hippocampus, PFC and BLA terminate on the same output neurons of the AcbSh 
(French and Totterdell, 2002, O'Donnell and Grace, 1995, Groenewegen et al., 1999a, 
Groenewegen et al., 1999b, French and Totterdell, 2003, Johnson et al., 1994) 
(Totterdell and Smith, 1989, Kelley et al., 1982, Wright and Groenewegen, 1995, 
Wright and Groenewegen, 1996, Fudge et al., 2002). Acb MSNs are usually 
physiologically “silent” in a “down state” characterised by a very hyperpolarised 
membrane potential and will only fire when in a relatively depolarised “up state” 
(Groenewegen et al., 1999b, O'Donnell and Grace, 1995). It has been suggested that 
excitatory inputs from the hippocampus gate the upstate (O'Donnell and Grace, 1995, 
Mulder et al., 1998, Groenewegen et al., 1999a) but activation of the PFC alone has 
been shown to sustain these up states also (Gruber and O'Donnell, 2009). 
 
Simultaneous excitation from multiple sources may be necessary to depolarise 
projection neurons enough to influence AcbSh output (Pennartz et al., 1992) (O'Donnell 
and Grace, 1995, O'Donnell et al., 1999, Goto and Grace, 2008). Dopaminergic inputs 
also terminate in apposition to convergent glutamatergic inputs on MSNs (Meredith, 
1999, Meredith and Totterdell, 1999). Dopaminergic inputs to AcbSh projection 
neurons have been shown to inhibit GABAergic neuronal activity at the D2 receptor 
and potentiate glutamatergic influence at the D1 receptor (West and Grace, 2002, West 
et al., 2003) thus modulating the influence and integration of afferent inputs to the 
region (Sesack and Grace, 2009). 
 
Section summary and functional implications 
Afferents from cortical and subcortical regions that have previously been implicated in 
food motivated behaviours terminate in the AcbSh. Information reaching the AcbSh via 
such connections from the neocortex, allocortex and thalamus will already have been 
highly processed (Stratford, 2007). There are also multiple inputs from areas of the 
brain that monitor homeostatic and energy balance, taste and visceral functions and 
levels of arousal (Stratford, 2007).  It has recently been suggested that cortical inputs 
promote goal directed behaviours, the ventral subiculum adds spatial and contextual 
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information, the PFC contributes executive control signals with regards to task 
switching and response inhibition and the BLA provides information about conditioned 
associations and affective value (Sesack and Grace, 2009). Stratford (2007) postulates 
that the major innervation from the thalamus might be the most important excitatory 
input for the control of intake and consummatory responses (Stratford, 2007). The 
thalamostriatal afferents might also direct attention to “behaviourally significant events” 
(Smith et al., 2004).  
 
Efferents from AcbSh to other regions of the brain 
While the AcbC and AcbSh broadly receive the same afferents, albeit topographically 
arranged within the various compartments, there are striking differences in the efferent 
projections from AcbC and AcbSh subregions (Heimer et al., 1991b, Zahm and Heimer, 
1990, Zahm and Brog, 1992, Zahm and Heimer, 1993). The Acb as a whole projects 
predominantly to midbrain mesotelencephalic dopamine neurons (Zahm and Brog, 
1992). However the AcbC connects to classic basal ganglia output targets while the 
AcbSh projects predominantly to limbic structures and midbrain dopamine neurons 
(Maldonadoirizarry et al., 1995). The projection neurons of the Acb are GABAergic but 
can be separated into two major classes depending on co-expression of substance-P, 
enkephalin and D1 or D2 receptors (See Table 1.1). For the majority of locations that 
receive AcbSh efferents no data is available yet as to which subtype of GABAergic 
MSNs are involved. 
 
Efferent projections from the AcbSh terminate primarily in the LH and preoptic area, 
the VTA, the VP and the extended amygdala with less dense projections to the bed 
nucleus of the stria terminalis (BNST), substantia innominata, substantia nigra pars 
compacta (SNc) and reticulata (SNr), RRF, the LC, the mesencephalic and mesopontine 
tegmentum, the raphe nucleus and the PAG (Nauta et al., 1978, Mogenson et al., 1983, 
Groenewegen and Russchen, 1984, Rye et al., 1987, Zahm et al., 1987, Zahm and 
Heimer, 1990, Haber et al., 1990, Heimer et al., 1991b, Berendse et al., 1992b, Usuda et 
al., 1998, Zahm, 2000).  The density of projections appear to diminish with increasing 
distance from their origin to the most distal structures (Zahm, 2000). 
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There appears to be a large degree of mediolateral and rostrocaudal topographical 
organisation of AcbSh outputs (Ikemoto, 2007, Usuda et al., 1998, Mogenson et al., 
1983). Projections from ventromedial portions of the AcbSh innervate the 
posteromedial VTA and lateral VTA, and from the ventrolateral AcbSh innervate the 
lateral VTA and SNc (Berendse et al., 1992b, Heimer et al., 1991b, Usuda et al., 1998, 
Zhou et al., 2003). The medial AcbSh projects to the ventromedial VP (Zahm and 
Heimer, 1990, Heimer et al., 1991b, Usuda et al., 1998) while the lateral AcbSh 
innervates the ventrolateral VP (Usuda et al., 1998). VP neurons that receive inputs 
from the AcbSh project to the LH suggesting an indirect pathway through which 
activity in the AcbSh can influence the LH (Groenewegen et al., 1993). The large 
majority of neurons that project to the VTA from the AcbSh are immunoreactive for D1 
receptors and substance P whereas projections to the VP primarily express D2 receptors 
and enkephalin but also D1 and substance P (Lu et al., 1997, Lu et al., 1998, Robertson 
and Jian, 1995). 
 
Some of the brain regions that contain terminal fields of AcbSh efferents only receive 
inputs from restricted origins in this structure. Only the rostral ventromedial AcbSh 
projects to the paramedian raphe nucleus, the caudal dorsomedial AcbSh uniquely 
projects to the BNST, the caudal ventromedial AcbSh uniquely projects to the LC and 
the caudal ventrolateral shell uniquely projects to the ventrolateral part of the VP 
(Usuda et al., 1998). 
 
Section summary and functional implications 
The AcbSh primarily innervates the LH and lateral preoptic area the VTA and the VP. It 
has access to thalamo-prefrontal and hypothalamic circuits via the VP. The AcbSh 
efferents do not reach brainstem or spinal chord motor pattern generators but do 
predominantly terminate in the basal forebrain, diencephalon and rostral brainstem in 
regions that can more directly contribute to the initiation and motor control of adaptive 
behaviours (Zahm, 2000). Although it is difficult to define clear direct and indirect 
pathways from the AcbSh that could be involved in behavioural activation and response 
inhibition because of the unusual variety of connections compared to classic basal 
ganglia regions (Sesack and Grace, 2009) some theories have been recently proposed.  
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First of all these pathways might be relayed through the VP with the direct pathway 
involving pallidothalamic connections and the indirect pathway reaching the 
subthalamic nucleus (Nicola et al., 2000, O'Donnell et al., 1997). Secondly the LH and 
regions in the basal forebrain may directly control some motor functions and direct 
innervation from the AcbSh would constitute the inhibitory pathway while indirect 
connections via the VP cause disinhibition (Nicola et al., 2000). Finally the VTA could 
be the relay with the direct pathway connecting via this region to the thalamus and the 
indirect pathway involving an extra set of synapses with the VP and then the VTA 
which would require GABAergic projections to the thalamus (Sesack and Grace, 2009). 
The pattern of involvement of D1 and D2 receptors in AcbSh efferent projections to the 
VP and VTA add support to such models (Sesack and Grace, 2009). 
 
Connections between AcbSh and AcbC subregions 
The AcbSh is robustly connected to the AcbC via a multisynaptic indirect feed-forward, 
striatopallido-thalamocortico-striatal pathway that terminates in the AcbC (Zahm, 1999, 
Zahm, 2000). While the AcbSh sends efferents to the VP this region in turn projects to 
the mediodorsal nucleus of the thalamus which innervates both the dorsal prelimbic and 
agranular insular cortex (Groenewegen, 1988, Zahm et al., 1996, O'Donnell et al., 1997, 
Groenewegen et al., 1993). These cortical regions send dense projections to the AcbC 
and the caudate putamen (Wright and Groenewegen, 1996, Sesack et al., 1989, 
Berendse et al., 1992a). The AcbSh is also strongly connected to the AcbC via its 
connection to the VTA (and to some extent the SNc), which in turn send massive 
projections to the AcbC (Haber et al., 2000, Otake and Nakamura, 2000). It has recently 
been suggested that the two subregions are reciprocally connected by a complex series 
of ascending spirals (Haber et al., 2000). 
 
Heimer et al., (1991) suggested that fibres within the Acb cross AcbC/AcbSh 
boundaries. It has recently been demonstrated that the AcbC and AcbSh are directly and 
reciprocally connected by axons from both MSNs and interneurons with specific 
topographic distribution shown in Fig. 1.5 (van Dongen et al., 2005). These authors 
suggest that “GABA may be a major neurotransmitter in inter-Acb communication to 
control behavioural selection”.  
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Figure 1.5. Schematic representation of the intra-accumbens projection patterns. 
Thick lines indicate strong projections and thinner lines moderate (straight) to 
weak (dashed) projections. There appears to exist a predominant caudal to rostral 
stream originating in the caudal core, reaching the rostral core and, subsequently, 
the rostral pole and rostral shell. Rostral and caudal shells are reciprocally 
connected. Several other projections are indicated between the rostral pole and 
different subareas in shell and core as well as between these subareas. These 
projections are in general weaker. Abbreviations: M, medial; L, lateral. (Copied 
from (van Dongen et al., 2005). 
 
 
Anatomical subregions of the Acb are functionally dissociable 
The evidence discussed so far points to specific functional specialisation of the AcbC 
and AcbSh and associated circuits. Since the AcbC and AcbSh subregions were 
identified the behavioural responses elicited by comparable manipulations have been 
extensively studied and, despite 1) the multiplicity of the levels of internal organisation, 
2) the poorly delineated transitional areas between the two and 3) the presence of 
pathways by which they can directly influence each other there is ample evidence that 
these regions play distinct and totally dissociable roles in some aspects of the integrated 
output of the Acb. 
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It has been suggested that the Acb is essential for “adaptive” responding whereby an 
organism integrates external information with internal cues to produce behaviours 
consistent with survival in a changeable environment (Zahm, 2000). In general it is 
thought that the AcbC is predominantly involved in the learning and execution of 
voluntary motor functions whereas the AcbSh plays a role in affective and motivational 
aspects of the behavioural output (Kelley, 2004). It has been suggested that the AcbC is 
critical for mediating the impact of external cues that an animal has learnt are relevant 
to both stimulate and guide actions (Cardinal et al., 2002a). In contrast the AcbSh is 
critical to the modulation of the expression of unconditioned behaviours including 
feeding (Kelley, 1999a, Cardinal et al., 2002a). 
 
The AcbSh, however, also appears to invigorate some types of learned behaviours that 
are coordinated through the AcbC (Voorn et al., 2004). The AcbC and AcbSh are part 
of interacting and intimately linked neuronal networks (Corbit et al., 2001) (Parkinson 
et al., 1999, van Dongen et al., 2005) and are directly linked to each other (van Dongen 
et al., 2005). It is possible that any true functional differentiation between the regions is 
only apparent in the context of their divergent connections to other structures with 
which they form anatomical macrocircuits that control specific processes. Ultimately 
Voorn et al. (2004) suggest that what really distinguishes the AcbSh from the AcbC is 
its unique role in the modulation of innate behaviours such as food intake. 
 
A role has been demonstrated specifically for the AcbSh in a variety of “innate” 
unconditioned behaviours such as responses to availability of sexual reward  (Moncho-
Bogani et al., 2005, Jenkins and Becker, 2001), defensive responses (Reynolds and 
Berridge, 2001, Reynolds and Berridge, 2002, Reynolds and Berridge, 2003, Beck and 
Fibiger, 1995, Reynolds and Berridge, 2008, Saul'skaya and Marsden, 1998, Inoue et 
al., 1994), maternal responses to pups (Li and Fleming, 2003, Parada et al., 2008, 
Olazabal and Young, 2006) prey killing (Albert et al., 1982, Albert et al., 1984, Albert 
et al., 1985), pair bonding (Aragona et al., 2006, Aragona and Wang, 2007) and to drugs 
of abuse or alcohol (Pontieri et al., 1994, Pontieri et al., 1995, Sorg et al., 1995, Orzi et 
al., 1996, Pontieri et al., 1998, Di Chiara et al., 1999, Ito et al., 2000, Cadoni and Di 
Chiara, 2000, Filip and Siwanowicz, 2001, Di Ciano and Everitt, 2001, Bassareo et al., 
2003, Ito et al., 2004, Cadoni et al., 2005, Lecca et al., 2006, Lecca et al., 2007) but far 
the most widely studied is its role in short-term intake of freely available food. 
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Figure 1.6. A schematic view of brain circuitry involved in food intake and 
motivation. Pathways coded by glutamate as the main neurotransmitter are shown 
in blue, while dopamine pathways are shown in red. Tan lines arising from the 
lateral hypothalamus (LH) indicate widespread direct and indirect projections 
from hypothalamus to neocortex and forebrain limbic structures. Arrows in black 
indicate projections that are coded by GABA (from striatal regions and the central 
nucleus of the amygdala), or that are unknown. Primary gustatory inputs arise 
from the nucleus of the solitary tract (NTS) and the parabrachial nucleus (PB), 
prior to converging on cortical and thalamic regions involved in affect, memory, 
and behavioural inhibition. Other abbreviations: Acb, nucleus accumbens; MD, 
mediodorsal; PV, paraventricular; BLA, basolateral amygdala; CEA, central 
nucleus of amygdala; PVN, paraventricular nucleus of hypothalamus; DMH, 
dorsomedial hypothalamus; VMH; ventromedial nucleus of hypothalamus. 
(Copied from Kelley et al., 2005b). 
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The AcbSh as part of a complex circuit subserving feeding 
While the preceding sections have considered the individual afferents and efferents of 
the AcbSh and some indirect pathways between the various structures it still remains to 
consider how the Acb is placed within functional macrocircuits known to subserve 
motivated behaviour. While a vast number of schemes have been published I will 
concentrate here on a scheme produced by Kelley and colleagues on the basis of their 
extensive exploration of the functions of this structure. Fig. 1.6 depicts many of the 
direct and indirect connections to and from the AcbSh that have been discussed so far. 
This model will be used throughout the remainder of the thesis when exploring how the 
AcbSh might exert influence over other regions in the circuit that subserve motivation.  
 
Evidence that the Acb as a whole is involved in feeding 
Given the possibility that aspects of the LH syndrome could be partially reproduced by 
damage to the nigrostriatal bundle which depleted DA in the striatum it was suggested 
that the nigrostriatal bundle was also involved in feeding, (Marshall, 1974). Systemic 
administration of DA agonists reinstated feeding and drinking in animals with 
nigrostriatal DA bundle lesions that reduced DA in striatum (Ljungberg and Ungerstedt, 
1976, Marshall, 1976). It was also recognised that, like the septum which was involved 
in feeding responses, the Acb contributed descending fibres to the MFB, received 
afferents from the VTA and hypothalamus through the MFB and was connected 
reciprocally to the septum (Lorens et al., 1970). 
 
Lorens (1970) reported that electrolytic lesions of the whole Acb caused a transient 
increase in feeding, no effect on drinking, increased spontaneous activity but did not 
increase responding for food on a conditioned reinforcement or fixed ratio schedule  
(Lorens et al., 1970, Lorens, 1971). In another study Acb lesions caused hyperphagia, 
had no effect on drinking, but did not increase in body weight and the authors 
concluded that the increased intake was due to increased restlessness, agitation and 
hyperactivity (Smith and Holland, 1976). 
 
Selective dopaminergic lesions caused mild hyperphagia for wet mash and dry food 
pellets in an experimental photocell cage but not in the home cage and these authors 
attributed increased intake to an inability to switch behaviours (Koob et al., 1978). 
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While it was consequently shown that feeding increased DA transmission in the Acb 
and hypothalamus (Heffner et al., 1980) dopaminergic lesions of the Acb did not appear 
to affect body weight (Winn and Robbins, 1985). Nevertheless other researchers 
showed that dopaminergic lesions of the Acb caused changes in feeding behaviour after 
locomotor effects had attenuated decreasing the latency to feed, increasing meal length, 
bout size and total intake (Evenden and Carli, 1985) The organisation of feeding 
behaviour was also disrupted by non selective electrolytic lesions of the whole Acb 
(Clifton and Somerville, 1994). 
 
Alternative lines of evidence for the role of the Acb in motivated processes in general 
(and by extension its importance in food motivated behaviour) relate to its response to 
reward and reward related cues. For example animals will self stimulate in the Acb 
(Rolls et al., 1980), neurons in the Acb fire in response to reward and reward related 
cues and novel stimuli (Williams et al., 1993, Rolls, 1994). Animals will also self 
administer a variety of drugs into the Acb including stimulants (Hoebel et al., 1983) 
injections of which induce conditioned place preference (Carr and White, 1983), opiates 
and opioid receptor agonists (Olds, 1982, Goeders et al., 1984), NMDA antagonists 
(Carlezon and Wise, 1996) and cholinergic agonists (Ikemoto et al., 1998). Electrical 
stimulation of the mesolimbic DA pathway induced feeding which was blocked by 
application of a DA antagonist in the Acb (Mogenson and Wu, 1982, Apicella et al., 
1991. Electrical stimulation in the MFB or VTA resulted in an increase in the release of 
DA in the Acb (Nakahara, 1989) and feeding also increased DA turnover in the Acb 
(Heffner et al., 1980). Instrumental responding for food reward and self stimulation in 
the LH also increase DA in the Acb (Hernandez and Hoebel, 1988).  
 
Section summary 
From the late 1970s through to the early 1990s evidence was emerging that the Acb as a 
whole structure is involved in reward related processes, motivation and specifically in 
feeding. These multiple lines of evidence included the behavioural effects of non-
selective and selective lesions, the electrophysiological responses of the region, the 
release of neurotransmitters and the effect of pharmacological agents. However there 
was some conflicting evidence as to the degree to which the Acb was specifically 
involved in feeding. 
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Regulation of free feeding by amino acids in the AcbSh 
Although a role for the Acb (as a unitary structure) in feeding was established by the 
1980s it was not until the mid 1990s that the potential for functional specialisation of 
AcbC and AcbSh subregions in motivated behaviour was investigated. Because a large 
proportion of afferents to the Acb are glutamatergic the behavioural role for excitatory 
amino acid (EAA) receptors in both regions was the focus of these early experiments 
(Kelley and Maldonado-Irizarry, 1995). 
 
Excitatory amino acids in AcbSh and feeding 
 
Intra-AcbC but not AcbSh infusions of an NMDA antagonist have been shown to 
reduce open field activity, exploration of novel objects, psychostimulant induced 
locomotor activity, spatial learning and spatial behaviours directed at procuring food 
(Maldonado-Irizarry and Kelley, 1994, Kelley and Maldonado-Irizarry, 1995, 
Maldonado-Irizarry and Kelley, 1995). NMDA antagonists however have no apparent 
effects on ad libitum feeding in either region (Maldonado-Irizarry and Kelley, 1994, 
Kelley and Maldonado-Irizarry, 1995, Maldonado-Irizarry and Kelley, 1995). 
 
The AMPA receptor was also shown to be involved in spatial learning and the 
expression of spatial behaviour but the pattern of the effects were distinguishable from 
those of the NMDA receptor (Maldonado-Irizarry and Kelley, 1995). Importantly the 
authors reported the incidental observation, made during these studies, that blockade of 
EAA input to AMPA/kainate receptors in the AcbSh but not the AcbC stimulated 
feeding when the animals were returned to the home cage (Maldonadoirizarry and 
Kelley, 1995). They also reported that NMDA lesions of the AcbC resulted in a 
decrease in body weight post operatively whereas lesions of the AcbSh caused an 
increase, suggesting a role for glutamatergic inputs to this region in ingestive behaviour 
(Maldonadoirizarry and Kelley, 1995).  
 
The same group went on to confirm a specific role for AcbSh but not AcbC 
AMPA/kainate receptors in feeding; a variety of antagonists caused rapid onset, robust 
and dose dependent increases in intake of freely available food that was reduced by 
systemic administration of D1 and D2 antagonists but not naloxone suggesting a 
modulatory role for dopamine in the response (Maldonadoirizarry et al., 1995). 
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(Stratford and Kelley, 1997b, Kelley and Swanson, 1997, Stratford et al., 1998, Kelley, 
1999a, Basso and Kelley, 1999). Conversely low doses of AMPA infused into the 
AcbSh reduced deprivation induced feeding and intake induced by a sucrose solution 
(Stratford et al., 1998). The effects of manipulation of AMPA/kainate receptor function 
were specific to food intake not water intake and receptor blockade did not induce non-
specific consummatory responses such as gnawing of non-food objects (Stratford et al., 
1998). 
 
It has since been reported that stimulation of AMPA receptors by infusion of high doses 
of AMPA into the AcbSh can increase feeding in a dose dependent manner although the 
effect is much delayed compared to the rapid onset of feeding responses seen with 
AMPA/kainate antagonists (Echo et al., 2001). Infusion of high doses of NMDA into 
the AcbSh produced a delayed onset increase in feeding that was shorter in duration 
than the AMPA effect, less robust and with an inverted-U-shaped dose response 
function (Echo et al., 2001). These authors suggest that a specific pattern of AcbSh 
activity is required to maintain “normal feeding” and that perturbation in this pattern by 
both significant increases or decreases in glutamatergic transmission can elicit feeding 
(Echo et al., 2001). Stratford (2007) offers the alternative hypothesis that the latency of 
the effect suggests that a high dose causes transmitter depletion or “neuronal fatigue” 
that results in delayed onset but temporary suppression of activity in AcbSh output 
neurons. 
 
Given the importance of the LH in feeding and the unique projections from the AcbSh 
to this region it was postulated that there could be a functional link between the two 
regions (Maldonadoirizarry et al., 1995). Concurrent blockade of activity in the LH 
inhibited the increase in intake induced by intra-AcbSh infusions of AMPA/kainate 
antagonists suggesting that the behavioural effects of blocking glutamate transmission 
in the AcbSh were dependent, at least in part, on this region (Maldonadoirizarry et al., 
1995). It was hypothesised that this effect was due to the disruption of tonic excitatory 
inputs to the AcbSh resulting in a decrease in the firing rate of a local population of 
neurons that were postulated to exert an inhibitory effect over neurons in the LH when 
active although, at the time, the neurotransmitter content of this pathway had not been 
identified (Maldonadoirizarry et al., 1995).  
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Inhibitory amino acids in AcbSh and feeding 
The establishment of a role for EAAs in feeding inevitably led to the hypothesis that 
stimulation of inhibitory amino acid (IAA) receptors would also have effects on feeding 
due to acute inhibition of neural activity similar to that caused by blocking glutamate 
transmission (Stratford and Kelley, 1997b). As a result a number of studies were 
published that used either the GABAA receptor agonist muscimol or the GABAB 
receptor agonist baclofen to inhibit activity of the AcbSh. 
 
Muscimol (GABAA agonist) 
The GABAA agonist muscimol has been extensively used to explore the role of 
accumbens GABA receptors in feeding (for review see Stratford 2007 or Kelley 2005a, 
2005b) and is one of the most widely used exogenous agonists of this receptor 
(Johnston, 1996). Muscimol (MW 114.10g) is a conformationally restricted analogue of 
GABA (Johnston, 2000) originally extracted from the fungus Amanita muscaria and 
demonstrated to be pharmacodynamically active in the mid 1960s (Mueller and Eugster, 
1965). It was confirmed to be a GABA analogue three years later (Johnston et al., 1968) 
and its actions were attributed to binding to synaptic GABA receptors (Beaumont et al., 
1978). 
 
In 1986 it was shown that it did not bind at the same site as the benzodiazepines (Deng 
et al., 1986).  The GABA receptor was reported to include at least two subtypes 
designated A and B (Bowery et al., 1981) and it was soon established that muscimol 
was a potent agonist at the GABAA receptor subtype with a much higher binding 
affinity than GABA itself ( Curtis et al., 1971, Krogsgaard-Larsen and Johnston, 1978).  
It also acts as a partial agonist at GABAC receptors but GABAC receptors are not 
present in the accumbens. Muscimol is thought to be inactive at GABAB receptors 
although there is some recent evidence that it may interact with these receptors – See 
Discussion, Chapter 5. It is a week inhibitor of GABA uptake and hence must be 
recognised by the endogenous GABA transport system but it is not recognised by 
GABA aminotransferase (Johnston, 1971, Krogsgaard-Larsen and Johnston, 1978, 
Johnston et al., 1978). 
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Baclofen (GABAB agonist) 
Baclofen is a conformationally flexible analogue of GABA (Kerr and Ong, 1995). In 
1979 it became evident that there were GABA receptors on presynaptic membranes that 
reduced the release of neurotransmitter but which were insensitive to a range of GABA 
receptor antagonists and agonists already in use (Bowery et al 1979). Baclofen (MW 
213.66g) would selectively bind to these novel receptors and they were eventually 
defined as bicuculline-insensitive baclofen-sensitive GABAB receptors (Hill and 
Bowery, 1981, Bowery et al., 1981, Bowery et al., 1983). It was the use of this GABA 
analogue that led Hill and Bowery (1981) to classify GABA receptors into subtypes A 
and B.  Baclofen is equipotent to GABA at the GABAB receptor (Bowery and Hudson, 
1979). The limited alteration of the GABA conformation exhibited by baclofen results 
in its specificity as an agonist only at the GABAB receptor (Kerr and Ong, 1995). It 
reduces the amount of transmitter released at a variety of synapses (Bowery, 1993) and 
reduces the amplitude of EPSPs and IPSPs evoked by electrical stimulation via a pre-
synaptic mechanism (Misgeld et al., 1995). 
 
Effects of GABA receptor agonists in AcbSh on feeding 
Intra-AcbSh but not AcbC infusions of either the GABAA agonist muscimol or the 
GABAB agonist baclofen significantly increases intake of laboratory chow in satiated 
animals (Stratford and Kelley, 1997b, Stratford and Kelley, 1997a, Basso and Kelley, 
1999, Stratford and Kelley, 1999, Ward et al., 2000, Soderpalm and Berridge, 2000, 
Znamensky et al., 2001, Reynolds and Berridge, 2001, Reynolds and Berridge, 2002). 
 
The effects of GABAA or GABAB receptor agonists on feeding could be selectively 
blocked by the respective GABAA (bicuculline) and GABAB (saclofen) receptor 
antagonists (Stratford and Kelley, 1997b, Znamensky et al., 2001). However infusion of 
GABA receptor subtype antagonists into the AcbSh does not alter food intake 
(Znamensky et al., 2001). Increasing local levels of endogenous GABA by infusing γ-
vinyl-GABA, an inhibitor of the metabolic enzyme GABA transaminase, also increased 
feeding in a dose related manner (Stratford and Kelley, 1997b). Infusion of the 
benzodiazepine agents (BZs) diazepam and midazolam into the AcbSh did not increase 
intake, consistent with the assertion that the increase in feeding is due to an increase in 
48 
endogenous GABA because BZs require GABA activity to exert their effects 
(Soderpalm and Berridge, 2000). 
 
The effects of GABAA and GABAB agonists were specific to nutrient consumption as 
there was no concomitant effect on water intake but infusions of muscimol did 
generalise to both solid dry food and a variety of macronutrient containing solutions, 
suggesting a very specific and fundamental role for a subset of AcbSh neurons in 
feeding rather than in general motivational processes (Stratford et al., 1998, Ward et al., 
2000, Basso and Kelley, 1999). Muscimol was however shown to have no effect on 
macronutrient selection and did not increase the intake of saline or saccharin solutions, 
which was taken to indicate that it could not modulate the palatability and hence the 
rewarding properties of food (Basso and Kelley, 1999).   Elsewhere it has even been 
reported that muscimol can actually reduce the intake of saccharin solutions of varying 
concentrations (Stratford and Wirtshafter, 2007).  
 
Reynolds and Berridge (2002) demonstrated that, not only did intra-accumbens GABAA 
receptor stimulation increase intake of a sucrose solution, it also produced a positive 
correlation between intake and hedonic or ‘liking’ facial reactions at rostral locations in 
the shell. These authors argued however that, although GABA stimulation appeared to 
elicit orofacial responses normally associated with subjective experience of liking, a 
dissociation between negative affective taste reactions elicited in caudal regions of the 
shell co-expressed with increased intake indicated that GABAergic neurotransmission 
may be separately responsible for determining the valence of affective behaviours and 
the amount of food intake (Reynolds and Berridge, 2002). 
 
The effects of GABA receptor stimulation in the AcbSh did not however cause any 
increases in oral behaviours directed at non-food objects such as gnawing of wooden 
blocks (Stratford et al., 1998, Ward et al., 2000, Stratford and Kelley, 1999). Animals 
also preferentially increased consumption of the most easily available food source but 
would feed from a less accessible source if no food was easily available or if food was 
replaced with wooden blocks (Ward et al., 2000). No oral stereotypies or vacuous oral 
movements have been reported for either GABA agonist or AMPA/kainate antagonist 
infusions into the AcbSh region. 
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GABAergic and glutamatergic effects on food intake were demonstrated to be 
regionally specific within the AcbSh, which consequently dictated the sites of infusion 
in further studies carried out by Kelley’s laboratory (Basso and Kelley, 1999). Lopes et 
al., (2007) reported that infusions of muscimol or baclofen made in more rostral regions 
than those investigated by Kelley and colleagues were just as effective in increasing 
free food intake. However examination of their diagrams of infusions sites shows that 
they actually infused within the same region. The relevance of these coordinates is that 
other laboratories have reported a more complex profile of behaviours elicited by both 
GABA agonists and AMPA/kainate antagonists depending on where along an extended 
rostrocaudal gradient they are infused. 
 
Reynolds and Berridge (2001, 2002) published evidence that GABA effects on intake 
and positive orofacial responses were restricted to rostral regions of the medial shell 
whilst, in caudal regions, defensive behaviours, negative affective responses and 
negligible effects on intake were produced. Between these rostral and caudal poles 
infusions into mid regions predominantly caused positive effects although a small 
proportion of infusions (<10%) caused mixed feeding and fear responses (Reynolds and 
Berridge, 2001, Reynolds and Berridge, 2002). The negative effects that Reynolds and 
Berridge (2001, 2002) reported included defensive treading and burying, fearful 
vocalisations and either escape behaviour from or direct aggression (biting) towards the 
handler. It does seem rather odd that none of the other authors mentioned this in any 
study using intra-AcbSh infusions of GABA agonists but it is possible that such 
responses were put down to the stressfulness of the infusion procedure. 
 
Despite the fact that distinct locations have been suggested for the sensitivity to 
infusions of GABA agonists and AMPA/kainate antagonists, between the various 
laboratories that have reported increased feeding, infusions have been effective across 
an extended rostro-caudal gradient.  Furthermore these laboratories used different 
strains and sexes including male or female Sprague Dawleys, female Wistars and male 
Hooded Listers. Thus it is quite possible that there could more variability in the 
rostrocaudal distribution of positive vs. negative valence, particularly between strains, 
than Reynolds and Berridge suggest. 
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Recent research indicates that there are also structural and functional gradients along a 
rostrocaudal axis in terms of positive or aversive taste responses to food (Reynolds and 
Berridge, 2002, Roitman et al., 2005, Taha and Fields, 2005b) place preference or 
avoidance (Reynolds and Berridge, 2002, Reynolds and Berridge, 2003) appetitive 
positive motivation and fear elicited negative motivation (Reynolds and Berridge, 2002, 
Reynolds and Berridge, 2003) and sexual experience (Bradley and Meisel, 2001). It has 
been suggested that previous emotional experience in an environment can reversibly 
increase the size of zones along this gradient in a context specific manner (Reynolds 
and Berridge, 2008) and that DA transmission is essential to the expression of both 
appetitive and aversive responses along this gradient (Faure et al., 2008) 
 
Other neurotransmitters/peptides in the AcbSh and feeding 
It was reported that DA but not selective DA receptor agonists could also increase 
feeding in AcbSh but no the AcbC, although the effect was modest compared to that of 
AMPA/kainate receptor blockade (Swanson et al., 1997). However DA antagonists did 
not reduce overall intake in hungry animals nor were the reported effects on the pattern 
of feeding specific to either subregion (Baldo et al., 2002). Endogenous DA 
transmission is increased significantly more in the AcbSh than in the AcbC during 
consummatory responses induced by un-cued presentation of food but pre-exposure to 
conditioned stimuli associated with food inhibits this response.  
 
There is no clear differentiation between the AcbC and AcbSh in terms of the robust 
increase in ingestion induced by infusion of µ-opioid receptor agonists and the most 
sensitive regions were reported to fall within ventrolateral aspects of these subregions 
i.e. not the same area that was most sensitive to GABA agonists or AMPA/kainate 
receptor blockade (Zhang and Kelley, 2000). However, regional mapping of the effects 
of microinfusions of opioids into the Acb suggests that there is a hedonic “hot spot” in 
the rostromedial shell where liking is mediated despite the observation that the effects 
on intake are widely distributed (Pecina and Berridge, 2005, Pecina et al., 2006, Smith 
and Berridge, 2007, Pecina and Berridge, 2000). 
 
The dissociable effects of intra-Acb opioids appears to be consistent with the contention 
that they also subserve feeding related functions other than palatability (Glass et al., 
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1999). Stratford (2007) states that the evidence that areas of maximum efficacy of 
amino acid or opioid receptor manipulation are regionally distinct suggests that the two 
systems could also be functionally discrete. However, although areas that subserve 
maximum intake fall in medial (GABA/glutamate) vs. lateral (opioids) plains the opioid 
hot spot for liking occupies a 1mm3 area that overlaps with the region where positive 
orofacial responses are elicited by GABA/glutamate modulation (Pecina et al., 2006). 
 
Opioid induced feeding is not initiated as rapidly as GABAA induced feeding, is less 
intense but lasts longer (Bakshi and Kelley, 1993b). Stratford (2007) suggests that 
opioids affect intra-meal processes that determine the persistence of already initiated 
feeding whereas GABA can directly initiate ingestive behaviour. However intra-Acb 
opioid receptor stimulation has net inhibitory effect on the excitability of local neurons 
(McCarthy et al., 1977, Hakan and Henriksen, 1989, Yuan et al., 1992, Yuan, 1996, 
Brundege and Williams, 2002) suggesting that opioid induced feeding is also due to 
disinhibition of neurons in terminal regions due to inhibition of GABAergic output 
(Zhang and Kelley, 2000). 
 
The potential role for a variety of other endogenous neuroactive substances in AcbSh in 
the control of feeding responses has only begun to be investigated in the last five or so 
years. Melanin concentrating hormone (MCH) infused into the AcbSh increases intake 
of food and the effect is blocked by a specific MCH receptor antagonist (Georgescu et 
al., 2005, Guesdon et al., 2009). Ghrelin infused into AcbSh also increases feeding 
although no ghrelin receptors have been located in this region as yet (Naleid et al., 
2005). Nevertheless there are neuronal processes in the AcbSh that express ghrelin 
(Cowley et al., 2003). It has been reported that hypocretin/orexin in the AcbSh has no 
effect on feeding (Baldo and Kelley, 2001) but in a more recent study it stimulated 
feeding which was blocked by a selective orexin receptor antagonist (Thorpe and Kotz, 
2005). AcbSh infusions of the endocannabinoids anadamine and 2AG results in potent 
increases in food intake, a decrease in latency to begin feeding and the effect is blocked 
by pre-treatment with a specific CB1 selective antagonist (Mahler et al., 2007, Soria-
Gomez et al., 2007, Williams and Kirkham, 2002, Kirkham et al., 2002).  
 
CART infused into AcbSh inhibits spontaneous, deprivation induced and muscimol 
induced feeding and food deprivation decreases CART in the AcbSh (Yang et al., 2005, 
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Osei-Hyiaman et al., 2005). CCK can act directly to suppress inhibitory and excitatory 
postsynaptic potentials in the Acb but the total effect appears to be to be excitation of 
the MSNs (Kombian et al., 2004, Kombian et al., 2005). As indicated earlier the VTA 
sends dense CCK projections to the AcbSh co-expressed with DA (Lanca et al., 1998). 
However CCK infused into the Acb does not suppress mild deprivation induced feeding 
(Blevins et al., 2000) but it does decrease sucrose intake in animals that have a high 
baseline intake (Sills and Vaccarino, 1996). Antagonists of CCK receptors increases 
sucrose consumption in animals that previously had low baseline intake but 
paradoxically decreases intake of high baseline consumers (Sills and Vaccarino, 1996).  
 
The role of the Acb subregions in food motivated learning  
 
There is a vast literature on the effects of manipulating the function of the entire Acb 
using electrolytic lesions, excitotoxic lesions (e.g. ibotinic acid), cell type specific 
lesions (e.g. 6-OHDP), or infusing a variety of agents that act at specific receptors, on 
the acquisition and expression of conditioned responses. Nevertheless, with the 
realisation that this structure consisted of distinct AcbC and AcbSh regions, the 
potential for functional dissociations in their contribution to basic mechanisms 
subserving motivated learning and performance of Pavlovian associations or 
instrumental responses or the interaction between the two was explored.  
 
It would appear that there is no direct role for the AcbSh in modulating Pavlovian 
approach behaviour but AcbC lesions disrupt acquisition, depress responding post 
acquisition and disrupt discrimination between conditioned and unconditioned cues 
(Parkinson et al., 1999, Hall et al., 2001, Parkinson et al., 2000, Corbit et al., 2001, 
Cardinal et al., 2002b). The CeA is also involved in the acquisition of approach and it is 
believed that this region may influence the role of the Acb by controlling DA in the 
VTA (Cardinal et al., 2002b).  
 
Intra-Acb DA enhances conditioned reinforcement whilst dopaminergic lesions abolish 
it (Taylor and Robbins, 1984, Taylor and Robbins, 1986, Robbins et al., 1989). The 
AcbSh is necessary for the potentiating effects of amphetamine on conditioned 
reinforcement but the AcbC is necessary for response accuracy suggesting a role for the 
AcbSh in the ability of Pavlovian cue salience to potentiate instrumental responses and 
the AcbC to organise motor output (Parkinson et al., 1999).  
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Intra-AcbSh DA also enhances Pavlovian to Instrumental Transfer (PIT) (Wyvell and 
Berridge, 2000). Excitotoxic lesions of the AcbC but not the AcbSh have been shown to 
abolish PIT, as did lesions of the CeA but not the BLA suggesting that a dopaminergic 
circuit via the VTA between the CeA and AcbC was responsible for the transfer (Hall et 
al., 2001). In another study published in the same month however it was reported that 
lesions of the AcbSh but not the AcbC abolished PIT (Corbit et al., 2001). It has 
emerged since these studies that there are two forms of PIT; generalised and outcome-
specific that might recruit different circuits within the brain (Corbit and Balleine, 2005). 
The conflicting results probably arose out of procedural differences with the former 
study using a generalised procedure and the latter an outcome-specific procedure (Belin 
et al., 2009). The role of the amygdala is also somewhat dependent on the type of PIT 
procedure in question and it is possible that a CeA/AcbC circuit is dominant in 
generalised PIT whereas a BLA/AcbSh circuit takes over in outcome-specific PIT 
(Corbit and Balleine, 2005, Holland and Gallagher, 2003). 
 
Lesions of the Acb that abolish PIT do not, however, affect the ability of animals to 
evaluate instrumental outcomes suggesting that the Acb is a critical part of the circuit 
that subserves the attachment of incentive value to cues but not to the reward (de 
Borchgrave et al., 2002). Further work on the relationship between PIT and the value of 
the reinforcer suggested that this depends to some degree on the amount of training and 
on whether a general or outcome-specific form of PIT has been learnt which could 
explain why either the AcbC or the AcbSh can modulate PIT (Holland, 2004).  
 
To summarise both DAergic and GABAergic mechanisms in the AcbC are involved in 
the acquisition and expression of Pavlovian approach but the AcbSh is not directly 
involved. In conditioned reinforcement of instrumental responses the AcbC organises 
motor output while the AcbSh is involved in the modulation of the salience of the 
Pavlovian cue. The AcbC is necessary for the expression of generalised PIT whilst the 
AcbSh is involved in outcome specific PIT. It has been suggested that the AcbSh can 
potentiate responding for reward related cues and is responsible for salience attribution 
whereas the AcbC confers directionality of these behaviours (Wickens et al., 2007). 
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Role of AcbSh in expression of conditioned behaviours 
On the basis that modulation of neurotransmitter signals in AcbSh had been implicated 
in both appetitive responses to food and in defensive behaviours as well as being 
activated by feeding, noxious stimuli and stress (for a review of the evidence see 
Reynolds and Berridge, 2001) the effects of intra-AcbSh GABAergic and glutamatergic 
signalling on conditioned place preference/avoidance has been investigated. Reynolds 
and Berridge (2002) found that animals developed place preference for the chamber 
paired with rostral infusions of muscimol and place avoidance for the chamber paired 
with caudal infusions. In contrast AMPA/kainate receptor blockade induced a univalent 
gradient of place avoidance from mild but significant avoidance in rostral regions to 
more robust avoidance at caudal extremes (Reynolds and Berridge, 2003). 
 
Following the serendipitous establishment of a functionally specific role for GABA in 
free feeding behaviour, Kelley and colleagues turned their attention to investigating 
both the putative extended circuitry underlying the effect and the specific behavioural 
mechanisms by which this circuitry regulated feeding. In seeking to determine the 
behavioural mechanisms, investigators in Kelley’s laboratory began to characterise the 
effects of muscimol on what they termed the “feeding central motivational state” based 
on the theoretical construct described by Bindra (1974). 
 
When considering the problem couched within these terms, it was reasonable for 
Kelley’s group to hypothesise that if muscimol increased intake it might do so via direct 
effects on the incentive motivational properties of the reward or on external reward 
related stimuli. Despite the apparent lack of evidence of effects of GABA stimulation in 
the Acb on the perceived incentive value of freely available food reward (Basso and 
Kelley, 1999), increases in intake were so large and animals ate so voraciously that it 
was hypothesised that it might also affect food seeking behaviours, for example operant 
responding for food (Kelley et al., 2005b).  
 
In 2003 Zhang et al. employed a Progressive Ratio (PR) schedule to investigate food-
seeking behaviour following intra-Acb GABAA receptor stimulation. In a PR schedule 
an increase in willingness to work for a palatable food reward i.e. an increase in break 
point is taken to indicate increased motivation for the reward (Hodos, 1961, Hodos and 
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Kalman, 1962). In this case the GABAA agonist muscimol failed to increase the rate of 
lever pressing, accuracy of pressing on the reinforced lever or the break point (Zhang et 
al., 2003).  
 
In a later study, Kelley’s laboratory attempted to specifically address the problem of 
whether or not GABAergic stimulation of the Acb resembled a state of ‘hunger’. They 
posed the question; does this manipulation mimic “a motivational state of food 
deprivation that commonly enables animals to learn a new operant response to obtain 
food?” (Hanlon et al., 2004). Their data indicated that stimulation at the GABAA 
receptor was insufficient alone to potentiate the acquisition of lever pressing for food in 
satiated animals whereas deprivation significantly increased the rate at which they learnt 
relative to non-deprived animals (Hanlon et al., 2004). In other words muscimol did not 
appear to be mimicking the natural internal motivational state associated with hunger 
and/ or the potential re-evaluation of the rewarding properties of food or food cues 
when hungry (Dickinson and Balleine, 1995). 
 
Section summary  
There is now a large body of evidence demonstrating that the AcbSh plays a critical role 
in regulating both consummatory and appetitive responses to food reward. It would 
appear that inhibition of activity in AcbSh projection neurons ether via blockade of 
glutamate receptors or stimulation of GABA receptors induces feeding in satiated 
animals. A variety of other neurotransmitter systems in the AcbSh have been implicated 
in incentive motivation processes that may subserve food seeking. In addition the role 
of the AcbSh in learning responses to food availability and food seeking strategies 
appears to depend on the form of learning (Pavlovian vs. instrumental) and the 
complexity of the task. However stimulating GABAA receptors neither potentiates 
Pavlovian conditioning, nor expression of an instrumental response to food. 
 
Current hypotheses to explain the role of GABAergic neurons 
in the AcbSh in motivated behaviour  
 
It has been variously argued that the Acb processes outcome predictions (e.g. see 
Wilson, 2005, Day et al., 2007), or that it processes signals regarding the saliency of 
stimuli that allow behavioural switching (Redgrave et al., 1999), that it gates convergent 
inputs (Goto and Grace, 2008, Taha and Fields, 2005a, Taha and Fields, 2006) that it is 
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part of an action selection circuit (Wickens et al., 2007, Nicola, 2007) or a feedback 
circuit that modulates behavioural initiation (Balleine and Ostlund, 2007). Much of the 
controversy surrounding the role for the Acb in motivation has arisen because of the 
prevalence of papers that continue to treat it as a unitary structure.  
 
Kelley and colleagues hypothesised that the AcbSh, which has unique access to 
“feeding selective nodes” in a behavioural control column in the LH (Swanson, 2000), 
usually inhibits activity in these areas. However when GABA receptors in the AcbSh 
are stimulated the GABAergic MSNs are inactivated thus disinhibiting the LH and 
activating the nodes, which in turn recruit motor pattern controllers (Kelley et al., 
2005b).  They also propose that only a subset of downstream motor pattern generators 
are eventually recruited, thus fragments of feeding behaviour only would be expressed, 
biasing animals towards consummatory responses.  
 
Kelley’s theory precludes the possibility of effects on motivational components of food 
seeking or consummatory processes (Kelley et al., 2005b). Furthermore they state that 
this pharmacological manipulation actually bypasses “higher corticolimbic networks” 
that subserve the more complex responses and computations underlying operant 
responding (Kelley et al., 2005b). The hypothesis specifically excludes the possibility 
that pharmacological manipulation of GABA tone has effects on the hedonic response 
to food (Kelley et al., 2005b, Basso and Kelley, 1999) or on behavioural output when 
more complex food-seeking strategies e.g. lever pressing, are required (Kelley et al., 
2005b). AcbSh neurons predominantly seem to be involved in release of predetermined 
behaviour patterns in relation to unconditioned stimuli (Meredith et al., 2008). 
 
This hypothesis raises a number of questions. For example is the site of action of 
GABA (at A or B receptors) critical to the expression of food motivated behaviours and 
what other areas of the brain are activated as a consequence? Does the feeding 
behaviour elicited by stimulating GABA receptors resemble physiologically induced 
feeding? Does GABA in the Acb modulate intake via effects on the initiation of 
feeding, in the maintenance of the consummatory act or in satiety processes that 
terminate feeding? Alternatively will the evidence point to a single underlying process? 
These questions will be investigated using behavioural measures that can dissociate 
effects on appetite and satiety in free feeding animals or instrumental responding.  
57 
Aims and chapter overviews 
This thesis will further explore the behavioural impact of activating subtypes of GABA 
receptors in the AcbSh on both food intake and food seeking behaviours. On the basis 
of the findings reported a model of the functional organising principles of neuronal 
networks that encompass the Acb will be discussed with respect to endogenous 
inhibitory motivational control in this region. This thesis investigates the role of GABA 
in the Acb in the organisation of innate consummatory responses and instrumental 
appetitive behaviour. Studies reported in data chapters 3-6 utilised methods that can 
separate out the stages of feeding behaviour i.e. initiation of appetitive food seeking 
behaviour, maintenance of consummatory behaviour and the termination of feeding as 
satiety is reached. 
 
Throughout the thesis the effects of intra-Acb GABAA and GABAB receptor agonists 
were measured in animals that were pre-satiated and hence not driven to feed by 
physiological mechanisms. The behavioural paradigms chosen (see Chapter overviews 
below for details) provide measures that dissociate between innate consummatory 
responses to food and instrumental responding for food reinforcement. The 
methodological approach is described in Chapter 2, which also covers details of the 
animals used, welfare considerations, health and ethical issues associated with animal 
experiments involving central administration of drugs. The surgical procedure to 
implant bilateral cannulae for infusions into the Acb is described and I provide details 
of the drugs that will be administered centrally or systemically. 
 
In Chapter 3 the results from experiments using the first paradigm, the behavioural 
satiety sequence (BSS) are reported. The hypothesis put forward by Kelley (2005a, 
2005b) suggests that GABA in the Acb contributes to the expression of innate 
consummatory responses through control of motor behaviours. However the effects on 
feeding of the GABAA agonist muscimol and the GABAB agonist baclofen have only 
previously been measured in terms of total ad libitum intake. The BSS is sensitive to 
manipulation of the organisation of the consummatory response but also to potential 
disruption of the natural sequence of associated feeding related behaviours (Clifton and 
Cooper, 1996). Thus it is a useful measure of feeding specific versus non-specific 
effects of pharmacological treatments. These studies therefore further characterise the 
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effects of intra-Acb GABAA and GABAB receptor agonists on free feeding. Because 
Kelley suggests that GABA receptor activation does not cause changes in motivational 
processes these results were compared with the BSS expressed following physiological 
and pharmacological manipulations known to affect motivation. To this end the BSS 
was also recorded following fasting, intra-Acb administration of a µ-opioid agonist or 
systemic administration of a benzodiazepine.  
 
In Chapter 4 I report the results of a set of studies that used a second order operant 
schedule designed to measure both appetitive and consummatory responding for food 
reinforcement (Thornton-Jones et al., 2005). The effects of intra-Acb administration of 
the GABAB receptor agonist baclofen on instrumental responding were recorded across 
a range of doses and, once again, compared with the effects of a µ-opioid agonist 
known to affect motivational processes. Free intake was recorded both prior to and 
following operant test sessions to confirm the behavioural efficacy of the doses tested 
and to confirm that the drug was targeting a region of the Acb that is involved in control 
of feeding responses. Complimenting these two approaches (operant responding vs. free 
intake) was an extensive analysis of videos recorded during operant testing to identify 
and quantify behaviours other than appetitive instrumental and consummatory 
responses that might be modified by manipulation of accumbens function.  
 
Chapter 5 covers a second set of studies using the second order schedule and a range of 
doses of the GABAA receptor agonist muscimol. Once again free intake was recorded 
prior to and following the operant test sessions and videos were analysed for any effects 
on other behaviours. 
 
The penultimate chapter, Chapter 6, gives details of a standard immunohistochemical 
approach for identifying the presence of the protein Fos in the nuclei of neurons, which 
can be used as a marker for the immediate early gene c-fos (Morgan and Curran, 1991). 
This is widely used as a tool to highlight areas of neuronal activation (Herrera and 
Robertson, 1996). In this case it was used to identify and compare the elements of the 
macrocircuit activated by accumbens GABA receptor subtype stimulation. The final set 
of studies reported in this Chapter used Fos-like immunoreactivity (FLI) as a marker of 
neuronal activation following infusion of either baclofen or muscimol in the same 
animals for which free intake and instrumental responding had been measured in 
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Chapters 4 and 5. This approach meant that it was not possible to directly compare the 
activity of brain regions following behaviour under the influence of drug. However it 
was important to establish if there was any difference in the profile of activation with 
baclofen or muscimol prior to initiation of behavioural responses because this had not 
been done before. The behavioural data confirmed that the doses of baclofen and 
muscimol use to induce c-fos expression were also functionally active. 
 
Finally Chapter 7 is a general discussion. In this chapter I will consider potential 
explanations for the results reported in the four preceding data chapters when all of the 
data is considered together. I will set these findings within the context of what is already 
known about both the structure and neurochemistry of the AcbSh and its place within 
the wider circuitry that subserves motivated behaviour. I will then consider the 
implications of the results for understanding the role of Acb GABA in the integration of 
motivation and action with reference to current hypotheses. As far as is possible within 
the scope of this thesis I will construct a modified model to explain endogenous 
inhibitory transmission effects in the Acb on motivational control. I will suggest future 
directions for this research in order to further explore the conclusions I have come to 
and to test the validity of the modified model mentioned described. 
 
In summary, the main aims of this thesis are: 
1) To characterise and compare feeding and related behaviours or instrumental 
appetitive behaviours following GABA receptor subtype stimulation in the AcbSh. 
2) To compare the effects of GABA receptor subtype stimulation in the AcbSh with 
other pharmacological manipulations that affect specific phases of ingestive 
behaviour. 
3) To compare the effects of GABA receptor subtype stimulation in the AcbSh with 
physiological manipulations that increase feeding and food motivated behaviours. 
4) To investigate the effects of GABA receptor subtype stimulation in the AcbSh on 
neuronal activity in other areas of macrocircuits subserving motivational processes. 
5) To further investigate the hypothesis that GABA receptor stimulation in the AcbSh 
simply results in increased intake because of disinhibition of downstream motor 
pattern generators. 
6) To set all of the above in the context of their relevance to the ‘natural’ effects of 
hunger and satiety on food motivated behaviours and hence motivation in general. 
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Chapter 2 
 
Methods 
 
Introduction 
This chapter covers essential information with regards to the animals used for this 
thesis, their welfare, health and ethical considerations. Given that most of the studies 
reported involve central administration of drugs, there is then a description of the 
surgical procedure to implant the necessary guide cannulae and histological methods 
used for subsequent identification of infusion sites. The majority of the subsequent 
experiments relied on behavioural testing in two key paradigms; the recording of a 
behavioural satiety sequence (BSS) and a 2nd order operant schedule. The methods used 
for both are described in detail below. Where relevant, additional methodology or 
modifications to either the BSS study or testing on the 2nd order operant schedule will 
be described in Chapters 3, 4 and 5. 
 
Also included is a description of the method used to measure intake in response to 
freely available food, which was tested in parallel with the operant work reported in 
both Chapters 4 (2nd order studies with baclofen) and 5 (2nd order studies with 
muscimol). Because video footage was recorded for the operant experiments in 
Chapters 4 and 5 it was subsequently possible to look at incidental behaviours not 
measured at the time of testing. The method and categories used to assess these 
behaviours are described here. Finally I provide details of the drugs used throughout the 
various studies presented. Chapter 6 reports studies using an immunocytochemical 
labelling method to visualise areas of the brain activated as a consequence of drug 
infusions. Given that this method was only used for those studies the detailed 
methodological description will be included within the chapter itself. 
 
Animals and housing conditions 
Outbred male Lister hooded rats (strain HsdOla:LH, Harlan UK) were used in all the 
studies reported in this thesis. Starting weights for each batch of animals were chosen 
on the basis of the procedure through which the animals were to go. Those destined for 
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a prolonged period of training were bought in relatively small so as to be an appropriate 
size for stereotaxic surgical techniques at the time of guide cannulae implantation (e.g. 
for the 2nd order schedule described below). Those that went through a short period of 
habituation prior to direct behavioural observations were bought in at a larger size so as 
to be an equivalent weight to the surgery groups at the time of testing. Specific animal 
weights for each experiment are indicated in the relevant chapters. 
 
The animals were housed in a Home Office approved unit at the University of Sussex 
following the appropriate code of practice from the Home Office (ASPD, 2005). 
Holding and test rooms were adequately ventilated for the stocking density and 
maintained at controlled temperature (19-22oC) and humidity (45-55% saturation) under 
a 12hr light / dark cycle. Animals had ad libitum access to water throughout the study 
but periods of restricted access to food were imposed, as detailed in each chapter. 
 
Acclimation to the new environment, handling procedures and to the presence of an 
observer took a minimum of one week. Animals were group housed but, when surgical 
procedures were involved, they were habituated to single housing in Perspex walled, 
solid bottom cages (See Fig. 2.1) for at least 7 days prior to any procedure. Apart from 
the fact that the Home Office states that rats should be group housed unless the 
experiment requires otherwise (ASPD, 2005) group housing also appears to speed up 
operant training (Greenhalgh, 2007).  
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.1. Perspex cages used to house single animals undergoing surgery. 
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Welfare and health 
Housing 
When animals were kept in groups of three or four (depending on their size) the largest 
standard rat cage available was used. This was a solid bottomed cage width 36cm, 
length 53cm and height 25cm (model RC2R, North Kent Plastic Cages LTD., UK). A 
cage of this size provided a floor area of 400cm2, adequately meeting the required floor 
area for animals as large as 550g. The lid height also exceeds the recommended 
minimum of 20cm. When animals were housed singly the Perspex cages were not 
visually isolated and perforations in the walls (for ventilation) meant that they were also 
able to smell and hear the presence of other animals, which is believed to reduce the 
stress associated with isolation (Lawlor, 1984, Lawlor, 2002). When animals were taken 
out for training they were allowed brief periods of contact with other animals and as 
much time as possible playing with and being handled by myself. 
 
Both group and singly housed animals were provided with enough sawdust bedding to 
allow natural hoarding and defensive behaviours, shredded dust free tissue nesting 
material and wooden blocks to chew on. In the group cages they also had a plastic tube 
big enough for all animals to fit in. In the single Perspex cages extra nesting material 
was provided to allow the animal to burrow into it and thus express natural behaviour. 
 
Monitoring of health 
Animals provided by Harlan had been screened for clinical or sub-clinical disease. Once 
at Sussex they were regularly handled and checked for signs of disease, stress or 
distress by both the unit staff and myself. Occasional signs of non-specific stress were 
observed with the occurrence of porphyrin around one or both eyes. This only occurred 
in animals post-operatively. In each case the eyes were bathed with sterile 0.9% saline 
to prevent blockage of the tear duct. This was often enough to prevent it happening 
again. No animal that developed persistent signs of disease, infection or non-surgical 
wounds was used for this thesis. At the time of testing only those animals that had 
apparently fully recovered from surgery were used and if animals showed signs of stress 
such as porphyrin they were tested when these were no longer apparent.  
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Topical medications 
There was only one case of noticeable self-directed behaviour with one of the animals 
licking a forearm until raw. This was treated twice daily with a topical agent, Viatop 
(Boehringer Ingelheim, UK) purchased through the University of Sussex designated vet. 
The antiseptic gel (containing the natural ingredient raffinose, to relieve itching) rapidly 
stopped further licking of the affected area and allowed fur re-growth within a week.  
 
Ethical considerations 
All animal care and experimental work was carried out in accordance with the Animals 
(Scientific Procedures) Act 1986. Unit staff and the Project and Personal Licence 
holders also followed the guidelines set out in the Home Office codes of practice. The 
UK Government is particularly keen on promoting the application of ‘the 3Rs’ - the 
replacement of procedures with others which do not use animals, the reduction of the 
number of animals used and the refinement of procedures to minimise pain and 
suffering. The 3R’s have been revisited throughout the course of this studentship and a 
variety of steps have been taken to meet these principles in practice. 
 
No animal study was undertaken that could be replaced by non-animal alternatives such 
as tissue culture, computer modelling or molecular biological techniques. Clearly, given 
that this thesis addresses fundamental questions about behavioural neuroscience, this 
would not be possible at this time and the only way to advance our understanding of the 
link between brain function and behaviour is to study it directly in vivo. To meet the 
requirements for reduction all studies were carefully designed to gain the most power 
and validity using the smallest possible number of animals. To this end I followed the 
guidelines and advice found in Festing et al. (2002).  
 
All experiments were also designed to control variability as much as possible. Although 
Festing et al., (2002) recommend that one of the best ways to achieve this is to use 
isogenic inbred rats outbred Lister Hooded rats are routinely used for behavioural 
studies throughout the world. The Lister Hooded strain used for these studies has been 
maintained as a closed colony since 1932 at Harlan UK and individuals tend to be 
similar but their genotype at a given locus is unknown.  
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Subjects were bought in at a uniform weight, housed under optimum conditions (see 
above), fed standardised diets and handled on specific days by the unit staff for cage 
cleaning and for the rest of the time only by myself. Experiments were planned and 
designed prior to any animals being bought in to minimise numbers of rats used.  
 
The need for refinement under the Act was addressed by the use of appropriate 
medications to reduce pain and to avoid post-operative infection (see below) and by 
adhering to aseptic techniques for the preparation of all solutions to be used during 
surgery (i.e. saline for cleaning the wound) or to be administered centrally. The 
introduction of a rapid setting dental resin during the surgical procedure significantly 
reduced the amount of time each animal was anaesthetised. Care was taken to ensure 
animals were very well habituated to the operator prior to testing to reduce the stress 
associated with the infusion process. 
 
Methods for central administration of drugs 
Surgical procedure to implant guide cannulae 
Rats were anaesthetised using 4% Isoflurane (Abbott Animal Health, UK), 0.4L/min 
oxygen and 0.4L/min nitrous oxide in an induction chamber. Gas flow was switched to 
a nose cone and subjects transferred to the stereotaxic apparatus (Stoelting Co., USA). 
Isoflurane concentrations were adjusted gradually from 4% down to 1% to maintain a 
constant rate of anaesthesia during the subsequent procedure. 
 
The surgical technique was based on a standard flat skull technique employed by Ward 
et al. (2000) with the incisor bar set at IO – 5mm. In this case narrow thin wall, 26-
guage, 16mm stainless steel cannulae (Coopers Needleworks, UK) were implanted 
bilaterally aimed 2.2mm above the AcbSh. Coordinates were initially based on those 
used previously in this laboratory for a University colony of Lister hooded rats bred 
from Charles River UK stock (Ward et al., 2000). These coordinates were aimed 2.2mm 
above the AcbSh at anteroposterior (AP), + 1.2mm, mediolateral (ML), ± 1.5mm 
relative to bregma and dorsoventral (DV), -5.8mm relative to skull surface. Histological 
examination revealed core involvement in infusion sites in some animals (excluded 
from the final analysis). 
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For subsequent experiments coordinates were adjusted on the basis of a review of the 
range of coordinates reported in the literature for various strains of rat (Stratford and 
Kelley, 1999, Stratford and Kelley, 1997b, Basso and Kelley, 1999, Zhang et al., 2003, 
Hanlon et al., 2004, Stratford, 2005, Reynolds and Berridge, 2002, Lopes et al., 2007). 
These were compared to the initial placements in these Lister Hoods from Harlan and, 
relating the brain anatomy to photomicrographs in an appropriate stereotaxic atlas 
(Paxinos and Watson, 1998), new coordinates were chosen that placed the infusion 
point in the medial caudal shell region only.  
 
For cannula implantation a trepan, 3mm in diameter, was used to make two holes in the 
bone directly above the target area. The 26-guage cannulae were consequently aimed 
2.2mm above the AcbSh at AP + 1.4mm, ML ± 0.9mm and DV-5.8mm. A burr drill bit 
was used to make shallow guide holes and three 3.2 mm stainless steel bone anchor 
screws (Stoelting Co., USA) and Geristore dental resin (Dkap International Ltd., UK) 
were used to anchor the cannulae to the skull. This resin anchor was reinforced by the 
addition of a plastic collar filled with Simplex self-cure acrylic dental resin (Associated 
Dental Products Ltd., UK). 33-gauge stainless steel obdurators (Coopers Needleworks, 
UK) were inserted to prevent occlusion. After closure of the initial incision around the 
collar it was lightly dusted with the topical antibiotic powder Cicatrin 
(GlaxoSmithKline, UK), which contains neomycin as the active ingredient. This was 
also employed post-operatively if the wound showed signs of infection.  
 
Post-operatively, recovering animals were placed in absorbent paper lined cages on heat 
mats. Cages were covered to provide a dark, warm sheltered environment and animals 
were immediately provided with water and wet mash containing an analgesic and 
antibiotics (see below for details of products used). Post-op analgesia was provided for 
a minimum of 48 hours and animals were allowed to recover for at least 7 days. Weight 
was monitored and, when all subjects were gaining weight rapidly, they were put back 
on to restricted diet for a minimum of two days prior to re-habituation to the apparatus. 
 
Use of analgesia post-operatively 
Analgesia was employed immediately post operatively for all animals undergoing 
surgical procedures. I used Metacam Oral Suspension for Dogs (Boehringer Ingelheim, 
UK) containing the equivalent of 0.05 mg per drop when delivered from the integral 
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dropper. Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam 
class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-
inflammatory, analgesic, anti-exudative and antipyretic (reduces body temperature in 
the case of fever) effects. It is recommended for rats per os (PO - by mouth) (Flecknell 
and Waterman-Pearson, 2000). In this case the analgesia was given immediately post 
operatively in wet mash. Flecknell and Waterman-Pearson (2000) state that, in rats, a 
dose of up to 1mg per kg is appropriate and the named vet suggested a dose rate of 
0.1mg per kg. For the purposes of post-operative analgesia in this laboratory a dose rate 
of 0.2mg per kg was used. A second dose was administered at 24 hours post surgery and 
a third at 48 hours. Analgesia was discontinued after 3 days to avoid renal problems 
(Flecknell and Waterman-Pearson, 2000).  
 
Use of antibiotics post-operatively 
Rats were given a broad-spectrum antibiotic, Oxytetracycline (Sigma Aldrich, UK) also 
known as Terramycin, post-operatively. This was used to prevent postoperative 
infection and is indicated in particular for mild upper tract respiratory problems and soft 
tissue infections. The recommended dose range is 10-20mg /kg PO for rats (Poole et al., 
1999). There was some evidence that the animals found the taste in their drinking water 
aversive so it was dissolved in the water with the analgesic, used to make up the wet 
mash and administered for three days. If animals showed signs of ill health (see below) 
after 3 days the antibiotic regime was continued until their condition improved  
 
Dealing with weight loss and/or dehydration post operatively 
In a small number of animals unusual weight loss was observed (more than ~ 2.5% 
body mass) within the first few days post-operatively. This was sometimes 
accompanied by listlessness and obvious signs of dehydration and/or a lack of appetite. 
These animals were treated with antibiotics as above and, where there was obvious 
discomfort, one or more additional doses of analgesia was administered. They were also 
placed on a heat-pad in the home cage and were hand fed a 0.9% / 5% sucrose solution 
using a syringe. Between feeding with the nutritive solution they were regularly offered 
water in the syringe and wet mash was left in the cage. Once the animals looked 
healthier and had gained weight they were given prolonged access to the wet mash to 
encourage quick recovery and weight gain. They were not considered for testing until 
they weighed more than they had done pre-operatively. 
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Infusions and maintenance of guide cannulae patency 
The stainless steel obdurators used to occlude the cannulae between infusions were 
rotated and cleaned daily. If cannulae became sticky or blocked, animals were 
anaesthetised (as above) and the obdurators were carefully removed with the head held 
stable in the ear bars. Clean obdurators were inserted. If obdurators were lost in the cage 
they were replaced as soon as the loss was discovered. For the infusions 31g stainless 
steel injectors were made in house. These had a stainless steel collar fitted such that the 
remaining length of injector extended 2.2mm beyond the tip of the guide cannulae to 
reach the target structure. These injectors were connected via number 10 PPE tubing 
(Harvard Apparatus LTD., UK) to 10µl Hamilton microsyringes. A microinfusion 
syringe pump model 802 (Univentor, Malta) operated the injectors, which held two 
microsyringes facilitating simultaneous bilateral infusions. During post-op re-training, 
subjects underwent two habituations to the infusion procedure (which involved gentle 
restraint in the hands) using dummy injectors that did not extend beyond the tip of the 
guide cannulae. One sham infusion of sterile 0.9% saline was administered two days 
prior to testing. 
 
On test days intra-AcbSh infusions of drug or vehicle were made bilaterally and 
simultaneously at a rate of 0.5µl per side over 30 seconds (1µl of drug solution infused 
in total). Injectors were left in for a further minute to allow diffusion of drug away from 
the tip. Any discharge from the cannulae post infusion was noted and blotted away with 
a medical wipe (Kimberly-Clark, UK). The obdurators were cleaned in ethanol, dried 
and replaced. Subjects were then placed in the test cage immediately post infusion. 
Between animals the infusers were dipped in ethanol to clean and sterilise them and 
then the drug solution was run through for a couple of seconds to get rid of any 
contamination, air bubbles or blockage. Infusion sites were later verified histologically. 
 
Perfusion method 
At the end of each experiment subjects were deeply and terminally anaesthetised using 
an overdose, via the i.p route, of 0.8ml of Euthatal (Merial Animal Health Ltd., UK), a 
sodium pentobarbital solution (200mg/ml) used exclusively for euthanasia in small 
animals. Rats were transcardially perfused using a peristaltic pump, model 205U 
(Watson and Marlow, UK). Approximately 150mls of 0.1M phosphate buffered saline 
(PBS) was pumped through over a period of five minutes followed by 200mls of 10% 
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formal saline. Alternatively, if the brains were to be run through an 
immunohistochemical procedure paraformaldehyde (PFA) was used as a fixative 
instead of formal saline. A guillotine was used to decapitate the animal post perfusion 
and the cerebellum was exposed using bone Rongeurs to peel away the skull. Heads 
were post-fixed in formal saline/PFA for at least 24 hours. Brains were then dissected 
out and returned to the fixative for a further 24 hours. Finally the brains were blocked 
and cryoprotected in phosphate buffered 30% sucrose solution by immersing them for a 
minimum of 48 hours prior to freezing at -80oC. 
 
Histology and placement verification 
Brains were sectioned coronally at 60µm on a freezing microtome. Relevant sections 
were mounted on gelatinized slides and, following alcohol dehydration, run through a 
standard Nissl staining procedure using Thionin. By comparing key landmarks with the 
appropriate figures in Paxinos and Watson (1998), the location of infusion sites was 
determined. The length of the infuser extending beyond the cannula tip (2.2mm) was 
scaled down to the final section size and the infusion site taken as being the point at 
which this ended within the lowest area of gliosis. 
 
Only animals with correctly placed cannulae were included in the final analysis i.e. 
those that had no core involvement and little or no involvement of more medial or 
ventral structures. A correct placement was defined as being within the shell region 
mediolaterally and between anterior-posterior co-ordinates of 1.4mm ± 0.5mm. Animals 
with gliosis that appeared to have spread too extensively dorsoventrally (into other brain 
structures) were excluded from the final group for analysis. Drawings of the infusion 
sites are shown for each experimental group in the relevant chapters. 
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Key methods and apparatus for behavioural testing 
Simple measure of increases in intake:  
For the BSS experiments (described below), intake was measured within the test 
apparatus used for the main study. In all other studies intake in response to freely 
available food within the same apparatus was recorded prior to testing the animals on 
the main schedule to verify behavioural activity of the infusion sites. Following testing 
on some of the operant schedules an equivalent dose response curve for intake in 
response to freely available food was established after the main study (see data chapters 
for details). 
 
To this end animals were habituated to receiving normal laboratory chow pellets in an 
easily accessible glass dish in an environment that was distinguishable from the home 
cage. The ‘test cage’ was a standard solid bottom cage (RB3R, North Kent Plastic 
Cages Ltd., UK) width 28cm, length 45cm and height 20cm. A small amount of 
sawdust (~10mm depth) was present but not enough to allow hoarding of pellets. Food 
was removed from the home cage one hour before testing and replaced with 5 fresh 
pellets to which rats had access for 30 minutes. Animals were then transferred to the test 
cage for a further 30 minutes to compensate for initial arousal and finally given access 
to a pre-weighed pot of fresh laboratory chow for a set period in the presence of an 
observer. Habituation continued until intake was stable over a period of 4 days. On test 
days, following administration of drug, animals were either returned to the test cage in 
the absence of food for an appropriate amount of time to allow optimum drug effect (in 
the case of i.p. injections) or, in the case of infusions of drug, the test meal was 
immediately provided and the session began (see Fig. 2.2 for timeline). 
 
Where practical the operator was present and recorded gross behaviour directly, 
otherwise the session was filmed for later behavioural analysis. Food pots were 
retrieved and the sawdust was fingertip searched for any spillage. Checks run with 
paper in the bottom of the cage instead of sawdust demonstrated that crumbs and dust 
too small to be collected with a fingertip search weighed < 0.2g and hence were not 
considered to be a significant loss in the sawdust filled cages. Where water was 
provided the bottles were weighed prior to and post test session and the total amount of 
water consumed was calculated. 
70 
 
 
 
Figure 2.2. A comparison of the timelines for the behavioural satiety sequence, 2nd 
order and free intake test schedules.   indicates the point at which infusion of 
drug into the AcbSh took place. 
 
 
 
Behavioural Satiety Sequence (BSS):  
Apparatus 
All subjects were habituated to the test cages in a test room isolated from the holding 
room. The cage rack was designed to allow behavioural assessment in cohorts of 12. A 
microprocessor was programmed to illuminate LEDs, mounted adjacent to each test 
cage, at consecutive 2.5 s. intervals. These provided a signal for the observer to press 
the key on the keypad that corresponded with the behaviour the animal was engaged in 
at the time that the LED came on. The press turned the LED off but the next LED 
would illuminate 2.5s later irrespective of when the observer pressed the key. 
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Habituation and training 
The method was based on procedures previously described (Clifton et al., 1989; Vickers 
et al., 1996). Habituation was identical to that described for simple measures of 
increases in intake (above). The length of access to food during habituation was 
determined by the final test period to be used (see data chapters for details). As 
expected, consumption was low but acclimation to the test environment continued until 
there was no significant difference in the mean meal size over four consecutive days.  
 
Testing procedure 
Following habituation some of the test groups underwent surgical implantation of guide 
cannulae, were allowed to recover for a minimum of seven days and then reintroduced 
to the test cages and given access to food on a daily basis until responding was stable. 
On test days, as with the habituation period, food was removed from the home cage one 
hour before testing and replaced with 5 fresh pellets (~7g) to which rats had access for 
30 minutes. Animals receiving i.p injections were given drug at this stage and then 
transferred to the test cage for a further 30 minutes to compensate for initial arousal. For 
those animals receiving centrally administered drugs it was after this 30 minute period 
in the test cage that the infusions took place (see Fig. 2.2 for timeline). 
 
Animals were administered vehicle or drugs at various doses according to a within 
subjects procedure using a Latin square design then returned to the test cage. They were 
then presented with a pre-weighed dish of test diet for the designated test session 
period. Their behaviour was either videoed and then analysed at a later date or, at the 
time, using the keypad. During feeding, individuals were observed at 30 second 
intervals (the time taken for the LEDs to illuminate for every member of the cohort) 
across the total test period. Behaviour was subdivided into four mutually exclusive 
categories (based on those employed by a variety of laboratories) for scoring: 1) Ingest, 
2) Active, 3) Groom and 4) Inactive (See Table 2.1 for detailed definitions). 
 
 
 
 
72 
Table 2.1. Categories employed to record the behavioural satiety sequence in rats. 
The first four columns show categories that have been used in the past and the 
final column lists the categories developed from previous studies for this thesis. 
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Second-order operant responding (2nd order) 
Apparatus 
Animals were trained and tested in standard operant chambers (width 25cm x length 
25cm x height 21cm) controlled by the Paul Fray operating system (Paul Fray Ltd., UK) 
run on an Archimedes computer, using Arachnid. Each chamber was housed in a sound-
attenuating box with a fan to maintain adequate ventilation and to reduce the impact of 
ambient noise. The boxes were housed separately from the holding room, eliminating 
general procedural noises and olfactory or auditory stimuli from rats not undergoing 
testing. 
 
Chamber illumination came from ceiling mounted house lights and a separate cue light, 
6cm above the food magazine, could be independently programmed.  Presses on one of 
two, 4cm wide, levers inserted on either side of the food magazine could activate the 
cue light, deliver pellets or both. These pellets were delivered from an external pellet 
dispenser into a recessed well accessed by pushing a Perspex flap mounted at the front 
of the magazine. 10mm x 10mm galvanised wire mesh was used as flooring. Below this 
flooring was a waste pan containing sawdust.  
 
Habituation and training 
Initially rats were put onto a restricted diet of 14-16g of chow per animal (depending on 
average body weight calculated for each cage of 4 animals). After an initial weight loss 
down to 85-90% of free feeding weight this meal size was maintained as it provided 
adequate calories to support slow but steady weight gain. Once growth rate was 
stabilized on this restricted diet (<7 days), 45mg standard Noyes pellets (Formula A/I) 
were introduced with their meal for two days prior to the start of training.  
 
Rats initially received 2 days of habituation during which pellets were automatically 
delivered on a 120 s random time (RT) schedule until a total of 15 pellets had been 
delivered over a 30 minute period. Levers were retracted during the habituation phase. 
Once subjects were removed, the magazine was checked to make sure pellets had been 
consumed. With all subjects taking all of the pellets by the second session, training 
commenced the following day. Training sessions were 30 minutes long. Animals were 
initially trained on an FR1 schedule; one press on the correct lever (reinforced) resulted 
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in the stimulus light coming on for 8s and, 2s into this period, one pellet was delivered. 
Pressing on the other lever (incorrect) had no programmed consequences. 
 
The 8s centre light illumination was coincident with pellet delivery and hence the two 
became associated resulting in the light becoming a CS. The 8s period of illumination 
also indicated that the FR requirement had been fulfilled and any further lever presses 
on the correct lever after pellet delivery had no programmed consequences (referred to 
as non-reinforced presses). Levers were inserted for a total of 30 minutes. The position 
of the actively reinforced lever, left or right, was balanced for all experimental groups. 
When all animals were responding to the reinforced lever around 100 times (~ 3 days) 
the response requirement was increased to an FR5; five presses = CS and delivery of 
one pellet. They were trained on this contingency for 2 days. Next it was increased to an 
FR5 (2) where the animals had to complete a set of 5 presses for the CS twice for 
delivery of 2 pellets. 
 
At this stage training continued until all animals made 90% of their responses on the 
reinforced lever. The response requirement was then increased to an FR5 (3) for two 
days before the introduction of a five minute period (Fixed interval: FI5) at the start of 
the session in which responding on the reinforced lever resulted in a CS but no pellet 
delivery. Again, 90% correct responding was required before moving on to the final 
schedule, an FR5 (5) such that 5 reinforced presses = CS and 5 CSs (total of 25 presses) 
were consequently rewarded with delivery of 5 pellets (see Fig. 2.3). During this period 
animals were split up and re-housed in Perspex cages (as described above) but surgery 
was only undertaken when responding on the FI5/FR5 (5) schedule was stable over four 
consecutive days following the split. 
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Figure 2.3. Detailed timeline for the 2nd order operant schedule. In the first 5 
minute period 5 presses on the reinforced lever = cue light for 8s but none of the 
presses are rewarded. In the following 25 minutes 5 presses = cue light and 5 cue 
light illuminations are rewarded with 5 pellets. 
 
Once animals were fully trained they were returned to an ad libitum feeding regime. 
They were also habituated to palatable wet mash, which maintains hydration in post op 
animals and facilitates efficient oral administration of medication. Following recovery 
from surgery food was once again restricted to 14-16g / animal / day. After four days, 
food restricted subjects were re-trained on the FI5/FR5 (5) schedule until responding 
was not significantly different from pre-operative levels and remained stable for at least 
four consecutive days. 
 
Testing procedure 
On test days animals were pre-fed 1 hour prior to drug infusions to reduce baseline food 
reward responses to a low level. During pre-feeding, animals were allowed access to 5 
pellets of standard laboratory chow (~7g) for 30 min as for the BSS experiments (see 
Fig. 2.2 for timeline). The rats were infused in the holding rooms to minimise arousal 
caused by moving them to the test rooms. Animals were well habituated to the 
procedure and did not make any noise or show signs of distress that might affect the 
other animals in the room. Infusions were made as described above following a 
counterbalanced Latin Square design such that each animal served as its own control 
and subjects were tested in pairs to counter the potential effects of the lag time 
associated with administration. The drugs and doses used are specified in the data 
chapters. 
Appetitive phase Consummatory phase 
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Once a pair of animals had been infused they were moved to the testing room and 
placed in the operant boxes. Testing started at approximately 11:00 am so that the 
session finished well before the dark cycle began and before the expected feeding time 
for restricted animals. At least 48 hours was left between infusions and animals were re-
trained drug free on the days in between testing. 
 
 
Gross behavioural analysis 
Apparatus 
Miniature webcams were inserted into the door of each operant chamber. These were 
linked into a circuit board that tessellated the 4 images before they were fed to a VCR 
machine to record all four camera outputs simultaneously.           
 
 
 
Table 2.2. Behavioural categories used for analysis of videos recorded during 
second operant studies. 
 
 
Behavioural 
category 
Definition 
 
Active Moving around cage, rearing, sniffing, standing alert, circling, 
jumping and any other behaviour not defined elsewhere. 
Lever Pressing, touching or holding the lever. 
Hopper Poking of nose or paws into the pellet delivery hopper or touching 
of the Perspex flap covering the entrance to the hopper 
Pellet Handling or actively chewing pellets outside the hopper  
Rearing Front paws raised off the floor and nose directed at point above 
paw level. 
Groom Grooming, biting or licking of head, body or tail using mouth or 
limbs. 
Oral Oral stereotypy expressed as licking or chewing, predominantly of 
flooring but may be directed at walls of operant box. 
Inactive Absence of movement in a resting posture (head and/or body 
lowered) with or without eye closure. 
Off screen Completely off screen or obscured to the point that behaviour 
cannot be defined. 
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Testing procedure 
Behaviour in the 2nd order operant schedule was videoed and later analysed (blind) with 
a keyboard that triggers a computer to interrogate the video in terms of time and number 
of frames for the category of key pressed. The categories are 1) Active, 2) Lever, 3) 
Hopper, 4) Pellet, 5) Rearing, 6) Groom, 7) Oral, 8) Inactive and 9) Off screen (see 
Table 2.2). These are based on those used by Greenhalgh et al. 2007 and modified to 
best accommodate the behaviours exhibited by animals in these studies (see Chapter 4 
for detailed explanation). Each half hour segment of footage for the 2nd order test period 
was analysed in real time. A keypad with 8 keys was linked, with the VCR machine to a 
computer. ‘VideoTranscriber’ software, written in house by Prof. Pete Clifton, was used 
to record key presses and produce an output file that contained data points relative to 
the time and duration of key presses. Unix shell scripts were used to extract data for 
individual behaviours, providing numbers for total duration and frequency of 
occurrences of each behaviour under various drug conditions.  
 
Drugs, doses and chemical designations  
Muscimol (GABAA agonist) 
Drug preparation and storage 
Muscimol (Sigma, UK) was dissolved in 0.9% sterile saline, which gave a solution with 
a pH of around 7.5 without any adjustment (Table 2.4). Initially a 10 times (10X) 
concentration stock solution of 1 mg/ml was made up. The stock was filtered using a 
Millex GV 0.22µm sterile syringe filter unit (Millipore, USA) in a laminar flow cabinet. 
Further dilution and aliquoting was carried out in this sterile environment. All 
glassware, tips etc had been previously autoclaved. Behavioural efficacy of this dose in 
terms of intake was initially tested in a pilot study (not reported here) at a dose of 
880ρmols/µl-1, made up by further dilution of the 10X stock. This dose was chosen 
because it has been shown to cause a highly significant increase in chow consumption 
in previous experiments, being the most effective dose used by Stratford and Kelley 
(1997). 
 
Observations of behaviour indicated significant motor impairment in animals given 
880ρmols/µl-1, of muscimol. Although muscimol is used as a sedative when 
administered peripherally it does not follow that it would have sedative effects when 
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administered in the accumbens. Nevertheless it has been reported that infusions of the 
drug may induce catalepsy, muscular rigidity and postural asymmetry or a more general 
reduction in motor activity (Turski et al., 1984, Anden et al., 1979). A range of more 
appropriate doses for this strain was used for further tests by serially diluting the 10X 
stock to give solutions of 55, 110, 220, 440 and 660ρmols/µl-1 concentration. Table 2.3 
indicates how this range of doses compares with dose ranges tested previously by other 
laboratories. Aliquots were stored at  -20oC. The doses used for each set of tests are 
indicated in the relevant chapters.  
 
Baclofen (GABAB agonist) 
Drug preparation and storage 
Baclofen (Sigma, UK) was dissolved in 0.9% sterile saline and the pH of the solution 
adjusted to around 7.5 using 1M sodium hydroxide (Table 2.4). Initially a 10 times 
(10X) concentration stock solution of 1.88mg/ml was made up and pHing was carried 
out prior to any further dilution of this stock. Further dilution and aliquoting was carried 
out in this sterile environment as described above. Intake was tested in a pilot study (not 
reported in thesis) at a dose of 880ρmols, which was made up from the 10X stock. This 
dose was chosen because it has been shown to cause a highly significant increase in 
chow consumption in previous experiments (Stratford and Kelley, 1997; Ward et al, 
2000) and is equimolar to Stratford and Kelley’s (1997) most effective dose of 
muscimol. 
 
Observations of behaviour indicated significant motor impairment in animals given 
880ρmols of baclofen and it has been reported that the drug may affect motor activity 
or, more specifically, have a myorelaxant effect when administered into the accumbens 
(Lorenc-Koci et al., 1994, Jelen et al., 1994, Wachtel and Anden, 1978).  The range of 
doses that were consequently used in the rest of the experiments was 110, 220, 440 and 
660ρmols/µl-1. Table 2.3 indicates how this range of doses compares with dose ranges 
tested previously by other laboratories. Aliquots were stored at -20oC. The doses used 
for each set of tests are indicated in the relevant chapters.  
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Table 2.3. Table to show molar equivalents of baclofen and muscimol doses used 
by other laboratories compared to doses used for this thesis. 
 
 
Bretazenil (benzodiazepine) 
Drug preparation and storage 
Bretazenil (RO16-6028, Roche, UK) was made up at a concentration of 1mg/ml in 0.9% 
saline with 1 drop of Tween 20 added for every 5ml of saline (Table 2.4). The solution 
was sonicated for ~ 45minutes to fully dissolve the drug. Bretazenil was administered 
i.p. at a volume of 1ml/kg and hence a dose of 1mg/kg body weight. The bottle was 
shaken well between animals as there was a tendency for the bretazenil to come out of 
solution and for fine sediment to settle at the bottom. Testing did not begin until 30 
minutes post injection and during this time animals were returned to the home cage 
without access to their regular chow pellets. An appropriate volume of fresh drug 
solution was made up on each test day. 
 
DAMGO (µ-opioid agonist)  
Drug preparation and storage 
DAMGO (Sigma, UK) was made up in 0.9% sterile saline (Table 2.4) in sterile 
conditions and filtered as described previously. Initially a dose of 0.25ng/µl DAMGO 
was chosen having reviewed the range of doses utilised by a number of other 
laboratories. This dose was appropriate for the BSS study (Chapter 3) but Kelley’s 
 
Kelley and Stratford 
1997 
Ward et 
al. 2000 
Reynolds & 
Berridge 
2002 
Zhang et 
al. 2003 
Hanlon et 
al. 2004 
Dose range used in this 
thesis 
Molar 
equivalent 
Baclofen 
(ng) 
Muscimol 
(ng) 
Baclofen 
(ng) 
Muscimol 
(ng) 
Muscimol 
(ng) 
Muscimol 
(ng) 
Baclofen 
(ng) 
Muscimol 
(ng) 
pmols 
       6.25 55 
      23.5 12.5 110 
38 20       175 
      47 25 220 
74 40   40    350 
      94 50 440 
      141 75 660 
188 100 188  100  188 100 880 
   150     1320 
376 200   200 200   1750 
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laboratory suggests that some locomotor depression may occur which impairs lever 
pressing but wears off prior to the timing of maximum drug effect on feeding 30-60 min 
post-infusion (Zhang and Kelley, 1997; Zhang et al., 2003). It was decided, therefore, 
that their lower dose of 0.025ng/µl would be more appropriate to increase lever pressing 
in the consummatory phase of the 2nd order schedule (Chapter 4) with no confounding 
locomotor impairment and no need for a pre-treatment period prior to testing. Aliquots 
were stored at -20oC. The doses used for each set of tests are indicated in the relevant 
chapters.  
 
 
 
Table 2.4. Chemical designations and suppliers of compounds used in this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug name Chemical designation Carrier pHing to      
~ 7.4 
Supplier 
Baclofen (±)-Baclofen 
(±)- -(Aminomethyl)-4-
chlorobenzenepropanoic 
acid 
Lioresal 
0.9% saline 
 
+ 1M 
NaOH 
Sigma UK 
(Poole)  
Muscimol 3-Hydroxy-5-aminomethyl-
isoxazole 
 5-Aminomethyl-3-hydroxy-
isoxazole 
5-Aminomethyl-3-
isoxazolol 
0.9% saline NA Sigma UK 
(Poole) 
DAMGO [D-Ala2, N-Me-Phe4, Gly5-
ol]-Enkephalin acetate salt  
Tyr-D-Ala-Gly-N-methyl-
Phe-Gly-ol 
0.9% saline NA Sigma UK 
(Poole) 
Bretazenil Ro 16-6028 
9H-Imidazo[1,5-
a]pyrrolo[2,1-
c][1,4]benzodiazepine-1-
carboxylic acid 
0.9% saline 
Tween 20 
NA Roche UK 
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Data analysis and statistics 
Although group housing was based on the order in which animals came out of the 
transport boxes, the order in which they were consequently allocated to experimental 
conditions, operated on and given infusions or injections of drugs was randomised using 
numbers generated in Excel. Animals were numbered and caged consecutively as they 
came out of the transport box but which test cage location or operant box in which they 
were consequently trained was randomised. Using fully counterbalanced, within subject 
experiments where each animal acted as its own control the day on which they 
underwent surgery was also allocated randomly. Animals that underwent surgery on 
different days were then randomly allocated to each dose group for the first day of an 
experiment. Each study followed a formal experimental design, for example a Latin 
Square design, and statistical analysis was planned in advance using appropriate 
reference texts to supplement the basic approach recommended by Festing et al., (2002) 
(Howell, 2007, Howell, 2001, Field, 2000). Basic analysis procedures and statistics are 
described below and, in further detail, in each data chapter. 
 
All data were analysed in Genstat (version 9.1, VSN International, UK) using ANOVA 
with a repeated measures within subject design where appropriate and an alpha level of 
0.05. Data sets were checked for homogeneity of variance and a normal distribution of 
residuals using SPSS 11 for Mac OS X. Where results departed from normality or 
unequal variances were identified the analysis was adjusted to take this into account. 
Post hoc analyses were carried out using the Dunnett’s t test to compare treatments with 
the control condition. Where there was a reason to compare between treatments the 
Bonferroni test was applied. Any other statistical procedures used will be indicated in 
the data chapters. 
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Chapter 3 
GABA receptor subtype stimulation in the accumbens: 
effects on the behavioural satiety sequence (BSS). 
 
Introduction 
In 1997 Stratford and Kelley reported that GABA agonists infused directly into the Acb 
shell (AcbSh) robustly increased intake of solid food and had “specific effects on 
feeding behaviour”.  This led to their suggestion that GABA-sensitive cells in this brain 
region may constitute an “important component of the central mechanisms controlling 
food intake”. Both GABAA and GABAB receptors present in the Acb have, over the 
following decade, been amply demonstrated to play a role in the control of feeding (see 
introduction) but the exact nature of that role has yet to be firmly established. GABA 
receptor manipulation in the shell has been described as producing “behaviourally 
selective” effects on feeding (Stratford, 2007) but, as Kelley’s hypothesis suggests, this 
may only represent a release of basic motor response components of the ingestive 
process (Kelley et al., 2005b, , 2005a). 
 
In the introduction to this thesis I presented evidence that, although the orexigenic 
effects of GABA receptor agonists in the Acb are undisputed, there is actually little 
additional data published on the complete feeding behavioural profile or functional 
specificity of this manipulation. There is no research available on the macrostructure or 
microstructure of the behaviourally selective effects associated specifically with eating 
solid food. In particular, there is only a minimal amount of incidental information 
pertaining to the effects of intra-Acb GABA agonists on specific phases of feeding i.e. 
appetitive, consummatory and satiety stages (see Introduction for details). There is also 
no report that demonstrates a simultaneous assessment of the effects of GABA receptor 
agonists on total intake when food is freely available, feeding behaviours and non-
feeding behaviours. 
 
To date researchers appear to have relied on the evidence that the manipulation of 
endogenous levels of GABA and the blockade of glutamate transmission in the Acb 
also induces hyperphagia to support the assertion that the effects of GABA agonists on 
food intake are functionally significant and physiologically relevant (for a review see 
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Stratford 2007). Another compelling factor appears to be that stimulation of GABA 
sensitive cells does not increase in the intake of water or non-caloric solutions (Stratford 
et al., 1998, Basso and Kelley, 1999, Ward et al., 2000). It has also been demonstrated 
that intra-AcbSh GABA receptor stimulation has no effects on locomotor activity or 
motor coordination whilst animals are feeding (Stratford and Kelley, 1997b, Lopes et 
al., 2007). This certainly does not exclude the possibility that intra-Acb GABA receptor 
stimulation simultaneously disrupts the expression of other species specific non-feeding 
behaviours (Tallett et al., 2008). 
 
When animals stop feeding it might not be a specific sign of satiety (Antin et al., 1975) 
given that they may do so to engage in other behaviours such as drinking, grooming, 
exploring, resting, social interaction and defensive behaviours (Bolles, 1960, Richter, 
1922, Barnett, 1956) or because of other factors such as nausea or malaise (Blundell et 
al., 1985). It has long been recognised that an undisrupted meal progresses in a 
predictable manner. A complete temporal profile that directly compares multiple 
behaviours associated with the progression of a meal under the influence of central 
GABA agonists or vehicle could allow distinctions to be made between functionally 
specific and non-specific drug effects. For this thesis a well established time sampling 
method will be used to record such a behavioural profile, which is described in more 
detail below. 
 
The transition from feeding to post-prandial behaviours is termed the Behavioural 
Satiety Sequence (BSS). Richter first described the predictable pattern of activity that 
follows feeding (the BSS) in 1922, observing that there was a distinct profile of 
behaviours displayed by his rats when given access to food. This was characterized by 
an initial period of feeding followed by a considerable amount of exploratory and 
general activity once feeding had terminated. Animals would spend much time 
grooming themselves and eventually would either cease all other activity and ‘rest’ or 
fall asleep. Richter designed a two-chamber cage with very basic pressure sensors 
attached to a smoke drum to record a trace representing activity in each chamber. In the 
smallest chamber food was accessible but not removable so that only feeding activity 
was recorded in this area. Recordings of activity in the other chamber were 
supplemented by observations of what the animal was actually doing during each 
period. His work highlighted the value of observing an extensive component or 
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repertoire of species-specific behaviour as well as measuring discrete indices of a 
response to external manipulation. 
 
Bolles (1960) expanded on Richter’s method by using a modified time-sampling 
procedure based on that described by Bindra and Blond (1958) to visually scan the 
behaviour of rats feeding on pellets in their home cage. By allowing the animals to 
manipulate and carry the food where they wanted to a more natural BSS could be 
recorded. He separated out observations into three categories of ‘grooming’ behaviour 
and four other categories: eating, drinking, sleeping and a general ‘miscellaneous’ 
category encompassing exploring, sniffing and ‘being active’; active behaviours which 
could not be reliably distinguished by different observers (Bolles, 1960). The results 
indicated that grooming usually occurred “after other kinds of directed behaviour”, for 
example after eating, and that it was “predictable from its behavioural context” (Bolles, 
1960). Thus the idea of a predictable sequence of events following feeding began to 
emerge.  It was not until the mid 1960’s however that careful behavioural observations 
based on Richter’s work were regularly used in conjunction with manipulations of 
feeding behaviour (Smith, 1997). 
 
By 1974 Smith et al. were following up the concept suggested by Bolles that it was 
specifically the onset of satiety that was characterised by this clear sequence of 
behaviours and, in 1975, this group confirmed the existence of a “specific behavioural 
sequence of satiety” that could be manipulated by exogenous cholecystokinin (CCK), a 
gut hormone thought to be a mediator of satiety (Antin et al., 1975). The BSS, as it 
became known, was shown to develop with the gradual cessation of normal feeding but 
did not progress if the food did not reach the stomach or if it was made unpalatable 
using quinine (Antin et al., 1975, Liebling et al., 1975, Young et al., 1974, Antin et al., 
1977). Halford  (1998) suggests that the credibility of the BSS was established in 
particular through G.P. Smith’s work, a strong proponent of Richter’s seminal research 
(Smith, 2007). Antin et al. (1975) also used a modified time sample method to measure 
behavioural components of feeding in response to presentation with a liquid diet. Their 
behavioural categories were much more specifically defined than those employed by 
Bolles (1960) and inter-rater reliability was high (Antin et al., 1975). 
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It is now widely accepted that the BSS can be observed with the natural operation of 
satiety (Bolles, 1960) and better reflects the process than cessation of feeding alone 
(Blundell et al., 1985). The BSS is particularly sensitive to the organization of 
consummatory components of feeding and related behaviour patterns (Clifton and 
Cooper, 1996). The sequence is preserved but temporally shifted after treatments that 
enhance or decrease satiety and those that specifically affect appetite, for example, via 
palatability estimation (Halford et al., 1998). Observation of this consistent sequence of 
events in response to a meal is now regularly used as a tool to study the physiological 
relevance of peripheral and central manipulations of feeding on the basis that this 
pattern can be modified or even totally disrupted by various orexigenic and 
anorexigenic compounds (Halford et al., 1998).  
 
In the context of this thesis two potential gross effects on the BSS will be considered. 
First of all, if the treatment causes a behaviourally selective increase in feeding but does 
not directly affect other behaviours a temporal shift of the whole BSS to the right is 
expected. All four behaviours specified in the methods section i.e. ingestion, activity, 
grooming and inactivity will most likely still be present but, the proportion of the latter 
three behaviours may be relatively reduced if they are yet to be fully expressed due to 
the delay in the onset of satiety. One might predict that, for example, if the BSS was 
very delayed resting behaviour may not appear within the standard test period. 
 
In contrast to this temporal shift it might also be possible to see a significant 
enhancement or reduction in non-feeding behaviours such that the order of progression 
of the BSS is actually disrupted. For example if one or more of the behavioural 
components was robustly reduced or even absent the BSS could be described as being 
disrupted. The same would hold true if one or more of the behavioural components was 
significantly enhanced at the expense of the appearance of another behaviour and again 
the BSS would be described as disrupted. 
 
There are some more subtle shifts that will be considered on a case by case basis when 
interpreting the results reported here, for example if the BSS is preserved but the timing 
of its onset rather than the termination of the meal is shifted. Nevertheless, where the 
BSS is described as “temporally shifted” or “disrupted” the meaning of these terms 
should be taken as they are described here i.e.: Temporal shift  = presence of all four 
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behaviours but shifted to the right (with the possible loss of the final stages of the BSS 
i.e. inactivity); Disruption = Significant reduction or absence of one or more behaviours 
without effects on other categories or significant reduction or absence of one or more 
behaviours because of an increase in other categories. Care must be taken with this 
latter interpretation of disruption as, without extending the test period, this could 
represent a major temporal shift and this will be taken into account when interpreting 
the findings. 
 
To illustrate what we would expect to see in a control group of animals maintained on 
an ad libitum diet but habituated to gaining direct access to fresh chow for a limited 
period each day, I have shown a “typical” BSS (see Fig. 3.1). This is based on the 
average proportions of behaviour recorded from a group of animals given a wet mash 
diet (from Halford et al. 1998). Pilot studies carried out prior to the experiments 
reported in this chapter indicated that animals given access to chow follow a similar 
BSS despite the smaller volume of food consumed. Indeed Antin et al. (1975) reported a 
recognisable BSS with a liquid diet and the value of using the BSS would be 
questionable if the general pattern only held for one meal type. Note that in Fig. 3.1. 
some grooming behaviour is present throughout the session but there is a trend towards 
an increase as feeding trails off. 
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Figure 3.1. Example of a ‘typical’ behavioural satiety sequence (BSS) expressed by 
rats given access to a wet mash diet for 40 minutes (based on Figure 2, Halford et 
al. 1998). The vertical line indicates the point at which there is a transition from 
ingestion to inactive behaviour. 
 
 
The methodological approach for recording the BSS has changed somewhat over the 
years. Although the behaviours recorded predominantly reflect the main categories 
described by Richter (1922) there appears to be no clear consensus on the precise 
definitions (refer to Table 2.1, Chapter 2, page 72). There also remain differences in 
opinion as to how the incidence of each behaviour should be recorded. In general, 
however, data is currently collected in one of two ways. First of all, total time spent 
engaging in each behaviour can be recorded after the event from videos/DVDs of test 
sessions using a continuous monitoring technique (e.g. Ishii et al., 2003a/b). The data is 
usually then parsed into time bins e.g. of 5 minutes and duration is plotted against 
period of test session. 
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The second method involves direct observation during the test session and recording of 
the current behaviour at discrete time points for a number of animals simultaneously 
(Clifton, 2005). Although, in essence, it is a form of one-zero sampling (such that a 
behaviour is absent or present at the sampling time) the instantaneous or scan sampling 
method (for groups) involves recording the current behavioural state of the animal 
assuming that the sample period is much shorter than the average duration of that 
behaviour (Altmann, 1974).  
 
The method described by Clifton (2005) is also referred to as a Momentary Time 
Sampling (MTS) procedure (Powell et al., 1977). Altmann (1974) concludes that this 
method is particularly useful for estimating the proportion of time spent engaged in 
non-social behaviours using easily distinguishable categories, very short observation 
periods and evenly distributed sampling points. It has been suggested that the latter 
method permits an increase in statistical power because more subjects and treatment 
conditions can be handled in one study (Clifton, 2005) and this method is the one used 
regularly in this laboratory (See Chapter 2, page 70). This is the method described in 
detail in Chapter 2. 
 
Halford et al. (1998) describe the BSS as a “powerful biobehavioural assay of drug 
action on appetite” and have employed this approach extensively within the laboratory 
at Leeds over the last two decades. Consequently the characterisation of the BSS 
elicited by the manipulation of GABAA or GABAB receptor function in the Acb 
constituted one of the primary methods used to answer the questions posed in this 
thesis. Building a record of the BSS is a useful approach to characterising the full 
profile of behaviours associated with ingestion induced by GABAA or GABAB agonists 
because the animals can express natural behaviour without restraint. The effects of both 
can be compared and it will also allow analysis of the microstructure of behaviours over 
time. The BSS should help to highlight any drug effects that are not specific to feeding.   
 
One of the other key aims stated in the introduction, Chapter 1 (page 59), is to compare 
the effects of GABA receptor subtype stimulation in the Acb with other 
pharmacological manipulations believed to independently affect specific phases of 
ingestive behaviour. In this Chapter the actions of intra-Acb GABA agonists (which 
were introduced in detail in the introduction to this thesis); muscimol (GABAA) and 
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baclofen (GABAB) on the BSS are compared to those associated with intra-Acb 
injections of an opioid agonist, systemic administration of a benzodiazepine (both of 
which increase intake) and to natural effects of hunger induced by periods of fasting. 
 
It was deemed prudent to include a drug comparison using a compound that also 
robustly increases intake (but via different mechanisms) when injected directly into the 
same region of the Acb as the GABA agonists. A large body of evidence would suggest 
that the release of the opioid peptide enkephalin and stimulation of opioid receptors 
within the striatum is associated with increased food intake (Kelley et al., 2002). In this 
case the obvious choice was a selective µ-opioid agonist. The effects of peripheral and 
central administration of these compounds has been widely studied (see Chapter 1, page 
50) and, in particular, their effects in the AcbSh are well characterised. The µ-opioid 
receptor in the Acb has been implicated in increases in intake (Bakshi and Kelley, 
1993b) particularly for highly palatable and preferred meals including sucrose, non-
caloric saccharin, dilute saline solution and lipids (Mucha and Iversen, 1986, Kelley et 
al., 1996, Kelley et al., 2002, Zhang and Kelley, 2002, Zhang and Kelley, 2000, Zhang 
and Kelley, 1997). 
 
DAMGO ([D-Ala2,N-Me-Phe4-Gly5-ol]-enkephalin) is a synthetic opioid peptide that 
has a high affinity for the µ-opioid receptor (Handa et al., 1981). It would appear that 
opioid signalling in the Acb promotes consummatory behaviours via the perceived 
palatability of the food and that these effects are amplified in previously more 
hedonically rewarding food types which subsequently reinforces responding in operant 
schedules and shapes food preferences (Gosnell and Patel, 1993, Hanlon et al., 2004, 
Bodnar, 2007, Bodnar, 2004). Nevertheless DAMGO also increases intake of chow 
(Bakshi and Kelley, 1993b) and would be expected to produce a BSS similar to that 
associated with enhancement of palatability e.g. by adding sucrose to the meal (Ishii et 
al., 2003b). This can then be directly compared to the BSS recorded with baclofen or 
muscimol to establish if there are any signs of appetitive processes being mediated by 
GABA in the Acb. 
 
It has also been important to keep in mind that another aim was to elucidate how closely 
GABA receptor stimulation alone can been seen as necessary and adequate for the 
expression of naturalistic, physiologically driven feeding responses. Ishii et al. (2003) 
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point out that, to adequately interpret the effects of pharmacological manipulations on 
the BSS, it is important to use a reference profile of natural motivational manipulations 
of the behavioural repertoire. In this case an experiment will be included that will 
involve subjecting animals to systematically varied periods of fasting prior to a free-
feeding test period with chow. The effects of hunger on the BSS have been 
demonstrated before using a mash meal (Ishii et al., 2003a) and, as with the control 
conditions, it is predicted that the BSS in response to chow following fasting will fit 
much the same general pattern. 
 
Systemic BZs have also been shown to robustly and consistently increase intake via 
interactions with a variety of brain regions but probably not the Acb (Soderpalm and 
Berridge, 2000). The use of BZs could provide an interesting counterpoint to the data 
from the experiments using centrally administered drugs. The effects of BZs are also 
believed to be due to palatability enhancement (Cooper, 2005, O'Hare et al., 2006) as is 
the case with DAMGO but the structures involved are different to those that subserve 
the latter effect. 
 
One of the difficulties with using BZs to study hyperphagia however is the prevalence 
of common and robust side effects such as sedation (Haefely et al., 1993) and the 
possibility that, at higher doses, full agonist effects increase intake due to anxiogenesis 
(and/or reduction in neophobia) rather than via effects on appetite (Shephard and Estall, 
1984). Nevertheless it is now widely accepted that the hyperphagic effect is 
independent of other behavioural effects and is directly mediated by BZs (Cooper, 
2005). The discovery of a range of compounds that act as partial BZ agonists led to the 
realisation that there is a sliding scale of efficacy for various behavioural measures with 
some partial agonists exhibiting a limited effect on motor responding but a robust effect 
on intake (Martin et al., 1993). 
 
One of these partial agonists, bretazenil, is more behaviourally selective than the full 
agonists (Pieri et al., 1988, Martin et al., 1988, Haefely, 1984) and causes a robust 
increase in intake when administered peripherally (Yerbury and Cooper, 1987). Cooper 
(2005) goes as far as to quote Martin et al (1993) who say that it is “an example of an 
appetite-selective drug for which the hyperphagic activity can be completely dissociated 
from the major side-effects of full agonists”.  The distinct profile of the BSS associated 
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with this increase in intake has been characterised, as have the longer term effects on 
meal patterning (Clifton and Cooper, 1996). Bretazenil also facilitates conditioned place 
preference (Di Scala et al., 1992) in a manner consistent with a number of other 
orexigenic compounds (Spiteri et al., 2000, Tzschentke, 1998, Schechter and 
Calcagnetti, 1998). As such it is an ideal candidate as a point of comparison between 
hyperphagic effects that are behaviourally specific and attributed to enhanced appetite 
mediated by structures other than the Acb and the effects of GABA agonists that may or 
may not encompass an appetite-enhancing component. 
 
The results reported in this Chapter will begin, therefore, to address four of the key aims 
of this thesis. The first two experiments, 3.1 and 3.2, will provide a record of the BSS 
elicited by intra-Acb baclofen or muscimol which will contribute to the characterisation 
and comparison of the effects of GABA receptor subtype stimulation on feeding related 
behaviours. Both of these experiments will also test the hypothesis put forward by 
Kelley and colleagues that GABA receptor stimulation in the Acb simply results in 
increased intake because of the consequent release of downstream motor pattern 
generators. On the basis of their hypothesis it would be predicted that the increase in 
motor behaviours specifically directed at food consumption could limit the expression 
of the rest of BSS behavioural repertoire in both cases. 
 
In experiments 3.3 and 3.5 the use of other pharmacological manipulations i.e. intra-
Acb DAMGO and peripheral bretazenil will help to elucidate whether the effects of 
GABA receptor stimulation are specific to different phases of ingestion e.g. anticipatory 
responding, consummatory behaviour and satiety mediated by the Acb. By comparing 
hyperphagia induced by intra-Acb baclofen and muscimol with that induced by hunger 
in experiment 3.4 it will help to put the role of GABA in the context of naturally elicited 
feeding and motivational control in general. 
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The final experiment compares the effects of testing a peripherally administered drug 
with a chow meal (as used in the first five experiments) or a mash meal. This 
experiment was carried out because, as will be demonstrated in experiment 3.5 below, 
the BSS recorded with bretazenil and chow does not mimic that previously reported for 
bretazenil and a mash meal. This could raise questions about the use of chow as the test 
diet in the first five experiments, which will be discussed at the end of this chapter. 
 
To summarise, previous research shows that rats presented with a familiar and freely 
accessible meal exhibit a distinct profile of behaviour as they eat. Initially their 
behaviour is dominated by ingestion, and then succeeded by periods of activity, 
grooming and finally rest. The pattern of this sequence is preserved but temporally 
shifted in specific ways by experimental manipulations of initial appetite, palatability or 
satiety (Ishii et al., 2003a, Halford et al., 1998, Ishii et al., 2003b). The sequence is 
disrupted by drugs that reduce intake through nausea, general malaise, sedation or 
hyperactivity (Halford et al., 1998).  The six experiments reported in this chapter: 
 
1) Characterise and compare the effects of GABAA and GABAB agonists on 
feeding related behaviours (Experiments 3.1 and 3.2). Do the GABA agonist 
subtypes produce similar BSS profiles with a chow meal? 
2) Test the hypothesis that the effects are due to the release of downstream motor 
pattern generators (Experiments 3.1 and 3.2). Do the GABA agonist subtypes 
shift or disrupt the BSS? 
3)  Compare the effects of GABA agonists in the Acb to those of other drugs 
injected into the same region and known to affect specific phases of ingestive 
behaviour (Experiment 3.3). Do the GABA agonist subtypes enhance appetite, 
increase consummatory behaviour or delay satiety? 
4) Put these results in the context of the known effects of hunger, and hence, the 
broader category of motivated behaviour (Experiment 3.4). Do the effects of the 
GABA agonist subtypes mimic the effects of hunger on the BSS? 
5) Compare the effects of Acb receptor manipulation with peripheral drug effects 
also known to affect specific phases of ingestive behaviour but via different 
mechanisms (Experiment 3.5). Do the effects of GABA subtype agonists 
represent an Acb specific control of feeding or a more general effect mediated 
by multiple brain regions? 
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6) Begin to address potential issues raised by using different meal types to 
characterise a BSS (Experiment 3.6).  
 
On top of these key questions the overarching question asked in this chapter is: 
 
Does intra-Acb administration of the GABA receptor subtype agonists baclofen and 
muscimol modify responses to food in a manner consistent with behaviourally selective 
effects on appetite and/or satiety rather than simply via the release of downstream motor 
components that perpetuate the physical act of consumption? 
 
Experiments presented in this chapter 
Experiment 3.1 
BSS with chow following bilateral intra-Acb infusions of the GABAB agonist baclofen.  
 
Experiment 3.2 
BSS with chow following bilateral intra-Acb infusions of the GABAA agonist 
muscimol.  
 
Experiment 3.3 
BSS with chow following bilateral intra-AcbSh infusions of the µ-opioid agonist 
DAMGO. 
 
Experiment 3.4 
BSS with chow following periods of food restriction (4 and 8 hours). 
 
Experiment 3.5 
BSS with chow following peripheral administration of the benzodiazepine bretazenil. 
 
Experiment 3.6 
BSS with mash following peripheral administration of the benzodiazepine bretazenil. 
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Materials and methods 
Animals 
A group of drug naïve animals (n=12) were used for Experiment 3.1 (BSS with 
baclofen). After a break the same group were then run through the BSS test again for 
experiment 3.3 (BSS with DAMGO). Experiment 3.2 (BSS with muscimol) was carried 
out whilst measuring dose effects on intake in a group of animals that had previously 
undergone testing in a 2nd order operant experiment (experiment 5.2, Chapter 5). A 
second group of drug naïve animals (n=12) was used for experiments 3.4 (BSS with 
fasting) and 3.5 (BSS with bretazenil). These two experiments were run together using a 
counterbalanced design (see procedures below). Finally, a third batch of drug naïve 
animals (n=12), were used for experiment 3.6 (BSS with bretazenil and mash meal). 
Figure 3.2. illustrates the order in which groups of animals were used. Subjects were 
bought in weighing between 250-275g. 
 
Given the relatively short period of habituation required before surgery the first naïve 
group brought in for experiments 3.1 / 3.3 were housed singly in Perspex cages upon 
arrival. For experiment 3.2 animals that came from the 2nd order experiment (carried out 
in experiment 5.2, Chapter 5) were already housed in Perspex cages. The second naïve 
cohort used for both experiments 3.4 and 3.5 (that did not undergo surgery) were 
initially housed in groups of three in standard cages then transferred to standard single 
cages for 7 days prior to testing. The third and final naïve group used for the systemic 
drug administration in experiment 3.6 were housed singly in standard cages upon 
arrival.   
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Figure 3.2. Diagram to show which groups of animals were used for more than one 
test procedure within experiments 3.1 - 3.6 and the timeline for each experiment. 
Apparatus and habituation 
 
 
The apparatus and habituation procedure for the BSS experiments are described in 
detail in Chapter 2 (page 70). Irrespective of their origin (naïve from Harlan or used 
following on from a previous experiment) animals were habituated to the test cages and 
testing procedure in the same way. The only caveat is that the animals in experiment 3.2 
(BSS with muscimol) were habituated whilst they were still food restricted for the 2nd 
order experiment. They received 5 fresh pellets at the same stage in the habituation 
procedure as all other groups so as to reduce intake to a low baseline level (refer to 
training and testing timeline in Fig. 2.2, Chapter 2, page 70). Groups that did not 
undergo surgery were given an extra four days habituation to parallel the re-training 
period that postoperative animals received (indicated by the extended habituation phase 
depicted in Fig. 3.2). In experiment 3.6 (BSS with bretazenil and mash) animals were 
given access to a glass pot of mash in the home cage for 2 days prior to introduction of 
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this meal in the test cage during habituation. Animals undergoing infusions in 
experiments 3.1, 3.2, and 3.3 were habituated to the procedure as described in Chapter 
2, (page 67). Animals in experiments 3.4/3.5 and 3.6 were habituated to receiving i.p. 
injections using a 0.9% saline sham on two occasions prior to testing.  
 
Experiments 3.1 – 3.5 tested the BSS in response to standard laboratory chow pellets 
(10 fresh pellets in a glass pot) whilst in 3.6 the BSS with wet mash was tested. Testing 
procedures for the BSS experiments are described in Chapter 2, (page 71). In all cases a 
within subject, counterbalanced, Latin square design was used such that each subject 
acted as its own control. Animals were not put in test cages between test days. 
 
Specific procedural details – central drug administration 
Only two animals were tested at a time when drugs were centrally infused (experiments 
3.1, 3.2 and 3.3) to compensate for the time taken for each infusion. The total test 
period for central experiments was 30 minutes so that all 6 pairs could be tested over as 
short a period as possible between 10:00 and 16:00. This meant that behaviour for each 
of the two animals was recorded every 2.5 seconds and therefore a total of 360 
observations were recorded for each. There was a minimum of 48 hours between 
infusions. 
 
Experiment 3.1 
In experiment 3.1 animals were infused with a dose range of 110, 220 and 440 
ρmols/µl-1 baclofen or vehicle (0.9% sterile saline – used throughout) immediately 
before being transferred to the test cages. After testing with baclofen these animals were 
given a few days drug free and then this experiment was followed by a BSS test using 
DAMGO (see details for Exp. 3.3 below).  
Experiment 3.2 
In experiment 3.2 a dose range of 220, 440, 660 ρmols/µl-1 muscimol plus vehicle was 
tested. This higher dose range was used because this was the range that had been 
previously tested in the 2nd order experiment. The BSS data were collected at the same 
time as measuring the effect of this dose range on total intake. 
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Experiment 3.3 
In experiment 3.3 only one dose of 0.25ng/µl-1 of DAMGO or vehicle was tested. This 
dose has previously been shown to be behaviourally effective in terms of increased 
intake when infused into the Acb (Hanlon et al., 2004). 
 
Specific procedural details – other BSS studies 
The test period for systemic experiments or those using physiological manipulation was 
40 minutes as used in this laboratory previously (Clifton et al., 1989). In this case, 
where animals were tested as a cohort of twelve, each animal’s behaviour was observed 
every 30 seconds and 80 observations were recorded in total for each. For experiments 
3.4 (BSS with fasting) and 3.5 (BSS with bretazenil) a counterbalanced design was used 
so that each animal experienced both fasting and bretazenil treatment categories as well 
as the control condition over the course of testing. There was a minimum of 72 hours 
between i.p. injections. 
 
Experiment 3.4 and 3.5 
In these experiments animals received five possible treatment options encompassing 
either bretazenil doses or periods of fasting. The treatment categories were: 
 
1) vehicle + no fast = control condition 
2) vehicle + 4hr fast = 1st condition Exp. 3.4 
3) vehicle + 8hr fast, = 2nd condition 3.4 
4) 0.3mg/kg-1 bretazenil + no fast = 1st condition Exp. 3.5 
5) 1.0mg/kg-1 bretazenil + no fast.  = 2nd condition Exp. 3.5 
 
For the fasting treatment categories all food was removed at a) 7.30am and animals 
were tested at 15.30 (8 hour fast) or b) 11.30am and animals were tested at 15.30 (4 
hour fast). Thirty minutes prior to recording the BSS fasted animals or un-fasted control 
animals were given a vehicle injection i.p.. Those animals receiving bretazenil were also 
injected at this time. Note that in every condition animals received an injection even if it 
was only vehicle to ensure that the level of stress experienced was equivalent.  
 
 
 
98 
Experiment 3.6 
In experiment 3.6, the BSS in response to mash was tested with vehicle or 1.0mg/kg-1 
bretazenil only. 
 
Data analysis 
The final analysis groups were decided on the basis of histological verification of 
infusion sites. The cumulative data for the proportion of time point samples represented 
by each behaviour were extracted for these animals from the raw output data then 
amalgamated into five minute time bins using Unix Shell scripts. The results parsed into 
time bins provided 60 recording of behaviour per animal per bin in experiments 3.1, 3.2 
and 3.3. For experiments 3.4/3.5 and 3.6 there were 10 recordings of behaviour per 
animal per bin. 
 
The mean proportion of each behaviour in each time bin and the relative changes in 
these proportions over time were compared between doses using a repeated measures, 
mixed design ANOVA with dose, behavioural category and time-bin as factors. The 
effects on total intake was analysed using a within subjects, repeated measures ANOVA 
with dose as factor. Data were plotted as stacked columns for each 5 minute bin to show 
the relative proportions of each behaviour and the same data were also represented in 
line plots to better illustrate the change in the proportion of individual behaviours across 
the test session. 
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Results 
Experiment 3.1: BSS with chow following bilateral intra-AcbSh 
infusions of the GABAB agonist baclofen at 110, 220 & 440ρmols/µl -1. 
 
 
 
 
 
 
Figure 3.3. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma. Bilateral target coordinates (n=10) 
were (AP), + 1.2mm, mediolateral (ML), ± 1.5mm relative to bregma and 
dorsoventral (DV), -7.8mm relative to skull surface. 
 
 
 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
β  +1.0mm 
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A schematic illustration of Acb infusion site placements is given in Fig. 3.3. A total of 
n=10 animals were found to have placements that fell within the acceptable target area 
defined in Chapter 2 (page 68) . 
 
Baclofen infused into the Acb of pre-satiated animals dose dependently increased chow 
intake relative to intake with vehicle [Fig. 3.4; F (3,27) =15.48, p < 0.001], significantly 
so at 110ρmols/µl-1 (p < 0.05), 220 and 440ρmols/µl-1  (p < 0.001).  
 
 
 
 
 
 
 
 
Figure 3.4. The effects of bilateral infusions of saline and a range of doses of 
baclofen into the Acb in pre-fed rats (n=10) given access to laboratory chow over a 
30 minute test session. Error bars represent ±SEM. Significant differences from 
vehicle are denoted by * p<0.05, ** p < 0.01. 
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The BSS was also affected in a dose dependant manner (Fig. 3.5). Overall there was a 
highly significant interaction between drug and time manifested as an increase across 
the early part of session for the category ‘Ingest’ [F (15,135)=1.87, p=0.032]. The 
significant interaction for the ‘Active’ category [F (15,135)=3.78, p < 0.001] reflected 
both a decrease and consequent increase, and the ‘Inactive’ category saw a reduction  [F 
(15,135)=8.64, p < 0.001]. There was no significant effect on grooming. 
 
Planned post-hoc analysis using Dunnett’s test indicated that the increase in feeding 
behaviour was only significant 5-10 minutes into the session at the lowest dose of 
110ρmols (p < 0.05), between 0-15 minutes at 220ρmols (0-5 minutes, p < 0.05; 5-15 
minutes, p < 0.01) and throughout the last 25 minutes of the session at the highest dose 
of 440ρmols (5-15 minutes, p < 0.01; 15-20 minutes, p < 0.05; 20-25, p < 0.01; 25-30 
minutes, p < 0.05). 
 
Active behaviour was significantly lower during the first 0-15 minutes at doses of 
220ρmols (0-10 minutes p < 0.01 and 10-15 minutes, p < 0.05) and 440ρmols (0-15 
minutes, p < 0.01) of baclofen. It was also lower during this period at 110ρmols but 
only significantly so between 5-10 minutes (p < 0.05). There was no significant 
difference in activity at any dose between 15-25 minutes but the proportion was slightly 
but significantly higher in the last 5 minutes at 220ρmols (p < 0.05). 
 
Inactive behaviour was almost completely absent over the entire 30 minute test period 
at all three doses. In the last 10 minutes inactive behaviour was significantly lower than 
with vehicle at all doses of baclofen (20-30 minutes, p < 0.01). Fig 3.6 shows that the 
transition from feeding to inactivity occurred between 15 and 20 minutes (but closer to 
20 minutes) with vehicle. There was no transition within the 30 minutes with drug 
treatment. 
 
Whilst recording the BSS it was noted that animals treated with baclofen increasingly 
engaged in some additional behaviour including consumption of sawdust or faeces and 
licking the floor for crumbs, particularly at the highest dose.  This was recorded as part 
of the ‘Ingest’ category.  
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Figure 3.5. The behavioural satiety sequence (BSS) with a range of doses of 
baclofen compared to vehicle (n=10). The relative proportions of each behaviour 
are shown in 5 minute time bins over a 30 minute period of free access to chow.  
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Figure 3.6. The effects of various doses of baclofen compared to vehicle on the time 
course of ingestive, active, grooming and inactive behaviours split into 5 minute 
bins (n=10). The vertical line on the ‘vehicle’ chart indicates the point at which 
there is a transition from ingestion to inactive behaviour. This does not occur 
within the 30 minute time frame at any of the doses of baclofen. 
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Experiment 3.2: BSS with chow following bilateral intra-AcbSh 
infusions of the GABAA agonist muscimol at 220, 440, 660ρmols/µl-1. 
 
 
 
 
 
 
Figure 3.7. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma. Bilateral target coordinates (n=8) 
were (AP), + 1.4mm, mediolateral (ML), ± 0.9mm relative to bregma and 
dorsoventral (DV), -7.8mm relative to skull surface. 
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A schematic illustration of Acb infusion site placements is given in Fig. 3.7 A total of 
n=8 of the original n=12 animals were found to have placements that fell within the 
acceptable target area defined in Chapter 2 (page 68).  
 
Muscimol infused into the Acb of satiated animals increased chow intake relative to 
intake with vehicle [Fig. 3.8; F =3,20(1), p < 0.001], significantly so at all doses (p < 
0.001) but there was no difference in the total amount of chow consumed between 
doses. 
 
The BSS was significantly different from vehicle with all drug treatments but, again, 
there was no apparent dose dependant effect (Fig. 3.9). Overall there was a highly 
significant interaction between drug and time manifested as an increase in the category 
‘Ingest’ [F (15,100(5))=2.01, p=0.021], across the session.  The interaction for the 
‘Active’ category [F (15,100(5))=3.09, p < 0.001] reflected a decrease as it did for the 
category ‘Inactive’ [F (15,100(5))=4.32, p < 0.001]. There was an effect of drug on 
grooming [F(3,20(1))=15.2, p < 0.001] but there was no interaction between drug and 
time. 
 
Planned post-hoc analysis using Dunnett’s test indicated that the increase in feeding was 
significant at all doses across all time bins (p < 0.01). Active behaviour was 
significantly lower at all doses for the first 20 minutes (0-20 minutes, p < 0.01 at all 
doses). There was no significant difference in activity at any dose during the last 10 
minutes. Inactive behaviour was significantly lower at all doses in the first 5 minutes (p 
< 0.05). There was no inactive behaviour at any dose between 5–15 minutes, no 
significant difference at 15-20 minutes and it was significantly lower than with vehicle 
at all doses in the final 10 minutes (p < 0.05). The lack of interaction between drug and 
time for grooming behaviour reflects a proportional decrease across every time bin with 
all three doses of muscimol. 
 
Fig. 3.10 shows that the transition from feeding to inactivity occurred between at 
approximately 20 minutes with vehicle. There was no transition within the 30 minutes 
with drug treatment. Whilst recording the BSS it was noted that animals treated with 
muscimol were in contact with the food much of the time although not necessarily 
eating. Additionally animals forced so much food into their mouths that they would 
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often chew and gag for long periods before collecting the next pellet, animals appeared 
to be less aware of their surroundings or non responsive to cues that were not in their 
immediate vicinity. They were seemingly oblivious to the observer. This was not true 
for animals previously observed under the effects of baclofen. 
 
 
 
 
 
 
Figure 3.8. The effects of bilateral infusions of saline and a range of doses of 
muscimol into the Acb in pre-fed rats (n=8) given access to laboratory chow over a 
30 minute test session. Error bars represent ±SEM. Significant differences from 
vehicle are denoted by ** p < 0.01. 
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Figure 3.9. The behavioural satiety sequence (BSS) with a range of doses of 
muscimol compared to vehicle (n=8). The relative proportions of each behaviour 
are shown in 5 minute time bins over a 30 minute period of free access to chow.  
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Figure 3.10. The effects of various doses of muscimol compared to vehicle on the 
time course of ingestive, active, grooming and inactive behaviours split into 5 
minute bins (n=8). The vertical line on the ‘vehicle’ chart indicates the point at 
which there is a transition from ingestion to inactive behaviour. This does not 
occur within the 30 minute time frame at any of the doses of muscimol. 
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Experiment 3.3: BSS with chow following bilateral intra-AcbSh 
infusions of the µ-opioid receptor agonist DAMGO (0.25ng/µ l-1) 
 
Refer to Fig. 3.3 experiment 3.1 for a schematic illustration of Acb infusion site 
placements. A total of n=7 animals from the original 10 that were found to have 
placements that fell within the acceptable target area were used in this experiment. One 
animal from the group used for the final analysis in experiment 3.1 was eliminated from 
this experiment because one of the guide cannulae became blocked. Two others were 
eliminated because they were unable to feed or express any other behaviours due to an 
apparent sedative effect post infusion. In both cases the drug may have ended up more 
posterior unilaterally than the average placement seen in the other animals included in 
the analysis. 
 
DAMGO infused into the Acb of satiated animals increased chow intake relative to 
intake with vehicle [Fig. 3.11; F (1,6) =12.84, p=0.012].  
      
 
Figure 3.11. The effects of bilateral infusions of saline or DAMGO into the Acb in 
pre-fed rats (n=7) given access to laboratory chow over a 30 minute test session. 
Error bars represent ±SEM. Significant differences from vehicle are denoted by * 
p<0.05. 
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The BSS was significantly modified by bilateral infusion of DAMGO (see Fig. 3.12). 
There was no significant effect of drug on ‘Active’, ‘Groom’ or ‘Inactive’ behavioural 
categories. However, there was a significant effect of drug [F(1,6)=12.43, p=0.012] and 
time [F(5,30)=8.16, p < 0.001] on the ‘Ingest’ category. This was reflected in a 
significantly higher proportion (relative to that elicited by vehicle) of this behaviour in 
the last 15 minutes of the session (15-20 minutes, p < 0.01; 20-30 minutes, p < 0.05). 
For the vehicle treatment the transition from feeding to inactive behaviour occurred 
between 20 and 25 minutes into the test session. There was no transition with drug 
within the 30 minute period (see Fig. 3.13). 
 
 
 
    
 
 
             
 
 
Figure 3.12. The behavioural satiety sequence (BSS) with vehicle and DAMGO 
(n=7). The relative proportions of each behaviour are shown in 5 minute time bins 
over a 30 minute period of free access to chow.  
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Figure 3.13. The effects of vehicle and DAMGO on the time course of ingestive, 
active, grooming and inactive behaviours split into 5 minute bins (n=7). The 
vertical line on the ‘vehicle’ chart indicates the point at which there is a transition 
from ingestion to inactive behaviour. This does not occur within the 30 minute 
time frame with drug. 
 
 
Experiment 3.4: BSS following periods of food restriction of 4 or 8 
hours. 
 
The whole cohort n=12 were used in the analysis for this experiment. Fasting 
significantly increased intake [Fig. 3.14; F(2,22)=57.93, p = < 0.001) and this increase 
was significant at both 4 and 8 hours (p < 0.01). There was no significant difference 
between the amount consumed at 4 and 8 hours.  
 
There was a significant effect of length of fasting on the BSS expressed (Fig. 3.15). 
Overall fasting significantly increased the proportion of behaviour in the category 
‘Ingest’ [F(2,22)=19.23, p < 0.001] and the proportion changed over time 
[F=7,77=39.25, p < 0.001]. There was no interaction between fasting period and time.  
There was a significant interaction between fasting period and time for the category 
‘Active’ [F(14,154)=2.94,       p < 0.001] which both decreased and subsequently 
increased across the session. There was a significant increase in the ‘Groom’ category 
with time [F(7,77)=4.74, p=<0.001] but no significant effect of drug. The same was true 
for the ’Inactive’ category, which showed a significant increase over time 
[F(7,77)=27.38 p=<0.001] but no significant effect of drug. 
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Planned post-hoc analysis using Dunnett’s test indicated that both periods of fasting 
increased the time spent feeding in the first 20 minutes (p < 0.001).  Significantly less 
time was spent in active behaviours in the first 15 minutes with a 4 or 8 hour fast (0-10 
minutes, p < 0.05 for both; 10-15 minutes, p < 0.01 for both). Over the following 10 
minutes there was no significant difference between the treatments but activity rose 
steadily with a 4 hour fast so that between 25-30 minutes it was significantly higher (p < 
0.05).  Activity then declined but there was no significant difference by the end of the 
session. Grooming was unaffected by fasting but inactive behaviour was decreased 
relative to vehicle (NS). 
 
Fig. 3.16 demonstrates a transition from feeding to inactive behaviour in the ad lib fed 
condition between 20 and 25 minutes. The transition was delayed by approximately 5 
minutes with fasting for 4 and 8 hours. 
 
 
 
Figure 3.14. The effects of periods of fasting on intake in rats (n=12) given access 
to laboratory chow over a 40 minute test session. Error bars represent ±SEM. 
Significant differences from vehicle treated group are denoted by ** p < 0.01. 
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Figure 3.15. The behavioural satiety sequence (BSS) with no fast compared to 4 
and 8 hours food restriction (n=12). The relative proportions of each behaviour are 
shown in 5 minute time bins over a 40 minute period of free access to chow.  
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Figure 3.16. The effects of no food restriction compared to periods of 4 and 8 hours 
fasting on the time course of ingestive, active, grooming and inactive behaviours 
split into 5 minute bins (n=12). The vertical lines on the charts indicate the point at 
which there is a transition from ingestion to inactive behaviour. This is shifted to 
the right in fasted animals. 
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Experiment 3.5: BSS with chow following peripheral administration of 
the benzodiazepine bretazenil at 0.3 and 1.0mg/kg-1. 
 
The whole cohort n=12 were used in the analysis for this experiment. Bretazenil 
increased intake [Fig. 3.17; F=(2,22)=6.66, p=0.005] and this was dose dependent, 
significant at 0.3mg/kg (p < 0,05) and 1.0mg/kg (p < 0.01).  
 
 
 
Figure 3.17. The effects of vehicle and two doses of bretazenil administered 
systemically on intake in rats (n=12) given access to laboratory chow over a 40 
minute test session. Error bars represent ±SEM. Significant differences from 
vehicle treated group are denoted by * p < 0.05 and ** p < 0.01. 
 
Bretazenil also dose dependently affected the BSS (see Fig. 3.18). Overall there was a 
significant effect of drug significantly increased the proportion of observations in the 
‘Ingest’ category [F(2,22)=12.69, p < 0.001] and the proportion decreased over time 
[F(7,77)=32.58, p < 0.001]. There was no interaction between drug and time. ‘Active’ 
behaviour was significantly reduced as a consequence of drug [F(2,22)=13.98, p < 
0.001] and time [F(7,77)=3.23, p=0.005] but again there was no interaction. There was 
a significant effect of drug decreasing observations in the ‘Groom’ category 
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[F(2,22)=4.08, p=0.031] but no significant effect of time and finally the ‘Inactive’ 
category was not significantly effected by drug but increased over time [F(2,22)=31.78, 
p < 0.001].  
 
Planned post-hoc analysis using Dunnett’s test indicated that the proportion of ingestive 
behaviour was significantly higher at both doses over the first 15 minutes of the test 
session (for 0.3mg and 1.0mg of bretazenil at 0-5 minutes, p < 0.01; 5-10 minutes, p < 
0.05; 10-15 minutes, p < 0.01). For the remainder of the session the lower dose had no 
significant effect on feeding but 1.0mg of bretazenil resulted in a continued elevation in 
ingestive behaviour between 20 and 30 minutes (p < 0.05). There was no significant 
effect of either dose of drug on intake in the last 10 minutes. 
 
Active behaviour was significantly reduced at both doses for the first 15 minutes (0-10 
minutes, p < 0.01 for both doses; 10-15 minutes, p < 0.05 at 0.3mg and p < 0.01 at 
1.0mg). This extended through the next 5 minutes for 1.0mg (15-20 minutes, p < 0.05) 
and then, as active behaviour increased in the vehicle condition activity again became 
significantly lower at both doses (20-25 minutes, p < 0.01 for both doses). Finally for 
the last 15 minutes of the session there was no significant difference in activity between 
the treatment groups.  The effect of drug on grooming only became apparent at the end 
of the session with a significantly lower proportion at both doses from 30-35 minutes (p 
> 0.05). 
 
In Fig. 3.19 the transition from feeding to inactive behaviour under vehicle treatment 
occurred between 15 and 20 minutes. The transition was delayed to between 25 and 30 
minutes with both drug treatments. 
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Figure 3.18. The behavioural satiety sequence (BSS) with vehicle and two doses of 
bretazenil administered systemically (n=12). The relative proportions of each 
behaviour are shown in 5 minute time bins over a 40 minute period of free access 
to chow.  
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Figure 3.19. The effects of vehicle and two doses of bretazenil administered 
systemically on the time course of ingestive, active, grooming and inactive 
behaviours split into 5 minute bins (n=12). The vertical lines on the charts indicate 
the point at which there is a transition from ingestion to inactive behaviour. This is 
shifted to the right in drug treated animals. 
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Experiment 3.6: BSS with mash following peripheral administration of 
the benzodiazepine bretazenil at 1.0mg/kg-1). 
 
The whole cohort n=12 were used in the analysis for this experiment. A dose of 1.0mg 
of bretazenil significantly increased intake of wet mash relative to vehicle [Fig. 3.20; 
F(1,11)=37.9, p < 0.001]. Bretazenil also affected the BSS (see Fig. 3.21). Overall there 
was a significant increase in the proportion of observations and an interaction between 
drug and time in the category ‘Ingest‘ [F(7,77)=5.6, p < 0.001]. There was a significant 
reduction in the proportion of observations in the ‘Active’ category [F7,77)=9.8, p < 
0.001] and the ‘Groom’ category [F(7,77)=2.41, p=0.028]. There was a significant 
increase in the ‘Inactive’ category due to drug [F(1,11)=5.77, p=0.035] which changed 
over time [F(7,77)=65.47, p < 0.001] but there was no interaction. 
 
 
 
 
 
Figure 3.20. The effects of vehicle or bretazenil administered systemically on 
intake in rats (n=12) given access to mash over a 40 minute test session. Error bars 
represent ±SEM. Significant differences from vehicle treated group are denoted by   
** p < 0.01. 
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Planned post-hoc analysis using Dunnett’s test indicated that the proportion of ingestive 
behaviour was significantly higher between 5-20 minutes (5-10 minutes, p=0.002; 10-
15 minutes p < 0.001 and 15 – 20 minutes, p=0.028). Active behaviour was 
significantly lower from 5 to 35 minutes (5-10 minutes, p= 0.032; 10-20 minutes, p < 
0.001; 20-25 minutes, p=0.003, 25-30 minutes, p=0.017 and 30-25 minutes, p=0.043). 
 
The effect of drug on grooming resulted in a significant reduction between 5 and 15 
minutes (5-10 minutes, p=0.013; 10-15 minutes p=0.012). Grooming was not 
significantly lower between 15 and 20 minutes but by 25 minutes this difference was 
significant again (p < 0.001). Grooming remained lower for the rest of the session but 
this was not a significant difference. From 15 minutes onwards the proportion of 
inactive behaviour displayed with bretazenil was higher than with vehicle in every time 
bin but the difference was only significant between 30-35 minutes (p=0.029). Fig. 3.22 
shows the transition from feeding to inactive behaviour occurred between 20-25 
minutes with and without drug treatment. 
 
 
    
 
 
Figure 3.21. The behavioural satiety sequence (BSS) with vehicle or bretazenil 
administered systemically (n=12). The relative proportions of each behaviour are 
shown in 5 minute time bins over a 40 minute period of free access to mash.  
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Figure 3.22. The effects of vehicle or bretazenil administered systemically on the 
time course of ingestive, active, grooming and inactive behaviours split into 5 
minute bins (n=12). The vertical lines on the charts indicate the point at which 
there is a transition from ingestion to inactive behaviour. This is shifted very 
slightly to the right in drug treated animals. 
 
Discussion 
The experiments presented in this chapter addressed the lack of data with regards to the 
immediate and short term effects of intra-Acb GABA receptor subtype stimulation on 
the progression of feeding and associated non-feeding behaviours. Specific behaviours 
were recorded as part of the BSS in response to standard laboratory chow.  In addition, 
BSS data were collected as a point of comparison for a number of other manipulations, 
both pharmacological and physiological, known to modify specific phases of ingestion. 
 
A recognisable BSS was expressed in response to a chow meal eaten during the light 
phase by animals in the control condition. Pre-satiated animals given an infusion or i.p 
injection of saline vehicle ate a small amount of chow but consumed it rapidly and, 
predominantly, early in the test session. As the proportion of time spent feeding 
decreased, so the animals progressed through the satiety sequence engaging in active 
behaviours followed by grooming and finally a period of inactivity. The transition from 
ingestive behaviour to inactivity occurred between approximately 20 to 25 minutes into 
the test session. The distribution of the mean proportion of behaviours over time was 
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also very similar to that previously observed using wet mash rather than chow (Clifton 
and Cooper, 1996). 
 
In experiment 3.1 intra-Acb baclofen, the GABAB agonist, enhanced intake of chow in 
a dose dependent manner in pre-satiated animals by increasing the proportion of time 
spent feeding at the start of the session. The proportion of ingestive behaviour remained 
high across the 30 minute test period at the highest dose. Active behaviour was 
significantly lower at the start of the session at all doses but, as ingestive behaviour 
tailed off, so active behaviour increased as would be expected in a normal BSS. 
Grooming was unaffected by drug treatment at any dose but the increase in the 
proportion of ingestive behaviour was reflected in a consequent absence of inactive 
behaviour over this timescale. This consequently meant that there was no transition 
from feeding to inactivity over the 30 minute test. The possibility that this represents a 
temporal shift in the BSS due to effects on motivation rather than via non-specific drug 
effects will be discussed in detail below. 
 
In contrast, in experiment 3.2, the GABAA agonist muscimol increased intake (to a 
similar degree at all the doses tested) but also significantly changed the pattern of 
expression of all other behavioural categories in the BSS. It would aoppear that 
increased feeding behaviour was expressed at the expense of the rest of the behavioural 
repertoire throughout the 30 minute test period. In other words, activity and grooming 
were significantly lower across the session and inactive behaviour was conspicuous by 
its almost total absence. 
 
DAMGO had no significant effect on any of the non-feeding behaviours. DAMGO 
prolonged feeding by enhancing the proportion of time spent in ingestive behaviour in 
the latter part of the BSS test session which, in turn, decreased the incidence of inactive 
behaviour expected at this stage (but not significantly so). The delayed peak in the 
proportion of ingestive behaviour resulted in there being no transition from feeding to 
inactive behaviour within the 30 minute test. The pattern of behaviour observed with 
DAMGO is clearly different to that observed with either of the GABA agonists. 
Fasting for 4 or 8 hours increased feeding across the session, significantly so at the 
onset of recording, whilst it concurrently decreased active behaviour. The pattern 
looked similar to that recorded with the two lower doses of baclofen. Also, as with 
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baclofen, grooming remained unaffected but the amount of inactive behaviour 
appearing at the end of the session was reduced following fasting (but not significantly 
so). The increased proportion of feeding and decreased proportion of inactive behaviour 
was reflected in a delay in the transition from feeding to inactivity. 
 
Peripheral administration of the BZ bretazenil, which acts as an agonist at the GABAA 
receptor in a variety of brain regions, increased feeding in a dose dependent manner, 
which was expressed as a very high proportion of feeding behaviour in the first five 
minutes. The increase in the proportion of ingestive behaviour was only significantly 
higher during the first half of the session. In contrast to the effects of baclofen or 
fasting, active behaviour was reduced initially and an increase in activity to the 
equivalent seen in the vehicle condition occurred much later in the session. Grooming 
was also significantly reduced at the end of the session. When a mash meal was used 
instead of chow, bretazenil induced a very large proportion of feeding at the start of the 
session, as with the chow meal, but this rapidly gave way to inactive behaviour at the 
expense of the rest of the behavioural repertoire. This apparent ‘meal type’ induced 
disruption of the BSS will be further discussed below. 
 
The effects of GABA agonists on the BSS 
In experiment 3.1, animals given baclofen spent more time feeding in each time bin but 
this was only significant at the start of the session at the lower doses. The relative 
proportion increase was greater per time bin with each dose. At the two lowest doses, 
the overall pattern was characterised by a gradual decrease of ingestive behaviour over 
time which was similar to that observed with the control group. At the highest dose the 
proportion of ingestive behaviour remained higher than vehicle levels throughout the 
test period but still decreased slightly over time. The increase in the proportion of 
feeding with each dose echoes the dose dependent variation in total intake. 
 
Activity levels were lower with baclofen treatment at the start of the test session but this 
most likely reflects the increased proportion of time spent feeding rather than a direct 
drug effect on activity (Ishii et al., 2003a). This assertion is supported by the 
observation that, broadly, there was no significant difference in activity levels between 
the drug or vehicle treatments in the last 15 minutes of the test session (although a slight 
elevation is clear from the figures and there was a significant difference in the last 5 
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minutes at the 220ρmols dose). Grooming behaviour was unchanged by the drug 
treatment, which fits in with the postulation that an initial increase in the proportion of 
feeding behaviour due to GABAB mediated mechanisms does not concomitantly 
directly affect other species-specific motor behaviours. 
 
Inactive behaviour was conspicuous by its absence across the test period but, because 
more time was spent feeding in the drug condition, the point at which the transition to 
inactive behaviour occurs may not have been reached over a 30 minute session. With 
the lack of aberrant changes in the patterns of active and grooming behaviour it is 
suggested that the behaviour recorded could reflect a temporal shift in the BSS to the 
right (i.e. a delay). This conclusion is supported by observations in the laboratory that, 
when subjects were given access to chow for longer periods (i.e. 60 minutes), all 
animals did eventually settle down in a resting posture or even go to sleep. 
 
It should be mentioned here that the group of animals used for this experiment (and for 
Exp. 3.3 BSS with DAMGO, below) were implanted with guide cannulae using the 
original set of co-ordinates based on those used by Ward et al. (2000); (AP), + 1.2mm, 
mediolateral (ML), ± 1.5mm relative to bregma and dorsoventral (DV), -5.8mm relative 
to skull surface. This put some of the infusions very close to the core region (as Fig. 3.3 
above shows). Those animals that had purely core infusions on both sides were 
excluded from the final analysis. There were some infusions however that did 
potentially fall at the boundary between the two regions but the data from these animals 
was still used. The data reported were further analysed using the categories “shell only”, 
“boundary” and “core only”. No significant interaction between drug and infusion site 
was found. This tallies well with previous work in this laboratory that indicates that 
there is no relationship between individual baclofen infusion site and degree of feeding 
enhancement in this strain (Ward et al., 2000).  
 
It is also interesting to note that the animals treated with baclofen increasingly engage in 
some additional behaviour including what appeared to be consumption of sawdust or 
faeces and licking the floor for crumbs, particularly at the highest dose.  This was 
recorded as part of the ‘Ingest’ category. Despite this additional behaviour the incidence 
of active behaviours and grooming were not disrupted and this may account for the 
apparently prolonged meal at the highest dose. 
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Ward et al. (2000) concluded that baclofen probably does not induce a motor stereotypy 
for chewing because no responses were directed towards wooden blocks shaped like 
chow pellets. If the additional behaviours observed here were not an expression of 
stereotypy then they could be directed at getting every last scrap of food which certainly 
appeared to be what the animals were doing. In addition, coprophagy is a normal 
species-specific behaviour; rats will consume 50-65% of faeces in the home cage 
(Barnes et al., 1957) and it is possible that this too would increase as a part of an 
enhancement of the normal feeding process although it has not been reported before.  
 
Muscimol infused into the Acb in experiment 3.2 also robustly increased intake of 
chow. In contrast to baclofen however, the GABAA agonist appeared to disrupt the 
normal BSS even at the lowest dose of 220ρmols. The proportion of time spent engaged 
in ingestive behaviour was significantly higher throughout the test session at all doses 
of muscimol and active behaviours were consequently much lower than those observed 
with the vehicle treated group for the first 20 minutes of the session. Grooming 
behaviour was virtually absent at all doses of muscimol, as was inactive behaviour. It 
must be noted that, although the feeding is so voracious, it is possible that grooming and 
inactive behaviours would appear if the session were longer. Unfortunately none of the 
experiments carried out using muscimol extended beyond a 30 minute observation 
period so no comment can be made as to the pattern of the BSS over 60 minutes. 
 
It is interesting to note that, although the proportion of time spent engaged in feeding 
behaviour with muscimol takes up a disproportionate amount of the 30 minute period, 
the animals did not consume much more than the baclofen treated animals (e.g. total 
mean intake at 440ρmols baclofen = 4.31g ± 0.34 and at the molar equivalent dose of 
muscimol = 5.44g ± 0.45). This could be due to the fact that the ingest category 
includes handling of the food and animals that received muscimol were in contact with 
the food much of the time although not necessarily eating. Additionally animals forced 
so much food into their mouths that they would chew and gag for long periods before 
collecting the next pellet, a phenomenon previously reported (e.g. Kelley et al., 2005b).  
 
One potential reason for the different profiles of behaviour observed with baclofen and 
muscimol that should be considered when interpreting these results could be the 
different nutritional status of the animals prior to testing. The baclofen animals were fed 
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ad lib up until 1 hour before testing whereas the muscimol group were on a restricted 
diet but were pre-fed 1 hour prior to testing. It is, consequently, possible that there were 
differences in the relative motivational state of the animals.  
 
Food restriction has been widely demonstrated to modify the neurochemistry of the 
motivation control circuits in the brain and the levels of gut hormones that act as 
neurotransmitters. However, perhaps surprisingly, there appears to be no data on the 
effects of deprivation on endogenous GABA levels or GABA receptor expression 
despite their established role in feeding. Of course the behaviour expressed in the BSS 
with muscimol could be due to the interaction between GABAA receptor stimulation 
and modified function or expression of a multitude of neurotransmitters and/or their 
receptors elsewhere in the motivation control circuit. The implications of this are 
complex and will be discussed later in the thesis when the behavioural effects of intra-
Acb baclofen and muscimol are further elucidated. 
 
Despite evidence that the effects of acute and chronic food restriction on the expression 
and activity of receptors in the brain is very important in understanding the control of 
appetite the consequent acute effects of re-feeding are not clear. In particular there is 
minimal data available about the differences in the striatal gene expression for 
endogenous feeding related neurotransmitters (or their receptors) in the brains of 
animals depending on food motivational conditions prior to testing. At the level of the 
Acb the only data available refers to fluctuations in opioids. 
 
It would appear that preproenkephalin (PPE – the precursor to enkephalin) activity is 
reduced in animals that have recently eaten regardless of whether they have been food 
restricted or fed ad lib prior to a chow meal (Will et al., 2007). However Will et al. 
(2007) also found that, in the medial Acb region PPE was down regulated to a lesser 
degree by short-term satiation with chow pellets when the animals were food restricted. 
This would only be relevant however if the effects of GABA receptor stimulation were 
due to an interaction with the opiate control of feeding. This possibility will also be 
discussed later in the thesis. At this stage it can be stated that, without pharmacological 
intervention, the food restricted but re-fed animals in experiment 3.2 expressed a 
‘normal’ BSS in response to chow (compared to ‘typical’ BSS, Fig. 3.1 in introduction). 
Furthermore it has been previously demonstrated that, at a behavioural level, the effects 
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of prior deprivation are attenuated following satiation at the time of testing (Wong and 
Traupmann, 1973, Wong and Traupmann, 1975). 
 
It is acknowledged that if a lower dose of muscimol had been used an increase in the 
proportion of ingestive behaviour without the apparent disruption of the rest of the BSS 
may have been seen. The main argument against this possibility is that other 
investigators were unable to find a significant effect on intake at this dose whilst the 
molecular equivalent dose of baclofen did cause an increase in total intake (Stratford 
and Kelley, 1997b). This could only be confirmed by repeating this experiment with a 
wider dose range and ad libitum fed animals. 
 
The effects of an opioid agonist on the BSS 
In experiment 3.3 the effects of one dose of DAMGO were investigated and the pattern 
of feeding was quite different from that seen with the GABA receptor agonists. 
Although the proportion of feeding was elevated throughout the 30 minute session this 
was never to the levels observed with either baclofen or muscimol. The smaller increase 
in intake with DAMGO in each time bin compared to that with the GABA agonists 
could be due to the possibility that the dose used was not an equivalent in terms of its 
stimulatory effects on feeding. The mean total intake with DAMGO however was 4.63g 
± 0.96 which is very close to the amount consumed in the GABA experiments.  In 
contrast to muscimol and baclofen, which elevated the proportion of feeding at the start 
of the session, DAMGO did not significantly elevate intake relative to vehicle during 
the first 15 minutes but proportions remained high in the last 15 minutes as feeding 
dropped off in the vehicle group. Also, in contrast to the muscimol group, all other 
behaviours were left intact suggesting this reflects the normal progression of the BSS 
with a delayed onset of satiety causing a shift to the right.  
 
Halford et al. (1998) do point out that some drugs that cause mild sedation will reduce 
the frequency of behaviour but extend the duration and this could be posited as an 
explanation for these findings. Some of the animals infused with DAMGO showed clear 
signs of sedation but were eliminated from the final analysis. For the others, the 
proportion of feeding behaviour at the start of the DAMGO induced BSS was still 
higher than that elicited by vehicle infusions (if not significantly so) so the pattern seen 
in Fig. 3.12 and 3.13 is not believed to be due to sedative effects. 
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Hanlon et al. (2004) returned animals to the home cage following DAMGO infusions 
prior to behavioural testing because “the maximum effect of DAMGO on food intake 
occurs 30–60 min post-infusion”. However this was in response to a highly palatable 
sucrose solution (Zhang and Kelley, 1997). Earlier work in the same laboratory showed 
that the effects of DAMGO on consumption of laboratory chow had a delayed onset 
with a peak in intake between 1-2 hours (Bakshi and Kelley, 1993a). It was not suggest 
that the delay is due to sedative effects but most likely an initial suppression of 
locomotion (Zhang and Kelley, 1997), which was reported many years ago (Babbini & 
Davis, 1972). The results reported here for DAMGO could indicate that the process of 
satiety is delayed and would be consistent with a delayed peak in feeding behaviour 
with this drug at 1-2 hours post infusion. Further studies to confirm the conclusion that 
the BSS described reflects a behaviourally selective effect on feeding could be carried 
out using a lower dose of DAMGO or imposing a delay post-infusion before testing. 
 
It is also possible that the results are consistent with the evidence that opioids have an 
effect on palatability of the meal (Kelley et al., 2002, Woolley et al., 2006, Pecina and 
Berridge, 2000). The BSS was somewhat delayed in a similar manner to the effects of 
adding saccharin to test food which causes a “modest delay” in the progression of the 
BSS caused by what was termed “atypical” feeding late in the session (Ishii et al., 
2003b). In simple terms this could be viewed as the animal continuing to enjoy the food 
beyond the point at which they would normally reach sensory specific satiety. Indeed 
Ishii et al. (2003a) suggest that a pattern characterised by prolonged feeding but no 
intense increase in the initial response may indicate an effect on satiety rather than 
“hunger motivation”. Certainly our results would indicate that intra-Acb DAMGO does 
not produce a BSS resembling that recorded after a period of fasting nor does it look 
anything like that recorded with baclofen or muscimol. 
 
The effects of fasting on the BSS 
Not surprisingly, in experiment 3.4, withholding food from the rats before testing 
enhanced the amount of food consumed but, interestingly, there was no significant 
difference in the total amount consumed after a 4 or 8 hour fasting period suggesting a 
ceiling effect of acute induction of hunger over this timescale. Ishii et al. (2003a) point 
out that it has been widely demonstrated that short periods of fasting <24 hour increase 
the amount ingested in a nonlinear fashion. Here, the proportion of ingestive behaviour 
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was increased in each 5 minute time bin, significantly so early on in the session, and the 
meal was slightly prolonged with a delay in the transition from feeding to inactivity. 
There was a consequent reduction in activity at the start of the BSS and a slight 
elevation 30 minutes into the session following 4 hours of food deprivation. Grooming 
was unaffected but resting behaviour was decreased (although, in this case, not 
significantly so). The reduction in inactive behaviour was probably due to the increase 
in time spent feeding. This data represents a BSS temporally shifted to the right and 
reflects the effects of an increase in hunger motivation or “appetite”. 
 
There is good agreement between these data and the general pattern observed by Ishii et 
al. (2003a) although their animals had been habituated to a 1 hour test period and hence 
their behaviour may have been shaped by the expectation of a longer period of access. 
This group reported that fasting increased the total duration of feeding whilst 
concurrently reducing active behaviour, delayed peak grooming and shifted the 
transition to inactive behaviour to the right (Ishii et al. 2003). They do not report the 
pattern of active behaviours later in the session preferring only to give absolute values 
for total duration and frequency. 
 
It is well known that fasting causes increases in activity as well as in total food 
consumption (Finger, 1951, Cornish and Mrosovsky, 1965, Finger and Mook, 1971) 
and this may explain the slight increase in activity part way through the session. In the 
presence of food, mechanisms that control the urge to eat could override the more 
general effects on locomotion but once the animal is satiated, increases in activity may 
be expressed. It is interesting that a similar increase was also seen with the 220ρmols 
dose of baclofen.  The BSS recorded at the two lower doses of baclofen looks similar to 
the BSS with 4 and 8 hours of fasting. The only difference is the greater reduction in 
inactive behaviour with the GABA agonist but it may support the conclusion that the 
baclofen BSS is temporally shifted without a direct affect on non-feeding behaviours. 
 
The effects of a peripheral benzodiazepine on the BSS 
Bretazenil administered systemically in experiment 3.5 significantly increased intake of 
chow, an effect that has not been demonstrated before, and there was no apparent 
disruption in the sequence at either dose. The amount of time spent eating in each time 
bin and the length of the meal was reflected in a reduction of other active components 
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of behaviour. Active behaviour was concurrently reduced during the first 15 minutes 
while feeding behaviour was significantly higher. There was a smaller proportion of 
grooming at both doses in the last 5 minutes of the session but, since both doses shifted 
the BSS to the right by ~5 minutes this could be an artefact of this delay. This finding 
was surprising given that it has previously been suggested that the BSS is actually 
disrupted by bretazenil because it appears to speed up the transition from feeding to 
resting behaviour at the expense of intervening behaviours (Clifton and Cooper, 1996). 
As a result the experiment was repeated using a mash meal. 
 
The effects of a peripheral benzodiazepine and meal type on the BSS 
In experiment 3.6 systemic bretazenil increased intake of palatable mash although pre-
feeding prevented levels reaching the extremes reported previously (Clifton and 
Cooper, 1996). The animals then showed a rapid transition to inactivity, failing to 
engage in a normal level of active behaviour post feeding or to groom as much as they 
did under vehicle treatment thus the disruption in the BSS previously reported was 
replicated. These results suggest that it is the large volume of the mash meal consumed 
(intake at 1 mg/kg bretazenil: mash=19.0 ±0.3g whereas chow=4.3 ± 0.3g) that may 
lead to higher levels of resting rather than a disruption of the BSS due to direct 
increases in somnolence. 
 
The observation that resting may increase because of the volume of meal consumed is 
in agreement with a recent shift in the approach to understanding the effects of feeding 
on sleep in humans. In the late 1990s there was some interest in the existence of 
gastrointestinal effects on post-prandial somnolence, which appeared to be independent 
of hunger and necessary for the onset of sleepiness (Harnish et al., 1998). More recently 
it has been suggested that gut neurohormones (e.g. orexin) and autonomic responses to 
feeding may directly affect areas of the brain responsible for the control of sleep which 
overlap with those controlling hunger (Bazar et al., 2004). Irrespective of the possible 
explanation for the difference in the satiety sequence with a BZ and chow or mash what 
is most important here is that, with chow, there appears to be a normal but temporally 
shifted BSS. The BSS expressed during bretazenil induced hyperphagia in response to 
chow is actually fairly similar to that seen with baclofen but, surprisingly, is completely 
different from that induced by DAMGO despite the fact that both drugs are thought to 
increase intake via effects on palatability.  
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The apparent interaction between the type of meal used for assessing the BSS with 
bretazenil and the shape of the sequence produced could have important implications 
for interpreting all of the data presented here. John Blundell’s laboratory, probably the 
most prolific users of the BSS as a biobehavioural assay, favour the use of a highly 
palatable wet mash diet and have also started routinely testing animals in the dark phase 
of a reversed light/dark cycle so as to start with high baseline intake (Halford et al., 
1998, Ishii et al., 2003b, Ishii et al., 2003a, Tallett et al., 2008) because this “obviates 
the need for prior food deprivation” (Ishii et al., 2003b). Looking in detail at their 
method (Halford and Blundell, 1996) it would appear that often they also effectively 
fast the animals by removing food 4 hours before testing.  
 
This research group from Liverpool University argue elsewhere (Ishii et al. 2003a) that 
short fasts of between 2–4 hours only minimally increase free feeding (Bare and Cicala, 
1960) but in the same paper they state that a 3 hour fast “clearly produced a 
prolongation of feeding behaviour prior to peak grooming and the onset of resting”. In 
effect, therefore, they are starting with animals that are predisposed to express a 
modified BSS characterised by rapid onset of intense feeding behaviour in response to 
highly palatable diet and prolongation of the meal due to removal of food from the 
home cage prior to testing. The key here is that their model has only been used for 
testing anorectic drugs that reduce intake and, therefore, they prefer to start with a high 
baseline level of intake. It should be noted that food in the home cage was not removed 
4 hours prior to testing when they tested the effects of pre-satiation or food deprivation 
to produce reference profiles with which to compare drug effects (Ishii et al. 2003a). 
 
In contrast we have opted for test conditions in which animals are pre-satiated so as to 
start with low baseline intake, fed standard laboratory chow which is not as motivating 
as mash and tested during the light phase of the light dark cycle. There were a number 
of reasons for this decision. First of all it was felt that there might be some ceiling effect 
when using mash. For example there could be a physical limitation on how much could 
be consumed. Starting with satiated animals and giving them a food that they would not 
normally over consume leaves room for the large increases usually observed with 
GABA agonists infused into the Acb. Researchers from Blundell’s laboratory do 
themselves suggest that “ca. 22 g mash may approximate the upper limit of 
consumption under present test conditions”. Some of our drug treated animals 
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consumed more than double the amount of chow than they did in the control condition 
(see results section). In experiment 3.6 animals in the control condition ate 
approximately 15g of mash which did not leave much scope for the robust increases in 
intake expected following infusion of GABA agonists into the Acb. 
 
Another reason to use chow instead of mash was because studies that have 
demonstrated an orexigenic effect of intra-Acb GABA receptor stimulation have done 
so primarily using standard laboratory chow. It seems most appropriate to use the same 
food in the characterisation of the BSS. Furthermore, adding the element of high 
palatability may cause a meal type/drug interaction, as indeed is the case with opioids 
where the effects are more robust when sweet or fatty foods are provided (Bodnar, 
2007). Although no interaction between GABA receptor stimulation and meal type has 
been observed in terms of total intake of different macronutrients with muscimol (Basso 
and Kelley, 1999) no studies have focused on the microstructural changes that might 
occur in the pattern of consumption with GABA receptor agonism. 
 
Testing during the light phase rather than the dark phase could result in interactions 
between drug and time of testing due to neurochemical fluctuations associated with 
circadian rhythms. However, once again, consistency with previous studies on the 
effects of GABA agonists on intake was of primary importance for these experiments. 
A review of all the studies published by Kelley’s laboratory showed that testing was 
always carried out during the light phase. Tallett et al. (2008) do report a slightly lower 
amount of resting behaviour in animals tested in the light phase rather than the dark 
phase in their laboratory but the overall pattern of the BSS was not changed. 
 
It must be pointed out that there is, predictably, a degree of inter-individual variability 
in the progression of the BSS and that the expected shape of a curve representing the 
BSS will never represent the specific behaviour of any one individual animal.  As 
Halford et al. (1998) state “the BSS is a clearly identifiable stochastic progression of 
behavioural trends over time (not a strict deterministic sequence)”. Nevertheless the 
credibility of our approach is supported by the production of a recognisable BSS in the 
control condition and the good agreement between our fasting data and that reported by 
Ishii et al. (2003a) who also tested during the light phase but used a mash meal rather 
than chow. Despite the much lower overall volumes of chow consumed (compared to 
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mash) the BSS for our pre-satiated, vehicle treated animals was very similar in the basic 
profile of each curve to those reported by Blundell’s laboratory. Ishii et al. (2003a) also 
report similar total intake of chow pellets (1.86g ± 0.46) to those presented in this 
chapter over an identical test session to that used to obtain their mash data but do not 
indicate what the BSS looked like.  
 
General methodological issues 
As mentioned in the introduction to this chapter there is some debate about the method 
used to record data for the BSS. Halford et al. (1998) point out that a MTS procedure 
underestimates the frequency of behaviour and only produces 10 observations for each 
animal per 5 minute time bin making “standard parametric analysis difficult”. However, 
in experiments 3.1 to 3.3 (central drug infusions) a total of 360 observations or 60 for 
each animal in each time bin were generated improving the resolution. In those 
experiments where a cohort of 12 animals were observed (3.4 to 3.6) only 10 
observations were recorded for each time bin but in both cases the data does, none the 
less, agree well with that published by laboratories using a continuous observation 
method (as discussed above). 
 
Halford et al. (1998) also introduces the concept of “event over state observer bias” 
whereby an observer is more likely to code an active behaviour or “event”  (e.g. rearing) 
when there is a transition occurring between this and a “state” behaviour (e.g. resting) 
when deciding what the animal is doing. Experience indicates that this is indeed a 
possible pitfall, however an awareness of this potential source of error, plenty of 
practice by the observer to speed up decision making and recognition of behaviours, 
minimises the effect of this bias even if it does not totally eliminate it. It is not believed 
to be a confounding factor in the results reported in this Chapter. The results from these 
experiments also indicate that the effects of different drug or physiological 
manipulations that induce hyperphagia can be readily distinguished using this 
experimental paradigm i.e. analysis of the BSS expressed by pre-satiated rats fed a 
chow meal during the light phase recorded using a MTS method. This raises some 
questions as to the methodological approach used by other laboratories that favour high 
baseline intake to test anorectic effects of drugs.  
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General discussion 
All in all the pattern of the BSS induced by the two lowest doses of baclofen probably 
represents a behaviourally selective temporal shift and the similarity to the BSS induced 
by fasting may also suggest that baclofen induced shifts in the BSS are due to an effect 
on the “hunger motivated” or appetitive phase of ingestion. Animals that were fasted in 
experiment 3.4 only started to transition from ingestive to inactive behaviours at ~30 
minutes (see Fig. 3.16), the point at which the baclofen test was ended which could 
explain the lack of a clear transition from feeding to inactivity with baclofen. 
 
As Ishii et al. (2003) point out, “if drug-induced changes in the temporal characteristics 
of the BSS truly reflect an action on the normal physiological mechanisms of appetite 
regulation, then these changes should resemble (at least in part) those seen in response 
to variation in nutritional status”, as they do here. The results reported here support the 
hypotheses that the hyperphagic action of baclofen is of physiological and functional 
significance (Stratford, 2007). It would also indicate that stimulation of the GABAB 
receptor might reflect selective effects on appetite or satiety but probably not through an 
increase in palatability estimation. 
 
A lack of effect of GABAB receptor agonists on palatability but an effect on appetite or 
satiety is consistent with the theory that there are two classes of Acb neurons that 
contribute to neural processing immediately before and during consumption via, 1) 
inhibition related to initiation (appetite) and maintenance of consummatory behaviours 
and 2) excitations that encode reinforcer palatability (Taha and Fields, 2005b). This is 
in turn consistent with data published by Ward et al. (2000) that showed that intra-Acb 
baclofen decreased licking bout size in response to a palatable solution whereas 
increased palatability estimation is reflected in increased bout size (Clifton, 2000). 
 
These results also raise questions as to how and why the pattern of behaviours induced 
by GABAB receptor manipulation is different from those exhibited with drug action at 
the GABAA receptor, which may well have significantly disrupted the normal sequence 
of satiety. One possible clue may be found in the apparent attention bias highlighted in 
the results section. During the BSS test phase it was noted that animals under the 
influence of centrally applied muscimol appeared to be ‘stuck’ in their behavioural 
expression of increased ingestion and were seemingly oblivious to the observer whereas 
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the baclofen group were much more aware of the surroundings and would break off 
feeding to observe what was going on in the test environment. This would seem to 
indicate that the application of the GABAA agonist does indeed lock the animals into a 
specific motor pattern expressed as a perseveration of the consummatory response in 
line with Kelley’s hypothesis. 
 
Recently it has been suggested that the striatum, including the Acb, contains central 
pattern generators (CPGs) (Grillner, 2006, Grillner et al., 2005) and “possesses the 
connectivity and intrinsic mechanisms to orchestrate pattern generation” (Carrillo-Reid 
et al., 2008). Carrillo-Reid et al., (2008) recently demonstrated that in the dorsal 
striatum blockade of fast glutamatergic transmission prevented subsequent correlated 
firing but blockade of GABAergic transmission locked the neuronal microcircuits into a 
single dominant state that eliminated assembly diversity. If this turns out to hold true for 
the very similar cellular assemblages present in the ventral striatum then this could go 
some way to explaining the ability of GABA at the two receptor subtypes to 
differentially effect downstream outputs via MSNs. MSNs from the Acb project to the 
hypothalamus, which contains a series of nuclei, termed the behavioural control column 
(Swanson, 2000), that in turn recruit and modulate motor pattern generators in the 
hindbrain and spinal chord. The circuit could therefore be locked into stimulation of a 
subset of pattern generators responsible for ‘feeding’ with GABAA receptor stimulation. 
 
The GABAB induced behaviour presented here, dominance of one behaviour (feeding) 
but ability to express other behaviours, is more akin with the prevention of correlated 
firing observed with blockade of fast glutamatergic transmission than with locking of 
neuronal microcircuits into a single dominant state.  This would be consistent with 
baclofen’s actions at heteroreceptors on glutamatergic inputs. This would suggest that 
the route by which the MSN output is inhibited (presynaptic GABAB receptors or 
postsynaptic GABAA receptors) is critical in determining subsequent behaviour 
exhibited and global inhibition of the shell does not reflect the endogenous role of 
GABA at different receptor subtypes. This concept will be discussed in more detail in 
the final chapter, Chapter 7. 
 
So to summarise, the results presented in this chapter show that intra-Acb baclofen 
releases intense feeding sequences but the broad behavioural organisation associated 
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with the onset of satiety is maintained whereas muscimol disrupts the progression of the 
satiety sequence. The hyperphagic action of intra-Acb baclofen is consistent with an 
enhanced motivation to feed observed following short periods of fasting. The temporal 
shift in the BSS with baclofen does not look like that observed with intra-Acb opioid 
agonists posited to delay satiation by disrupting the process of sensory specific satiety. 
Neither does it mimic the effects of enhanced palatability caused by a peripheral BZ.  
 
The data are not consistent with the view that intra-Acb baclofen simply leads to the 
indirect release of downstream motor components of feeding behaviour (Kelley et al., 
2005b, Kelley et al., 2005a) but the effects of muscimol could well be due to the 
predominance of specific feeding related motor behaviours expressed at the expense of 
the remainder of the behavioural repertoire. This is the first demonstration that 
stimulation of GABAB receptors in the Acb has an effect on the motivational control of 
feeding. 
 
Questions raised 
The most important questions raised here are about the possible differentiation between 
the effects of GABAA and GABAB agonists. If GABA at the GABAB receptor affects 
motivation how will it affect an animal’s willingness to work for a food reward and the 
various stages of ingestion? These questions will be approached in the next two 
chapters where the results from experiments using an operant schedule to test the affects 
of baclofen (Chapter 4) and muscimol (Chapter 5) will be presented. The nature of the 
potential behavioural differences between intra-Acb infusions of these different agonists 
will be further investigated in both chapters where the results from the analysis of 
videos of behaviour elicited by the operant schedules will be presented. As a starting 
point in attempting to establish whether the differential effects of GABAA and GABAB 
agonists in the Acb occur at a structural macrocircuit level neuronal activation in 
feeding related circuitry marked by Fos like immunoreactivity will be compared in 
Chapter 6.  
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Chapter 4 
 
GABAB receptor stimulation in the accumbens: effects 
on instrumental responding by pre-fed rats in a second 
order operant schedule 
 
Introduction 
In the previous chapter it was suggested, on the basis of Kelley’s hypothetical 
explanation for the role of intra-Acb GABA in feeding, that disinhibition of a fragment 
of motor behaviours required for ingestion could interfere with other feeding related 
behaviours. On this basis it was predicted that the BSS would be significantly disrupted 
by both intra-Acb baclofen and muscimol. In contrast the experiments reported in 
Chapter 3 demonstrated that the GABAB agonist baclofen caused an increase in feeding 
behaviour without the loss of other behavioural components that make up the BSS when 
pre-fed rats were given free access to laboratory chow. The BSS was temporally shifted 
to the right (the onset of satiety was delayed) in a manner consistent with the effects of 
hunger following periods of fasting.  
 
One of the key questions raised by these results was therefore, if intra-Acb GABAB 
receptor stimulation affects direct intake of freely available food in a manner consistent 
with the effects of hunger, would this be reflected in an increase in motivation to 
perform more complex, goal-directed behaviours such as operant responding for food, 
as would be the case with a state of deprivation? The effects of intra-Acb muscimol on 
operant responding for food has been investigated using a PR schedule and a test of the 
rate of acquisition of a food rewarded operant response (Hanlon et al., 2004, Zhang et 
al., 2003). It was concluded that accumbens GABAA receptor stimulation does not 
affect food motivated operant responding (Kelley et al., 2005b, Kelley et al., 2005a). 
 
No direct comparison of the actions in the accumbens of GABAA agonists, GABAB 
agonists and the manipulation of endogenous GABA levels on motivational processes 
have been reported. The finding that the BSS recorded for baclofen differed from that 
recorded with muscimol indicates that baclofen might also have a different effect on 
operant responding for food. This possibility will be explored further in the experiments 
reported in this chapter. 
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The lack of comparable operant studies with muscimol and baclofen to date appears to 
be due to an assumption being made that the end-point, inhibition of MSN output, is the 
same whether this occurs via direct stimulation of GABAA receptors located on the 
output neurons or by stimulation of GABAB receptors on glutamate nerve terminals 
(Kelley et al., 2005b). Presumably this original assumption was based on a pivotal study 
that demonstrated that the predominant effect of baclofen in the Acb was to inhibit 
glutamate release presynaptically (Uchimura and North, 1991). The upshot of this has 
been that, for the experiments that lead to the consequent formulation of Kelley’s 
working hypothesis to explain the role of GABA sensitive neurons in the Acb in 
ingestive behaviour, only the effects of muscimol were further explored. 
 
Previous experiments with muscimol focused predominantly on discovering the effects 
of GABAA receptor stimulation on motivation for food reward through 
neurobiologically regulated effects on the value of the food. The basic premise with 
both the PR schedule and in the acquisition of lever pressing was that hunger makes 
food reward more desirable and hence animals will learn more efficiently what needs to 
be done to obtain food and will work harder to gain access. Since intra-Acb muscimol 
did not mimic these effects of hunger GABA was deemed incapable of mediating 
motivational processes in isolation. It is possible however that this conclusion was 
reached because of the nature of the tests applied rather than because GABA in the Acb 
does not have a specific role in motivation. 
 
The PR schedule has been used extensively to study the effects of modifying reward 
strength (Hodos, 1961) either by manipulating internal state or by directly adjusting the 
desirability of both food (e.g. palatability) and addictive drugs (e.g. concentration) 
(Richardson and Roberts, 1996). However, when using this schedule to explore the 
effects of muscimol, the authors themselves ((Zhang et al., 2003) point out that a 
change in break-point does not distinguish effects on motor effort directed at incentive 
stimuli (i.e. pressing the lever) from effects on the perceived rewarding value of the 
reinforcer. In other words, these investigators did not use schedules that could 
specifically discriminate between the neuronal processes involved in appetitive food 
seeking behaviours and consummatory food taking behaviours. Hence it would not be 
possible to directly evaluate the effects of intra-Acb GABA receptor agonists on these 
two (allegedly) dissociable mechanisms using a PR schedule. Furthermore, the nature of 
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the schedules used previously means that the animals’ motivation to press is primarily 
tested following the ingestion of the food reward. It was not possible therefore to 
exclude confounding factors, such as the process of satiety, competing with the strength 
of drug effects on appetitive and consummatory behaviour.  
 
There is good reason to believe that measuring the salience of cues that drive appetitive 
responding independently from those that drive consummatory behaviours is important. 
Kelley et al., (2005b) point out that the large and instant increase in feeding seen with 
intra-Acb GABAA or GABAB receptor agonism (or manipulation of endogenous GABA 
levels) looks much like the orexigenic effects of electrical stimulation of the lateral 
hypothalamus (ESLH) (Berridge and Valenstein, 1991) or infusion of a glutamate 
receptor agonist into the LH (Stanley et al., 1996, Duva et al., 2001). It has been 
suggested that stimulation of the LH causes an increase in feeding via effects on 
incentive salience (Berridge and Valenstein, 1991). 
 
There are indirect connections between the Acb and the LH via the VP and a unique 
direct connection between the AcbSh and the LH. Infusions of baclofen and muscimol 
both activate this area (Heimer et al., 1991b, Groenewegen et al., 1993, Stratford and 
Kelley, 1997a, Stratford and Kelley, 1999, Stratford, 2005). By inference then a 
pathway involving GABA receptors that could disinhibit the LH via receptor 
manipulation at the level of the Acb might also increase incentive salience attribution. 
As a result it was important to choose a schedule for which effects on incentive salience 
as well as on reward value could be measured. 
 
Berridge and Valenstein (1991) also suggest that different mechanisms might control 
feeding when it is induced by mild or severe deprivation and that ESLH might recruit 
components of neural circuitry that are only involved in the former state. Given the 
suggestion that the Acb can exert both direct and indirect control over the LH (Stratford, 
2007), the lack of effects of the GABAA agonists in the schedules tested thus far (Kelley 
et al., 2005b) could be due to the possibility that the schedules were not sensitive 
enough to provide the behavioural resolution needed to distinguish effects across a 
spectrum of motivational ‘severity’. The schedule chosen for the experiments reported 
here had therefore to provide more sensitivity and detail for an instrumental response in 
terms of, for example, effects on reaction times.  
140 
It is also relevant that there has been some lack of consistency in the approach to testing 
potential dose related effects of GABA receptor stimulation in the past. For example, a 
study to regionally map and characterise macronutrient and taste preference following 
bilateral muscimol infusion into the accumbens (discussed in Chapter 1) utilised two 
doses; 40 and 100ng (350 and 880ρmols)(Basso and Kelley, 1999).  In the PR study a 
dose range of 40, 100 and 200ng (350, 880 and 1750ρmols) of muscimol were infused 
in total bilaterally (Zhang et al., 2003). The ability of muscimol to potentiate the 
acquisition of pressing for a food reward (Hanlon et al., 2004) was only tested at a dose 
of 200ng (1750ρmols), which did not have any effect. Hanlon et al. (2004) themselves 
point out that there may have been different effects on acquisition of instrumental 
responding if more doses of muscimol were tested. 
 
Given that, at least at 100ng (880ρmols) of muscimol or above, there are potentially 
confounding motor effects that could disrupt instrumental responding (Scheel-Kruger et 
al., 1977b, Scheel-Kruger et al., 1977a) the results from the experiments above may not 
demonstrate a lack of effect of the drug on motivation. As a consequence, the GABAB 
agonist used in this chapter was tested at doses previously demonstrated to be 
behaviourally active in terms of intake but low enough not to cause overt myorelaxant 
effects during testing (See results, Chapter 3). In the following chapter the same 
approach will be taken when further testing the effects of the GABAA agonist muscimol 
on operant responding. 
 
The experiments highlighted above i.e. the effects of intra-Acb GABA agonism on 
responding on a PR schedule responding on a PR schedule (Zhang, 2003) and on 
conditioning (Hanlon et al., 2004) therefore raise three key issues relevant to the choice 
of studies carried out for this thesis; 1) only the effects of a GABAA agonist on 
motivated behaviours has been tested previously 2) motivational effects were always 
measured in response to the expected incentive value of the reward and the 
postingestional consequences of consuming it in close temporal association to each 
other  and 3) the doses of GABA agonist used could have disrupted motor behaviours 
and masked motivational effects.  
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In this Chapter therefore a group of experiments will be reported for which an 
alternative schedule that allows the independent measurement of food-seeking 
behaviour versus food taking behaviour was used. This schedule also needed to provide 
an opportunity to measure intra-Acb GABA receptor agonist effects on food seeking 
(appetitive responding) in the absence of concomitant affective responses to the reward 
and without potential postingestional processes. A second order operant schedule was 
chosen to a) study goal-directed food motivated behaviours in pre-satiated animals, b) 
separate out the stages of feeding behaviour i.e. appetitive food seeking behaviour and 
maintenance of consummatory behaviour and c) minimise postingestional effects 
leading to satiety, a second order operant schedule was chosen. 
 
With this type of schedule both reward seeking and reward taking behaviour can be 
characterised and compared by carrying out a separate analysis of the behaviour that 
occurs prior to and following the first reinforcer presentation (Everitt and Robbins, 
2000, Arroyo et al., 1998). Such a schedule allows separate analysis of responses for 
reward vs. responses affected by access to the reward (providing a measure of the 
reinforcing efficacy of the reward) but also of the impact of reward-associated cues on 
responding (Everitt and Robbins, 2000). 
 
Second order operant schedules were designed following modifications to chained 
conditioned reinforcement schedules developed in the 1950’s to study motivation for 
food (Kelleher, 1966). Intermittent reinforcement of a number of identical units of 
responding with a conditioned reinforcer maintains operant behaviour in the absence of 
the primary reinforcer for long periods (Kelleher and Goldberg, 1977). Consequent 
studies of both fixed interval and fixed ratio versions of second orders schedules 
confirmed that only very intermittent presentation of food supported schedule 
maintained constant rates of responding (Goldberg and Tang, 1977, Kelleher and 
Goldberg, 1977, Goldberg et al., 1981) whilst a selective association between a CS and 
the primary reinforcer could be established (Goldberg et al., 1975). Everritt and 
Robbins (2002) point out that FR(FR) schedules result in strong A-O associations and 
could also amplify the role of the CS in supporting responding. With the latter 
approach, the willingness of the animal to work for a reward can be initially studied 
without the confounding effects of satiety on motivation because the CS can robustly 
support responding. 
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The use of second order schedules to double dissociate neural mechanisms underlying 
behaviours driven by the primary reinforcer from those related to motivational, reward 
seeking behaviours (partially driven by conditioned stimuli that have acquired salience 
by their association with the reward) have been demonstrated for appetitive 
instrumental responding for sexual reinforcement (Everitt and Stacey, 1987, Everitt et 
al., 1987, Everitt et al., 1989), self-administration of drugs (for reviews see (Everitt and 
Robbins, 2000, Schindler et al., 2002) and ethanol reinforcement (Samson et al., 2000). 
Second order schedules have been used to assess effects of natural reinforcer magnitude 
in pigeons (Lee and Gollub, 1971, Stubbs, 1971) primates (Kelleher and Goldberg, 
1977, Goldberg et al., 1981) and rats (Everitt et al., 1987, Everitt et al., 1989)  
 
The second order schedule employed in this thesis was based on a version designed to 
assess both appetitive and consummatory responses within the same trial (Thornton-
Jones et al., 2005). The schedule exploited the ability of the conditioned stimulus (CS), 
in this case a light, to maintain instrumental responding for an extended period of time 
whilst allowing minimal access to the reinforcer (Schindler et al. 2002). The most 
widely employed schedule type involves FI units during which FR units must be 
performed to gain access to the CS and, if criterion is reached during the FI, the reward 
(Schindler et al., 2002, Everitt and Robbins, 2000). 
 
The schedule used here is described in detail in Chapter 2 (page 73).  It has previously 
been employed to characterise the effects of various pharmacological manipulations 
known to reduce ingestion (Thornton-Jones et al., 2005, Greenhalgh, 2007, Greenhalgh 
et al., 2008). The schedule employs units of fixed ratio (FR) responding with a further 
fixed ratio of ratios superimposed upon this. An initial 5 minute fixed interval (FI 5), 
during which FR responding for the acquisition of the light CS (FI(FR5: S) without 
subsequent food reward, provides a measure of food-seeking behaviour (‘the appetitive’ 
phase). This is then followed by 25 minutes when the animal must perform five presses 
for the light CS and turn on the light five times, described by the notation FR5(FR5: S), 
before the food is delivered. This constitutes the consummatory phase. Although there 
will be some components of appetitive behaviour during the consummatory phase, the 
first 5 minutes is considered to be purely appetitive since the animals gain no access to 
the food reward. The entire schedule can thus be denoted FI5(FR5: S), FR5(FR5: S) 
according to the nomenclature developed by Kelleher (1966). 
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The 2nd order schedule is also suitable for testing responding in animals that have been 
pre-satiated prior to experimental treatment. It has long been known that pre-feeding 
reduces instrumental behaviour for food (Toates, 1981, Toates, 1986), even in highly 
trained rats (Dickinson and Balleine, 1994) but cues that signal food while animals are 
food deprived can still initiate a meal and potentiate eating when those animals are 
satiated (Weingarten, 1983, Weingarten, 1984, Weingarten and Martin, 1989). Pre-fed 
rats would therefore be expected to exhibit a low level of operant responding that could 
be increased by a pharmacological manipulation that affected motivation. 
 
The presence of some responding even in pre-satiated animals would allow a direct 
comparison between the pattern of responding due to the motivational effects of the CS 
and any change in motivation following intra-Acb GABA receptor stimulation. 
Thornton et al. (2005) reported that pre-feeding animals kept on a restricted diet and 
maintained at 85% of free-feeding weight prior to testing on this second order schedule 
resulted in an overall reduction in reinforced lever pressing but had no significant effect 
on non-reinforced or incorrect lever presses. 
 
The data presented in Chapter 3 suggested that the introduction of baclofen could cause 
changes in responding specifically in the appetitive phase, the consummatory phase or 
both. Nevertheless, the current model proposed for the mode of action of GABA 
agonists in the AcbSh would suggest that if the effects of GABAA and GABAB agonist 
on motivated behaviour are the same there should be no effect on instrumental 
responding (Baldo and Kelley, 2007, Kelley et al., 2005b, Kelley et al., 2005a). 
Consequently a positive pharmacological experimental control was also run. In this case 
a compound that has both a well documented effect on ingestive behaviour and 
associated effects on operant responding for a food reward was required. Two possible 
candidates were considered. 
 
It has been previously demonstrated that the reinforcing value or incentive salience 
attributed to the CS can be robustly increased by intra-Acb infusions of the indirect 
dopamine agonist, d-amphetamine, which potentiates instrumental responding for the 
CS (Phillips et al., 1994, Taylor and Robbins, 1984) however there is no concomitant 
increases in free feeding. In contrast a role for peripheral opioids in modulating 
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responding to freely available food and in performing operant responses for 
unconditioned food reinforcers has been well established. It would appear therefore that 
an opioid agonist would be the more appropriate positive control although the specific 
role of intra-Acb opioids (rather than peripherally administered agonists) in operant 
responding is not entirely clear. 
 
Although results from earlier studies using a variety of opioid agonists are mixed 
(Kelley and Domesick, 1982, Cunningham and Kelley, 1992b, Cunningham and Kelley, 
1992a) it has been shown that DAMGO increases responding on a CR paired lever 
(Phillips et al., 1994). Zhang et al. (2003) demonstrated that DAMGO infused into the 
accumbens significantly increased both the rate of lever pressing and the breakpoint in a 
PR schedule for sucrose pellet reward. The authors suggested that “enhancement of 
positive hedonic properties of food” could be directly translated into a high level of 
motivation (and hence into increases in food seeking behaviour) (Zhang et al., 2003). 
For this set of studies therefore the µ-opioid agonist DAMGO (used in Chapter 3) was 
used as the positive control. 
 
The experiments reported in this chapter will examine the effect of 1) a low dose range 
baclofen; 110, 220 and 440 ρmols/µl-1, 2) a higher dose range baclofen; 220 and 660 
ρmols/µl-1 or 3) DAMGO at 0.025ng/µl-1. Effects will be analysed in terms of the 
magnitude and accuracy of responding on two operant levers with respect to the 
programmed schedule. The efficacy of the dose ranges chosen on intake of freely 
available food will be confirmed by measuring total intake of chow in the same 
experimental groups using the same doses following the operant schedule test phase. 
 
These experiments will contribute to our understanding of the specific effects of intra-
Acb GABAB receptor stimulation revealed in Chapter 3 and will also address four of the 
key aims of the thesis. In experiment 4.1 the effects of an identical range of doses of 
baclofen for which the BSS was characterised will be recorded for 5 minutes of purely 
appetitive responding for a CS and for 25 minutes of mixed appetitive/consummatory 
behaviour on the second order schedule. The effect on total intake of freely available 
chow of infusions of the highest dose of baclofen from the range will also be assessed in 
the same cohort of animals. 
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The aim of experiment 4.1 will be to test whether baclofen a) potentiates appetitive 
responding for food-paired stimuli in the absence of ingestive behaviour and the 
consequences of ingestion and b) potentiates responding when the primary reinforcer 
becomes intermittently available. This will further test the hypothesis put forward by 
Kelley and colleagues that GABA receptor stimulation in the Acb causes increased 
intake because of the consequent release of downstream motor pattern generators. 
Detailed temporal analysis of responding across the session, the relationship between 
CS presentations and pressing and between pellet delivery and pressing will allow an 
interpretation of the results in terms of motivation theory and the neurobiology 
underlying any effects. 
 
Experiment 4.2 will involve intra-Acb infusions of one dose of the µ-opioid agonist 
DAMGO. Although it is not clear if this pharmacological manipulation will have any 
effect during the appetitive phase of the schedule it is predicted to at least increase 
responding during the consummatory phase. Because of this possible dichotomy in 
effects on appetitive vs. consummatory responses the use of DAMGO could help to 
clarify whether or not the schedule is sensitive to both aspects of motivation for reward.  
 
A comparison between the temporal analysis for DAMGO, which is known to effect 
intake via effects on palatability, and the results from the baclofen manipulation may 
provide insights into the behavioural mechanisms underlying the latter results. This will 
also help to elucidate whether the effects of GABA receptor stimulation are specific to 
different phases of ingestion e.g. anticipatory responding, consummatory behaviour and 
satiety mediated by the Acb. The effect on total intake of freely available chow of 
infusions of the same dose will also be assessed in the same cohort of animals. 
 
Finally in experiment 4.3 the effects of baclofen in the second order schedule will be 
further explored across a broader dose range in view of the results reported in 
experiment 4.1. This will include the analysis of the effects of baclofen on behaviours 
other than lever pressing using videos of the test sessions. In this experiment a full dose 
range, free-feeding intake study will be carried out following completion of the second 
order schedule testing phase using the same counterbalanced design to allow a direct 
comparison between any effects on operant responding and on intake. Given that the 
effects of hunger and satiety have already been reported for the schedule (Greenhalgh, 
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2007, Thornton-Jones et al., 2005) it will help to put the role of GABA in the context of 
naturally elicited feeding and motivational control in general. Results reported in this 
chapter and in Chapter 5, where the effects of muscimol will be further investigated 
using the second order schedule, will further contribute to the characterisation and 
comparison of the effects of GABA receptor subtype stimulation on feeding related 
behaviours. 
 
To summarise, previous research indicates that, although intra-Acb GABAA agonist 
infusion increases intake of freely available food, it does not potentiate the acquisition 
of a stimulus-food reward association nor does it increase operant responding in a PR 
schedule. However, the effects of GABAB agonists on acquisition or performance of 
operant responses has not been investigated. Furthermore, the effects of muscimol were 
tested across a narrow dose range that encompasses concentrations that could cause 
motor disruption. Finally the schedules used previously tested appetitive responding in 
close temporal association with consummatory responses. This meant that the effects of 
GABA receptor stimulation on a specific subset of the mechanisms underlying food 
motivation could not be distinguished. Neither could the potential confounding effects 
of post-ingestional processes and satiety mechanisms be excluded when interpreting the 
results. The three experiments reported in this chapter will: 
 
1) Test the effects of a range of doses of a GABAB agonist on instrumental 
behaviour in the second order schedule (Experiment 4.1 and 4.3). Does the 
GABAB agonist baclofen affect operant responding? 
2) Characterise the magnitude and temporal pattern of responses made following 
intra-Acb GABAB infusion during both appetitive and consummatory operant 
phases (Experiment 4.1 and 4.3). Does the GABAB agonist baclofen cause any 
divergence in responding depending on the phase? 
3) Test the effects of a range of doses of a GABAB agonist on behaviours other 
than lever pressing expressed during an operant schedule (Experiment 4.3). 
Does the GABAB agonist baclofen have any effects on general activity, other 
indices of motivated behaviour or on adjunctive behaviours not picked up by 
measuring lever pressing alone? 
4) Test the effects of a µ-opioid agonist infused into the same location on operant 
responding in the second order schedule (Experiment 4.2). Does the µ-opioid 
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agonist DAMGO, at a dose that increases free intake, affect operant responding 
on this specific type of schedule? 
5) Characterise the magnitude and temporal pattern of responses made following 
intra-Acb µ-opioid agonist infusion during both appetitive and consummatory 
operant phases (Experiment 4.1 and 4.3). Does the µ-opioid agonist DAMGO 
cause any divergence in responding depending on the phase? 
6) Compare the effects of a GABAB agonist to those of a µ-opioid agonist in the 
Acb on the magnitude and temporal pattern of responses made during appetitive 
and consummatory operant phases (Comparison of data from experiments 4.1, 
4.2 and 4.3). Does the GABAB agonist baclofen control operant responding for 
food via similar mechanisms known to underlie µ-opioid agonist effects on 
intake? 
 
The overarching question posed in this chapter is:  
Does intra-Acb administration of the GABAB agonist baclofen potentiate any aspect of 
complex goal-directed motivated behaviour on a second order schedule in a manner 
consistent with selective effects on appetitive and/or consummatory behaviours? 
 
Experiments presented in this chapter 
Experiment 4.1 
The effects of bilateral intra-Acb infusions of a range of doses of baclofen in pre-fed 
rats trained to respond on a second order operant schedule. 
 
Experiment 4.2 
The effects of bilateral intra-Acb infusions of DAMGO in pre-fed rats trained to 
respond on a second order operant schedule. 
 
Experiment 4.3 
The effects of bilateral intra-Acb infusions of a higher range of doses of baclofen in pre-
fed rats trained to respond on a second order operant schedule, on associated behaviours 
and on free intake. 
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Materials and methods 
Animals 
Drug naïve animals (n=12) were used for Experiment 4.1 (2nd order with baclofen). This 
same group of animals were then run through the test again for Experiment 4.2 (2nd 
order with DAMGO). A second drug naïve group of animals (n=12) was used in 
Experiment 4.3 (2nd order with higher dose range baclofen). Subjects were bought in 
weighing between 150-200g. This meant that, on a restricted diet and over the longer 
habituation and training period associated with the schedule, animals had reached 
approximately the same size as those used in chapter 3 when surgery was undertaken. 
This ensured that their position in the stereotaxic equipment was not significantly 
different as can be the case with larger animals that have developed greater musculature 
and/or fat deposits in the cheeks. In all cases the animals were housed in pairs during 
training on the 2nd order schedule. They were then split and housed singly in Perspex 
cages for a minimum of 7 days prior to surgery and for the remainder of each 
experiment.  
 
 
 
 
Figure. 4.1. Diagram to show which groups of animals were used for more than 
one test procedure within experiments 4.1, 4.2 and 4.3 and the timeline for each. 
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Apparatus and habituation 
The apparatus, habituation and training procedure for the 2nd order schedule is described 
in detail in Chapter 2. All animals were food deprived for a minimum of 7 days prior to 
magazine training and returned to an ad lib diet for a minimum of 4 days prior to 
surgery. Post surgery and recovery, animals were put back on a restricted feeding 
regime, re-trained and then given sham infusions as described in Chapter 2 (page 67). 
 
Post surgery, animals were also habituated to the test cages for the free intake test 
sessions. Habituation to eating chow pellets in a non-food deprived state (to match the 
motivational state of animals tested in Chapter 3) required that the rats be pre-fed prior 
to being transferred to the intake test cages (see habituation procedure described in 
Chapter 2 (page 69). To recap, food was removed from the home cage one hour before 
habituation and replaced with 5 fresh pellets to which rats had access for 30 minutes 
before being transferred to the tests cages for a 30 minute acclimation period. As a 
result it was necessary to weigh how much was eaten during the pre-feeding period and 
in the intake test cages and to adjust the amount they would subsequently be fed for the 
day to maintain their weight at 85% of free feeding weight. 
 
Animals were also pre-fed in the home cage prior to infusions for the 2nd order test 
session. In this case food was removed from the home cage one hour before habituation 
and replaced with 5 fresh pellets to which rats had access for 30 minutes and then they 
remained in the home cage for a further 30 minutes leading up to the infusion. All of 
these experiments were carried out using a within subject, counterbalanced, Latin 
square design such that each animal served as its own control. Animals were always re-
exposed to the schedule in a food deprived state the day before a test session, 
irrespective of how many days had elapsed between tests. 
 
Specific procedural details – central drug administration 
On test days only two animals were infused at a time to compensate for the time taken 
for each infusion. The programme controlling the operant boxes allowed each box to be 
started individually. This meant that testing of each animal could be temporally 
staggered and there were 4 operant boxes. Infusions for the next batch of 4 animals to 
be tested began a few minutes before the previous batch was due to come out and the 
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whole cohort could be run over a period of approximately 4 hours (between 12.00 and 
16.00). There was a minimum of 48 hours between infusions. 
 
Experiment 4.1 
The range of doses of baclofen to be tested in the 2nd order schedule was the same as the 
range used in Chapter 3, experiment 3.1 i.e. 110, 220 and 440 ρmols/µl-1 or vehicle 
(0.9% sterile saline – used throughout) infused immediately before transfer to the 
operant boxes. Initially a counterbalanced intake probe using the highest dose of 
440ρmols vs. vehicle was run to ensure that the placements were behaviourally active in 
terms of increased feeding in pre-fed rats (for method for intake test see Chapter 2, page 
69). This was followed by the test run on the 2nd order schedule (as detailed in Chapter 
2, page 75) using the whole dose range of baclofen. These animals were given >2 days 
drug free. This experiment was followed by a second run with DAMGO (Exp. 4.2).  
 
Experiment 4.2 
In experiment 4.2 only one dose of 0.025ng/µl-1 of DAMGO and vehicle were tested. 
This dose was chosen because the higher dose of 0.25 ng/µl-1 used in the BSS study 
reported in Chapter 3, experiment 3.3 caused sedative effects in some of the animals. 
Following 2nd order test days the animals were run through a counterbalanced intake 
test with chow using the same dose of DAMGO and vehicle. 
 
Experiment 4.3 
In response to the results for experiment 4.1 (see below) a broader range of baclofen 
doses was tested. As a result an intermediate dose between the highest (440ρmols) used 
in experiment 4.1 and 880ρmols used by Stratford and Kelley (1997) was chosen. The 
final range tested here was therefore 220, 660 ρmols/µl-1 baclofen or vehicle. Initially a 
counterbalanced intake probe using the highest dose of 660ρmols vs. vehicle was run to 
ensure that the placements were behaviourally active in terms of increased feeding in 
pre-fed rats (for intake test method see Chapter 2, page 69). This was followed by the 
test run on the 2nd order schedule (as detailed in Chapter 2, page 75). The 2nd order test 
was followed by a counterbalanced dose response test of intake of chow in pre-fed 
animals using the same range of doses. Finally duration and frequency data for distinct 
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categories of behaviours exhibited during responding were extracted from videos of the 
2nd order operant test sessions (see below for details of video analysis). 
 
Data analysis 
The final analysis groups were decided on the basis of histological verification of 
infusion sites as before. Unix Shell scripts were written, by Prof. Pete Clifton and 
myself, to extract all of the following information from the raw output recorded at the 
time of testing. 
 
First of all, total reinforced, non-reinforced and incorrect presses data for each treatment 
group were consolidated from the raw output and compared using a repeated measures, 
mixed design ANOVA with dose and press category as factors. To recap, presses on the 
correct lever made while the CS was on could not contribute to the next ratio (and hence 
to delivery of food) and hence were defined as ‘non-reinforced’. Incorrect presses were 
those made on the second lever that had no programmed consequences. Next data for 
each treatment group for the mean cumulative reinforced lever presses were extracted 
and plotted to illustrate the way in which treatments affected the gross temporal 
progression of responding on the schedule. 
 
Rates of responding were calculated for the two different phases; the appetitive phase 
(first 5 minutes) and the consummatory phase (remaining 25 minutes) derived on the 
basis of the total number of presses per minute made during each phase. Comparisons 
of rate could then be statistically compared using a within subjects, repeated measures 
ANOVA with phase and dose as factors. 
 
Next 5 minute timebin reinforced presses (and non-reinforced in experiment 4.1 only) 
were consolidated from the raw output. By splitting the pressing behaviour into time-
bins it was possible to look at the temporal structure of the test session in more detail. 
The mean total presses in each time bin and the relative changes in these totals over 
time were compared between doses using a repeated measures, mixed design ANOVA 
with dose, and time-bin as factors. 
 
The total number of pellets delivered was extracted to give a measure of intake within 
the operant schedule compared to intake when pre-fed animals were given free access to 
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chow. Pellets received were analysed with a within subjects, repeated measures 
ANOVA with dose as factor. In all cases where post hoc comparisons were carried out 
Dunnett’s test was used to compare drug effects with vehicle control or the Bonferroni 
test was used if it was of interest to compare effects between all treatments. 
 
Next the mean cumulative proportion of inter-lever press intervals (ILIs) of discrete 
durations of between 0 – 30 seconds was parsed from the data. Of the possible 
transitions that these intervals spanned i.e. from the first press of an FR5 to the second, 
from the second to the third etc. the period of interest was the progression from the 5th 
press that elicited the CS and the press that followed this. By looking at how long this 
ILI was in relation to the 8s period of the CS presentation it was possible to see if 
animals were responding to the contingency requirement of the schedule and if the drug 
treatments disrupted this. Therefore only data for the 5th to 1st ILI were further extracted 
and characterised. These data were split into the cumulative ILIs during the first 5 
minutes of unrewarded pressing and the subsequent 25 minutes when reward was 
available. Due to the nature of the data output generated for the ILIs it was only 
analysed as far as providing descriptive statistics. 
 
A script was also used to calculate the interval between the delivery of pellets and the 
next time the animals made a reinforced lever press. This interval was termed the inter 
pellet-lever interval (IPLI). Because there was a unequal number of IPLIs for each 
animal for each dose the mean length of all IPLIs between the vehicle and drug 
treatment group were compared in SPSS using Levene's test for equality of variances 
and, dependant on the outcome, followed by the appropriate one-way ANOVA or one-
tailed t-test. The one-way ANOVA was followed by planned post-hoc analyses. 
Hochberg’s GT2 was specified (which uses a harmonic mean to exclude bias from data 
with unequal sample sizes) and the results for the comparisons were verified using the 
Games-Howell procedure (Field, 2005). 
 
Where relevant the effects on total intake was analysed using a within subjects, repeated 
measures ANOVA with dose as factor. When reporting all of the above data in the 
results section post hoc analysis using Dunnett’s test will be referred to as paired 
comparisons but where the Bonferroni test was used to compare effects between drug 
doses or Games-Howell procedure (as above) were used these will be specified. 
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Data extraction from videos 
In experiment 4.3 other behaviours associated with responding in the operant box on the 
2nd order schedule were recorded from the videos of each test session. Unix Shell scripts 
were used to extract the total durations and frequency of each behaviour and to parse the 
data into 5 minute time bins for more detailed temporal analysis. The means for total 
duration and frequency of behaviours in each treatment group were compared using a 
repeated measures ANOVA with dose and behavioural category as factors. The timebin 
data were analysed using the same ANOVA design but including dose, behavioural 
category and time-bin as factors. Timebin data were plotted as line plots to illustrate the 
change in the durations and frequencies of each individual behaviour across the session. 
 
It was then possible to calculate the rate of ingestion of pellets from the duration of 
eating behaviour recorded for each animal and the total number of pellets consumed. 
The mean rate of feeding for the treatment groups was then compared using a repeated 
measures ANOVA with dose as factor. The same approach was taken for calculating the 
overall rate of lever pressing across the session from the time spent at the reinforced 
lever and the total number of presses made on this lever (reinforced + non-reinforced).  
 
Whilst recording occurrences of rearing behaviour from the videos a separate tally was 
kept for rears made specifically to the cue light and/ or the sound of the pellet delivery 
hopper turning. The mean proportion of rears to the CS vs. the total number of rears 
made was then compared between treatment groups using a repeated measures ANOVA 
with dose as factor. 
 
Next the relationship between lever pressing and number of nose-pokes into the 
magazine was investigated. The total number of reinforced lever presses vs. total 
duration and frequency of nose-pokes was calculated and the means compared using a 
repeated measures ANOVA with dose as factor. 
 
Preliminary observations suggested that there might be dose related effects on grooming 
behaviour so the presence or absence of a normal grooming sequence characterised by a 
rule-driven (syntactic) chain with a stereotyped order of paw, head and body 
movements (Berridge and Whishaw, 1992, Aldridge et al., 2004) was recorded. Any 
other changes in the pattern of behaviour were noted while coding the 8 categories. 
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Results 
Experiment 4.1: The effects of bilateral intra-Acb infusions of baclofen 
at 110, 220 & 440ρmols/µl-1 in pre-fed rats on free intake and 
responding on a second order operant schedule for food. 
 
 
 
 
 
Figure 4.2. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β). Bilateral target coordinates 
(n=7 of original n=12 with acceptable placements) were (AP), + 1.4mm, 
mediolateral (ML), ± 0.9mm relative to bregma and dorsoventral (DV), -7.8mm 
relative to skull surface. 
 
 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
β  +1.0mm 
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Prior to testing animals in the operant chambers, responsiveness to baclofen in pre-fed 
animals was verified at a dose of 440ρmols baclofen. Two of the original cohort of 
n=12 animals were noted to have consumed less chow at this dose than with vehicle 
treatment. These were among the animals excluded from the final analysis on the basis 
of the histology. A total of n=7 animals were verified as having acceptable placements, 
as defined in Chapter 2, and were included in the final analysis. A schematic illustration 
of Acb infusion site placements is given in Fig. 4.2. These animals consumed 
significantly more chow with baclofen treatment than with vehicle over a 30 minute 
period [Fig. 4.3: F(1,6)=84.46, p<0.001].  
 
 
Figure 4.3. The effects of intra-Acb bilateral infusions of saline or baclofen in pre-
fed rats (n=7) given access to laboratory chow over a 30 minute test session. Error 
bars represent ±SEM. Significant differences from vehicle are denoted by ✭✭✭  
p<0.001. 
 
 
In the operant test session, rats that had been pre-fed (access to 5g of chow for 30 
minutes) prior to infusions of a range of doses of baclofen nevertheless demonstrated a 
significant increase in the total number of reinforced lever presses for food [Fig. 4.4: 
F(3,18) =10.95, p<0.001]. Planned post-hoc analysis using the Bonferroni test revealed 
that the 220ρmols significantly increased reinforced responding relative to vehicle 
(p<0.01) and to both other doses of baclofen (p<0.05 in both cases). The 440ρmols dose 
also significantly increased reinforced responding relative to vehicle (p<0.05). There 
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was no significant increase in errors due to drug i.e. there was no increase in presses on 
the ‘incorrect’ lever but there was a significant increase in non-reinforced presses [Fig. 
4.4: F(3,18) =4.03, p=0.024]. Paired comparisons revealed that the total number of non-
reinforced presses was only significantly increased relative to vehicle levels at 
220ρmols. When the total number of non-reinforced presses was expressed as a 
proportion of total presses on the reinforced lever (i.e. non-reinforced / non-reinforced + 
reinforced) there was no significant difference between the doses i.e. the increase in 
non-reinforced lever presses was proportional to the increase in reinforced lever presses. 
 
 
 
Figure 4.4. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on total lever presses in a 30 minute second 
order operant test session. Error bars represent ±SEM. Significant differences 
from vehicle are denoted by ✭  p<0.05, ✭✭  p<0.01. Significant differences versus 
the next higher drug dose are denoted by ✝  p<0.05. Significant differences versus 
the preceding lower drug dose are denoted by $ p<0.05. 
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There was no significant effect of previous drug treatment on the total number of 
reinforced lever presses made by food deprived rats on the training days immediately 
following testing. Furthermore there was no significant difference between pressing on 
these training days and the levels of pressing prior to the start of testing on the 2nd order 
schedule. 
 
 
 
Figure 4.5. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on cumulative reinforced lever presses over 
a 30 minute second order operant test session.  
 
 
 
The plots of cumulative reinforced lever presses over time shown in Fig. 4.5 above 
suggest a linear increase in total lever presses with baclofen treatments as the session 
progressed. In contrast, rats under the vehicle condition appeared to decrease their 
response rate after the first 5 minute appetitive phase. The rates of lever pressing, 
expressed as reinforced presses per minute, across the first 5 minutes (appetitive) and 
subsequent 25 minutes (consummatory) of the schedule are shown for each treatment in 
Table 4.1. 
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With vehicle, 110ρmols and 440ρmols of baclofen, the rate of pressing in the late phase 
was lower than in the early phase but not significantly so. With the 220ρmols treatment 
the rate of pressing during the late phase was significantly greater than during the early 
phase [F(1,6)=21.26, p = 0.004]. A comparison of the rates of pressing between each 
treatment during the early phase indicated that there was no significant difference. 
During the subsequent 25 minutes there was a main effect of drug, increasing the rate of 
pressing above vehicle levels  [F(3,18)=15.37, p <0.001]. Multiple post hoc 
comparisons made using the Bonferroni test revealed that, at 220ρmols the rate was 
greater than with vehicle (p < 0.01), 110ρmols dose (p < 0.01) or 440ρmols (p < 0.05). 
At the 440ρmols dose, the rate of pressing was significantly greater than with vehicle (p 
< 0.05).  
 
 
 
Table 4.1.  The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on the rate of reinforced lever pressing 
during the first 5 minutes (appetitive phase) and last 25 minutes (consummatory 
phase) of a second order operant test session. Significant differences between 
phases for each treatment are indicated by the ‘p’ values reported in the last 
column. Significant differences between treatments for each phase for drug vs. 
vehicle are denoted by ✭  p<0.05, ✭✭  p<0.01. Significant differences relative to 
lower drug doses are denoted by $$ p<0.01. Significant differences relative to 
higher drug doses are denoted by ✝  p<0.05. 
 
 
Treatment Phase Rate 
presses/min 
Difference 
between phases 
p = 
Appetitive  3.49 ± 0.99 
Vehicle  
Consummatory 1.29 ± 0.57 
NS 
 
Appetitive  4.00 ± 1.05 
110pmols baclofen 
Consummatory 3.25 ± 0.91 
NS 
 
Appetitive 4.29 ± 1.01 
220pmols baclofen 
Consummatory 6.27 ± 1.01 /$$/  
0.004 
 
Appetitive 4.46 ± 0.97 
440pmols baclofen 
Consummatory 3.69 ± 1.03  
NS 
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When the data were split into 5 minute bins no significant main effect of time on 
reinforced lever pressing was revealed but there was a significant interaction between 
drug and time (see Fig. 4.6). Further analysis, restricting the ANOVA to individual time 
bins, revealed that the animals given drug pressed significantly more frequently on the 
reinforced lever from 5 minutes onwards. Multiple comparisons made using the 
Bonferroni test showed that only the 220ρmols dose significantly increased pressing 
above vehicle levels between 5 and 30 minutes (5–15 minutes, p<0.05 and 15–30 
minutes, p<0.01). Between 15 and 20 minutes pressing with 220ρmols was also 
significantly higher than with either of the other two drug doses (110ρmols, p<0.05; 
440ρmols, p<0.01). 
 
 
 
Figure 4.6. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on reinforced lever presses across a 30 
minute second order operant test session. Error bars represent ±SEM. Significant 
differences from vehicle are denoted by ✭ p<0.05, ✭✭ p<0.01. Significant 
differences versus the next higher drug dose are denoted by ✝  p<0.05, ✝✝  p<0.01. 
Significant differences versus the preceding lower drug dose are denoted by $ 
p<0.05, $$ p<0.01. 
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The effect of drug on non-reinforced lever pressing was revealed to be due to a 
significant main effect of dose [F(3,18)=4.03, p = 0.024]. Paired comparisons revealed 
that only the 220ρmols dose significantly increased non-reinforced presses and only 
between 15-25 minutes (p<0.05). The significantly higher level of non-reinforced 
pressing coincided with the peak in reinforced presses on this lever (Fig. 4.7 compared 
to Fig. 4.6). 
 
 
 
 
 
Figure 4.7. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on non-reinforced lever presses across a 30 
minute second order operant test session. Error bars represent ±SEM. Significant 
differences from vehicle are denoted by ✭ p<0.05. Significant differences versus 
the preceding lower drug dose are denoted by $ p<0.05.  
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The cumulative mean proportions of the length of inter lever press intervals (ILIs) 
between the 5th press of an FR5 response and the 1st press of the next FR5 across the 
first 5 minutes of the 2nd order schedule are depicted in Fig. 4.8 below. The distributions 
of ILIs for the remaining 25 minutes of the test session are shown in Fig. 4.9. In the first 
5 minutes of the session, when no lever presses could be rewarded with the primary 
reinforcer, animals did not press during the CS with vehicle but did do so with all drug 
treatments. At 110ρmols an average of 20% of ILIs were within the first 8 seconds i.e. 
when the cue light was still on. An average of 34% ILIs at 440ρmols but only 5% for 
the 220ρmols dose were made during the CS. There was no apparent trend in the 
maximum amount of time animals waited to press. 
 
 
 
Figure 4.8. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on cumulative ILIs between the 5th and 1st 
presses of the FR5 requirement on the reinforced lever. Data represents 
responding across the first 5 minute unrewarded phase of a second order operant 
test session. The shaded phase represents the duration of the CS (8 seconds). The 
CS indicated that criterion had been met and that concomitant presses would not 
be reinforced. 
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For the remaining 25 minutes of the session some animals pressed during the CS with 
all treatment conditions but, with the higher two doses of baclofen, some of the animals 
did not wait at all to start pressing. With 220ρmols of baclofen the inter lever latencies 
were shifted the to the left relative to vehicle. 
 
 
 
 
  
 
 
Figure 4.9. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on cumulative inter lever press intervals 
between the 5th and 1st presses of the FR5 requirement on the reinforced lever. 
Data represents responding across the last 25 minute rewarded phase of a second 
order operant test session at A) all doses tested and B) with just vehicle or 
220pmols. The shaded phase represents the duration of the CS (8 seconds). The CS 
indicated that criterion had been met and that concomitant presses would not be 
reinforced. 
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There was a significant increase in the number of pellets delivered with drug treatment 
relative to vehicle [Fig. 4.10, F(3,18)=15.56, p<0.01]. Paired comparisons revealed that 
the increase in the number of reinforced presses with the 220ρmols dose of baclofen 
resulted in a significant increase in the total number of pellets delivered (p<0.01). The 
highest dose of 440ρmols also significantly increased the number of pellets delivered 
relative to vehicle (p<0.05). Not all of the animals at all of the doses pressed enough 
times to receive pellets over the 30 minute period. As a result, any calculation of a mean 
latency to pellet delivery for each treatment group would have had to have been based 
on a different numbers of subjects. Because of this it was not possible to carry out a 
meaningful statistical analysis on latency to first pellet delivery. 
 
 
 
 
Figure 4.10. The effects of intra-Acb bilateral infusions of saline or a range of 
doses of baclofen in pre-fed rats (n=7) on total number of pellets delivered due to 
responding on the reinforced lever over a 30 minute second order operant test 
session. Error bars represent ±SEM. Significant differences from vehicle are 
denoted by ✭  p<0.05 and ✭✭  p<0.01. 
 
 
 
164 
For those animals that pressed frequently enough to receive a food reward the average 
amount of time consequently taken to start pressing for reward again, the inter pellet-
lever latency (IPLI) is depicted in Fig. 4.11. Levene’s test confirmed that there was 
equal variance between treatment groups. There was a significant main effect of drug on 
the duration of the IPLIs [F(3,86)=4.74, p=0.004] i.e. one or more of the doses 
decreased the latency to press post pellet delivery. Planned post hoc analysis using the 
Games-Howell procedure revealed that there was no significant difference in the 
duration of IPLIs between vehicle and the 110ρmols or 440ρmols doses. At 220ρmols, 
animals returned to pressing following pellet delivery significantly faster than with 
vehicle (p=0.018) or 110ρmols of baclofen. Observation of the behaviour of the animals 
from videos of the test sessions indicated that the pellets were consumed before the 
animals, under the influence of 220ρmols baclofen, went back to pressing. 
 
 
 
Figure 4.11. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on the total duration of intervals between 
pellet delivery and next reinforced press (IPLIs). Data represents responding 
across a 30 minute second order operant test session. Error bars represent ±SEM. 
Significant differences from vehicle are denoted by ✭ p<0.05. Significant 
differences versus next higher drug dose are denoted by ✝  p<0.05. 
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Summary of results for experiment 4.1 
In experiment 4.1 n=7 of n=12 subjects were included in the final analysis. The 
440ρmols dose of baclofen significantly increased intake of freely available chow prior 
to testing on the 2nd order operant schedule.  
 
Both 220ρmols and a higher 440ρmols dose significantly increased the total number of 
reinforced presses across the 30 minute operant session. The 220ρmols dose also 
increased the total number of non-reinforced presses for 10 minutes of the session but 
this was proportional to the overall increase in responses on the reinforced lever and 
only significant at the peak of reinforced pressing. 
 
Analysis of reinforced lever pressing across 5 minute time bins revealed that 220ρmols 
baclofen significantly increased the total number of reinforced lever presses during the 
first 10 minutes of the operant test session which encompassed 5 minutes when no 
primary reinforcer was available. The total presses per bin and the rate of lever pressing 
with 220ρmols also increased relative to vehicle and other drug doses once reward 
became available during the latter 25 minutes of the session. 
 
Over the first 5 minutes of the session baclofen increased the proportion of pressing on 
the reinforced lever that occurred during CS presentations at all doses although this 
appeared to be due more to presses being made prematurely i.e. before the CS 
terminated rather than animals failing to stop pressing when the CS first came on. This 
effect was not apparent over the remainder of the test session. 
 
The increase in reinforced lever pressing at 220ρmols and 440ρmols resulted in the 
delivery of significantly more pellets than with vehicle. The 220ρmols dose of baclofen 
might have decreased the latency to first pellet delivery but the total number of animals 
that received pellets with vehicle was too low to carry out a statistical verification of 
this effect. The 220ρmols dose did however significantly decrease the length of the 
interval between pellet delivery and the next reinforced lever press that was made. 
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Experiment 4.2: The effects of bilateral intra-Acb infusions of DAMGO 
at 0.025µg/µl-1 in pre-fed rats on free intake and responding on a 
second order operant schedule for food. 
 
Refer to Fig. 4.2, experiment 4.1 for a schematic illustration of Acb infusion site 
placements. In the 2nd order schedule there was no significant effect of 0.025µg 
DAMGO infused into the Acb of pre-fed animals on the total number of reinforced, 
non-reinforced or incorrect lever presses (Fig. 4.12A). There was a significant main 
effect of time on reinforced lever pressing [F(5,30)=3.01, p=0.026]  reflecting a 
decrease in the number of presses across each 5 minute time bin as the session 
progressed (Fig. 4.12B). There was no interaction between drug and time. 
 
 
 
 
Figure 4.12. The effects of intra-Acb bilateral infusions of saline or DAMGO in 
pre-fed rats (n=7) on A) total lever presses and B) reinforced lever presses across a 
30 minute second order operant test session. Error bars represent ±SEM.  
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Figure 4.13. The effects of intra-Acb bilateral infusions of saline or DAMGO in 
pre-fed rats (n=7) on cumulative reinforced lever presses over a 30 minute second 
order operant test session.  
 
 
 
 
Table 4.2.  The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=7) on the rate of reinforced lever pressing 
during the first 5 minutes (appetitive phase) and last 25 minutes (consummatory 
phase) of a second order operant test session. Significant differences between 
phases for each treatment are indicated by the ‘p’ values reported in the last 
column. 
 
 
 
Treatment Phase Rate 
presses/min 
Difference 
between phases 
p = 
Appetitive  3.86 ± 1.17 
Vehicle  
Consummatory 1.86 ± 0.72 
NS 
 
Appetitive  3.40 ± 1.02 
DAMGO 
Consummatory 1.73 ± 0.61 
NS 
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Fig. 4.13 illustrates the distribution of cumulative reinforced lever presses across the 30 
minute 2nd order operant session with intra-Acb infusions of vehicle or DAMGO. The 
figure suggests there was no effect of drug. The rates of lever pressing, expressed as 
reinforced presses per minute, across the first 5 minutes (appetitive) and subsequent 25 
minutes (consummatory) of the schedule are shown for each treatment in Table 4.2. 
There was a main effect of phase that the rate was lower during the final 25 minutes 
than the first 5 for both treatments [F(1,6)=7.97, p=0.03] but no main effect of drug or 
an interaction. 
 
The cumulative proportions of the length of ILIs between the 5th press of an FR5 
response and the 1st press of the next FR5 during the first 5 minutes of the 2nd order 
schedule (unrewarded) are depicted in Fig. 4.14. The distributions of ILIs for the 
remaining 25 minutes of the test session are shown in Fig. 4.15. There was no apparent 
effect of DAMGO compared to vehicle. 
 
Figure 4.14. The effects of intra-Acb bilateral infusions of saline or DAMGO in 
pre-fed rats (n=7) on cumulative ILIs between the 5th and 1st presses of the FR5 
requirement on the reinforced lever. Data represents responding across the first 5 
minute unrewarded phase of a second order operant test session. The shaded 
phase represents the duration of the CS (8 seconds). The CS indicated that 
criterion had been met and that concomitant presses would not be reinforced. 
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For the remaining 25 minutes of the session some animals pressed during the CS with 
vehicle and DAMGO. However with DAMGO 13.1% of presses were made 4 seconds 
before the CS was due to terminate compared to only 2.7% with vehicle.  
 
 
 
Figure 4.15. The effects of intra-Acb bilateral infusions of saline or DAMGO in 
pre-fed rats (n=7) on cumulative inter lever press intervals between the 5th and 1st 
presses of the FR5 requirement on the reinforced lever. Data represents 
responding across the last 25 minute rewarded phase of a second order operant 
test session. The shaded phase represents the duration of the CS (8 seconds). The 
CS indicated that criterion had been met and that concomitant presses would not 
be reinforced. 
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A few days after testing on the 2nd order schedule the same animals pre-fed with chow 
before treatment with 0.025µg DAMGO significantly increased their consumption of 
freely available chow relative to vehicle over 30 minutes [Fig. 4.16; F(2,10) = 31.63, 
p<0.001].  
 
 
Figure 4.16. The effects of intra-Acb bilateral infusions of saline or DAMGO in 
pre-fed rats (n=7) given access to laboratory chow over a 30 minute test session. 
Error bars represent ±SEM. Significant differences from vehicle are denoted by 
✭✭ p<0.01. 
 
 
Summary of results for experiment 4.2 
DAMGO at a dose of 0.025µg had no significant effect on the total number of 
reinforced, non-reinforced or incorrect presses or the rate of reinforced lever pressing 
relative to vehicle across the session. Analysis of the microstructure of reinforced 
pressing across 5 minute time bins revealed that there was no significant effect at any 
stage during the 30 minute test session. During the first 5 minutes, when pressing could 
not be rewarded with the primary reinforcer, DAMGO had no significant effect on the 
duration of inter lever intervals. Over the remaining 25 minutes of the test session 
nearly 5 times as many lever presses were made ≤4 seconds into the CS presentation 
than with vehicle. This dose of DAMGO significantly increased intake of freely 
available chow. 
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Experiment 4.3: The effects of bilateral intra-Acb infusions of baclofen 
at 220 and 660ρmols/µ l -1 in pre-fed rats on free intake and responding 
on a second order operant schedule for food. 
 
 
 
 
 
 
Figure 4.17. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β). Bilateral target coordinates 
(n=8 of original n=12 subjects with acceptable placements ) were (AP), + 1.4mm, 
mediolateral (ML), ± 0.9mm relative to bregma and dorsoventral (DV), -7.8mm 
relative to skull surface. 
 
 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
β  +1.0mm 
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Prior to testing animals in the operant chambers, responsiveness to baclofen was 
verified in pre-fed animals at 660ρmols/µl-1 baclofen. Mild myorelaxant effects were 
noted in some of the animals at the start of the test session but these animals were 
subsequently excluded on the basis of histology. One animal had blocked cannulae and 
also had to be excluded from the study at this stage. A total of n=8 of the original n=12 
animals were verified as having acceptable placements, as defined in Chapter 2, and 
were included for the final analysis. A schematic illustration of Acb infusion site 
placements is given in Fig. 4.17. These animals consumed significantly more chow with 
660ρmols/µl-1 baclofen than with vehicle over a 30 minute period [Fig. 4.18: 
F(1,7)=30.69, p<0.001].  
 
 
 
 
Figure 4.18. The effects of intra-Acb bilateral infusions of saline or baclofen in pre-
fed rats (n=8) given access to laboratory chow over a 30 minute test session. Error 
bars represent ±SEM. Significant differences from vehicle are denoted by ✭✭✭  
p<0.001. 
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In the operant test sessions, rats that had been pre-fed prior to infusions of a range of 
doses of baclofen significantly increased total reinforced lever presses due to drug [Fig. 
4.19: F(2,14)=12.83, p<0.001]. Planned post-hoc analysis using the Bonferroni test 
revealed that only the 220ρmols dose increased responding relative to vehicle (p<0.01) 
and relative to the higher 660ρmols dose (p<0.01). There was no significant increase in 
errors or in non-reinforced presses (see Fig. 4.19). When the total number of non-
reinforced presses was expressed as a proportion of total presses on the reinforced lever 
(i.e. non-reinforced / non-reinforced + reinforced) there was actually a significantly 
lower proportion relative to vehicle at both 220ρmols (p<0.05) and 660ρmols (p<0.01). 
 
 
 
Figure 4.19. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on total lever presses in a 30 minute second 
order operant test session. Error bars represent ±SEM. Significant differences 
from vehicle are denoted by ★★ p<0.01. Significant differences versus the 
preceding lower drug dose are denoted by $$ p<0.01. 
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There was also no significant effect of previous drug treatment on the total number of 
reinforced lever presses made by food deprived rats on the training days immediately 
following drug treatment. Furthermore there was no significant difference between 
pressing on these training days and levels of pressing prior to the start of testing. 
 
Plots of cumulative reinforced lever presses, shown in Fig. 4.20 below, suggest a 
possible linear increase in total lever presses as the session progresses with the 
intermediate 220ρmols baclofen treatment. Rats under the highest dose treatment 
appear to decrease their response rate after the appetitive phase.  
 
 
 
 
 
 
Figure 4.20. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on cumulative reinforced lever presses over 
a 30 minute second order operant test session.  
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The rate of lever pressing, expressed as reinforced presses per minute, across the first 5 
minutes and subsequent 25 minutes of the schedule is shown for each treatment in Table 
4.3. With both vehicle [F((1,7)=10.12, p =0.015] and 660ρmols of baclofen 
[F(1,7)=7.99, p = 0.025], the rate of pressing in the late phase is significantly lower than 
in the early phase. The rate of pressing during the late phase with the 220ρmols 
treatment is not significantly different from the early phase. 
 
Comparing the rates of pressing between treatments during the early phase (first 5 
minutes) indicates that there is a main effect of drug [F(2,14)=5.5, p = 0.017] due to a 
significant increase above vehicle and 660ρmols levels at the 220ρmols dose, revealed 
using the Bonferroni test (p < 0.05 in both cases). During the subsequent 25 minutes 
there was also a main effect of drug on the rate of pressing [F(2,14)=8.80, p = 0.003]. 
Multiple comparisons made using the Bonferroni test revealed that the 220ρmols dose 
significantly increased the rate of pressing above vehicle levels (p < 0.01) and the rate 
with 660ρmols (p < 0.01).  
 
Table 4.3.  The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the rate of reinforced lever pressing 
during the first 5 minutes (appetitive phase) and last 25 minutes (consummatory 
phase) of a second order operant test session. Significant differences between 
phases for each treatment are indicated by the ‘p’ values reported in the last 
column. Significant differences between treatments for each phase for drug vs. 
vehicle are denoted by ✭  p<0.05, ✭✭  p<0.01. Significant differences relative to 
higher drug dose are denoted by ✝ p<0.05, ✝✝ p<0.01. 
 
 
 
Treatment Phase Rate 
presses/min 
Difference 
between phases 
p = 
Appetitive  2.73 ± 0.49 
Vehicle  
Consummatory 1.35 ± 0.25 
0.015 
 
Appetitive 4.60 ± 0.35 /  
220pmols baclofen 
Consummatory 3.74 ± 0.51 /  
NS 
 
Appetitive 2.68 ± 0.68 
660pmols baclofen 
Consummatory 1.02 ± 0.54 
0.025 
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When the data were split up into 5 minute bins a significant increase in reinforced 
presses due to drug was found [F(2,14)=20.39, p<0.001] as well as a significant effect 
of time [F(5,35)=5.38, p<0.001] but there was no interaction due to the broadly similar 
pattern in the levels of lever pressing across time-bins for each dose (see Fig. 4.21). 
Nevertheless, post hoc analysis using the Bonferroni test revealed that the intermediate 
dose of 220ρmols of baclofen significantly increased reinforced lever pressing relative 
to both other treatments in the first 5 minutes (p<0.05) and then again between 15 and 
20 minutes (p<0.001). At 20-25 minutes pressing was higher at 220ρmols than at 
660ρmols (p<0.05). A transient increase in pressing with vehicle at this time point 
meant that the level of pressing at 220ρmols was not significantly higher. By 25 to 30 
minutes pressing at 220ρmols was again significantly higher than with vehicle and 
660ρmols (p<0.01). 
 
 
Figure 4.21. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on reinforced lever presses across a 30 
minute second order operant test session. Error bars represent ±SEM. Significant 
differences from vehicle are denoted by ✭  p<0.05, ✭✭  p<0.01. Significant 
differences versus the preceding lower drug dose are denoted by $ p<0.05, $$ 
p<0.01. 
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The cumulative proportions of the duration of ILIs between the 5th press of an FR5 
response and the 1st press of the next FR5 for the first 5 minutes of the 2nd order 
schedule (unrewarded) are depicted in Fig. 4.22.  The distributions of ILIs for the 
remaining 25 minutes of the test session are shown in Fig. 4.23. In the first 5 minutes of 
the session, when lever presses could not be rewarded with the primary reinforcer, 
animals under the influence of vehicle or the high dose of 660ρmols baclofen started to 
press, at the earliest, 1 second before the cue light went off. In contrast, at 220ρmols, 
7.7% of presses were made only 3 seconds after the light came on.  
 
 
 
 
 
Figure 4.22. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on cumulative inter lever press intervals 
(ILIs) between the 5th and 1st presses of the FR5 requirement on the reinforced 
lever. Data represents responding across the first 5 minute unrewarded phase of a 
second order operant test session. The shaded phase represents the duration of the 
CS (8 seconds). The CS indicated that criterion had been met and that concomitant 
presses would not be reinforced. 
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For the remaining 25 minutes of the session (Fig. 4.23) those presses that occurred 
within 8 seconds of a completed FR5 were infrequent for vehicle with only an average 
of 3.4%. At the 220ρmols dose 20% of presses were made during the CS but half of 
these only occurred 1 second before the termination of the CS. At 660ρmols an average 
of 14.3% of presses were made as soon as the CS was presented and more than half of 
the first presses in an FR5 were made during the CS (57.1%). Presses made once the CS 
had gone off were closer together with both doses of baclofen with more than 80% of 
all ILIs less than 18 seconds long compared to 80% of ILIs less than 25 seconds long 
with vehicle.  
 
 
 
 
 
Figure 4.23. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on cumulative inter lever press intervals 
between the 5th and 1st presses of the FR5 requirement on the reinforced lever. 
Data represents responding across the last 25 minute rewarded phase of a second 
order operant test session. The shaded phase represents the duration of the CS (8 
seconds). The CS indicated that criterion had been met and that concomitant 
presses would not be reinforced. 
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There was a significant increase in the number of pellets delivered due to drug treatment 
[F(2,14)=8.49, p=0.004]. Paired comparisons confirmed that the increase in the number 
of reinforced presses with the 220ρmols dose of baclofen resulted in a significant 
increase relative to vehicle in the total number of pellets that were consequently 
delivered at this dose (p<0.01). Not all of the animals at all of the doses pressed enough 
times to receive pellets over the 30 minute period. As a result, the calculation of the 
mean latency to first pellet delivery for each treatment group would have to have been 
based on different numbers of subjects so it was not possible to carry out any 
meaningful statistical analysis.  
 
 
 
 
 
Figure 4.24. The effects of intra-Acb bilateral infusions of saline or a range of 
doses of baclofen in pre-fed rats (n=8) on total number of pellets delivered due to 
responding on the reinforced lever over a 30 minute second order operant test 
session. Error bars represent ±SEM. Significant differences from vehicle are 
denoted by ✭✭  p<0.01. 
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For those animals that pressed frequently enough to receive a food reward the average 
duration of IPLIs is depicted in Fig. 4.25.  Only 3 out of 8 animals at the highest dose 
pressed enough to receive pellets so these data were not taken to be representative of the 
group and were consequently excluded. As a result statistical analysis was only carried 
out to compare the effects of vehicle treatment with 220ρmols of baclofen for the n=8 
subjects. Levene’s test confirmed that there was equal variance between treatment 
groups. A one-tailed t-test revealed a significant decrease in the mean duration of the 
IPLIs with drug [t(30)=3.33, p=0.001]. 
 
 
 
 
Figure 4.25. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the total duration of intervals between 
pellet delivery and next reinforced press (IPLIs). Data represents responding 
across a 30 minute second order operant test session. Error bars represent ±SEM. 
Significant differences from vehicle are denoted by ✭✭✭ p<0.001.  
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A few days after testing on the 2nd order schedule the same animals pre-fed with 
standard laboratory chow prior to treatment with 220ρmols and 660ρmols of baclofen 
exhibited a significant increase in consumption of chow over a subsequent 30 minute 
test (Fig. 4.26). They then continued to consume chow over a further 30 minute period. 
Paired comparisons revealed that both drug doses significantly increased intake relative 
to vehicle at both times points (p<0.01). There was no significant difference in the 
amount of food consumed with 660ρmols at this stage compared to that consumed the 
first time the animals were given free access to chow (prior to the 2nd order testing 
phase). 
 
 
 
 
Figure 4.25. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the total duration of intervals between 
pellet delivery and next reinforced press (IPLIs). Error bars represent ±SEM. 
Significant differences from vehicle are denoted by ✭✭p<0.01. 
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Associated behaviours 
Analysis of the videos of testing in the operant boxes for experiment 4.3 revealed a 
significant interaction between dose of baclofen and total duration of the 8 behaviours 
recorded [Fig. 4.27: F(16,112)=5.66, p<0.001]. The same was true for the frequencies 
of these behaviours across the session [Fig. 4.28: F(16,112)=2.15, p=0.011]. The pattern 
of the effects of drug on duration and frequency did not always correspond (see Fig. 
4.27 & 4.28). The relationship between duration and frequency is described for each 
behavioural category in the following sections. The amount of the behaviour that was 
coded as off screen was low and there was no significant difference in duration or 
frequency at any dose. Consequently behaviours that could have occurred off screen 
(and therefore have been underestimated) i.e. oral stereotypy, active, rear, groom or 
ingest were not adjusted. 
 
 
Figure 4.27. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the total duration of 8 behaviours 
recorded across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★ p<0.05, ★★ 
p<0.01.  
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Figure 4.28. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the total frequency of 8 behaviours 
recorded across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★ p<0.05. 
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Oral stereotypy 
The total duration [Fig. 4.27; F(2,14)=7.35, p=0.007] and frequency [Fig. 4.28; 
F(2,14)=7.2, p=0.007] of behaviours categorised as oral stereotypy was significantly 
increased by drug over the 30 minute session. Paired comparisons revealed that this was 
due to a significant increase at 660ρmols relative to vehicle levels in duration (p<0.01) 
and frequency (p<0.05). When the duration and frequency data were further split into 
time bins there was no interaction between drug effects and time across the session (Fig. 
4.29). Observations from the videos indicated that oral stereotypy was predominantly 
expressed as licking and chewing of the mesh flooring. At the high dose this was 
sometimes directed towards the magazine or to the levers (possibly over-inflating the 
press counts). 
 
 
 
 
 
 
Figure 4.29. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of ORAL 
STEREOTYPY across a 30 minute second order operant test session. Error bars 
represent ±SEM.  
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Activity 
The total duration of active behaviours were significantly and dose dependently reduced 
by baclofen [Fig. 4.28; F(2,14)=10.88, p<0.001] but there was no significant effect on 
the frequency. Paired comparisons showed that duration at both drug doses was lower 
than with vehicle (p<0.05 at 220ρmols, p<0.01 at 660ρmols). When duration data were 
split into 5 minute bins an interaction between drug and time was revealed [Fig. 4.30A: 
F(10,70)=3.01. p=0.003]. At 220ρmols activity was significantly lower relative to 
vehicle between 10 and 15 minutes (p<0.05).  At 660ρmols activity was significantly 
lower relative to vehicle between 5 and 25 minutes (p<0.01). There was no interaction 
between time and drug for frequency (Fig. 4.30B). It was noted that behaviour coded as 
‘active’ varied considerably from rapid jumping to ‘active standing’. In the latter case 
animals remained on all fours (thus the behaviour could not be coded as inactive) but 
stayed relatively motionless for long periods. At 660ρmols some of the behaviour 
coded as active involved animals moving around the cage whilst lying down using 
‘swimming’ motions of the four limbs. 
 
  
 
Figure 4.30. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of 
ACTIVE behaviours across a 30 minute second order operant test session. Error 
bars represent ±SEM. Significant differences from vehicle are denoted by ★ 
p<0.05 and ★★ p<0.01.  
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Rearing 
Although baclofen had a significant main effect on the total duration of rearing 
[F(2,14)=4.76, p=0.026] post hoc analysis using the Bonferroni test revealed that this 
was only due to significantly less time spent rearing with 660ρmols relative to the 
220ρmols drug dose (p<0.05) (See Fig. 4.27). There were no significant effectss on 
total frequency. Analysis of the total number of rears to the CS indicated that there was 
a significant main effect of baclofen [F(2,14)=6.45, p=0.01]. Paired comparisons 
revealed that only 220ρmols significantly increased the total number of rears to the CS 
relative to vehicle (See Fig. 4.31A, p<0.05). There was no significant difference in the 
number of rears that were directed at the CS as a proportion of total rears made with 
each dose (see Fig. 4.31B). 
 
 
 
 
   
 
Figure 4.31. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) the total number of rears to the CS 
and B) the proportion of the totals rears made that were directed towards the CS 
across a 30 minute second order operant test session. Error bars represent ±SEM. 
Significant differences are denoted by ★ p<0.05.  
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Splitting the durations of all rearing behaviour into 5 minute time bins revealed that 
there was a significant effect of time on rearing [Fig. 4.32A; F(5,35)=20.58, p<0.001] 
but there was no interaction between drug and time because, in all three treatments, the 
duration of rearing gradually decreased across the session. There was no interaction 
between time and drug for frequency (Fig. 4.32B). 
 
 
  
 
Figure 4.32. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of 
REARING across a 30 minute second order operant test session. Error bars 
represent ±SEM.  
 
Lever 
Baclofen had no significant effect on the length of time spent interacting with the levers 
but there was a significant dose related increase in the frequency of visits to the levers 
[Fig. 4.28; F(2,14)=9.4, p=0.003]. Paired comparisons revealed only baclofen at 
220ρmols significantly increased frequency relative to vehicle (p<0.05). Splitting 
duration data into time bins did not reveal any effects of time or interactions between 
time and drug (see Fig 4.33A). When the frequency data were split into time bins there 
was a significant effect of time on the number of visits to the levers [F(5,35)=12.71, 
p<0.001] but no interaction between drug and time (see Fig. 4.33B). 
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The duration of lever interactions encompasses a number of different types of lever 
pressing. Observations from the videos indicated that, whilst in contact with the lever, 
some animals made clear pressing motions whilst others appeared to hold it down for a 
prolonged period. Furthermore, some animals used their noses rather than their paws. 
 
 
 
 
 
 
Figure 4.33. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8)  on A) duration and B) frequency of LEVER 
PRESSING across a 30 minute second order operant test session. Error bars 
represent ±SEM.  
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Headpokes into magazine 
Baclofen had a significant and dose dependant effect on both the duration [Fig. 4.27; 
F(2,14)=7.21, p=0.007] and frequency of head pokes into the magazine [Fig. 4.28; 
F(2,14)=4.38, p=0.033]. Both the duration (p<0.05) and frequency (p<0.05) of 
headpoking into the magazine were significantly higher at 220ρmols than with vehicle. 
 
  
Figure 4.34. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of 
headpokes into the MAGAZINE across a 30 minute second order operant test 
session. Error bars represent ±SEM. Significant differences from vehicle are 
denoted by ★ p<0.05 and ★★ p<0.01.  
 
Further splitting the durations and frequency of responses into time bins revealed an 
interaction between drug and time in both cases; [duration; Fig. 4.34A; F(10,70)=2.32, 
p=0.02] and [frequency; Fig. 4.34B; F(10,70)=2.33, p=0.02]. Paired comparisons 
showed that there was an increase in the duration at the 220ρmols dose compared to 
vehicle between 5-20 and 25-30 minutes (5-15, p<0.05; 15-20, p<0.01; 25-30, p<0.05).  
The effect of baclofen on frequency of headpokes into the magazine was shown to be 
due to a significant increase at 220ρmols relative to vehicle between 15 and 20 minutes 
(p<0.05) and 25 to 30 minutes (p<0.01).  
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When the total duration or frequency of headpokes into the magazine was compared to 
the total number of reinforced lever presses at each dose there was no significant 
differences in the duration of interaction with the magazine per press. When the 
duration per press data were broken down and compared across time bins for vehicle 
and the 220ρmols baclofen there was a relationship between the phase in the session 
and the amount of time subjects interacted with the magazine (Fig. 4.35). In both cases 
the duration of headpokes per press rose across the last 25 minutes of the session with a 
peak occurring just prior to the mean time point at which pellets were first delivered. 
 
 
Figure 4.35. The effects of intra-Acb bilateral infusions of saline or 220ρmols 
baclofen in pre-fed rats (n=8) on the duration of headpokes into the magazine per 
reinforced lever press for 5 minute time bins across a 30 minute second order 
operant test session. The vertical lines indicate the mean time of first pellet 
delivery under baclofen or vehicle treatment. 
 
Observations recorded whilst coding the videos revealed that ‘duration’ of headpokes 
into the magazine masked the variability in strategy employed by individuals. Some 
animals put their head in and waited whilst others repeatedly removed and replaced 
their head in the hopper whilst apparently checking the cue light. Some headpoked then 
reared to the CS. 
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Ingest 
There was no significant effect of drug on the duration of ingestive behaviour. Baclofen 
had a significant main effect on frequency [F(2,14)=4.31, p=0.035] but post hoc 
analysis using the Bonferroni test revealed this to be due only to a significant difference 
between the 220ρmols dose relative to 660ρmols (p<0.05). Timebin analysis revealed 
that, with both the duration [F(10,70)=2.33, p=0.02] and frequency [[F(10,70)=2.74, 
p=0.007] of ingestive behaviours, there was a significant interaction between the effects 
of drug and time (Fig. 4.36). Paired comparisons revealed a significant increase in the 
duration of ingestion with the 220ρmols dose relative to vehicle between 20 and 25 
minutes (Fig. 4.36A; p<0.01). Frequency was also significantly increased with 
220ρmols relative to vehicle between 20-25 minutes (Fig. 4.36B; p<0.01). 
 
 
 
 
Figure 4.36. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of pellet 
INGESTION across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★★ p<0.01.  
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The time taken to eat each meal of 5 pellets (calculated from the total duration of 
ingestion versus pellets consumed by each individual) is shown in Fig. 4.37. Not all 
animals in the cohort pressed enough times to achieve a food reward at every dose so 
statistical comparisons could not be made. 
 
 
 
 
Figure 4.37. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on the average time to ingest 5 pellets across 
a 30 minute second order operant test session. Error bars represent ±SEM.  
 
 
It was noted whilst watching the videos that there was very little variability in ingestive 
behaviour. All pellets were eaten very close to the hopper and there was rapid retrieval 
of the next pellet once the preceding one had been consumed. There were also relatively 
few meals of 5 pellets rewarded to the animals for the amount of effort expended with 
only three rats pressing enough to receive reward with 660ρmols of baclofen.  
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Groom 
There was no significant effect of baclofen on either the total duration or frequency of 
grooming (see Fig. 4.27 and Fig. 4.28) however timebin analysis revealed a significant 
interaction between baclofen and time on the duration [Fig. 4.38: F(10,70)=2.35, 
p=0.019]. Paired comparisons revealed a significant increase with 660ρmols relative to 
vehicle between 15 and 20 minutes (p<0.05). There was no interaction between drug 
and time for frequency of grooming behaviour (see Fig. 4.38A) 
 
  
 
 
Figure 4.38. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of 
GROOMING across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★ p<0.05.  
 
Whilst coding the behaviour in the videos there was a particular type of ‘grooming’ 
behaviour that stood out. At the 660ρmols dose, none of the animals exhibited a normal 
grooming sequence characterised by a rule-driven (syntactic) chain with a stereotyped 
order of paw, head and body movements (Berridge and Whishaw, 1992, Aldridge et al., 
2004). Instead 6 out of 8 animals predominantly groomed either the tail or genitals. In 
particular tail grooming occurred over long periods without interruption. Animals 
looked as if they had become fixated on the tip of the tail specifically. Genital and tail 
grooming was accompanied by a great deal of what appeared to be rolling around or 
falling over. This pattern of behaviour was not seen during BSS experiments, Chapter 3. 
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Of the 2 animals that did not display this group of behaviours, one was almost 
constantly on his belly indicative of a strong myorelaxant effect. The other animal 
appeared to be at the opposite end of the scale behaving more like a rat under the lower 
220ρmols dose (performing reinforced presses and rearing more than the rest of the 
cohort at this dose). In contrast animals under the other doses of drug or with vehicle all 
exhibited this syntactic chain during the test session and also tended to groom after 
pellet consumption and a short period of activity (a bit like a mini BSS).  
 
Inactive 
There was no significant effect of baclofen on the duration or frequency of inactive 
behaviour (See Fig. 4.27 and 4.28) nor was there any interaction between drug and time. 
Looking at the data split into time bins in Fig. 4.39 there was, nevertheless, more 
inactive behaviour expressed at the highest dose of 660ρmols across the session. 
  
 
Figure 4.39. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of baclofen in pre-fed rats (n=8) on A) duration and B) frequency of 
INACTIVE across a 30 minute second order operant test session. Error bars 
represent ±SEM.  
 
Watching the videos it became evident that there may have been a myorelaxant effect at 
the 660ρmols with some animals frequently adopting a particularly languid position 
with limbs splayed and head resting on the mesh rather than on the forepaws (as was 
seen during inactive behaviour with vehicle or 220ρmols of baclofen). 
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Summary of results for experiment 4.3 
In experiment 4.3 n=8 subjects were included in the final analysis. With these animals 
660ρmols of baclofen significantly increased intake of freely available chow prior to 
testing on the 2nd order operant schedule. Both 220ρmols and 660ρmols also 
significantly increased total chow intake relative to vehicle treatment a few days 
following testing on the operant schedule. There was no significant difference between 
the amounts of chow consumed with 660ρmols prior to and following multiple 
infusions for the operant test. 
 
The 220ρmols dose of baclofen significantly increased the total number of reinforced 
presses across the 30 minute operant session, total reinforced presses in the first 5 
minutes only and the rate of reinforced pressing during this 5 minute appetitive phase. 
The rate of pressing with 220ρmols did not increase significantly once reward became 
available during the latter 25 minutes. There was a significant increase in total presses 
in the 5 minute bin after the mean time point at which the first batch of pellets was 
delivered. In contrast there was no significant effect of 660ρmols baclofen on either the 
total number of presses or the rate of pressing across the phases. With vehicle and 
660ρmols baclofen, pressing rate during the latter 25 minutes was significantly lower 
than during the first 5 minutes. There was no significant effect of either dose of 
baclofen on total non-reinforced or incorrect lever presses but the proportion of non-
reinforced presses to total presses made on that lever was lower with both drug doses. 
The increase in reinforced lever pressing with 220ρmols resulted in the delivery of 
significantly more pellets. 
 
At 220ρmols, baclofen appeared to have little effect on the proportion of presses that 
were made during CS presentations. With the 660ρmols dose however >50% of presses 
were made during the CS i.e. when presses could not be rewarded. Nevertheless, given 
that presses that occurred during the CS were classified as non-reinforced presses this 
shift in the pattern of behaviour was not significant. For those presses that were made 
once the CS was terminated baclofen dose dependently decreased the interval between 
lever presses shifting the cumulative ILIs curve to the left, particularly at 660ρmols. 
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The increase in reinforced lever pressing at 220ρmols resulted in the delivery of 
significantly more pellets. This dose of baclofen might have decreased the latency to 
first pellet delivery but the total number of animals that received pellets was too low to 
carry out a statistical analysis. The 220ρmols dose did significantly decrease the length 
of interval between pellet delivery and the next reinforced press compared to vehicle. 
 
Of the 8 other behaviours that were recorded from the videos of the test sessions 
baclofen significantly modified the total durations of oral stereotypy (increased at 
660ρmols), activity (shorter durations at 220ρmols and 660ρmols) and headpokes into 
the magazine (increased at 220ρmols) compared to durations with vehicle. When the 
total frequencies for these three were compared only oral stereotypy (increased at 
660ρmols) and headpokes into the magazine (increased at 220ρmols) were affected by 
baclofen. There was an increase in frequency of interactions with the lever at 220ρmols. 
 
Analysis of each behaviour split into 5 minute time bins revealed that, with 220ρmols 
of baclofen, the duration of activity was significantly reduced relative vehicle between 
10-15 minutes. At 220ρmols activity was replaced by more frequent visits to the lever 
across the session (although there was no significant interaction between time and dose 
for specific bins) and an increase in the duration and frequency of headpokes into the 
magazine as the session progressed. Head poking peaked in the time bins preceding an 
increase in the duration and frequency of bouts of ingestion between 20 to 25 minutes 
and just before the mean time point of first pellet delivery. An increase in the total 
duration of rears, although not significant, must also have contributed to the overall 
reduction in other activities at 220ρmols. Significantly more rears were made to the CS 
at this dose but the increase was proportional to the increase in rearing as a whole. 
 
At 660ρmols the duration of bouts of activity dropped after the first 5 minutes and was 
even lower than with the 220ρmols dose throughout the rest of the session. Instead, at 
this dose, animals were significantly engaged in frequent and long bouts of oral 
stereotypy. There also appeared to be an increase in grooming (although abnormal 
grooming patterns were exhibited) and in inactive behaviour as oral stereotypy 
decreased over time but a large degree of inter-individual variability meant that this was 
not significant across time bins. 
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Discussion 
The experiments reported in this chapter were designed to investigate the acute effects, 
across a range of doses, of intra-Acb GABAB receptor stimulation on ingestion versus 
performance of food motivated operant responses in pre-fed rats. In this case a 2nd order 
schedule was used to record operant responding for a previously food paired CS during 
an ‘appetitive’ phase and to the CS and intermittent primary reinforcer deliveries during 
a ‘consummatory’ phase. The effects were compared with those of intra-Acb DAMGO, 
a µ-opioid agonist that has been previously demonstrated to increase operant 
responding. In the final experiment the effects of baclofen on 8 mutually exclusive 
categories of behaviour expressed during responding on the 2nd order schedule were 
analysed from videos of the sessions. Intake of freely available chow was subsequently 
measured using an identical counterbalanced range of doses in the same cohort of 
animals. 
 
Reinforced lever presses with baclofen 
In experiment 4.1 220ρmols and 440ρmols of baclofen significantly increased total 
reinforced lever presses and the total number of pellets delivered over 30 minutes. In 
experiment 4.3, it was confirmed that 220ρmols significantly increased total reinforced 
lever presses and number of pellets delivered. A higher dose of 660ρmols did not 
significantly alter reinforced lever pressing. None of the doses of baclofen tested had 
any effect on incorrect presses on the second lever.  
 
Phases of responding with baclofen 
In experiment 4.1 there was no significant effect of baclofen on the total reinforced 
presses in the first 5 minutes but there was a significant increase at 220ρmols within 10 
minutes (prior to first pellet delivery). There was no significant effect of drug on rate of 
responding in the first 5 minutes but a significant increase across the final 25 minutes at 
220ρmols and 440ρmols. The rate across the final 25 minutes was also significantly 
higher with 220ρmols than with the other drug doses.  In experiment 4.3, during the 
first 5 minutes and across the last 25 minutes, the 220ρmols dose significantly increased 
total reinforced lever presses and the rate of lever pressing relative to vehicle and 
660ρmols baclofen. During this final phase the rate of pressing was significantly lower 
than during the first 5 minutes with vehicle and 660ρmols of baclofen. In experiment 
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4.1 the mean latency to first pellet delivery fell between the second and third 5 minute 
time bins. Pressing in the third timebin was consequently higher than in the second 
suggesting an invigoration of responding following food reward. The same relationship 
held true in experiment 4.3 but mean pellet delivery fell between the third and fourth 
time bins with a subsequent increase in pressing in the fourth bin. 
 
Other behaviour durations and frequency with baclofen 
In experiment 4.3 the main changes in behaviour seen on the videos at the 220ρmols 
dose were specific and significant increases in reward related behaviours. This included 
an increase in the frequency of interactions with the lever, rears to the CS, duration and 
frequency of headpokes into the magazine and in the frequency of bouts of pellet 
ingestion. These increases were associated with a concomitant decrease in the duration 
of other active behaviours. When the data for the 220ρmols dose were parsed into 5 
minute time bins it became evident that, as the session progressed, animals spent more 
time headpoking into the magazine per reinforced lever press as the delivery of pellets 
became imminent. This was accompanied by a decrease in the duration and frequency 
of rearing across successive time bins followed by an increase in time spent ingesting.  
 
In contrast, 660ρmols significantly decreased activity and rearing whilst causing an 
increase in oral stereotypy. Analysis of behaviour split into time bins demonstrated an 
increase in the duration but not the frequency of oral stereotypy from 5 minutes 
onwards. By 20 minutes the duration and frequency of oral stereotypy began to fall as 
grooming behaviour increased. There was a small increase in inactive behaviour but 
individual variability masked any significance. Observations recorded from the videos 
indicated that, at this dose, some animals appeared to be suffering myorelaxant effects. 
 
Free food intake with baclofen and DAMGO 
In experiment 4.1 a dose of 440ρmols baclofen significantly increased intake of freely 
available chow prior to the animals being run through the 2nd order testing phase. These 
same animals still increased their intake of chow when they were tested later with 
DAMGO having previously been infused on multiple occasions with both baclofen and 
DAMGO during the 2nd order testing phase. In experiment 4.3 a dose of 660ρmols 
baclofen increased intake prior to 2nd order testing and both 220 and 660ρmols baclofen 
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also increased free feeding after the 2nd order testing. There was no significant 
difference in the amount of food consumed prior to and post 2nd order testing with the 
660ρmols dose. 
 
Operant responding with DAMGO 
In experiment 4.2, a dose of 0.025µg DAMGO had no significant effect on the rate of 
pressing, the total number of reinforced presses or on the pattern of pressing across the 
session when it was broken down into 5 minute time bins. There was also no significant 
effect of this dose of DAMGO on the proportion of presses made during CS 
presentations across the first 5 minutes of the schedule. For the remaining 25 minutes, 
when the primary reinforcer became available, some presses were made prematurely i.e. 
before the CS terminated. This dose of DAMGO did, however, significantly increase 
intake of freely available chow following testing on the operant schedule.  
 
Preliminary interpretation of key results summarised above 
It would appear that, firstly, an optimum dose of baclofen infused into the Acb can 
increase operant responding for a 2nd order reinforcer in the absence of the primary 
reinforcer i.e. appetitive responding, without causing a breakdown in the relationship 
between the schedule requirements (response accuracy) and associated behaviours. In 
both experiments 4.1 and 4.3 the most effective dose of 220ρmols increased total 
reinforced presses and the rate of pressing but did not perseverate responding on the 
lever once criterion had been met. A small proportion of presses at this dose were made 
prematurely (before the CS had terminated), particularly during the appetitive phase. In 
experiment 4.1 these non-reinforced presses were only significant across a short period 
of the session and the increase was proportional to the total increase in pressing on that 
lever. There was no significant increase in premature, non-reinforced responses in 
experiment 4.3.  
 
Secondly the most effective 220ρmols dose of baclofen increased the total amount of 
reinforced responding relative to vehicle levels during the ‘consummatory’ phase. The 
number of reinforced lever presses made in each time bin decreased across the session 
but increased shortly after the mean time point at which animals received their first 
batch of pellets. Nevertheless, animals under the influence of baclofen pressed 
significantly more than with vehicle both prior to and following food reward and the 
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overall rate of pressing across the consummatory phase was increased relative to vehicle 
levels. 
 
Finally 220ρmols significantly modified motivated behaviours including lever pressing, 
rearing to the CS and headpoking into the magazine without causing any disruption in 
other behaviours such as non-cue oriented rearing or grooming. In contrast the higher 
dose of 660ρmols caused the emergence of oral stereotypy, abnormal grooming patterns 
and decreased activity accompanied by a possible breakdown in response accuracy. 
With a large percentage of presses occurring during the CS at this high dose and a lack 
of effect on the rate or total number of reinforced presses these results suggest a 
disruption of the normal pattern of schedule induced responding seen with vehicle.  
 
Thus, not only does baclofen potentiate operant responding in a food motivated 
schedule at doses that also increase free intake of chow but it does so in a dose 
dependant manner that could reflect motivational effects on both appetitive and 
consummatory aspects of ingestive behaviour. In contrast DAMGO, infused in a cohort 
of animals previously shown to be responsive to baclofen, has no significant effect on 
appetitive or consummatory operant responding on this type of schedule at a dose that 
subsequently increased free intake of chow. 
 
The effect of baclofen on reinforced lever pressing suggests a classic inverted U-shaped 
dose response function over the dose range tested (0 - 660ρmols). In contrast, data from 
both experiments 3.1 (Chapter 3, Fig. 3.4) and experiment 4.3 suggest that there was a 
positive linear relationship between dose of baclofen and total intake of freely available 
chow (see Fig. 4.40). 
 
 
201 
 
 
 
Figure 4.40. Representative data for total intake of freely available chow over 30 
minutes (based on means from all intake experiments reported in Chapter 3 and 
Chapter 4) compared to total reinforced lever pressing in a 30 minute 2nd order 
operant test session (based on mean pressing data from experiments 4.1 and 4.3).  
 
Possible explanations for baclofen induced increase in lever pressing 
It could be argued that the increase in lever pressing following infusions of baclofen 
into the Acb was not due to effects on food associated motivational processes per se but 
on, for example, locomotor activity, inhibitory control over cue-evoked responding or 
on attentional processes. All of these processes have previously been demonstrated to 
be influenced either by destruction or temporary inactivation of the Acb and these 
issues will be further dealt with in context below. Taking into account the combined 
findings from the analysis of pressing data broken down into; 1) the two phases, 2) 5 
minute time bins and 3) intervals between presses as well as the behavioural measures 
taken from the videos potential explanations for a significant effect relating to 
procedural and methodological issues will be discussed: 
1) Spread of baclofen to other critical brain regions in the motive circuit 
2) Location of infusions relative to ‘hot spots’ or behavioural gradients in AcbSh 
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3) The nature of the behaviour induced by a 2nd order schedule. 
 
The following alternative explanations for the results will be also be discussed: 
4) Psychomotor activation 
5) Reduction of response inhibitory control 
6) Improved attention (increased vigilance to cues or decreased latent inhibition) 
7) Increased hedonic impact of primary reward 
8) Increased transfer of hedonic properties to the neutral cue 
9) Increased attribution of salience to the cue in the absence of hedonic effects 
 
Finally a putative mechanisms for the effects reported will be discussed with reference 
to both the chemical and structural processes that might be involved and the 
implications of this hypothesis for work in further chapters will be highlighted. 
 
1) Spread of baclofen to other brain regions 
Before a hypothesised mechanism to explain the results is suggested potential 
explanations based on methodological issues need to be taken into account. As 
highlighted in Chapter 3 it could be argued that there was some potential spread of 
baclofen or DAMGO infusions into either the boundary between the core and shell or 
into more ventral structures such as the ventral pallidum (VP). Infusion of a GABAA 
antagonist into the VP has been shown to increase intake in satiated animals (Stratford 
et al., 1999) and to increase positive taste reactivity following conditioned taste aversion 
(Inui et al., 2007). The GABAA agonist muscimol in the VP decreases instrumental 
responding on an FR5 schedule for food (Farrar et al., 2008). 
 
Extensive studies of the role of the VP in mediating ‘liking’ reactions demonstrate that 
activity in this region selectively tracks hedonic values of tastes and there is strong 
evidence for neural coding of natural sensory “pleasures” (Tindell et al., 2006). Thus 
infusions of baclofen into medial portions of the VP might be expected to cause a 
decrease in intake, a decrease in responding on the reinforced lever and, perhaps, 
augmentation of these effects during the consummatory phase compared to the 
appetitive phase. This is clearly not the case so it can be concluded that it is unlikely the 
results reported are due to infusions spreading into regions ventral to the AcbSh. 
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The divergent roles of the core and shell in cue driven behaviours is considered in this 
discussion but it would appear that the results are also unlikely to be due to direct 
inhibition of neurons in the core. If the core were involved then a somewhat different 
behavioural pattern would be expected. For example lesions of the AcbC significantly 
reduce Pavlovian approach behaviour and animals also fail to discriminate between 
CS+ and CS- (Parkinson et al., 1999, Cardinal et al., 2002b). Lesions of the AcbC also 
cause significant elevations in premature responses in the 5CSRTT (Christakou et al., 
2004) and have also been shown to cause hyperactivity (Parkinson et al., 1999). 
Probably most important however is the fact that infusions of GABA agonists into the 
core have been shown to have little effect on free intake (Kelley and Maldonado-
Irizarry, 1995, Stratford and Kelley, 1997b). 
 
2) Location of infusions within the AcbSh 
The second explanation relates to the location of the infusions. By chance the mean AP 
co-ordinate for the group of animals deemed to have acceptable placements in 
experiment 4.1 was more rostral (approximately β+1.5mm) than in experiment 4.3 
(approximately β+1.3mm). In two micro-injection mapping studies to assess the effects 
of AMPA/kainate receptor blockade or GABA receptor stimulation in different 
locations of the AcbSh it was shown that a more caudal infusion was most effective in 
terms of free food intake (Kelley and Swanson, 1997, Basso and Kelley, 1999) and 
Stratford an Kelley (1997) found an infusion at an AP coordinate of β+1.4mm to be 
most effective. 
 
Reynolds and Berridge (2002) reported that muscimol infused into the AcbSh caused 
increases in positive hedonic taste reactivity more rostrally but that the robust increase 
in intake was positively correlated with suppression of this effect further back. 
Although the distances seem very small this shift occurred between β+1.6mm and 
β+1.2mm. Thus the coordinates for experiment 4.1 fall closer to the region where 
hedonic responses were increased but effects on intake were lower and the coordinates 
for experiment 4.3 fall within the region where there was a positive correlation between 
hedonic suppression and increased intake. 
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This lends some support to the general assertion that I will elaborate on in the rest of 
this discussion that a hedonic explanation for the results with baclofen is unlikely but a 
salience attribution hypothesis could explain the data. Extensive mapping studies using 
opioids suggest that there are “hot spots” within the AcbSh for the effects of 
neurotransmitter function in terms of intake and hedonic effects (Zhang and Kelley, 
2000, Pecina and Berridge, 2000, Pecina and Berridge, 2005, Pecina et al., 2006). It is 
also possible that this phenomenon could be important in the control of cue saliency 
attribution. It has been demonstrated that there are significant gradients in the levels of 
DA activity in the AcbSh (Wickens et al., 2007) which, as will also be discussed below, 
is involved in the response of the Acb to cue presentations (see electrophysiological 
evidence). 
 
3) Nature of behaviour induced by the schedule 
Another potential issue is the observation that there are some differences between the 
results reported in experiments 4.1 and 4.3. Specifically 1) while there were significant 
increases in responding during the first 5 minutes in experiment 4.3 this effect was not 
evident until 10 minutes into the session in experiment 4.1, 2) that animals pressed less 
overall and took longer to reach criterion and hence pellet delivery in experiment 4.3 
and 3) that there was a pronounced effect of baclofen on the latency to respond post CS 
in experiment 4.3 but this was milder in experiment 4.1 (see length of ILIs). 
 
Two potential explanations for these differences are suggested. First of all it is well 
known that responding under a fixed ratio schedule does not produce the highly 
structured pattern of responding that one might expect with, for example, an FI 
schedule. As Everitt and Robbins (2002) point out animals could take 5 or 50 minutes to 
make the same number of responses and the FR(FR) type 2nd order schedule does not 
exert strong temporal control over responding. Secondly, unlike the method based on 
that designed by Kelleher (1966) where the FI period of appetitive responding is 
indicated by the presence of a distinctive light cue, the animals in this schedule had no 
explicit knowledge of when the 5 minute appetitive phase ended. Thus differences in 
the timing of peak appetitive responding or the total number of presses between 
experiments are probably irrelevant. 
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4) Psychomotor activation 
The simplest explanation for the results with 220ρmols could be that baclofen at this 
dose simply indiscriminately increased spontaneous activity (including active 
behaviours directed towards the levers) during this schedule. Nevertheless there are 
some straightforward reasons to reject this hypothesis. First of all there was no 
generalised effect on total pressing per se. Increased motor activation, for example, 
would be expected to significantly increase pressing on both the reinforced and 
incorrect levers but, even at the highest dose that disrupted schedule control over 
reinforced pressing, the animals did not increase their responses on the incorrect lever. 
 
The second key point here is that, if anything, the behavioural data from the videos 
indicated that activity was slightly reduced at the dose that was most effective at 
increasing lever pressing. Nevertheless this was only significant over a short period that 
coincided with significantly increased engagement in other behaviours (e.g. lever 
pressing, rearing, head poking into the magazine) suggesting a lack of any direct 
psychomotor effects. This is supported by the fact that it has been previously 
demonstrated that transient ‘inactivation’ of the AcbSh using baclofen doses ranging 
from 88 – 876ρmols has no significant effect on locomotor activity in a standard cage 
(Stratford and Kelley, 1997b) and permanent inactivation using excitotoxic lesions does 
not affect motor activity in an open field test (Maldonadoirizarry and Kelley, 1995). At 
higher doses baclofen infused into the Acb causes locomotor depression due to 
myorelaxation (Stefanski et al., 1990, Jelen et al., 1994), which would disrupt pressing. 
 
5) Response inhibitory control 
An increase in operant responding at 220ρmols could be argued to be an indication of a 
lack of behavioural inhibition over prepotent behaviour, which constitutes a form of 
impulsivity (Evenden, 1999). Response inhibition can be expressed as control over 
impulsive action or impulsive choice (which requires action restraint) or over 
compulsive action (which requires action cancellation) (Robinson et al., 2009, Evenden, 
1999, Dalley et al., 2008, Schachar et al., 2007). 
 
Although potentially distinct roles for the AcbC and AcbSh have begun to emerge it is 
likely that their involvement is co-modulatory (Murphy et al., 2008) and, in the majority 
of cases, only manipulation of AcbC function has any significant impact on various 
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measures of impulsive action and impulsive choice (Cole, 1989, Cardinal, 2001, 
Pothuizen, 2005, Acheson, 2006). However, just because a distinct role for the AcbSh 
has not yet been identified, it does not mean that it does not exist. Afferents to the shell 
could also influence the core by “channelling information via cascading reciprocal and 
non-reciprocal feedback and feedforward loops” (Murphy et al., 2008). The 2nd order 
schedule used here might offer animals opportunities to exhibit impulsive actions, 
impulsive choices or compulsive actions and each will be dealt with in turn. 
 
Impulsive action 
Impulsive actions are manifested as inappropriate behaviours either in terms of the 
timing or target of operant responses and could be measured on this schedule as 
premature responses on the reinforced lever or increased presses on the incorrect lever. 
The latter case can be excluded immediately since there were no significant effectss at 
any drug dose on incorrect lever pressing. In both experiments with baclofen, presses 
that occurred during the CS under the influence of drug did occur prematurely i.e. 
before the CS was terminated (ILI <8s, see Fig 4.8, 4.9, 4.22 and 4.23). Nevertheless 
there was no significant increase in the total number of these non-reinforced presses at 
110, 440 or 660ρmols. At the 220ρmols dose there was an increase in non-reinforced 
presses in experiment 4.1 but not in experiment 4.3. The increase in experiment 4.1 was 
proportional to the total increase in reinforced pressing and coincided with time bins in 
which reinforced pressing was at a peak.  
 
Given the lack of significance of the total number of premature (non-reinforced) presses 
across the majority of the test session in experiment 4.1 and no repetition of the effect in 
experiment 4.3 this cannot be taken as a strong indication of impaired impulse control. 
This is consistent with the view that the AcbSh is not the predominant locus of 
impulsive action control (see Chapter 1, introduction).  
 
Compulsive action 
The schedule might also be considered to encompass elements of a go-no-go task 
whereby the absence of a cue is the “go” signal and the presence of the cue is the “no-
go” signal that terminates responding. Alternatively it could mirror aspects of a stop 
signal reaction time task whereby animals have to stop an already initiated chain of 
responses when the cue (stop signal) comes on. Vehicle treated animals in all three 
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experiments consistently withheld responding during the CS suggesting that the cue did 
indeed set in motion processes that inhibited ongoing prepotent responses. In this case if 
baclofen caused an inability to withhold perseverative responses during the CS this 
could indicate an effect of the drug on compulsive action.  
 
As explained above, although animals under the influence of 220ρmols did make a 
proportion of presses during the CS these were not usually a continuation of pressing as 
the CS came on (ILI of 0, see Fig 4.8, 4.9, 4.22 and 4.23) but premature responses just 
before it was due to terminate. Not only did the rats stop pressing when the CS came on 
but, observations of their behaviour in the videos showed that they consequently made a 
combination of headpokes and/or rears to the CS while they were waiting. Some 
animals even clearly looked up to check the CS whilst headpoking. 
 
Impulsive choice 
The large amount of pressing required for delivery of primary reward may be perceived 
as a delay by the animals or could affect the perceived probability of reward delivery. In 
this case the animals might make a choice about how to allocate their effort across the 
schedule. The use of an FR schedule plus an unrewarded phase, the end of which is not 
signalled, means that the timing of the delay to and the probability of reward might 
appear somewhat random to the subjects. Thus the schedule could be particularly 
conducive to impulsive choice behaviours usually seen on delay or probability 
discounting tasks. Evidence presented in the introduction to this thesis in delay or 
probability suggests that impulsivity can be expressed in terms of choice to press more 
at a particular stage in a schedule (rather than a lack of control over incorrect or 
unrewarded responses). 
 
However impulsivity on a delay-discounting task is measured as a tendency to choose 
small immediate reward, which, unless the CS itself is perceived as inherently 
rewarding (see further discussion later) is not an option on this task. Equally if the task 
was very unpredictable they might chose small guaranteed reward over large 
improbable reward if acting impulsively with baclofen. Again this could only be 
manifested as a choice to respond more for the CS, which would be more predictable 
than getting pellets. Experimental evidence in the literature suggests that this would be a 
core mediated effect (Cardinal, 2001). Thus an effect of baclofen on impulsive choice 
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would depend on changes in the value of the CS and it would require an explanation 
involving AcbSh mediation of an AcbC mediated process. 
 
It has been postulated that the shell may be capable of indirectly modulating some 
aspects of impulsivity by affecting core and dorsal striatum function via a circuit 
through the SN (Jongen-Relo et al., 2002). It has since emerged that there are also direct 
connections between the core and shell sub-regions (van Dongen et al., 2005) so an 
interaction between the two and, hence, a shell mediated effect on impulsive choice 
cannot be ruled out. Nevertheless it is not believed that effects on impulsive choice 
could fully account for the results at 220ρmols. 
 
6) Attentional effects 
In considering the issue of ‘attention’ in this discussion the term is used not in reference 
to explicit behaviours such as eye movements and orienting behaviours but with respect 
to an implicit role for attentional processes in the way in which animals learn about 
their environment and adapt those associations during schedule responding. Increased 
vigilance to discrete programmed cues within the schedule or decreased latent inhibition 
(LI) to contextual cues in the environment associated with food might serve to increase 
reinforced lever pressing by making the experience more arousing and/or salient.  
 
There is an established role for the Acb in attentional processes but, as with impulsivity, 
the contribution of AcbC and AcbSh regions is probably distinct. Jongen-Relo et al., 
(2002) conclude that inactivation of the AcbC disrupts attentional processes related to 
discrete cues engaged during PPI whereas inactivation of the AcbSh attenuates LI. It is 
therefore more likely that any effects of baclofen would be due to inactivation of the 
AcbSh and hence decreased LI rather than increased vigilance to discrete cues.  
 
As was noted in Chapter 3 that there did appear to be some basis for considering effects 
on attention. With muscimol animals appeared not to be paying attention to external 
cues such as movement of the observer, noises from other animals or rearing of another 
animal in the cages beside them. In contrast, with baclofen, animals were generally 
more vigilant and did clearly respond to such events. Baclofen infused into the shell 
region might not significantly disrupt responding to discrete cues, as appears to be the 
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case with muscimol, but could have attenuated previously established LI over cues 
other than the CS. 
 
Animals were pre-exposed to the box on multiple magazine training days prior to the 
first instrumental conditioning session and hence may have learned to ignore contextual 
cues such as the sound of the fans etc. These contextual cues experienced in the training 
environment (and hence during the delivery of food reward when hungry) could have 
become influential on responding if LI was attenuated. This explanation is very hard to 
confirm or discount just on the basis of the results reported here without further tests but 
it does not necessarily supersede a more direct motivational explanation and may 
contribute to other effects of baclofen. 
 
7) Hedonic effects on primary reward value 
It is generally thought that the Acb modulates motivated behaviours elicited by both 
primary reinforcers and by cues associated with these reinforcers (Robbins et al., 1989) 
(Everitt et al., 1999, Cardinal et al., 2002a, Holland and Petrovich, 2005). It is possible 
therefore that an increase in reinforced pressing at 220ρmols could be mediated by a 
perceived increase in the hedonic value of the food reward (primary reinforcer) at this 
dose. However it must be taken into account that in experiment 4.3 there was a 
significant increase in responding in the first 5 minutes at the 220ρmols dose when 
animals could not access the primary reward. There is also the problem that DAMGO, 
was expected to increase operant responding by increasing palatability of the reinforcer, 
did not increase pressing during either phase. These factors will be addressed in the 
following discussion of the possible effects of baclofen on primary reward value. 
 
Appetitive and consummatory phase with DAMGO 
As discussed in the introduction to this chapter, DAMGO probably does not affect 
appetitive behaviours in the absence of the primary reinforcer. This finding was 
confirmed in experiment 4.2 where DAMGO had no significant effect on operant 
responding during the appetitive phase of the schedule in contrast to the significant 
effect of baclofen. However DAMGO also had no significant effect on pressing during 
the consummatory phase, despite the fact that the dose used has previously been 
demonstrated to increase operant responding for food reward on a PR schedule (Zhang 
et al., 2003). 
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This lack of effect cannot be explained by any delay in the action of DAMGO because 
there was no sign of a biphasic inhibitory-stimulatory effect (Meyer et al., 1994) on 
operant responding at the dose used in experiment 4.2. The peak levels of correct 
responding on the reinforced lever occurred within the first 10 minutes post infusion 
which was the same pattern seen with the vehicle treated animals. Free intake of chow 
was also significantly increased in the 30 minute period following DAMGO infusions. 
 
The most likely explanation for a lack of effect probably relates to the type of schedule 
used. It has previously been reported that the mixed µ and δ-agonist morphine infused 
directly into the Acb increases responding for a conditioned reinforcer or, conversely, 
has no effect (Kelley and Domesick, 1982, Cunningham and Kelley, 1992b, 
Cunningham and Kelley, 1992a). The mixed µ and δ-agonist [D-Ala2-Met5]-
enkephalin (DALA), the µ-agonist DAMGO and the δ-agonist [D-Pen2,5]-Enkephalin 
(DPEN) were initially shown to have no significant effect on responding to a CR 
(Cunningham and Kelley, 1992b) but, in a second study DPEN, significantly increased 
responding (Cunningham and Kelley, 1992a). Elsewhere it has been shown that DALA, 
DAMGO and DPEN all increase responding on a CR paired lever (Phillips et al., 1994). 
On the PR schedule used by Zhang et al. (2003), a small work requirement at the start 
meant that the animals experienced the food reward under the influence of DAMGO as 
soon as they made an operant response. It has been demonstrated that close contiguity 
between the timing of DAMGO infusions and food consumption is critical for reversing 
sensory specific satiety in pre-fed animals and that the effect is short term and 
temporary (Woolley et al., 2007). What probably happened is that, on the 2nd order 
schedule, pre-fed animals under the influence of DAMGO simply did not get to 
experience the primary reward before they lost interest in pressing.  
 
Appetitive phase with baclofen 
Any hedonic effect of baclofen on pressing pre-reward delivery in the schedule used 
here would have to be explained in terms of a previous experience of baclofen’s effects 
on reward value. It is possible that experiencing the ingestional consequences of 
consuming chow under the influence of baclofen during the intake probe test in each 
experiment resulted in a subsequent revaluation of the expected rewarding properties of 
the pellets because of their similarity to the chow. This hypothetical transferral of 
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inflated value to the pellets could then be responsible for an increase in reinforced 
pressing across the appetitive phase. 
 
Balleine (1992), however, argues that learning processes link the hedonic value of the 
reward to the motivational state in which it was experienced which consequently 
restricts the conditions under which the new incentive value will modify instrumental 
actions. If this is the case then only a combination of experiencing the chow reward 
under the influence of baclofen prior to testing and experiencing the same baclofen 
induced state during testing with pellets would mediate operant responding. Since 
increased responding only occurred at the 220ρmols dose but the animals increased 
their consumption of chow at 440ρmols (Exp. 4.1) and or 660ρmols in (Exp. 4.3) this 
explanation is not adequate to account for the results 
 
It is also significant that animals that experienced chow under the influence of DAMGO 
did not subsequently respond to the chance to access pellets as if they were more 
rewarding when given the same dose in the operant session. This finding suggests that 
there is no link between the hedonic value of the chow consumed and the pellets used in 
the operant session. It seems highly unlikely therefore that increased responding during 
the appetitive phase could be explained by hedonic effects of baclofen on primary 
reward value. 
 
Consummatory phase 
In the experiments presented, detailed analysis of the pattern of lever pressing across the 
30 minute session, combined with temporal analysis of associated behaviours indicated 
that there could have been an effect of intra-Acb baclofen on the motivating value of the 
reward post pellet delivery. Animals returned to lever pressing following ingestion of 
pellets significantly faster under the influence of the most effective dose of baclofen 
than with vehicle and the total number of lever presses increased post pellet delivery.  It 
was also shown that, during the consummatory phase, baclofen shifted the latency of 
lever presses post CS presentation to the left. In experiment 4.1, the rate of pressing 
across this phase was significantly higher than during the appetitive phase. In 
experiment 4.3 the rate of pressing across this phase was higher than with vehicle or the 
higher drug dose. 
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A shift in the association between action and outcome (A-O) could be responsible for 
some of these behaviours in line with an incentive theory such as that originated by 
Tolman in the late 1940s and revisited by Dickinson and Balleine (e.g. see Dickinson 
and Balleine, 1994). The premise of this argument would be that intra-Acb baclofen 
modified the incentive value of the reward and that, following the operant action, the 
more rewarding consummatory experience consequently increased the drive to perform 
the action again and to do so sooner. This hypothetical process has been referred to as 
“incentive learning” (Balleine and Dickinson, 1992, Dickinson, 1994, Dickinson, 
1995). Post-training reinforcer revaluation procedures (Rozeboom, 1958) have become, 
as Holland (2008) points out, a gold standard for measuring the presence or absence of 
instrumental associations and the degree to which the association changes following 
alterations of the value of the reward. 
 
Dickinson (1994) also argues however that changes in the hedonic value of a reward 
(liking) alone are not enough to initiate ingestion (and therefore food seeking) and only 
the establishment of a learned association between the new value and contiguous cues 
will support increased operant responding. Thus only repeated exposure over time to the 
consumption of pellets under the influence of baclofen might modify responding on the 
2nd order schedule (Dickinson and Balleine, 1994). It is unlikely that the very low 
number of primary reward presentations would support the development of a strong 
association between increased value and contiguous cues within the consummatory 
phase of one session. Furthermore the counterbalanced design meant that animals did 
not experience the same baclofen induced state across repeated test sessions.  
 
All the evidence for the effects of incentive learning on A-O revaluation has come from 
changes recorded between test sessions and there is no evidence that this is a process 
than can be measured within one operant test session. It has also been suggested that 
revaluation effects are actually quite small in absolute terms given, for example, that 
animals will still make numerous operant responses even following devaluation 
(Holland, 2008). Even more compelling is recent evidence that operant responding 
based on expectancy of a particular reward following revaluation may depend very little 
on what is actually presented (Galarce et al., 2007). Furthermore, in this study, a lack of 
any carry over of effect onto pressing between test days would tend to argue against an 
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increased hedonic value of the pellet reward subserving a learned increase in operant 
responding.  
 
If the animals have not learnt to press more for a hedonically more valuable cue would 
an increase in hedonic value still have an acute effect on pressing immediately post 
ingestion? In a study designed to directly assess the impact of length of training it was 
shown that, following long periods of exposure to a schedule, instrumental responses 
were predominantly governed by current motivational state and not by prior 
manipulation of reward value through incentive learning (Dickinson et al., 1995). 
However, it is widely believed that when an animal is well trained (or ‘over’ trained), as 
they are on the 2nd order schedule, their operant responses become habitual and are 
insensitive to presentations of the reward regardless of current motivational state (e.g. 
see Holland, 2004). This is evident even in the earliest studies designed to explore the 
impact of varying presentations of food or drug reward and reward related cues on a 2nd 
order schedule (Kelleher and Goldberg, 1977, Goldberg et al., 1981) 
 
Thornton-Jones et al., (2005) reported that pre-feeding animals with chow prior to 
testing in this second order schedule resulted in an overall reduction in reinforced 
pressing but their data also indicated a significant increase in pressing on this lever once 
pellets became available. Pre-feeding suppressed responding during the 5 minute 
appetitive phase but the availability of food in the consummatory phase invigorated 
responding to the extent that there was no difference between pressing in hungry or pre-
fed animals (Thornton-Jones et al., 2005). This means that our 2nd order schedule is 
sensitive to both current motivational state and to primary reward presentation. This is 
consistent with Everitt and Robins’ (2002) suggestion that an FR(FR) type 2nd order 
schedule does not engender habitual responding as robustly as an FI(FR) type. 
 
Thornton-Jones et al. (2005) suggested that increases in pressing after primary reward 
presentation could reflect an increase in feeding due to the initial activation of positive 
feedback mechanisms that promote feeding, in line with studies carried out in the 1970s 
(Wiepkema, 1971). They also suggested that, alternatively, the pellets might differ 
enough from the chow consumed during pre-feeding that they effectively re-invigorated 
feeding in animals that had reached sensory specific satiety for chow. This explanation 
was in line with numerous studies investigating the effects of presenting diets that differ 
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from those that have been recently ingested (Clifton et al., 1987, Treit et al., 1983). 
Most importantly in the context of the studies reported here this indicates that, despite 
devaluation of food reward by pre-feeding with chow to satiation, the pellets were still 
subsequently rewarding.  
 
It was not clear from the data presented in experiment 4.1 that this re-invigoration 
phenomenon occurred following the delivery of pellets to the pre-satiated, vehicle 
treated group. The total number of lever presses was lower than those reported for pre-
satiated animals by Thornton-Jones et al., (2005). Only four rats in the vehicle treatment 
pressed enough to receive pellets and, as a result, there is a great deal of variability in 
the total number of presses made by individuals across the time bin immediately 
following mean first pellet delivery time. It does not therefore adequately represent post 
pellet pressing with vehicle. In experiment 4.3, however, there is a clear increase in 
pressing during the timebin immediately following mean pellet delivery time for 
animals in the vehicle condition. It is concluded therefore that the invigoration of 
responding by pellets during the consummatory phase, either via positive feedback 
mechanisms or by overriding sensory specific satiety, was replicated in these studies. 
 
Increases in rate of pressing post pellet delivery might mean that schedule controlled 
responding in these experiments could well be sensitive to acute effects of baclofen on 
reward value during the consummatory phase. However if this were the case two 
separate mechanisms, both modulated by GABAB receptors in the AcbSh would need to 
be present to increase appetitive responding and to increase consummatory responding. 
A more parsimonious theory would encompass a single mechanism that could subserve 
both effects. Furthermore there are alternative explanations for some of the potential 
evidence of increased responding due to hedonic effects mentioned above. For example, 
although animals returned to lever pressing post pellet delivery more quickly with the 
optimum dose of baclofen this could have been because they consumed the pellets more 
rapidly rather than because they valued the next batch of pellets more highly. 
 
Also it should be noted that with the 440ρmols dose that also increased the total number 
of reinforced presses, animals did not return to lever pressing more rapidly post pellet 
delivery, there was no concomitant increase in the rate of pressing during the 
consummatory phase and no significant increase in pressing in time bins following 
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pellet delivery. Thus an operant effect of baclofen was recorded without associated 
evidence of increased reward value. Finally, although lever pressing was increased post 
pellet delivery with 220ρmols in experiment 4.3, the relative frequency and duration of 
headpokes per press i.e. consummatory behaviour, was not increased. In other words 
animals were pressing more but were not trying harder to gain access to the pellets.  
 
It is suggested therefore that GABAB receptor stimulation in the Acb must have affected 
appetitive responding via acute effects on a mechanism other than increased reward 
value and that the further increase in pressing post pellet delivery was primarily due to 
the same acute effects superimposed on positive feedback processes or on satiety 
mechanisms previously reported (Thornton-Jones, 2004). This is consistent with the 
view that intra-Acb GABAA stimulation does not increase the hedonic impact of food 
(Kelley et al., 2005b, Kelley et al., 2005a, Baldo and Kelley, 2007) although it does not 
automatically follow that GABAB stimulation also fails to impact hedonic value.  
 
8) Hedonic effects associated with the CS 
One possible caveat to the argument above against hedonic effects of baclofen in the 2nd 
order schedule is that there is evidence that the CS itself might acquire hedonic 
properties from its association with the reward and that the AcbSh encodes this 
information (Kerfoot et al., 2007). 
 
Early studies showed that cues associated with sucrose or quinine could stimulate the 
same orofacial taste reactivity responses with unflavoured water (Delamater et al., 
1986). It was suggested however that the cues simply initiated a prepotent behavioural 
pattern, including orofacial responses, learnt as part of the initial S-R acquisition 
(Berridge and Schulkin, 1989). Berridge and Schulkin (1989) later showed however 
that, even when the animals had learnt aversive orofacial responses to a neutral flavour-
cue paired with an aversive concentration of sodium (S-R learning), they exhibited 
appetitive taste reactivity responses to the cue alone when sodium appetite was 
pharmacologically induced. Thus Berridge and Schulkin (1989) showed that positive 
taste reactivity responses could be transferred to, and controlled by a CS without 
explicit pairing with the revalued reinforcer. 
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It has been suggested that the spontaneous appearance of hedonic responses to cues post 
reward revaluation (despite the fact that the cues have not been explicitly linked to the 
new value) may depend on the degree to which the animal has been trained (Holland, 
2005). Thus in the early stages of development of a CS-US association the CS activates 
a large variety of processes usually activated by the US, including perception of the 
hedonic properties of the reward in its absence, but that extended training narrows the 
range of systems involved (Holland, 2008). 
 
Holland’s (2008) hypothesis was confirmed in a recent study carried out by the same 
laboratory, which showed that taste reactivity to a CS occurred after limited training but 
was absent after extended training (Holland et al., 2008). It is unlikely therefore that the 
results reported here are associated with any hedonic value or ‘liking’ attributed to the 
cue because the extended training on the 2nd order schedule would likely have 
eliminated this effect. 
 
9) Increased attribution of salience to the cue 
In the context of motivational theories such as those discussed in the introduction to this 
thesis (e.g. Toates, 1981, Toates, 1986, Bindra, 1969, Bindra, 1974b, Bindra, 1978) 
saliency attribution is an intrinsic part of the learning processes that leads to cue driven 
instrumental actions. The saliency attribution hypothesis suggests that there is a process 
or processes whereby animals actively assign “salience and attractiveness to visual, 
auditory, tactile, or olfactory stimuli that are themselves intrinsically neutral” (Berridge 
and Valenstein, 1991). Berridge and Valenstein (1991) hypothesise that some 
manipulations of brain function can bypass the need for an association to be made 
between a neutral stimulus and the hedonic effects of a reward for cues to become 
salient and independently exert control over reward seeking behaviour. 
 
In attempting to explain the apparent paradox that ESLH both rewards instrumental 
behaviour (self administration) and initiates behaviour (food seeking in satiated rats) but 
does not enhance hedonic responses, Berridge and Valenstein (1991) suggested that it 
only increases the incentive salience of stimuli. Since both Kelley and Stratford have 
commented on the similarity between behaviours following ESLH and intra-Acb 
GABA receptor stimulation (e.g. see Stratford, 2007, Stratford and Kelley, 1997b, 
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Kelley, 1999a), it would make sense that manipulating the circuit at the Acb level could 
also have an effect on the salience of cues, perhaps via the LH. 
 
In the experiments reported here there was an increase observed in the number of 
reinforced presses prior to any interaction with the primary reinforcer. This could have 
been due to a direct result of increased cue saliency and hence increased ‘wanting’ 
without any effects on reward value. As is evident from the preceding discussion, other 
explanations cannot be completely discounted for this result reported on its own but it is 
suggested that this, combined with a decrease in reaction time to the cues across the 
session and an increase in approach responses to the cue, all point to increased cue 
salience. The relevance of decreases in various indices of reaction time and of increases 
in approach behaviours will be discussed first and then evidence that an increase in 
operant responding can indicate an increase in cue salience will be considered. 
 
Changes in reaction time to the CS 
Behavioural activation in operant schedules has already been discussed in terms of 
impulsivity and attentional processes however another index of potentiated operant 
responding is reaction time (RT) (Cole and Robbins, 1989). In experiment 4.1 and 4.3, 
baclofen at the most effective dose caused an increase in the rate of pressing across the 
session. In experiment 4.3 there was also a pronounced shift to the left in the latency to 
lever press once the CS was terminated. Calculation of the latency to resume pressing 
following pellet delivery in this experiment revealed a significantly shorter mean 
interval duration with the most effective dose of baclofen. All of these effects could 
indicate a decrease in RT to cues with baclofen. 
 
In a RT task that requires conditioned lever release the salience of available cues is 
associated with the value of the reward previously associated with those cues (Amalric 
and Koob, 1987). The mechanisms that control the speed of the animal’s behavioural 
output include information processing systems to evaluate stimulus saliency and 
response selection processes. The total time to react can be described as a choice 
reaction time (CRT) (Blokland, 1998b). When an animal performs cue-potentiated 
operant responses in the absence of primary rewards the CRT represents the speed of 
motor initiation and depends in part on the strength of the cue to activate behavioural 
output. When there is no breakdown in response inhibitory control (no premature 
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responses) or response accuracy (e.g. responding on the wrong lever) the CRT can be 
taken as the predominant process determining response rates. 
 
Rats have been shown to significantly decrease their CRT to cues predictive of larger 
rewards (Brown and Bowman, 1995, Hauber et al., 2000) and Hauber (2000) suggests 
that it is the expectancy of reward value that guides the speed of instrumental responses. 
In the 2nd order operant schedule the time taken to begin pressing again as the CS is 
terminated could be partially determined by the salience of the CS. Unlike the lever 
release based RT test designed by Amalric and Koob (1987) however, there could have 
been some possible confounding effects on the speed of the RT if the animals were not 
engaged in performing the task (e.g. grooming or exploring) at the specific time that 
termination of the cue indicated a response should be made. Also, during the 
consummatory phase the RT to respond to the cue will sometimes include the time 
taken to eat the pellets. Nevertheless since there were decreases in indices of CRT it 
may still be a useful indicator of the strength of cue saliency. 
 
The effect of manipulating activity of the striatum on RT has predominantly focused on 
the role of DA in this structure. Non selective DA receptor stimulation decreases RTs 
but decreases the rate of correct responding and increases impulsivity whilst the 
opposite is true with DA antagonists (for a review see (Blokland, 1998b). 
AMPA/kainate antagonists infused into the Acb have been shown to decrease reaction 
times to cues predictive of reward without disrupting the previously learned 
instrumental association with reward magnitude or impairing performance accuracy 
(Giertler et al., 2003). NMDA antagonism increases RT, blocks the decrease associated 
with DA and increases impulsivity (Blokland, 1998b, Hauber et al., 2000). The 
blockade of striatal muscarinic receptors does not affect RT but disrupts control over 
the pattern of responding (Blokland, 1998a). 
 
It would appear therefore that increased cue saliency decreases RT to perform operant 
responses, the Acb modulates this process and there is evidence that GABA could have 
an effect via glutamatergic transmission. Furthermore, glutamatergic influenced RT 
time is modulated via AMPA/kainate receptors but not NMDA receptors, which is also 
true for the increase in free intake due to glutamate receptor blockade 
(Maldonadoirizarry et al., 1995). Although this is a simple and compelling argument, 
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difficulties arise in trying to decipher the role of the Acb in stimulus evaluation and 
response selection because these processes could be dependant on the way in which the 
animals have acquired the task in the first place (Pavlovian or instrumental 
associations). This issue will be discussed in more detail in Chapter 7 (General 
discussion) 
 
Changes in approach behaviours 
It is also clear from the analysis of behaviours from the video that the CS elicited 
approach responses because the animals reared to the light and/or the area just above it 
(from which the sound of the food delivery mechanism emanated). These rears did not 
appear to be coincidental or random as they occurred in close contiguity with lever 
pressing and magazine head entries. The target area of this category of rears was also 
very specific. Other rears were usually made to the corners of the ceiling or the animals 
simply stood up in the open part of the box. CS rearing also increased in proportion to 
the total number of reinforced lever presses, the majority of which were associated with 
presentations of the CS not the primary reinforcer. 
 
The rears to the CS suggest that, while the animals were explicitly trained on a 2nd order 
schedule, they had concomitantly developed an approach response. In other words a 
subset of their behavioural repertoire in the box had been subject to autoshaping (Brown 
and Jenkins, 1968). It is generally accepted that autoshaping is under the control of 
Pavlovian not instrumental contingencies and this has been confirmed in the rat (Bussey 
et al., 1997). It is currently believed that processes that subserve the ability of cues to 
control behavioural output in different schedules e.g. CRF, PIT or Pavlovian approach 
are mutually exclusive (Holland and Petrovich, 2005, Galarce et al., 2007).  
 
Although aspects of Pavlovian approach directed at the lever could not be dissociated 
from instrumental responding the incidental autoshaping of approach behaviours to the 
CS allows a measure of any potential disruption of this aspect of behaviour. It might 
appear on the face of it that baclofen caused a significant increase in approach 
behaviour to the CS. However, on closer inspection, the number of rears to the CS 
increased in proportion to the increase in lever presses and to CS presentations that 
occurred as a result. In other words Pavlovian approaches to the CS were not directly 
potentiated but the CS was approached more because it appeared more. 
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One school of thought suggests that behaviours directed towards a CS associated with 
positive reinforcement potentiate operant responding by increasing the likelihood that 
the animal will find itself in the proximity of the response location (Krank et al., 2008). 
If this were the case then an increase in cue salience might be expected to elicit more 
approach behaviour. However, conditioned reinforcement with food reward has recently 
been shown to be independent of appetitive Pavlovian approach responses to the lever 
because potentiation of instrumental behaviour could be induced even when the location 
of the CS was incongruent (Di Ciano and Everitt, 2004). Thus an alternative school of 
thought suggests that cue-induced increases in instrumental responding are independent 
of approach responses (Holland and Petrovich, 2005). Moreover a disproportionate 
increase in approach behaviours to the cue has been demonstrated to disrupt operant 
responding (Krank, 2003). Thus a lack of a proportional increase in approach responses 
to the CS is not incompatible with an increase in the salience of the cue driving 
instrumental behaviours.  
 
Other evidence of increased cue-reinforced operant responding from the literature 
A variety of studies have been published that implicate the Acb in cue potentiated 
behaviours. For example it was shown that intra-Acb infusions of amphetamine 
enhanced the control of CRfs over responding for water and that, conversely, 
dopaminergic lesions of the Acb blocked this potentiating effect (Taylor and Robbins, 
1984, Taylor and Robbins, 1986, Robbins et al., 1989). Intra-AcbSh amphetamine 
infusions have been clearly shown to significantly increase cue-potentiated pressing 
without any concomitant increase in ‘liking’ of the primary reinforcer (Wyvell and 
Berridge, 2000). In another series of experiments Everitt and colleagues showed that the 
ventral striatum was involved predominantly in appetitive sexual behaviours but not in 
consummatory processes and that, at least to some degree, this was dependent on the 
association with cues that predict sexual reinforcement (Everitt et al., 1989). 
 
Other early studies of the role of the Acb in cue potentiated responding for food 
suggested that the structure as a whole was involved in operant behaviours potentiated 
by CRfs (Robbins et al., 1990). An interesting study using excitotoxic lesions showed 
that food carrying-to-leave behaviour (hoarding), a species-specific spontaneous 
expression of motivated behaviour related to cues other than the primary reinforcing 
value of the food, was blocked by loss of Acb neurons (Whishaw and Kornelsen, 1993).  
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Other behavioural evidence that the Acb is necessary for cue salience attribution? 
Cue-induced reinstatement tests are similar to tests of PIT and, like transfer, are known 
to depend on the ventral striatum (McFarland and Kalivas, 2001, Kalivas and 
McFarland, 2003, Floresco et al., 2008). The effects of baclofen on reinforced 
responding discussed in this chapter are supported by a recent report that ‘inactivation’ 
of the AcbSh using a cocktail of baclofen and muscimol resulted in significant 
potentiation of responding during cue induced reinstatement of food seeking behaviour 
while AcbC inactivation decreased responding (Floresco et al., 2008). These authors 
concluded that “the shell is involved in updating stimulus-reinforcer contingencies upon 
changes in the motivational relevance of conditioned stimuli”, a hypothesis consistent 
with our results. 
 
The finding that there can be potentiation of cue-induced reinstatement following 
infusions of GABA agonists into the Acb may appear counter-intuitive given that a 
current area of great interest in addiction is the apparent ability of GABA agonists such 
as baclofen to block reinstatement of cocaine, heroin, alcohol and nicotine seeking (e.g. 
see Filip and Frankowska, 2007, Spano et al., 2007, Maccioni et al., 2008, Fattore et al., 
2009). However baclofen/muscimol inactivation of the AcbC blocks reinstatement 
whereas the shell does not have any effect on cue-induced reinstatement of drug-
seeking or ethanol-seeking behaviour (Fuchs et al., 2004, McFarland and Kalivas, 2001) 
(Chaudhri et al., 2008). 
 
Filip and Frankoska (2007) also reported that blockade of cue-induced drug seeking 
behaviour by baclofen was more effective than for cue-induced food seeking. Floresco 
et al., (2008) suggest that one explanation for a AcbSh mediated potentiation of 
reinstatement for food but not drug related cues could be that differences in the circuits 
that mediate instrumental responding induced by drug related and food related cues at 
the level of the amygdala (McLaughlin and Floresco, 2007). Interestingly it has recently 
been suggested that context induced reinstatement may be more dependent on the 
AcbSh (Crombag et al., 2008, Fuchs et al., 2008) which could also have implications 
for the role of baclofen in increasing free feeding. 
Electrophysiological evidence of a role for Acb in saliency attribution to stimuli? 
The suggestion that intra-AcbSh baclofen could affect cue saliency is also supported by 
electrophysiological studies of Acb neuronal activity in behaving rats that demonstrate 
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phasic firing consistent with signals related to expectation and delivery of reward and to 
stimuli associated with reward. During instrumental responding for natural rewards 
(water, nutritive solution or food) sub-populations of Acb neurons fire in a specific 
phasic sequence (pre-response excitation, short post-response inhibition, prolonged 
post-response excitation) time locked to the temporal organisation of approach to the 
lever, response initiation, execution, completion and reward acquisition (Carelli and 
Deadwyler, 1994). This pattern does not simply represent the encoding of motor control 
(Schultz et al., 1992, Lavoie and Mizumori, 1994, Carelli and Deadwyler, 1997, Carelli 
and Deadwyler, 1994, Carelli et al., 2000, Hollander et al., 2002, Roop et al., 2002).  
 
Phasic sequences of temporally organised neuronal firing in the Acb is also reported to 
be determined by the behavioural state of the animals and the context in which testing 
takes place, is tightly stimulus bound and is conditioned in responsive populations of 
neurons (Carelli and Deadwyler, 1997, Carelli et al., 2000, Carelli, 2002, Carelli and 
Wightman, 2004). Patterned neuronal activity is attenuated during extinction of 
instrumental responses and rapid recovery during reinstatement is only seen in the post-
reinforcement active cell populations that probably respond to the A-O contingency 
(Hollander et al., 2002). Conditioned stimuli paired with natural reward (sucrose) evoke 
rapid DA release, transient increases in DA and the onset of the phasic firing sequence 
is coincident, DA fluctuations occur over the same time interval and with the same 
temporal synchrony as the previously described pattern in neuronal activity and neurons 
that do not exhibit fluctuations in DA do not show patterned phasic firing (Roitman et 
al., 2004, Carelli, 2004, Cheer et al., 2007). 
 
The sequence of the phasic firing pattern is not specifically related to the type of 
reinforcer (e.g. water or cocaine) but separate populations of neurons may be recruited 
by drug vs. natural rewards (Carelli and Deadwyler, 1994, Carelli and Deadwyler, 1997, 
Carelli et al., 2000). Separate populations of neurons also appear to specifically encode 
aversive vs. appetitive stimuli (Roitman et al., 2005) and fire according to the expected 
outcome that the stimuli represents (Wilson and Bowman, 2005). However these 
separate populations are evenly distribute throughout the core and shell of the Acb 
(Carelli and Wondolowski, 2006, Wightman et al., 2007). 
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This activity is greater when cues are better predictors of reward than when they are less 
predictive and when the animals makes a response than when none is made (Nicola et 
al., 2004). It has also been shown that neural activity in the ventral striatum reflects the 
proximity of upcoming rewards in ratio schedules of reinforcement (Bowman et al., 
1996). Interestingly it is also possible to dissociate between the pattern of activity 
induced by the cue and the primary reinforcer in a 2nd order operant schedule although 
the authors suggest partially overlapping mechanisms in the Acb process the 
information (Wilson and Bowman, 2004b).  
 
The evidence from the experiments reported in this chapter of an increase in operant 
responding prior to primary reward delivery, decreased reaction times to the CS 
combined with the multiple lines of evidence for a role for the Acb in cue-reinforced 
responding, cue induced reinstatement and from electrophysiological data is believed to 
offer strong support for a saliency attribution hypothesis to explain the effects of 
baclofen. This will be further discussed below. 
 
GABA mediated effects on saliency attribution at the neurotransmitter level 
On the basis of the discussion thus far it is postulated that the behavioural effects of 
baclofen reported in this chapter cannot automatically be attributed to inactivation of 
MSN outputs although the original premise of the numerous elegant experiments 
carried out by Kelley’s laboratory using GABA agonists was to do precisely that 
(Kelley, 1999b). Kelley found that blockade of AMPA/kainate (but not NMDA) 
receptors or stimulation of GABA receptors elicited robust free feeding 
(Maldonadoirizarry et al., 1995, Kelley and Swanson, 1997, Stratford et al., 1998, 
Stratford, 1997).  
 
However it has been shown that transient inactivation of the Acb using lidocaine 
(Giertler et al., 2004) or permanent inactivation using excitotoxins (Brown and 
Bowman, 1995) has no effect on cue potentiation of operant responding whereas 
blockade of AMPA/kainate receptors significantly decreases RTs to discriminative 
cues. Conversely, transient inactivation of the Acb using TTX or a cocktail of high dose 
glutamate antagonists to totally block the activity of MSNs has been demonstrated to 
cause an increase in the latency to respond to discriminative cues predicting sucrose 
reward whilst increasing responses to a non-rewarded stimulus, un-cued lever presses 
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and presses on an inactive lever (Yun et al., 2004a). It has been hypothesised that, when 
output of the Acb is completely inhibited, it can be bypassed and alternative circuits 
subsequently recruited in the control of behavioural output (Giertler et al., 2004).  
 
It has been suggested elsewhere that the large array of changes in behaviour following 
inactivation of the Acb via lesioning that have been published could be caused by the 
disruption of inputs originating in afferent structures rather than reflecting specific 
functions of the Acb per se (Goto and Grace, 2008). As Jongen-relo et al., (1991) point 
out, the specific method used to inactivate the Acb may also dictate the resultant 
behavioural effects given that, for example, electrolytic lesions destroy both cell bodies 
and fibre tracts that pass through the structure between other brain regions. 
 
It has also been reported that the shell and core subregions may be differentially 
sensitive to the type of excitotoxins used to destroy cell bodies (Parkinson et al., 1999). 
Furthermore it has been demonstrated that the standard staining procedure used to 
visualise the extent of the lesions (staining for Nissl substance) probably results in an 
underestimation of lesion size and regional overlap (Jongen-Relo et al., 2002). This 
could mean that behaviours attributed to the Acb could actually be modulated by other 
structures that are also lesioned at the same time. This, along with some of the 
conflicting evidence for the role of the Acb in a variety of behaviours discussed 
previously are taken as evidence that an ‘inhibition’ explanation is inadequate. 
 
It does not follow either that the unique effects reported here can be explained in terms 
of inhibition of Acb output because they occur at significantly lower doses of baclofen 
than have been previously used by other laboratories and are abolished at higher doses. 
Berridge and Wishaw (1992) point out that changes in natural sequential patterns of 
behaviour do not depend on learning and memory in the way that schedule controlled 
instrumental responses do. As such they are a good indicator of manipulations of neural 
function that effect behavioural sequencing of motor output. Given that Kelley’s theory 
for the role of GABA in the Acb suggests an action at the level of output to the LH and 
consequent motor patter generation, this is particularly relevant. 
It would appear that higher doses of baclofen disrupt the initiation and/or completion of 
a normal grooming syntactic chain. This dose is molecularly equivalent to a dose in the 
middle of the range of muscimol doses previously tested in operant schedules (see 
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introduction to this Chapter). An effect at this high dose of baclofen on grooming is 
consistent with the effects of excitotoxic lesions of the striatum, which prevents full 
expression of the normal sequence (Berridge and Fentress, 1987). It would seem 
therefore that, at the higher dose, baclofen caused behavioural deficits consistent with 
inactivation of striatal output but the lack of such effects at lower doses indicates that 
some other mechanism subserves the effects on operant responding. 
 
Thus it is suggested that there is no strong basis for concluding that the behavioural 
effects of baclofen can be fully explained by a postulated blockade of glutamatergic 
transmission within the Acb (Kelley et al., 2005b). It is hypothesised that the effects of 
low doses of baclofen on cue-induced instrumental responding could be due to 
interactions with other neurotransmitter systems within the AcbSh subserving 
motivational processes in the Acb. At low doses the pattern of interaction with local 
circuits results in increased cue salience that can drive instrumental responding but at 
higher doses inactivation of the AcbSh output might still restrict the consequent 
repertoire of motor patterns that can be expressed. There would be a crossover point at 
which this restriction does not reduce operant responding but it does increase free intake 
by narrowing behavioural selection to those involved in ingestion. Beyond this point 
instrumental responding is disrupted either by a breakdown in syntactic behavioural 
chains that control lever pressing or by myorelaxant effects (or both) but, where less 
complex behaviours are required, free feeding is still dose dependently increased via 
restricted release of specific feeding related motor patterns. 
 
GABA mediated effects on saliency attribution at the structural level 
Holland and Petrovich (2005) argue that cue-potentiated feeding in food-sated rats is 
mediated by a macrocircuit that includes the BLA and LH but probably not the CeA and 
Acb but they do not completely discount a role for the connection between the Acb and 
LH. Recent studies suggest that the LH is necessary for context induced reinstatement 
of reward seeking behaviour (Marchant et al., 2009, Hamlin et al., 2009). Habitual 
responding for an incentive represented by the CS could depend on serial processing 
between the BLA, the AcbC and the ascending intrastriatal circuitry that links this 
system to the dorsal striatum (Belin et al., 2009). However these circuits are involved 
specifically in Pavlovian associations and it has been argued that the processes that 
subserve Pavlovian and instrumental responding are dissociable (e.g. for a review see 
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(Balleine, 2005). However transfer of cue salience through Pavlovian processes could 
involve either a CeA/AcbC circuit or a BLA/AcbSh circuit depending on how the 
schedule is manipulating their behavioural output.  This is only a very brief suggestion 
of potential circuits involved because evidence presented in the following chapters 
(Chapter 5 and Chapter 6) will contribute to understanding the circuits which may be 
influenced by the action of baclofen in the AcbSh. 
 
Summary 
It has been demonstrated in this chapter that, contrary to predictions based on Kelley’s 
hypothesis, intra-AcbSh baclofen significantly increased instrumental responding for a 
food paired cue in a dose related manner without disrupting response accuracy or 
causing non-specific increases in Pavlovian approach behaviours. This increase 
occurred in the absence of the primary reinforcer and thus represented appetitive 
responding. This increase could be explained by a loss of behavioural inhibition over 
prepotent operant responding but this is more likely to be an AcbC mediated 
mechanism. Alternatively the effect could be due to an attenuation of AcbSh mediated 
latent inhibition of exteroceptive cues. It is unlikely that the animals experienced an 
increase in the value of the primary reward under the influence of baclofen and this 
would not explain increased responding during the appetitive phase but it is highly 
likely that the saliency of reward related cues (discrete CS or contextual) was 
potentiated. In contrast the highest dose of baclofen tested disrupted schedule control 
over operant responding, induced significant oral stereotypies and caused pronounced 
disruption of grooming motor patterns.  
 
It is postulated that low doses of baclofen control the saliency of reward related cues via 
interactions with other neurotransmitter systems at the local level, not via total 
inactivation of MSN output. At higher doses increases in free feeding without 
concomitant effects on instrumental responding could still be explained by total 
inactivation of the AcbSh and hence release of downstream feeding related motor 
patterns. These issues will be further discussed in light of the findings to be reported in 
Chapters 5 and 6. 
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Questions raised 
Much of the theoretical discussion here is probably as much associated with the way in 
which the Acb is involved in learning about the availability of food and the cues that 
predict reward as it is in the expression of appetitive and consummatory behaviours post 
acquisition. However this is because the acquisition process dictates which cortico-
striatal circuits are consequently activated when the animal responds to cues in the 
future. However the AcbSh and GABA transmission within this region clearly has a 
significant role in the behavioural output described in this chapter. 
 
The key questions raised by these results are 1) will low doses of muscimol infused into 
the AcbSh increase operant responding for a food paired cue? 2) What neuronal 
circuitry is recruited during intra-AcbSh baclofen induced increases in operant 
responding? 3) If the effect is not due to inhibition of MSN output what other 
mechanism could subserve this effect? The first will be addressed in the next chapter, 
Chapter 5, where instrumental responding will be tested again on the 2nd order schedule 
using muscimol. In Chapter 6 the presence of the immediate early gene c-fos will be 
used to map regional activation following intra-AcbSh infusions of baclofen or 
muscimol. The final question will be addressed in light of the results from Chapter’s 5 
and 6 and what is known about the functional anatomy of the AcbSh in the General 
Discussion, Chapter 7. 
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Chapter 5 
 
GABAA receptor stimulation in the accumbens: effects 
on instrumental responding by pre-fed rats in a second 
order operant schedule 
 
Introduction 
The studies presented in Chapters 4 and 5 have demonstrated that intra-AcbSh infusions 
of baclofen and muscimol have distinguishable effects on the BSS in response to freely 
available chow. The effects of baclofen on the BSS resembled the effects of food 
deprivation. Muscimol increased feeding at the expense of the rest of the behavioural 
repertoire in the BSS and it did not resemble the BSS following fasting. Neither 
treatment produced a BSS that looked like that associated with manipulations thought to 
affect reward value (intra-Acb opioid agonist or systemic benzodiazepine).  
 
Studies presented in Chapter 4 demonstrated that intra-AcbSh baclofen increases both 
appetitive and consummatory responses without affecting response accuracy on a 2nd 
order operant schedule in animals that have been pre-satiated. This effect was dose 
dependent and the pattern of responding suggested a classic inverted U-shaped dose 
response function over the range tested (0, 110, 220, 440, 660ρmols). Furthermore, at 
the most effective dose tested (220ρmols) baclofen modified several other indices of 
behaviour including increasing headpokes into the magazine as reward became 
imminent, decreasing the latency to return to lever pressing following reward delivery 
and increasing rearing behaviour including rears directed specifically at the CS. At the 
highest dose the oral stereotypical behaviour and abnormal grooming behaviour 
emerged.  
 
These results indicate that, contrary to current theory to explain the effects of GABA in 
the Acb on feeding (Kelley et al., 2005m), the effects of intra-AcbSh baclofen and 
muscimol on motivated behaviour may not be equivalent but the possibility remains that 
muscimol could also increase operant responding on the 2nd order schedule. This 
possibility remains because 1) not all the evidence for a lack of motivational effects of 
muscimol has come from an equimolar dose range as low as that shown to be effective 
with baclofen and 2) because the schedules used may have negated the possibility of 
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any independent measure of motivational effects because of satiety mechanisms 
associated with immediate access to reward (Zhang et al., 2003). 
 
The experiments from which this evidence comes are described in detail in the 
introduction to this thesis but, to recap some key findings, in a PR schedule intra-AcbSh 
muscimol at doses of 350, 880 and 1750ρmols failed to increase the rate of lever 
pressing, accuracy of pressing on the reinforced lever or the break point (Zhang et al., 
2003). The authors speculated that, because DAMGO and amphetamine did increase the 
breakpoint, neither increases in palatability or increases in incentive salience could 
increase the willingness of animals to work on this schedule. They concluded therefore 
that muscimol must have had no effect on motivation driven by wanting (incentive 
salience) or liking (palatability). However, as discussed in Chapter 4, a change in break-
point does not distinguish effects on motor effort directed at incentive stimuli (i.e., 
pressing the lever) from effects on the perceived rewarding value of the reinforcer 
(Hanlon et al., 2004).  
 
Muscimol at a dose of 1750ρmols also failed to potentiate the acquisition of a lever 
pressing response for food reinforcement (Hanlon et al., 2004). In this case it was 
suggested that the potentiation of acquisition of lever pressing for food required both 
increases in hedonic affect and in incentive salience at the same time. Again, given that 
muscimol appeared to have no effect on either of these proposed mechanisms, whether 
in combination or not, and did not enhance instrumental learning it was concluded that 
there was a dissociation between the effects of GABA on ingestion and on other 
behaviours “typically associated with an appetitive CMS” (Kelley et al., 2005b).  
 
Given that it was hypothesised in the previous chapter that baclofen may exert effects 
on the incentive attributed to the stimuli it is also important to test the possibility that 
the same is true for muscimol on an appropriate schedule at equimolar doses. Also, as 
was pointed out in Chapter 4, at 100ng (880ρmols) muscimol or above, there are 
potentially confounding motor effects that could disrupt instrumental responding 
(Scheel-Kruger et al., 1977b, Scheel-Kruger et al., 1977a). Muscimol across a low dose 
range will therefore be tested on the same 2nd order schedule as was used in Chapter 4. 
However it is predicted that, even at lower doses, muscimol will not increase operant 
responding. 
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Stratford (2007) points out that GABAA agonists will block activity in the vast majority 
of synapses within the AcbSh because the GABAA receptor is so widely distributed 
postsynaptically. This means that AcbSh output is blocked at a level one step removed 
from integration at the level of local interneurons and thus GABAA agonists are less 
likely to modulate the function of other receptor types as the GABAB agonist could. The 
data from Chapter 3 indicates that intra-AcbSh infusions of muscimol does not allow 
the full expression of the BSS and the results were consistent with the idea that 
muscimol inactivates this region rather than modulates local control over motivational 
processes. Because of this baclofen will be used in experiment 5.1 to confirm that the 
infusions sites are behaviourally active in terms of increased instrumental responding. 
 
The experiments reported in this chapter will examine the effect of 1) one dose of 
baclofen; 220 ρmols/µl-1 versus a low dose range of muscimol; 110, 220, 440ρmols/µl-1 
and 2) a higher dose range muscimol; 220 and 660ρmols/µl-1. Effects will be analysed 
in terms of the magnitude and accuracy of responding on two operant levers with 
respect to the programmed schedule. The efficacy of the dose ranges chosen on intake 
of freely available food will be confirmed by measuring total intake of chow in the 
same experimental groups using the same doses following the operant test phase. 
 
These experiments will contribute to our understanding of the specific effects of intra-
Acb GABAA receptor stimulation revealed in Chapter 3 and will also address three of 
the key aims of the thesis. In experiment 5.1 the effects of the optimum dose of baclofen 
tested in Chapter 4 will be compared with an equimolar range of doses of muscimol to 
those of baclofen used in experiment 4.1 will be recorded for 5 minutes of purely 
appetitive responding for a CS and for 25 minutes of mixed appetitive/consummatory 
behaviour on the second order schedule. The effect on total intake of freely available 
chow of infusions of the highest dose of muscimol from the range will also be assessed 
in the same cohort of animals.  
 
In experiment 5.1 the effects of muscimol in the second order schedule will be further 
explored across a broader dose range equimolar to those doses of baclofen tested in 
experiment 4.3. This will include the analysis of the effects of muscimol on behaviours 
other than lever pressing using videos of the test sessions.  In this experiment a full dose 
range, free-feeding intake study will be carried out following completion of the second 
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order schedule testing phase using the same counterbalanced design to allow a direct 
comparison between any effects on operant responding and on intake. 
 
As was pointed out in Chapter 4 the effects of hunger and satiety have already been 
reported for the schedule (Greenhalgh, 2007, Thornton-Jones et al., 2005) and these 
experiments will add further to the picture that is building up of the role of GABA in 
the context of naturally elicited feeding and motivational control in general. Results 
reported in this chapter will further contribute to the characterisation and comparison of 
the effects of GABA receptor subtype stimulation on feeding related behaviours in the 
context of the current hypothesised mechanism subserving these effects. 
 
To summarise, previous results reported in this thesis indicate that intra-AcbSh GABAB  
receptor agonist infusion increases intake of freely available food without disrupting the 
BSS and increases both appetitive and consummatory operant responding for food on a 
2nd order schedule. In contrast results reported in this thesis indicate that intra-AcbSh 
GABAA muscimol induced free feeding disrupts the BSS and it has been reported 
elsewhere that muscimol has no obvious effect on motivational processes subserving 
operant responding. However, the effects of muscimol on operant responding were 
tested at higher equimolar doses than the baclofen dose shown to be most effective in 
increasing operant responding in Chapter 4 and the range encompasses concentrations 
that could cause motor disruption.  Additionally the effects of muscimol have not been 
previously tested on a schedule that allows distinctions to be made between effects on 
stimulus saliency and reward value in the absence of potentially confounding post-
ingestional processes. 
 
The two experiments reported in this chapter will: 
 
1) Test the effects of a range of doses of a GABAA agonist compared to the effects 
of an optimum dose of a GABAB agonist on instrumental behaviour in the 
second order schedule (Experiment 5.1 and 5.2). Does the GABAA agonist 
muscimol affect operant responding when infused into the same region of the 
Acb where baclofen increases it? 
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2) Characterise the magnitude and temporal pattern of responses made following 
intra-Acb GABAA infusion during both appetitive and consummatory operant 
phases (Experiment 5.1 and 5.2). Does the GABAA agonist muscimol cause any 
divergence in responding depending on the phase? 
 
3) Test the effects of a range of doses of a GABAA agonist on behaviours other 
than lever pressing expressed during an operant schedule (Experiment 5.2). 
Does the GABAA agonist muscimol have any effects on general activity, other 
indices of motivated behaviour or on adjunctive behaviours not picked up by 
measuring lever pressing alone? 
 
The overarching question posed in this chapter is:  
 
Does intra-Acb administration of the GABAA agonist muscimol potentiate any aspect of 
complex goal-directed motivated behaviour on a second order schedule in a manner 
consistent with selective effects on appetitive and/or consummatory behaviours? 
 
Experiments presented in this chapter 
Experiment 5.1 
The effects of bilateral intra-Acb infusions of 220ρmols baclofen compared to a range 
of doses of the GABAA agonist muscimol on responding on a 2nd order operant 
schedule. 
 
Experiment 5.2 
The effects of bilateral intra-Acb infusions of a higher range of doses of the GABAA 
agonist muscimol on responding on a 2nd order operant schedule, on associated 
behaviours and on free intake. 
 
 
Materials and methods 
Animals 
One drug naïve group of animals (n=12) was used for Experiment 5.1 (2nd order with 
baclofen and muscimol) and a second drug naïve group of animals (n=12) was used in 
Experiment 5.2 (2nd order with high dose range baclofen). As in Chapter 4 subjects were 
bought in weighing 150-200g. In all cases the animals were housed in pairs during 
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training on the 2nd order schedule. They were then housed singly in Perspex cages for a 
minimum of 7 days prior to surgery and for the remainder of each experiment.  
 
Apparatus and habituation 
All apparatus and habituation procedures were identical to those used in Chapter 4 and 
the reader is referred to the relevant details on page 149. 
 
Specific procedural details – central drug administration 
On test days only two animals were infused at a time to compensate for the time taken 
for each infusion. The programme controlling the operant boxes allowed each box to be 
started individually. This meant that testing of each animal could be temporally 
staggered and there were 4 operant boxes. Infusions for the next batch of 4 animals to 
be tested began a few minutes before the previous batch was due to come out and the 
whole cohort could be run over a period of approximately 4 hours (between 12.00 and 
16.00). There was a minimum of 48 hours between infusions. 
 
 
 
 
Figure. 5.1. Diagram to show which groups of animals were used for more than 
one test procedure within experiments 5.1 and 5.2 and the timeline for each. 
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Experiment 5.1 
Initially a counterbalanced test was carried out on the 2nd order operant schedule 
(method as detailed in Chapter 2, page 75) using baclofen at 220ρmols/µl-1 or vehicle 
(0.9% sterile saline – used throughout). These animals were given a few days drug free 
and re-exposed to the schedule in this state (see Fig 5.1). This was followed by the test 
run on the 2nd order schedule using a dose range of muscimol equimolar to doses of 
baclofen used in Chapter 4, experiment 4.1 i.e. 110, 220 and 440 ρmols/µl-1 infused 
immediately before transfer to the operant boxes. Following testing on the second order 
schedule the same animals were tested with an intake probe using the highest dose of 
440ρmols vs. vehicle to ensure that the placements were behaviourally active in terms 
of increased feeding in pre-fed rats (for method for intake test see Chapter 2, page 69).  
 
Experiment 5.2 
The range of muscimol doses tested here was equimolar to those doses of baclofen used 
in Chapter 4, experiment 4.3 i.e. 220, 660 ρmols/µl-1 baclofen or vehicle. Initially a 
counterbalanced intake probe using the highest dose of 660ρmols vs. vehicle was run to 
ensure that the placements were behaviourally active in terms of increased feeding in 
pre-fed rats (for intake method see Chapter 2, page 69). This was followed by the test 
run on the 2nd order schedule (as detailed in Chapter 2, page 75). The 2nd order test was 
followed by a counterbalanced dose response test of intake of chow in pre-fed animals 
using the same range of doses. Finally duration and frequency data transcribed for 
distinct categories of behaviours exhibited during responding were extracted from 
videos of the 2nd order operant test sessions. 
 
Data analysis 
The final analysis groups were decided on the basis of histological verification of 
infusion sites as before. Data from the 2nd order operant tests were extracted and 
analysed exactly as described for the experiments carried out in Chapter 4 (page 151).  
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Data extraction from videos 
In experiment 5.2 other behaviours associated with responding in the operant box on the 
2nd order schedule were recorded from the videos of each test session. Unix Shell scripts 
were used to extract the total durations and frequency of each behaviour and to parse the 
data into 5 minute time bins for more detailed temporal analysis. The means for total 
duration and frequency of behaviours in each treatment group were compared using a 
repeated measures ANOVA with dose and behavioural category as factors. The timebin 
data were analysed using the same ANOVA design but including dose, behavioural 
category and time-bin as factors. Timebin data were plotted as line plots to illustrate the 
change in the durations and frequencies of each individual behaviour across the session. 
 
Whilst recording occurrences of rearing behaviour from the videos a separate tally was 
kept for rears made specifically to the cue light and/or the sound of the pellet delivery 
hopper turning. The mean proportion of rears to the CS vs. the total number of rears 
made was then compared between treatment groups using a repeated measures ANOVA 
with dose as factor. 
 
Because it was noted in Chapter 4 that baclofen had a dose related effect on grooming 
behaviour such that animals at the highest dose never exhibited a normal sequence 
characterised by a rule-driven (syntactic) chain (Berridge and Whishaw, 1992, Aldridge 
et al., 2004) the presence or absence of this was also recorded for these experiments. 
Any other changes in the pattern of behaviour were noted while coding the 8 categories. 
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Results 
Experiment 5.1: The effects of bilateral intra-Acb infusions of baclofen 
at 220 mols/µl-1 or muscimol at 110, 220 & 440ρmols/µl-1 in pre-fed 
rats on responding on a second order operant schedule for food. 
 
 
 
 
 
 
 
Figure 5.2. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β).  Bilateral target coordinates 
(n=6) were (AP), + 1.4mm, mediolateral (ML), ± 0.9mm relative to bregma and 
dorsoventral (DV), -7.8mm relative to skull surface. 
 
 
β  +1.0mm 
β  +1.2mm 
β  +1.6mm 
β  +1.7mm 
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Prior to testing animals with muscimol the effectiveness of baclofen at increasing 
reinforced pressing was verified at a dose of 220ρmols. Bilateral infusions of baclofen 
only increased pressing in 7 out of 12 subjects. Histological examination revealed that 
these n=7 of the original n=12 animals had placements that fell within the acceptable 
boundaries defined in previous chapters but one was excluded because 1 or more 
infusions had fallen outside the target site at some point (See Fig 5.2). The remaining 5 
animals that had placements outside the target site were those that were not responsive 
to baclofen in terms of total intake. 
 
A total of n=6 animals were therefore verified as having acceptable placements and 
were included in the final analysis. A schematic illustration of Acb infusion site 
placements is given in Fig. 5.2. These animals pressed significantly more on the 
reinforced lever with 220ρmols baclofen than with vehicle [Fig. 5.3A: F(1,5)=7.34  , 
p=0.042]. Muscimol had no significant effect on reinforced presses at any dose tested 
(Fig. 5.3B). Neither baclofen nor muscimol had a significant effect on total non-
reinforced or incorrect lever presses. 
 
 
 
Figure 5.3. The effects of intra-Acb bilateral infusions of saline or A) 220ρmols of 
baclofen and B) 110, 220 or 440ρmols of muscimol in pre-fed rats (n=6) on total 
lever presses in a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ✭  p<0.05. 
A B 
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Figure 5.4. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=6) on cumulative reinforced lever presses over 
a 30 minute second order operant test session.  
 
Fig. 5.4 illustrates the distribution of cumulative reinforced lever presses across the 30 
minute 2nd order operant session with intra-Acb infusions of vehicle or muscimol. The 
rate of lever pressing, expressed as reinforced presses per minute, across the first 5 
minutes and subsequent 25 minutes of the schedule was calculated and the early vs. late 
phase rates were compared within each dose (see Table 5.1). There was no main effect 
of drug dose but a main effect of time phase [F(1,5)=7.02, p=045] but no interaction 
between the two. A comparison of rates of pressing between treatments during the early 
phase or the subsequent 25 minutes indicated that there was no significant difference.  
 
When the data were split up into 5 minute bins (see Fig. 5.5) there was no main effect of 
drug on total pressing in each bin but a main effect of time [F(2,25)=4.49, p=0.005] and 
a significant interaction between the effects of drug and time [F(15,75=1.94, p=0.032]. 
Paired comparisons did not reveal any significant effects of dose of muscimol when 
restricted to individual time bins. The interaction probably reflects increased responding 
in both the 110 and 440ρmols treatment groups in the first 5 minutes. 
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Table 5.1.  The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=6) on the rate of reinforced lever pressing 
during the first 5 minutes (appetitive phase) and last 25 minutes (consummatory 
phase) of a second order operant test session. There were no significant 
differences. 
 
 
 
 
 
 
 
Figure 5.5. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=6) on reinforced lever presses across a 30 
minute second order operant test session. Error bars represent ±SEM.  
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The cumulative mean proportions of the length of inter lever press intervals (ILIs) 
between the 5th press of an FR5 response and the 1st press of the next FR5 across the 
first 5 minutes of the 2nd order schedule (unrewarded) are depicted in Fig. 5.6. The 
distributions of ILIs for the remaining 25 minutes of the test session are shown in Fig. 
5.7. In the first 5 minutes of the session, when no lever presses could be rewarded with 
the primary reinforcer, animals did not press at all during the first 5 seconds CS with 
vehicle, 110 and 220ρmols but at the highest dose 10% of presses were made within 1 
second of the CS coming on. 
 
 
 
 
 
Figure 5.6. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=6) on cumulative ILIs between the 5th and 1st 
presses of the FR5 requirement on the reinforced lever. Data represents 
responding across the first 5 minute unrewarded phase of a second order operant 
test session. The shaded phase represents the duration of the CS (8 seconds).  
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For the remaining 25 minutes of the session some animals made the first press of the 
next ratio during the CS with all treatment conditions. With vehicle 18% of presses 
were made while the CS was still on. At the 110ρmols dose 39.4% of presses were 
made while the CS was still on, at 220ρmols this was 28.6% and at 440ρmols 15.9%. 
Within a second of the CS terminating 68% of presses had been made at 110ρmols 
compared to 32% with vehicle, 38.1% with 220ρmols and 26.4% with 440ρmols. 
 
 
 
 
Figure 5.7. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=6) on cumulative inter lever press intervals 
between the 5th and 1st presses of the FR5 requirement on the reinforced lever. 
Data represents responding across the last 25 minute rewarded phase of a second 
order operant test session. The shaded phase represents the duration of the CS (8 
seconds).  
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A few days after testing on the 2nd order schedule the same animals, pre-fed with 
standard laboratory chow prior to treatment with 440ρmols muscimol, exhibited a 
significant increase in consumption of chow over a subsequent 30 minute test period 
[Fig 5.8; F(1,5)=18.38, p=0.008].  
 
 
 
Figure 5.8. The effects of intra-Acb bilateral infusions of saline or muscimol in pre-
fed rats (n=6) given access to laboratory chow over a 30 minute test. Error bars 
represent ±SEM. Significant differences from vehicle are denoted ✭✭p<0.01. 
 
 
Summary of results for experiment 5.1 
In experiment 5.1 n=6 subjects were included in the final analysis. The 220ρmols dose 
of baclofen significantly increased reinforced pressing on the 2nd order operant schedule 
but muscimol, at doses of 110, 220 and 440ρmols, had no significant effect on the total 
number of reinforced presses across the session or per 5 minute timebin. Muscimol also 
had no significant effect on the rate of pressing either during the first 5 minutes when 
reward was unavailable or during the following 25 minutes of the test session. At 
110ρmols the drug appeared to increase the proportion of presses that were made while 
the CS was on and within 1 second of it termination.  Muscimol at a dose of 440ρmols 
did increase free food intake in pre-fed animals over a 30 minute period. 
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Experiment 5.2: The effects of bilateral intra-Acb infusions of 
muscimol at 220, 440 and 660ρmols/µl-1 in pre-fed rats on free intake 
versus responding on a second order operant schedule for food. 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β). Bilateral target coordinates 
(n=8 of original n=12 subjects with acceptable placements ) were (AP), + 1.4mm, 
mediolateral (ML), ± 0.9mm relative to bregma and dorsoventral (DV), -7.8mm 
relative to skull surface. 
 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
β  +1.0mm 
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Prior to testing animals in the operant chambers, responsiveness to muscimol in terms 
of free intake in pre-fed animals was verified at a dose of 660ρmols/µl-1. A total of n=8 
animals out of the original n=12 were later verified as having acceptable placements on 
the basis of the histology and were included in the final analysis. A schematic 
illustration of Acb infusion site placements is given in Fig. 5.9. These 8 animals 
consumed significantly more chow with muscimol treatment than with vehicle over a 30 
minute period [Fig. 5.10: F(1,7)=34.46, p<0.001]. Some animals appeared to be mildly 
sedated but were still able to feed. There was no obvious correlation between infusion 
site and sedative effects. Muscimol had no significant effect on total reinforced presses 
at any dose tested (Fig. 5.11) nor did it affect the total number of non-reinforced or 
incorrect lever presses. 
 
 
 
 
 
 
Figure 5.10. The effects of intra-Acb bilateral infusions of saline or muscimol in 
pre-fed rats (n=8) given access to laboratory chow over a 30 minute test session. 
Error bars represent ±SEM. Significant differences from vehicle are denoted by 
✭✭ p<0.001. 
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Figure 5.11. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on total lever presses in a 30 minute second 
order operant test session. Error bars represent ±SEM.  
 
 
    
 
Figure 5.12. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on cumulative reinforced lever presses over 
a 30 minute second order operant test session.  
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Fig. 5.12 illustrates the distribution of cumulative reinforced lever presses across the 30 
minute 2nd order operant session with intra-Acb infusions of vehicle or muscimol. The 
rate of lever pressing, expressed as reinforced presses per minute, across the first 5 
minutes and subsequent 25 minutes of the schedule was calculated and the early vs. late 
phase rates were compared for each dose (see Table 5.2). There was no significant main 
effect of drug dose, of time phase or any interaction between the two. A comparison of 
the rates of pressing between treatments during the early phase indicated that there was 
no significant difference. During the subsequent 25 minutes there was again no 
significant difference between doses. 
 
 
Table 5.2.  The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on the rate of reinforced lever pressing 
during the first 5 minutes (appetitive phase) and last 25 minutes (consummatory 
phase) of a second order operant test session. There were no significant 
differences. 
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Figure 5.13. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on reinforced lever presses across a 30 
minute second order operant test session. Error bars represent ±SEM.  
 
 
When the data were split up into 5 minute bins there were no main effects of drug or 
time on total reinforced lever presses per bin. There was also no interaction between the 
dose of drug administered and time across the session (see Fig. 5.13). 
 
The cumulative mean proportions of the length of inter lever press intervals (ILIs) 
between the 5th press of an FR5 response and the 1st press of the next FR5 across the 
first 5 minutes of the 2nd order schedule (unrewarded) are depicted in Fig. 5.14. The 
distributions of ILIs for the remaining 25 minutes of the test session are shown in Fig. 
5.15. In the first 5 minutes of the session, when no lever presses could be rewarded with 
the primary reinforcer, animals did not press at all during the first 5 seconds CS with 
vehicle or any dose of muscimol. 
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Figure 5.14. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on cumulative ILIs between the 5th and 1st 
presses of the FR5 requirement on the reinforced lever. Data represents 
responding across the first 5 minute unrewarded phase of a second order operant 
test session. The shaded phase represents the duration of the CS (8 seconds).  
 
 
For the remaining 25 minutes of the session some animals made the first press of the 
next ratio during the CS with all treatment conditions. With vehicle a mean of 18% of 
presses were made while the CS was still on. While the CS was still on 13%, 13%, 17% 
and 18% of presses were made with vehicle, 220, 440 and 660ρmols of muscimol 
respectively. Within a second of the CS terminating a mean of 17% of presses with 
vehicle were made while 27%, 34% and 30% were made with 220, 440 and 660ρmols. 
A few days after testing on the 2nd order schedule the same animals, pre-fed with 
standard laboratory chow prior to treatment with 220, 440 and 660ρmols of muscimol, 
exhibited a significant increase in consumption of chow over a subsequent 30 minute 
test (Fig 5.16; [F(3,21)=13.76, p<0.001]). Paired comparisons revealed that all three 
doses significantly increased intake relative to vehicle (p<0.01 in all three cases). There 
was no difference in intake with 660ρmols prior to and post 2nd order testing. At the 
highest dose mild sedative effects were again noted in some animals but not across the 
entire 30 minute intake test session.  
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Figure 5.15. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on cumulative inter lever press intervals 
between the 5th & 1st presses of the FR5 requirement on the reinforced lever. Data 
represents responding across the last 25 minute rewarded phase of a second order 
operant test session. The shaded phase represents the duration of the CS (8 sec).  
 
 
Figure 5.16. The effects of intra-Acb bilateral infusions of saline or a range of 
doses of muscimol in pre-fed rats (n=8) given access to laboratory chow over a 30 
minute test session. Error bars represent ±SEM. Significant differences from 
vehicle are denoted by ✭✭p<0.01. 
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Associated behaviours 
Analysis of the videos of testing in the operant boxes revealed a strong tendency 
towards an interaction between dose of muscimol and the total duration of the 8 
behaviours recorded [Fig. 5.17; F(24,168)=1.55, p=0.059]. There was a significant 
interaction between drug and behavioural category for the frequency of the eight 
behaviours across the session [Fig. 5.18; F(24,168)=1.6, p=0.045]. The pattern of the 
effects of drug on duration and frequency of individual behaviours did not always 
correspond and are described in detail later (see Fig. 5.17 & 5.18). The amount of 
behaviour that was coded as off screen was low, as was the case in Chapter 4 (Fig. 4.27 
and Fig. 4.28). There was no significant difference in duration or frequency of off 
screen data recorded at any dose.  
 
 
Figure 5.17. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on the total duration of 8 behaviours 
recorded across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★ p<0.05.  
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Figure 5.18. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on the total frequency of 8 behaviours 
recorded across a 30 minute second order operant test session. Error bars 
represent ±SEM. Significant differences from vehicle are denoted by ★ p<0.05. 
 
Oral stereotypy 
The total duration [Fig. 5.17; F(3,21)=4.00, p=0.021]  and frequency [Fig 5.18; 
F(3,21)=4.03, p=0.021] of behaviours categorised as ‘oral stereotypy’ was significantly 
increased by drug but post-hoc analysis revealed that this effect occurred only at 
660ρmols (p<0.05 in both cases). When the duration data were split into 5 minute time 
bins there was a significant main effect of drug [F(3,21)=4.0, p=0.021] and main effect 
of time bin  [F(5,35)=4.66, p=0.002] but there was no interaction (See fig. 5.19A). 
There was also a significant main effect of drug [F(3,21)=4.03, p=0.021] and of time 
bin [F(5,35)=3.68, p=0.009] but no interaction for frequency (See Fig. 5.19B). Oral 
stereotypical behaviours represented less than a minute of behaviour across the entire 
session, even at the highest dose. It was noted during the video analysis that oral 
stereotypical behaviour only occurred in very short bouts rather than being prolonged 
sessions of floor licking as was seen with baclofen. Furthermore it was directed just as 
much at the levers, hopper and walls at to the floor. 
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Figure 5.19. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on A) duration and B) frequency of ORAL 
STEREOTYPY across a 30 minute second order operant test session. Error bars 
represent ±SEM.  
 
 
Activity 
There was a significant effect of muscimol on the total duration of active behaviour 
[Fig. 5.17; F(3,21)=3.21, p=0.044]. Post hoc analysis revealed that this was due to a 
significant decrease in the duration of activity at 220ρmols (see Fig. 5.17 p<0.05). 
There was no significant effect of muscimol on the total frequency of bouts of active 
behaviour (See Fig. 5.18). When the data were split into 5 minute time bins a significant 
main effect of drug on the duration of active behaviour [F(3,21)=3.2, p=0.044] was seen 
but there was no main effect of time bin or any interaction (See Fig. 5.20A). There was 
no main effect of drug on the frequency of periods of active behaviour, there was a 
main effect of time bin [F(5,35)=16.33, p<0.001] but no interaction (See Fig. 5.20B). 
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Figure 5.20. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on A) duration and B) frequency of 
ACTIVE behaviours across a 30 minute second order operant test session. Error 
bars represent ±SEM.  
 
 
 
 
 
Rearing 
Muscimol had no significant effect on the total duration or frequency of rearing (See 
Fig. 5.17 and 5.18). When the data were split into 5 minute time bins (not shown) there 
was a significant main effect of time on the duration [F(5,35)=16.17, p<0.001] and 
frequency [F(5,35)=11.64, p<0.001] of rears in each bin but no interaction with drug 
treatment. Analysis of the separate record of the number of rears to the CS indicated 
that there was no significant effect of drug (See Fig. 5.21A) and there was no significant 
difference in rears directed at the CS as a proportion of total rears with each dose (Fig. 
5.21B). 
 
 
A B 
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Figure 5.21. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on A) the total number of rears to the CS 
and B) the proportion of the totals rears made that were directed towards the CS 
across a 30 minute second order operant test session. Error bars represent ±SEM.  
 
Lever 
There was no main effect of drug on the total duration or frequency of interactions with 
the lever and splitting the data into time bin did not reveal an effect of drug, time or any 
interaction between the two on the duration or frequency per 5 minute bin.  
 
Headpokes into magazine 
The total duration and frequency of headpokes into the magazine was not changed by 
muscimol and there was no significant effect of drug or time on this behaviour across 5 
minute bins. 
 
Ingest 
The total duration and frequency of ingestion was not changed with muscimol at any 
dose and when the data were split into 5 minute bins there was no significant effect of 
drug in any bin. There was a significant main effect of time for both duration 
[F(5,35)=2.41, p=0.056] and frequency[F(5,35)=4.73, p=0.002) but no interaction with 
drug dose. 
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Groom  
The total duration of grooming behaviour was not affected by drug (see Fig. 5.17) but 
the total frequency was significantly increased [Fig. 5.18; F(3,21)=3.71, p=0.028]. 
Paired comparisons revealed this to be due to an increase in the frequency of bouts of 
grooming at 440ρmols (p<0.05) (See Fig. 5.18). When the data were split into 5 minute 
bins there was no main effect of drug on the duration, a significant effect of time 
[F(5,35)=3.48, p=0.012] but no interaction (See fig. 5.22A). For frequency there was a 
significant main effect of drug [F(3,21)=3.67, p=0.029] and of time bin [F(5,35)=5.47, 
p<0.001] but no interaction (Fig 5.22B). It was noted that animals at all drug doses 
would start a normal syntactic chain of grooming but often terminate it before it was 
complete at higher doses. Normal grooming behaviour was fragmented. The grooming 
stereotypies observed with baclofen (e.g. fixation on tail) were not seen. 
 
 
 
 
  
 
Figure 5.22. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on A) duration and B) frequency of 
GROOMING behaviour across a 30 minute second order operant test session. 
Error bars represent ±SEM.  
 
 
A B 
256 
Inactive 
There was no main effect of drug on the total duration (see fig. 5.17) or frequency (see 
Fig. 5.18) of inactive behaviour but a significant effect of time for both duration [Fig. 
5.23A; F(5,35)=2.41, p=0.056]  and frequency [Fig. 5.23B; F(5,35)=3.24, p=0.017] 
when data were split into 5 minute bins. It was noted from observations of the videos 
that while under the influence of 660ρmols some animals appeared mildly sedated once 
the initial arousal associated with being put into the boxes had dissipated. With both 
440 and 660ρmols animals would intermittently lie down throughout the session. In 
contrast inactive behaviour with vehicle and 200ρmols occurred near the end of the 
session and appeared to occur because animals had lost interest in doing anything else. 
 
 
 
 
    
 
Figure 5.23. The effects of intra-Acb bilateral infusions of saline and a range of 
doses of muscimol in pre-fed rats (n=8) on A) duration and B) frequency of 
INACTIVE behaviour across a 30 minute second order operant test session. Error 
bars represent ±SEM.  
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Summary of results for experiment 5.2 
In this experiment n=8 subjects were included in the final analysis. With these animals 
660ρmols of baclofen significantly increased intake of freely available chow prior to 
testing on the 2nd order operant schedule. Subsequently 110, 220 and 660ρmols also 
significantly increased total chow intake relative to vehicle treatment a few days 
following testing on the operant schedule. There was no significant difference between 
the amount of chow consumed with 660ρmols prior to and following multiple infusions 
for the operant test. There was also no significant difference between amounts of chow 
eaten with each dose. Muscimol, at doses of 220, 440 and 660ρmols, had no significant 
effect on the total number of reinforced presses or per 5 minute timebin. Muscimol also 
had no significant effect on the rate of pressing either during the first 5 minutes when 
reward was unavailable or during the following 25 minutes of the test session. Of the 8 
other behaviours that were recorded from the videos of the test sessions muscimol 
significantly increased the total duration and frequency of bouts of oral stereotypy at 
660ρmols, decreased total duration of active behaviour at 220ρmols and increased total 
frequency of bouts of grooming at 440ρmols. Observations from the videos suggested 
that behavioural patterns had become fragmented with only partial grooming sequences 
expressed and infrequent short bouts of oral stereotypy, particularly at the highest dose. 
 
Discussion 
This chapter primarily addressed the key question raised in Chapter 4; will low doses of 
muscimol infused into the AcbSh increase operant responding for a food paired cue in a 
second order schedule? Using the same approach as in Chapter 4, the two experiments 
reported here were designed to investigate the acute effects, across a range of doses, of 
intra-Acb GABAA receptor stimulation on ingestion versus performance of food 
motivated operant responses in pre-fed rats. In the first experiment responding with 
muscimol was directly compared in the same animals with intra-Acb baclofen at the 
220ρmols dose that was previously demonstrated to increase operant responding in 
Chapter 4. In the second experiment in addition to effects of muscimol on operant 
responding the effects on 8 mutually exclusive categories of behaviour expressed during 
responding on the 2nd order schedule were analysed from videos of the sessions. Intake 
of freely available chow was subsequently measured using an identical counterbalanced 
range of doses in the same cohort of animals. 
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Reinforced lever presses with baclofen and muscimol 
As was expected, in experiment 5.1 baclofen at a dose of 220ρmols significantly 
increased reinforced lever pressing but in contrast muscimol had no significant effect on 
total reinforced presses at any of the doses tested (110, 220, 440ρmols). In experiment 
5.2 the lack of effect of muscimol at these doses was confirmed and in addition it was 
shown that a higher dose of 660ρmols had no significant effect on reinforced 
responding. Baclofen and muscimol had no significant effect on non-reinforced or 
incorrect lever presses. 
 
Phases of responding with muscimol 
When the data were split into early (first 5 minutes) and late (last 25 minutes) phases 
there was no significant difference between phases for each dose or between doses for 
each phase in experiment 5.1 or 5.2. Further splitting the data into 5 minute time bins 
did not reveal any significant dose effect on total reinforced pressing in each time bin. 
 
Other behaviour durations and frequency with muscimol 
With 660ρmols muscimol there was a significant increase in both the duration and 
frequency of oral stereotypical behaviours however this only represented less than 1 
minutes worth of behaviour across the entire 30 minute session.  It was also noted from 
the videos that the pattern of oral stereotypical behaviour was different from that seen 
with baclofen. With muscimol animals only expressed short intermittent bouts of 
chewing/licking directed at the hopper, levers and walls as much as it was to the floor of 
the boxes. At 220ρmols there was a significant decrease in total activity across the 
session, which was seen as a gradual decrease over time. At 440ρmols there was a 
significant increase in the frequency but not in the duration of bouts of grooming. 
 
Free food intake with muscimol 
In experiment 5.1 440ρmols muscimol increased intake of freely available chow when 
animals were tested after the 2nd order test phase. In experiment 5.2 a dose of 660ρmols 
baclofen increased intake prior to 2nd order testing and doses of 220, 440 and 660ρmols 
baclofen also increased free feeding after the 2nd order testing. There was no significant 
difference in total intake prior to and post 2nd order testing with the 660ρmols dose. 
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Preliminary interpretation of key results summarised above 
The results reported in this chapter suggest that muscimol across the dose range tested 
does not have any effect on responding for food on a second order schedule. The results 
with baclofen in experiment 5.1 confirmed that infusions were reaching an area of the 
AcbSh that was behaviourally active in terms of increase in reinforced pressing. 
Muscimol infused in the same cohorts of animals post 2nd order testing caused a 
significant increase in feeding. The extended dose range in experiment 5.2 was infused 
at coordinates that were very similar to those in experiment 5.1 so it is unlikely that a 
placement issue was responsible for the lack of effect on operant responding. Again the 
muscimol infused post 2nd order testing caused a significant increase in intake. 
 
Because muscimol also had very little impact on the other behaviours that were 
recorded it is suggested that these results confirm that the changes in behaviour reported 
in Chapter 4 with baclofen are related to stimulation of GABAB receptors within local 
neurotransmitter circuits rather than occurring as a result of inactivation of Acb output. 
It is further suggested that activation of GABAA receptors does inactivate Acb output 
and cause a linear increase in ingestive behaviour through release of feeding related 
motor behaviours, a mechanism that does not support an increase in more complex food 
seeking behaviours. In contrast activation of GABAB receptors modulates local 
neurotransmitter function subserving motivational processes e.g. saliency attribution.  
 
Possible explanations for muscimol increase in intake but not operant responding 
The results of the experiments reported in this chapter are consistent with the theory put 
forward by Kelley et al. (2005a, 2005b) that activation of GABA receptors, in this case 
specifically GABAA receptors, results in inhibition of Acb output and hence 
disinhibition of downstream control over fragments of ingestive motor patterns. As such 
there is little more to add to the explanation of the effects of intra-AcbSh muscimol on 
feeding. However taking this proposed mechanism into account there are some issues 
that do need to be further explained. First of all muscimol at the doses tested did not 
appear to increase feeding in a linear manner as has been previously reported (e.g. 
Stratford and Kelley, 1997b, Basso and Kelley, 1999). Secondly analysis of the videos 
of behaviour did demonstrate some effects of muscimol on activity, grooming and oral 
stereotypy during operant responding. 
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Muscimol effects on free intake 
Baclofen and muscimol are reportedly equipotent in causing feeding in satiated rats 
(Stratford and Kelley, 1997b) but, while baclofen caused a linear increase in intake of 
chow in experiments 3.1 (Chapter 3) and 4.3 (Chapter 4) in experiment 5.2 there was no 
difference between the amount of food consumed with each dose of muscimol. In 
experiment 3.2 (Chapter 3) the 220 – 660ρmols dose range of muscimol was tested in 
the BSS for chow and here too there was no difference between the doses. Intake was 
not tested at the lowest dose of 110ρmols dose in this set of studies. Elsewhere a 
positive linear relationship between dose of muscimol and intake has been repeatedly 
observed (Stratford and Kelley, 1997b, Basso and Kelley, 1999). Nevertheless it is 
fairly straightforward to explain the apparent lack of a linear increase in free intake with 
increased doses of muscimol.  
 
It has been mentioned in Chapter 4 and in this chapter that there were signs of 
myorelaxation with baclofen at 660ρmols and sedation at 660ρmols muscimol. This 
was also noted during various pilot studies and it was concluded that this strain of rats 
(Lister Hooded rats from Harlan, UK) was actually much more sensitive to both 
baclofen in terms of myorelaxant effects and muscimol in terms of sedation than has 
been reported for other strains. For example Stratford and Kelley (1997b) did not record 
any locomotor effects up to and including a dose of 876ρmols muscimol in male 
Sprague Dawley rats (Harlan, Indianapolis, USA). There was no obvious correlation 
between the exact location of infusions and the degree of sedation (or lack of it) noted 
and putting the animals into the operant boxes appeared to override these effects to 
some degree. The sedative effects appeared to be much more pronounced in the free 
intake test sessions than during the operant test sessions. It is suggested that the more 
complex task and the more salient testing environment in the operant boxes causes a 
level of arousal in the animals that partially overrides the sedative effects.  
 
At 660ρmols there is also evidence that behavioural control patterns breakdown with 
both baclofen and muscimol and in this case they may both be acting via inactivation of 
Acb output. With baclofen a change in behavioural control patterns was manifested at 
660ρmols as a disappearance of normal syntactic grooming chains, their replacement 
with a stereotyped alternative grooming pattern and the emergence of oral stereotypy 
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directed at the mesh flooring.  However it should be noted that in the BSS study with 
baclofen the total duration of grooming was not affected  but animals did lick the 
floor/sawdust (experiment 3.1, Chapter 3). With muscimol as the dose increased 
animals would start to engage in a normal grooming sequence but terminate it 
prematurely and, at 660ρmols some possible oral stereotypies emerged although they 
were really just fragments of oral behaviour with no distinct target. In the BSS study 
with muscimol the duration of grooming behaviour was significantly reduced 
(experiment 3.2, Chapter 3). It is concluded therefore that the lack of linear increase in 
feeding between 220 and 660ρmols muscimol is due to a combination on sedative 
effects (that are partially overridden in the operant boxes) and a breakdown of control 
over chains of behaviour such as grooming that interferes with ingestive motor patterns. 
 
Muscimol effects on activity, grooming and oral stereotypy 
The only potential caveat to the argument that the effects of muscimol and baclofen are 
subserved by different mechanisms is that, at 660ρmols, both baclofen and muscimol 
caused the emergence of oral stereotypies during the schedule. Interestingly the total 
number of presses with the 220ρmols dose was higher (not significantly so) than with 
vehicle or the other drug doses in the first 5 minutes which is consistent with Zhang et 
al.’s (2003) finding that muscimol caused “slightly elevated” responding early in the 
session. It is possible that this is due to the possibility that muscimol might not be 
totally selective for GABAA receptors and could also stimulate GABAB  receptors 
(Yamauchi et al., 2000, Xiao et al., 2007, Morl et al., 2003). It is suggested therefore 
that the small effect of muscimol on oral stereotypy manifested as very short, less 
focused or unidirectional bouts than those seen with baclofen may be due to binding to 
the GABAB receptor rather than due to any GABAA mediated mechanism. However an 
alternative explanation based on the evidence to be reported in Chapter 6 will be 
discussed in the final chapter, Chapter 7. 
 
It is difficult to find any obvious functional reason why muscimol at 220ρmols would 
decrease activity. There is certainly no evidence in the literature that this would be the 
case. Looking at the inactive behavioural category there was an increase as the session 
progressed with this dose but the effect was not significant. It was noted however that 
not many of the animals pressed enough to get pellets and became increasingly 
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disinterested in doing anything in the operant box as the session progressed. The slight 
decrease in activity could be due to what is effectively boredom, perhaps exacerbated 
by the lack of opportunity to express ingestive motor patterns caused by inactivation of 
AcbSh output. Although the latter mechanism would also hold true at the 440 and 
660ρmols dose it has already been noted that disruption of specific motor behavioural 
patterns related to grooming and oral stereotypy increased with increasing dose and 
behaviour became fragmented. As a result there were more transitions between these 
fragments that were coded as ‘active’. 
 
It is proposed that three mutually exclusive but potentially interacting mechanisms are 
responsible for the results reported in Chapters 3, 4 and 5. First of all stimulation of 
GABAB receptors at low doses of baclofen engages motivational processes such as 
saliency attribution but at higher doses the net result of stimulation of GABAB receptors 
is inactivation of Acb output. This is the same mechanism that is responsible for free 
intake via stimulation of GABAA receptors but could disrupt operant responding. At the 
highest doses of baclofen and muscimol myorelaxant and sedative effects respectively 
also begin to block free intake. A schematic illustration of the contrasting effects of 
baclofen and muscimol on feeding versus operant responding is shown in Fig. 5.24 and 
the interaction of the three mechanisms is explained in more detail in the next section. 
 
Hypothesised mechanisms to explain baclofen vs. muscimol effects 
Numbered stages in Fig. 5.24 indicate the proposed shift between hypothesised 
mechanisms with muscimol or baclofen depending on dose such that: 
 
With baclofen 
 1) increased cue saliency at low doses of baclofen increases operant responding in a 
linear manner up to a maximum dose somewhere in the region of 220ρmols, 2) release 
of fragments of motor responding at doses of baclofen above 220ρmols begin to 
interfere with saliency effects on operant responding, 3) myorelaxation at high doses of 
baclofen disrupt operant responding, 4) increased cue saliency at low doses of baclofen 
could  also be responsible for increasing free intake in a linear manner but 5) release of 
fragments of ingestion related motor responding focus the animals behaviour into 
predominantly consummatory responses increasing it further as dose increases and 6) 
free feeding is disrupted by myorelaxation effects at the highest end of the dose range. 
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With muscimol 
7) Release of ingestion related fragments of motor responding at low doses of muscimol 
does not prevent operant responding but 8) at higher doses sedative effects disrupt it 
whilst 9) release of ingestion related fragments of motor responding could increase free 
feeding in a linear manner up to 10) higher doses which cause sedative effects that 
make it difficult to express feeding behaviour. 
 
Fig. 5.24. Schematic illustration of the effects of baclofen and muscimol across the 
dose range tested on free intake vs. responding on the 2nd order schedule. The 
proposed mechanisms that subserve this pattern are a) increased cue saliency 
(baclofen only), b) release of a subset of ingestion related motor patterns (baclofen 
and muscimol) and c) myorelaxation (baclofen) or sedation (muscimol). Detailed 
explanations for the numbered combinations across the dose range are given in the 
main text. 
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Summary 
It has been demonstrated in this chapter that, as would be predicted from Kelley’s 
hypothesis, intra-Acb muscimol does not increase operant responding at doses that 
increase free feeding. At higher doses there appears to be a breakdown in behavioural 
control patterns over grooming and oral stereotypy (although the latter effect may be 
due to activation of GABAB receptors by muscimol). It is postulated that, while low 
doses of baclofen could increase operant responding via effects on cue saliency 
subserved by changes in local neurotransmitter circuits, muscimol exerts its effects via 
inactivation of Acb output and hence disinhibition of the LH.  It is possible that the 
proposed mechanisms above and the interaction between mechanisms depending on 
dose effects on GABAA or GABAB receptors could well be subserved by different 
patterns of activation within brain circuitry involved in motivational processes and the 
control over ingestive behaviours. This provides a particularly compelling reason to 
investigate the effects of baclofen and muscimol on neuronal activation in other regions 
of the brain associated with motivation and reward. Some tentative explanations of the 
effects of baclofen at both the neurotransmitter and structural level have been discussed 
already in Chapter 4. Given that the results reported in this chapter have lead to the 
hypothesis that different mechanisms subserve baclofen and muscimol effects on 
ingestive behaviour, at least at low doses, any further functional explanations will be 
considered in light of the findings to be reported in the next Chapter. 
 
Questions raised 
The key questions raised by these results are 1) given that baclofen increases operant 
responding but muscimol does not is there any evidence of different brain circuits 
subserving their effects? And 2) if there are differences in the structures involved in the 
effects of baclofen and muscimol what could be going on at the level of the GABA 
receptors local to the AcbSh. As noted in Chapter 4 the first question will be addressed 
in Chapter 6 by using the presence of the immediate early gene c-fos to map regional 
activation following infusions of baclofen or muscimol. The potential mechanisms 
subserving the effects reported in Chapters 3, 4 and 5 will be discussed in full in light of 
the result from Chapter 6 in the General Discussion, Chapter 7. 
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Chapter 6 
 
GABAA and GABAB receptor stimulation in the 
accumbens: comparison of regional brain activation 
using Fos like immunoreactivity as a marker 
 
Introduction 
The results reported so far in Chapters 3,4 and 5 strongly suggest that, across the dose 
range tested, equimolar intra-Acb infusions of baclofen or muscimol could control 
feeding behaviour via different mechanisms. Baclofen increased intake of freely 
available chow at all the doses tested and delayed the onset of satiety without disrupting 
associated behaviours that constitute the BSS. Baclofen at 220ρmols increased operant 
responding on a 2nd order schedule during appetitive and consummatory phases without 
affecting response accuracy. There was a linear relationship between dose and total 
intake of chow whereas there was a classic inverted U-shaped dose response function 
for reinforced operant responding. The 220ρmols dose of baclofen also increased 
headpokes into the magazine in anticipation of pellet delivery and increased rears to the 
CS. The highest dose of baclofen, 660ρmols, did not affect the duration of grooming in 
the BSS but disrupted the normal pattern of expression of grooming in the 2nd order 
schedule. In the latter case this dose also elicited grooming and oral stereotypies.  
 
In contrast while muscimol increased intake of freely available chow and delayed the 
onset of satiety in the BSS it also significantly decreased the expression of all associated 
behaviours. While the relationship between dose of muscimol and total chow intake was 
very similar to that seen with baclofen this GABAA agonist failed to increase operant 
responding on the 2nd order schedule. Muscimol did not have any effect on response 
accuracy. At the highest dose tested, 660ρmols, muscimol reduced the total amount of 
grooming during the BSS and fragmented grooming behaviour into short bouts during 
the 2nd order schedule. This high dose also produced a significant amount of short bouts 
of oral behaviour that did not look like the stereotypy noted with baclofen. 
 
There has been very little evidence published to date to suggest that baclofen and 
muscimol infused into the Acb could increase feeding via different mechanisms. In his 
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2007 review of the role of the AcbSh in feeding Stratford suggests that no significant 
differences had been reported for the effects of either AMPA/kainate receptor 
antagonists, GABA receptor agonists or in manipulating endogenous GABA levels 
(Stratford, 2007). In the same year a paper was published that demonstrated that 
baclofen but not muscimol significantly increased the total amount of time animals 
spent feeding within a 60 minute period despite the observation that similar amounts of 
food were consumed (Lopes et al., 2007). Investigators in our laboratory found that 
intra-AcbSh baclofen did not increase intake of a palatable nutrient solution (Ward et 
al., 2000) as muscimol reportedly does (Basso and Kelley, 1999, Stratford and 
Wirtshafter, 2007) although it did change the bout structure of the liquid meal.  
 
While these two observations are hardly compelling alone it is important to remember 
that, as was highlighted in Chapters 4 and 5, the effects of intra-AcbSh baclofen on 
feeding have only been previously explored in terms of total intake. Baclofen had not 
been tested in any other kind of feeding related schedule. By applying some well 
established paradigms to explore AcbSh GABA mediated feeding I believe that two 
major differences have emerged 1) muscimol but not baclofen disrupts the normal 
progression of feeding by increasing intake at the expense of the rest of the behavioural 
repertoire and 2) baclofen increases unconditioned consummatory responses and 
complex appetitive instrumental responses both in anticipation of and during access to 
food. 
 
While one can only speculate what is going on in terms of inter-Acb GABA receptor 
subtype mediated mechanisms locally that determine output signals from this region it 
is highly likely that the different classes of behaviour recorded (consummatory vs. 
instrumental) are subserved by different neuronal macrocircuits. In Chapter 5, I 
hypothesised that there were indeed different mechanisms mediated by different 
receptor subtype and that, whether we know what they are or not, we can look for 
different patterns of activation within brain circuitry involved in motivational processes 
and the control over ingestive behaviours. 
 
Although anatomical investigations have indicated a variety of downstream components 
of circuits that could be modulated by activity in the Acb (discussed in Chapter 1) such 
data does not indicate a functional circuit that subserves any particular class of 
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behaviour.  Functional circuits can be identified with some confidence by comparing 
data on the ability of the Acb to exert physiological changes, modulate gene expression, 
influence electrophysiological responses and effect glucose utilisation in each 
anatomically connected region during a particular behaviour. A functional link can then 
be further tested by directly manipulating neural activity in apparent downstream sites 
during Acb manipulations and monitoring the consequences. One way to identify areas 
of the brain that constitute functional components of the circuits that subserve the 
behavioural effects of AcbSh manipulations is to look for increases in neuronal activity. 
 
The most widely used method to specifically visualise neuronal activation is the 
induction of cellular immediate–early genes (IEGs) such as c-fos, which are rapidly 
activated by a variety of stimuli and can be labelled with single cell resolution (e.g. see 
Sheng and Greenberg, 1990, Hoffman et al., 1993). In the 1980s it was demonstrated 
that the transduction cascades set in motion by excitatory neurotransmission resulted in 
the induction of many IEGs including c-fos (Greenberg et al., 1986, Sheng and 
Greenberg, 1990, Morgan and Curran, 1986). 
 
Gene expression following transduction cascades in neurons is mediated by 
neurotransmitters, electrical membrane activity and neurotrophic growth factors (Sheng 
and Greenberg, 1990, Hoffman and Lyo, 2002). Furthermore subsets of the 100s of 
IEGs identified to date are uniquely activated by only one of these pathways (e.g. 
Dijkmans et al., 2009, Liu et al., 2003). Nevertheless it was demonstrated early on that 
c-fos transcription occurs regardless of the specific route by which a critical influx of 
Ca2+ is triggered (Morgan and Curran, 1986, Greenberg et al., 1986, Sheng et al., 1988) 
and hence it has come to be viewed as a marker of general neuronal activity following 
acute stimulation. The low constitutive levels of c-fos observed would suggest that it is 
not a marker of activity per se (e.g. Melzer and Steiner, 1997, Cirelli and Tononi, 
2000). 
 
The IEG c-fos encodes for the protein c-Fos or Fos (Morgan and Curran, 1986). The 
Fos protein can be localised using simple chromagenic immunocytochemistry. The 
basic principle of this method is to bind a primary antibody that has specific affinity for 
the Fos protein and then attach a biotinylated secondary antibody to this that can be 
chromagenically labelled. In the method used in this chapter a standard peroxidase 
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avidin-biotin complex (ABC) bound to the biotin on the secondary antibody is used to 
pick up diaminobenzidine (DAB) stain. This process is illustrated in Fig. 6.1. DAB 
stained Fos protein is restricted to the nucleus of cells within the CNS (Morgan and 
Curran, 1991). 
 
Figure 6.1. Schematic illustration of the principal stages in the 
immunocytochemical method to visualise the protein Fos in neurons. A primary 
antibody bound to the antigen of interest reacts with a biotinylated secondary 
antibody. An avidin / biotinylated peroxidase complex (ABC) will bind to the 
biotin on the secondary antibody. When incubated with DAB the coloured 
insoluble product is deposited at sites in proximity to the enzymes (Modified from 
figures in Hoffman et al., 2008). 
 
 
The primary antibody for Fos also shows some affinity for other Fos related proteins 
(FRAs) (Herrera and Robertson, 1996) but the difference in the timing of induction of 
these (e.g. see Young et al., 1991, Morgan and Curran, 1989) minimises their 
contribution to marking of “active” neurons. However it is possible that basal levels of 
staining in ‘control’ conditions may include binding to the FRAs because they are 
expressed for longer periods than Fos (i.e. could have been previously activated) and 
may accumulate long-term (Pennypacker et al., 1995). Thus the use of the Fos protein 
as a quantifiable marker of c-fos expression can be complicated by the potential dual 
labelling of both Fos and FRAs activated prior to the specific stimulation of interest or 
related to the behavioural history of the subject. Because of this, neurons with labelled 
nuclei are sometimes described as exhibiting Fos-like immunoreactivity (FLI), a 
convention that will be adopted in describing the results in this chapter. 
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Because baseline levels of c-fos expression are low or even undetectable in quiescent 
cells (Sheng and Greenberg, 1990, Herdegen et al., 1995) inhibition of active brain 
regions is not easy to pick up. However some regions of the brain do show constitutive 
expression of c-fos (Chan et al., 1993) that could be repressed by inhibitory 
neurotransmission. Since the particular interest in this thesis lies in the short term acute 
effects of infusing GABA receptor subtype agonists into the Acb on initiating behaviour 
the use of an IEG such as c-fos as a marker is believed to be both appropriate and 
adequate for the purpose of highlighting areas of the brain that are activated. FLI has 
already been demonstrated to be a useful tool in confirming the general patterns of 
activation within the feeding motivation circuits modulated by the Acb and by specific 
neurotransmitter activation therein. 
 
Activation in a number of regions of the brain has been reported following both bilateral 
and unilateral infusions of muscimol into the AcbSh. Stratford (2005) argues however 
that following bilateral infusions it is not possible to be sure that activation occurs as a 
result primarily of changes in AcbSh output rather than, for example, as a consequence 
of secondary systemic effects. Following unilateral infusions unilateral, lateralised 
activation is a good indicator that there is a direct effect of the AcbSh manipulation on 
activity in the region in question. Table 6.1, summarises the regions of the brain that are 
reportedly activated  by intra-AcbSh muscimol infusions. 
 
It must be noted that, with the exception of Yoshida et al. (1997) and Stratford (2005), 
other authors have focused primarily on activation in various nuclei of the 
hypothalamus and have not systematically identified other regions of the brain activated 
by intra-AcbSh muscimol infusion. In addition only Stratford (2005) has undertaken 
quantitative assessment and statistical analysis of the significance of increases in FLI in 
a number of brain regions. For the majority of regions listed in Table 6.1, it has merely 
been observed that FLI appears to be greater than in control conditions.   In general the 
pattern of activity in various nuclei throughout the brain corresponds to the primary 
targets of AcbSh efferents discussed in Chapter 1 including the VP, LH, VTA and SN. 
Of the regions listed both Yoshida et al. (1997) and Stratford (2005) report primarily 
ipsilateral induction of activity only in the VP, LH, VTA and SNc. 
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In the experiments reported in this chapter therefore it was concluded that FLI in the 
VP, LH, VTA and SNc should be counted following unilateral infusions of baclofen or 
muscimol. Given that the LH extends quite a distance rostrocaudally, Stratford and 
Kelley (1999), Zheng et al., (2003), Baldo et al., (2004) and Stratford (2005) all 
investigated the amount of FLI at a number of different levels throughout the region. 
FLI in the LH was therefore counted at the four levels defined by Stratford (2005). This 
meant that it was not possible to process enough sections at the same time to include 
sections through the level of the SN defined by Stratford (2005) as being the point at 
which FLI counts were highest so this area was not analysed. 
 
Given the evidence presented in Table 6.1, counts were also made in the Arc, which 
contains numerous feeding related peptides, and in the PVN which is also critically 
involved in the control of ingestion (for a review of the role of these regions in feeding 
(see e.g. Nauta, 1961, Williams et al., 2000, Gao and Horvath, 2007, Williams et al., 
2001). Finally it was hypothesised in Chapters 4 and 5 that the effects of baclofen of 
instrumental responding could relate to changes in incentive motivation e.g. via the 
saliency of the reward or reward related cues. Given that the amygdala is critically 
involved in incentive processing (e.g. for a review see Balleine and Killcross, 2006), the 
Acb indirectly innervates both the CeA and the BLA (See Chapter 1, page 33) and the 
CeA at least was activated following muscimol infusion (Stratford, 2005) FLI was also 
counted in these two nuclei of the amygdala complex.  
 
To summarise, evidence presented in Chapters 3, 4 and 5 suggests that there could be 
differences in the mechanisms by which activation of GABAB and GABAA receptors in 
the AcbSh modulate ingestion and food motivated behaviours. Different mechanisms 
and consequent patterns of behavioural expression could be subserved by different 
functional macrocircuits of which the AcbSh is a critical node. One way to identify 
functional links in such circuits is to identify which areas of the brain are activated 
following infusions of baclofen or muscimol into the AcbSh using c-fos expression as a 
marker of neuronal activity. Unilateral infusions make it possible to identify direct 
uncrossed functional links between the AcbSh and regions of the brain activated 
ipsilaterally. On the basis of evidence from previous studies using muscimol, increases 
in the amount of FLI will be used as an index of c-fos expression to identify activation 
in the VP, four levels of the LH, the Arc, the PVN, the VTA and in the CeA and BLA. 
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Experiments presented in this chapter 
Experiment 6.1 
The effects of unilateral intra-Acb infusions of baclofen on regional c-fos expression. 
 
Experiment 6.2 
The effects of unilateral intra-Acb infusions of muscimol on regional c-fos expression. 
 
Materials and methods 
Animals 
Prior to looking at the effects of intra-Acb GABA receptor subtype agonists on Fos 
induction all subjects had been tested to establish behavioural profiles of these 
pharmacological manipulations. The animals used for the baclofen study, experiment 
6.1, came from experiment 4.3 following testing on the second order operant schedule 
and for free intake (n=5). Animals used for the muscimol study, experiment 6.2, came 
from experiment 5.2 following testing on the second order operant schedule and for free 
intake (n=5). Animals were given a minimum of 7 days post testing with no exposure to 
either the operant boxes or the intake test environment. They were still maintained on a 
restricted feeding schedule and fed at the same time of day as before. Fos induction took 
place during the light cycle across the same period as previous tests had been carried 
out i.e. between 12.00 and 16.00hrs. 
  
Procedure for Fos induction – central drug administration 
Transcription of c-fos is rapid and transient starting within 5 minutes and continuing for 
only 15 to 20 minutes while peak levels of accumulated mRNA occur at 30 – 45 
minutes following stimulation (Morgan and Curran, 1991). The protein encoded by c-
fos, called c-Fos or Fos, starts to appear 30 - 45 minutes post-stimulation and reaches a 
peak at about 2 hours but the gene is rapidly deactivated (Morgan and Curran, 1986) 
and the protein broken down, returning to basal levels within 4 hours (Zangenehpour 
and Chaudhuri, 2002). This time course determined the timing of the experiments 
carried out to induce Fos.  
 
On the day before testing soiled bedding and sawdust was replaced following feeding to 
ensure that there was no food hoarded in the home cage. Animals were randomly 
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allocated to receive unilateral infusions of the appropriate GABA agonist into the right 
or left cannulae. An identical infusion was made into the second cannulae using vehicle. 
The unilaterally infused animals were used as their own control on the basis of the 
arguments put forward by Stratford (2005, 2007) discussed briefly above and explained 
in more detail on the discussion at the end of the chapter. In both experiments 6.1 and 
6.2 animals were given this final infusion following exactly the same procedures 
described for testing in Chapters 3, 4 and 5. Immediately post infusion animals were 
replaced in the home cage where they had no access to food. 
 
In experiment 6.1 and 6.2 molar equivalent doses of baclofen and muscimol were used. 
The dose of baclofen that had previously been demonstrated to significantly and most 
effectively potentiate instrumental responding whilst also causing an increase in chow 
intake was chosen i.e. 220ρmols. The molar equivalent dose of muscimol that had also 
been previously demonstrated to significantly increase chow intake (but that had no 
effect on operant responding) was used (See Chapter 5). Infusions were temporally 
staggered to allow time for perfusions. A 90 minute period was allowed for Fos 
induction and after this period animals were heavily and terminally sedated using 
pentobarbital. They were then transcardially perfused using filtered phosphate buffered 
saline (PBS) followed by paraformaldehyde (PFA). Brains were further fixed for 24 
hours in PFA and cryoprotected in 30% phosphate buffered sucrose (>48 hours) before 
being stored at -80oC as described in Chapter 2, page 67. 
 
Tissue preparation for cFos immunocytochemistry 
The accuracy of the placements was checked histologically prior to putting sections 
through the immunohistochemical procedure. First of all brains were brought up to  -
20oC on a freezing microtome and 60µm coronal sections were taken through the 
cannulae tracks and any gliosis that extended rostrocaudally. These sections were 
mounted for anatomy whilst the brains were returned to storage at -80oC. Once the final 
group for the behavioural analysis for Chapters 4 and 5 had been decided on the basis of 
the histology a subset of animals were chosen for cFos regional mapping. This group 
was chosen on the basis of how close the infusion sites were to the target co-ordinates 
and also on the basis that a minimal amount of visible gliosis was present. A total of 
n=5 animals from the baclofen group and n=5 animals from the muscimol group went 
on to the next stage. 
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These 10 brains were sectioned coronally at 40µm on a freezing microtome and the 
tissue floated in 0.9% physiological saline. Every 6th section from relevant areas of the 
brain (see below) were mounted on gelatinized slides and, following alcohol 
dehydration, run through a standard Nissl staining procedure using Thionin. These were 
later used to identify landmarks for structural identification of areas of Fos positive 
nuclei present on the remaining sections. The block of sections started from the point at 
which the anterior commissure crosses the midline of the brain at approximately β -
0.25mm.  The most caudal sections were cut at approximately β -5.8mm (see Fig. 6.2). 
 
 
 
Figure 6.2. Saggital section at 1.4mm from the midline of the brain (ML co-
ordinate at which infusions were made showing the extent of brains sectioned for 
mapping of regional cFos expression (From Paxinos and Watson, 1998).   
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Method for immunohistochemical staining  
The procedures used here are based on a protocol described by Elmquist et al., (1996) 
and adapted in this laboratory for use with free floating rat brain sections on the basis of 
a protocol currently used by one of our collaborators (Kalinichev et al., 2000). The 
resultant protocol does not differ significantly from that described on “Data Sheet 
PC38” provided by Merck Chemicals Ltd. (UK) with the primary antibody. The final 
protocol used had previously been demonstrated in this laboratory to produce low 
background staining but a high immunocytochemical signal in the nuclei of neurons in 
rat brain slices (unpublished data). In each run at least two brains worth of sections were 
processed and stained simultaneously. Thus each run included brains from experiment 
6.1 (baclofen) and 6.2 (muscimol). 
 
Following removal of sections for anatomy alternate sections from those remaining 
were transferred into Tris buffered PBS/0.3% Triton X-100 solution, pH 7.4 (immuno 
buffer). Sets of three sections in sequence were placed into 1ml of immuno buffer in 
individual wells of a 25 well disposable plastic Petri dish (Bibby Sterilin Ltd., UK). 
Three more sections were taken randomly from the beginning, middle and the end of 
the run and placed in the final well to be used as negative controls for non-specific 
binding. Unless otherwise stated all washing and incubation stages described below 
took place at room temperature on an orbital shaker. 
 
Sections were first washed in immuno buffer for 15 minutes. The immuno buffer was 
pipetted off and the tissue was then incubated for 30 minutes in 1% hydrogen peroxide 
to remove endogenous peroxidases. This was followed by two 10 minute washes in 
immuno buffer. Next, non-specific antibody binding was blocked by incubating the 
sections for 1 hour in 2% goat serum (Sigma, UK) diluted in immuno buffer. The brain 
sections were then incubated for approximately 48 hours at 4oC to 2mls per well of the 
primary (1o) antibody (a 1:20,000 dilution of Anti-c-Fos (Ab-5) Rabbit pAb in immuno 
buffer, Calbiochem supplied by Merck Chemicals Ltd., UK). The 1o antibody was 
omitted at this stage for the negative control sections in the last well. 
 
On removal from the fridge sections were brought up to room temperature and then 
taken through three 10 minute washes in immuno buffer to remove all traces of excess 
1o antibody. They were then incubated for 2 hours in 0.8ml per well of the secondary 
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(2o) antibody (a 1:20,000 dilution of biotinylated goat anti-rabbit IgG (H+L) in immuno 
buffer, Vector Laboratories, USA). During this incubation period a horseradish 
peroxidase avidin-biotin complex (ABC) reagent from an Elite standard peroxidase 
ABC kit (Vector Laboratories, USA) was made up using 12 drops each of reagents A 
and B diluted in 30mls of immuno buffer and left to stand for at least 30 minutes prior 
to use. 
 
Unbound 2o antibody was removed with three 10 minute washes in immuno buffer. A 
graduated pipette was used to add 0.6mls of ABC reagent to each well and sections 
were incubated for 2 hours. The sections were taken through a further three 10 minute 
washes using a Tris-0.84M HCl buffer (Tris-HCl), pH 7.4. For the final reaction 
diaminobenzidine (DAB; 0.035%) was made up using a DAB Kit for peroxidase 
(Vector Laboratories, USA) following the manufacturers instructions. The nickel-
ammonium sulphate solution was excluded thus giving a brown coloured product not 
black/grey. 0.6ml of the DAB solution was pipetted into each well and the sections 
incubated for 10 minutes. Care was taken to make sure all the sections were submerged 
and the speed of the shaker was turned up to ensure that sections were well exposed to 
the DAB. 
 
The reaction was terminated by washing the sections for 10 minutes with Tris-HCl 
buffer. Finally the sections were given a last wash in 0.9% physiological saline from 
which they were mounted on gelatinised slides. Slides were air dried and the sections 
fixed in formaldehyde vapour for 1 hour. Sections were cleared in Histoclear (R.A. 
Lamb, UK) then cover slipped with Histomount (R.A. Lamb, UK). Once the mounting 
agent had fully set, slides were cleaned and polished with IMS. 
 
Light microscopy and image analysis 
For the purposes of evaluating Fos localisation and to allow counting of fos positive 
nuclei, tissue sections were viewed with a Zeiss Akioskop 2 plus microscope and 
images of sections were captured using an AxioCam HRc digital camera (Carl Zeiss, 
UK) using AxioVision 3.1 software (Imaging Associates, Bicester, UK). Once the FLI 
stained sections had been matched up to the anatomy sections the relevant brain areas 
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were identified and marked up. Individual coronal sections representing target regions 
were matched between animals.  
 
Criteria used to identify and define brain areas to be analysed 
Areas of interest and their respective coordinates were predominantly chosen on the 
basis of the AP coordinates for representative sections used by Stratford (2005) from 
the Paxinos and Watson (1998) 4th edition rat brain atlas. In this case LH counts were 
made in sections through the brain at β - 1.6, β - 2.6, β - 3.6 and β - 4.3 (See Fig. 6.3). 
Counts for the PVN and Arc were made at β - 1.88 and β - 2.8 respectively (See Fig. 
6.3). Counts for the CeA were made in sections at β - 3.14 (See Fig. 6.3). 
 
Where co-ordinates for the area of interest had not been specified by Stratford (2005) 
for the VP, BLA and VTA these were chosen on the basis of the highest level of 
staining recorded within available sections through the relevant structure for each 
animal. These were matched within the same series of three sections for that region 
between animals. Only the region of the VP caudal to the point at which the anterior 
commissure transacted the midline could be analysed because more rostral sections 
were damaged by the guide cannulae or exhibited gliosis around the cannulae tract. 
Nevertheless clear areas of Fos immunoreactivity were distinguishable at approximately 
β - 0.26mm (See Fig. 6.3). 
 
In the case of the BLA the sections chosen were slightly posterior to those where counts 
were made for the CeA within - 0.16mm of the coordinates for the CeN i.e. at β - 
3.30mm (See Fig. 6.3). The sections used for counts of FLI in the VTA were partially 
dependent on how far back those sections that fitted into one run of the labelling 
procedure went. However consistent areas of increased FLI were seen at β - 5.30mm 
where an obvious region of VTA cells in located (See Fig. 6.3). 
 
For those areas of the brain that could be clearly delineated visually on the basis of 
anatomical markers, a template was created from the relevant Nissl stained slide that 
could be superimposed onto the Fos stained sections. One template was created for each 
brain area based on the shape and size of the structure in the rat that exhibited the most 
extensive Fos staining in that structure (See Fig. 6.3 for outlines). No nuclei were 
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missed in the brains with the highest levels of activation due to some falling outside the 
boundary of a template and all were encompassed within the template when levels were 
low. 
 
Where a specific structure could not be delineated clearly a rectangular template was 
created representing a sample within the area of interest. This was only used for the 
rostral most level of the LH and the boundaries and size of the rectangular template in 
this case were based on those defined by Baldo et al., (2004). Following the approach 
employed by (Baldo et al., 2004) the division between medial and lateral hypothalamus 
was based on the position of the fornix. Using ImageJ software the cross section of the 
fornix was measured at its widest point. A dorsoventrally orientated line was drawn 
bisecting the hypothalamus through the midpoint of the fornix and the rectangular 
template was placed using this line as its medial boundary (See Fig. 6.3). 
 
Method used for counting FLI positive cells 
Counting was automated using ImageJ 1.4 for Mac which is an open source, image 
processing and analysis Java programme developed by the Research Services Branch of 
the National Institute of Mental Health, a division of the National Institutes for Health 
(USA). Photomicrographs of areas of Fos induction were transferred into ImageJ in .tif 
format and converted from RGB colour to 8-bit greyscale.  A template for the relevant 
brain area was pasted onto the image and rotated to for the structure in question. The 
remainder of the image outside this template was cleared and the section to be counted 
saved as a new image. 
 
 
 
 
Figure 6.3. (Next page) Illustrations from Paxinos and Watson (1998) of brain 
sections at stereotaxic coordinates at which ten regions of the brain were located in 
which neurons expressing FLI were counted following intra-AcbSh GABA 
receptor agonist infusions. The red shading represents the approximate shape of 
the templates used to delineate each region for the purposes of counting labelled 
nuclei. Counts were made bilaterally both in the side that was infused with 
muscimol and the side infused with saline.  
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Appropriate functions in ImageJ were used to clear up background noise and, if 
necessary, to adjust the brightness and contrast to highlight those cells that would have 
been identified as labelled in a count by hand. Next the thresholds for the density of 
staining to be included as “labelled” were set. Initially thresholds were set by eye so that 
the software whilst minimising overlap highlighted the maximum number of fos 
positive cells. For each brain area to be counted an outline was drawn around the 
smallest cell and largest cells that appeared to be Fos positive and the area of these in 
pixels was recorded. 
 
A boundary for inclusion based on area in pixels was then calculated at each 
magnification to encompass the smallest and largest cells. A preliminary count was then 
made. The mean size of the cells counted was checked and compared to the previous 
measures for representative cells at that magnification. If this did not match to within 
0.0001 units the threshold was adjusted accordingly and the count re-run. Once the 
mean size of cells for each brain area for each animal were in agreement the final counts 
were made and the output transferred to excel. 
 
A subgroup of sections from each region of the brain was also counted by hand to check 
the accuracy of the automated counting. This confirmed that there was never any more 
than a 1% difference between automated counts and hand counts made by eye. This 
agreed well with an extensive pilot study carried out in this laboratory to verify the use 
of the ImageJ software to quantify fos positive nuclei at various magnifications. In this 
large-scale comparison it was found that the mean manual counts were within 1.5% of 
the automated counts (Horwood 2007, unpublished data). 
 
Data analysis 
Total mean numbers of nuclei exhibiting FLI were compared for each drug using a 
within subjects, repeated measures ANOVA with treatment (drug or saline) and brain 
area as factors. Where there was a significant interaction between treatment and area the 
ANOVA was then restricted to individual levels of the brain. A comparison was also 
made between drug treatments using a repeated measures, mixed design ANOVA using 
drug type, treatment (drug or saline) and brain area as factors. 
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Results 
 
Experiment 6.1: The effects of unilateral intra-Acb infusions of 
baclofen on regional c-fos expression. 
 
 
 
Figure 6.4. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β). Placements for n=5 of original 
n=8 animals from experiment 4.3, Chapter 4. Bilateral target coordinates were 
(AP), + 1.4mm, mediolateral (ML), ± 0.9mm relative to bregma and dorsoventral 
(DV), -7.8mm relative to skull surface. 
 
 
The location of infusions in the group of n=5 animals used are shown in Fig. 6.4. 
Unilateral infusions of 220pmols baclofen into the AcbSh of n=5 rats (of n=8 used in 
Experiment 4.3, Chapter 4) resulted in a significant main effect of drug [F(1,4)=433.72, 
p<0.001] on the mean number of FLI cells which was increased in the side ipsilateral to 
the infusion compared to the contralateral saline infused side across the areas 
investigated. There was also a main effect of area [F(9,36)=15.93, p>0/001] and an 
interaction between drug and area [F(9,36)=27.94, p<0.001]. 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
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Figure 6.5. The number of cells with FLI in the side of the brain infused with 
220pmols baclofen or in the side infused with saline in ten different regions (n=5). 
Error bars represent ±SEM. Significant differences from vehicle are denoted by ✭  
p<0.05 and ✭✭  p<0.01. 
 
When the analysis was restricted to individual areas of the brain this dose of baclofen 
significantly increased the mean number of FLI cells throughout the rostrocaudal extent 
of the LH investigated in the side ipsilateral to the drug infusion compared to the saline 
infused side (See Fig. 6.5). The mean FLI count was significantly increased in the first 
LH level [F(1,4)=233.62, p<0.001],  in the second LH level [F(1,4)=84.26, p<0.001], in 
the third LH level including the perifornical nucleus [F(1,4)=94.14, p<0.001] and in the 
most caudal fourth level of the LH [F(1,4)=43.92, p=0.003]. Representative sections are 
shown in Fig 6.6.  
 
The mean FLI count was also significantly increased in the side ipsilateral to the drug 
infusion compared to the saline infused side in the PVN [Fig. 6.5; F(1,4)=15.2, 
p=0.018], Arc [Fig. 6.5; F(1,4)=74.37, p<0.001], VP [Fig. 6.5; F(1,4)=17.74, p=0.014], 
VTA [Fig. 6.5; F(1,4)=10.59, p=0.031] and in the CeA but not the BLA [Fig. 6.5; 
F(1,4)=16.75, p=0.015].  Representative sections are shown in Figs 6.7, 6.8 and 6.9. 
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Figure 6.6. Photomicrograph of representative sections showing FLI in cells in 
four levels of LH in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols baclofen (right column). The fornix is marked 
with a cross and the areas to the right are classed as LH. In each case the image is 
shown with medial structures to the left and lateral to the right regardless of which 
side of the brain it came from. Pictures were taken at a magnification of 50x. 
Images have been resized and computer enhanced for the purposes of clarity . 
LH at β - 1.6mm 
LH at β - 4.3mm 
LH at β - 3.6mm 
LH at β - 2.6mm 
× 
× 
× × 
× 
× 
× 
× 
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Figure 6.7. Photomicrograph of representative sections showing FLI in cells in the 
PVN and Arc in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols baclofen (right column). In each case the 
image is shown with medial structures to the left and lateral to the right regardless 
of which side of the brain it came from. Pictures of both the PVN and Arc were 
taken at a magnification of 100x. Images have been resized and computer 
enhanced for the purposes of clarity . 
 
 
 
 
 
 
 
 
 
 
 
 
PVN at β - 1.88mm 
Arc at β - 2.8mm 
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Figure 6.8. Photomicrograph of representative sections showing FLI in cells in the 
VP and VTA in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols baclofen (right column). The outline of the 
area classed as the VP is shown which excludes the basal region of the substantia 
innominata medially and the magnocellular preoptic nucleus that crosses the VP 
ventrally. The VTA was classed as the region bounded medially by the fasciculus 
retroflexus (marked with a cross) and laterally by the mammillary peduncle/ 
medial terminal nucleus of the accessory optic tract (structures to the right of the 
line). The approximate area in which VTA counts were made is outlined.  In each 
case the image is shown with medial structures to the left and lateral to the right 
regardless of which side of the brain it came from. Pictures of the VP were taken 
at a magnification of 50x and of the VTA at 100x. Images have been resized and 
computer enhanced for the purposes of clarity . 
 
 
 
 
 
 
 
 
VTA at β - 5.30mm 
× × 
VP at β - 0.26mm 
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Figure 6.9. Photomicrograph of representative sections showing FLI in cells in two 
nuclei of the amygdala in the side of the brain infused with saline (left column) and 
the opposite side infused with 220pmols baclofen (right column). While the outline 
of the CeA is clearly visible the area that circumscribes the BLA is marked with a 
box. In each case the image is shown with medial structures to the left and lateral 
to the right regardless of which side of the brain it came from. Pictures of the CeA 
were taken at a magnification of 100x and of the BLA at 50x. Images have been 
resized and computer enhanced for the purposes of clarity . 
 
 
 
 
 
 
 
 
 
 
CeA at β - 3.14mm 
BLA at β - 3.30mm 
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Experiment 6.2: The effects of unilateral intra-Acb infusions of 
muscimol on regional c-fos expression. 
 
 
 
 
 
Figure 6.10. Injection sites plotted on drawings taken from Paxinos and Watson 
(1998); sections are anterior relative to bregma (β). Placements for n=5 of original 
n=8 animals from experiment 5.2, Chapter 5. Bilateral target coordinates were 
(AP), + 1.4mm, mediolateral (ML), ± 0.9mm relative to bregma and dorsoventral 
(DV), -7.8mm relative to skull surface. 
 
 
The location of infusions in the group of n=5 animals used are shown in Fig. 6.10. 
Unilateral infusions of 220pmols muscimol into the AcbSh of n=5 rats (of n=8 used in 
Experiment 5.2, Chapter 5) resulted in a significant main effect of drug [F(1,4)=99.18, 
p>0.001] on the mean number of FLI cells which was increased in the side ipsilateral to 
the infusion compared to the contralateral saline infused side across the areas 
investigated. There was also a main effect of area [F(9,36)=36.8, p>0.001] and an 
interaction between drug and area [F(9,36)=24.4, p>0.001]. 
 
β  +1.7mm 
β  +1.6mm 
β  +1.2mm 
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Figure 6.11. The number of cells with FLI in the side of the brain infused with 
220pmols muscimol or in the side infused with saline in ten different regions (n=5). 
Error bars represent ±SEM. Significant differences from vehicle are denoted by ✭  
p<0.05 and ✭✭  p<0.01. 
 
 
When the analysis was restricted to individual areas of the brain this dose of muscimol 
significantly increased the mean number of FLI cells throughout the rostrocaudal extent 
of the LH in the side ipsilateral to the drug infusion compared to the saline infused side 
(See Fig. 6.11). The mean FLI count was significantly increased in the first LH level 
[F(1,4)=43.94, p=0.003], in the second LH level [F(1,4)=47.67, p=0.002], in the third 
LH level including the perifornical nucleus [F(1,4)=34.19, p=0.004] and in the fourth 
level of the LH [F(1,4)=10.24, p=0.033]. Representative sections are shown in Fig 6.12.  
 
The mean FLI count was also significantly increased in the side ipsilateral to the drug 
infusion compared to the saline infused side in the PVN [Fig. 6.11; F(1,4)=30.14, 
p=0.005], VP [Fig 6.11.; [F(1,4)=53.78, p=0.002] and in the VTA [Fig. 6.11; 
[F(1,4)=17.3, p=0.014]. There was no significant difference between sides in the Arc, 
CeA or BLA. Representative sections are shown in Figs 6.13, 6.14 and 6.16. 
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Figure 6.12. Photomicrograph of representative sections showing FLI in cells in 
four levels of LH in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols muscimol (right column). The fornix is 
marked with a cross and the areas to the right are classed as LH. In each case the 
image is shown with medial structures to the left and lateral to the right regardless 
of which side of the brain it came from. Pictures were taken at a magnification of 
50x. Images have been resized and computer enhanced for the purposes of clarity . 
LH at β - 1.6mm 
LH at β - 4.3mm 
LH at β - 3.6mm 
LH at β - 2.6mm 
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Figure 6.13. Photomicrograph of representative sections showing FLI in cells in 
the PVN and Arc in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols muscimol (right column). In each case the 
image is shown with medial structures to the left and lateral to the right regardless 
of which side of the brain it came from. Pictures of both the PVN and Arc were 
taken at a magnification of 100x. Images have been resized and computer 
enhanced for the purposes of clarity . 
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Figure 6.14. Photomicrograph of representative sections showing FLI in cells in 
the VP and VTA in the side of the brain infused with saline (left column) and the 
opposite side infused with 220pmols muscimol (right column). The outline of the 
area classed as the VP is shown which excludes the basal region of the substantia 
innominata medially and the magnocellular preoptic nucleus that crosses the VP 
ventrally. The VTA was classed as the region bounded medially by the fasciculus 
retroflexus (marked with a cross) and laterally by the mammillary peduncle/ 
medial terminal nucleus of the accessory optic tract (structures to the right of the 
line).  In each case the image is shown with medial structures to the left and lateral 
to the right regardless of which side of the brain it came from. Pictures of the VP 
were taken at a magnification of 50x and of the VTA at 100x. Images have been 
resized and computer enhanced for the purposes of clarity . 
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Figure 6.15. Photomicrograph of representative sections showing FLI in cells in 
two nuclei of the amygdala in the side of the brain infused with saline (left column) 
and the opposite side infused with 220pmols baclofen (right column). While the 
outline of the CeA is clearly visible the area that circumscribes the BLA is marked 
with a box. In each case the image is shown with medial structures to the left and 
lateral to the right regardless of which side of the brain it came from. Pictures of 
the CeA were taken at a magnification of 100x and of the BLA at 50x. Images have 
been resized and computer enhanced for the purposes of clarity . 
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Figure 6.16. Comparison between the total number of cells with FLI in the side of 
the brain infused with 220pmols baclofen or muscimol or between the opposite 
sides infused with saline in ten different regions (n=10). Error bars represent 
±SEM. Significant differences from vehicle are denoted by ✭  p<0.05 and ✭✭  
p<0.01. 
 
 
Following infusion of muscimol or baclofen sections from both experiments were run 
through the staining procedure simultaneously to allow direct comparison of the number 
of labelled neurons. Comparing the effects of baclofen and muscimol on the total 
number of FLI cells in the various regions of the brain investigated (See Fig. 6.16). 
revealed that baclofen increased FLI counts significantly more than muscimol in the 
most caudal fourth level of the LH and in the CeA. There was no difference in the 
number of FLI cells in the contralateral saline infused sides in either case.  In contrast 
muscimol increased FLI in the Arc significantly more than baclofen did. Furthermore in 
the side of the Arc contralateral to the baclofen infusion the number of FLI cells was 
significantly lower than in the side contralateral to the muscimol infusion. 
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Discussion 
The experiments reported in this chapter were designed to investigate the induction of 
c-fos expression in brain structures associated with feeding and food motivated 
behaviours following unilateral AcbSh infusions of baclofen or muscimol. The presence 
of FLI in cells was indicated by chromagenicaly labelling the Fos protein using an 
immunocytochemical method. In both experiments 6.1 and 6.2 two groups of n=5 
animals previously demonstrated to respond to drug infusions into the AcbSh were 
used. In both experiments the number of FLI cells in ten regions of the brain was 
counted after counterbalanced unilateral infusions of a 220ρmols dose of drug on one 
side and saline into the contralateral side of the AcbSh. While I have referred to FLI in 
cells throughout the results I will assume from now on that this was most likely 
indicative specifically of Fos synthesis. 
 
Unilateral infusions of baclofen at a dose of 220ρmols significantly increased Fos 
synthesis ipsilaterally to the infusion relative to activity in the saline infused side 
throughout the rostrocaudal extent of the LH, in the Arc, PVN, VP, VTA, CeA but not 
in the BLA. In contrast muscimol increased ipsilateral Fos synthesis in all levels of the 
LH, PVN, VP, VTA but not in the Arc, CeA or BLA. When the level of activity was 
compared between areas of the brain ipsilateral to the infusions of baclofen or muscimol 
it was shown that baclofen increased Fos synthesis significantly more in the caudal 
region of the LH than muscimol did. In addition baclofen caused a significant ipsilateral 
increase in Fos synthesis in the CeA relative to the levels seen ipsilateral to the 
muscimol infusion.  
 
When levels of Fos in the Arc were compared animals that had received unilateral 
infusions of muscimol had higher levels of synthesis in the Arc both ipsilateral and 
contralateral to the drug infusions compared to ipsilateral and contralateral levels 
following baclofen infusions. Since increased Fos synthesis is most likely a marker of 
increased neuronal activation (Sheng and Greenberg, 1990) it is concluded that neurons 
in the regions with significantly increased Fos synthesis probably increase their firing 
rate following infusion of GABA agonists into the AcbSh. 
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In the remainder of this discussion I will first deal with some potential methodological 
issues that could contribute to the explanation of the results reported in experiments 6.1 
and 6.2. These issues include: 
1) The possible effects of prior history of drug infusions into the AcbSh 
2) Induction of Fos synthesis in regions close to the infusion site. 
3) The implications of assessing neuronal activity following unilateral 
compared to bilateral infusions of drug. 
4) What does unilateral activation in regions of the brain mean and what can be 
concluded when animals are used as their own controls? 
It is most likely that the regions of the brain activated by infusions of baclofen or 
muscimol into the AcbSh form functional macrocircuits but to understand how these 
might be arranged it is useful to first consider both the anatomical and functional 
evidence for the role of each region in feeding and food motivated behaviour. The 
second part of the discussion will therefore consider each area investigated separately 
before an attempt is made to build up a picture of the functional associations between 
regions investigated. 
 
The pattern of neuronal activation in these experiments was purely a consequence of 
activation of GABA receptor subtypes in the AcbSh and does not indicate what patterns 
of activity might be seen in animals given the consequent opportunity to express 
behaviour in response to food or food related cues. The pattern of activation with 
baclofen and muscimol will be compared with evidence in the literature for the pattern 
of activation associated with hunger and with feeding. 
 
1) Effects of prior history of drug infusions into the AcbSh 
Fos protein synthesis was measured as FLI in cells following a number of prior 
infusions of baclofen or muscimol. Stratford (2005) suggests that it is possible that the 
results could be complicated by “expectation or conditioning effects”. Because the 
specific behavioural effects of GABA agonist infusions appear to vary across quite 
minor shifts along a rostrocaudal gradient it was believed to be important to investigate 
c-fos expression following infusions that are known to be behaviourally active in the 
individuals used. It was therefore deemed more important to use animals that had been 
behaviourally tested than to use naïve animals to avoid possible experience related 
complications. 
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Very similar patterns of neuronal activation have been reported in the brains of both 
drug naïve animals (Stratford, 2005) and those that had previously experienced the 
opportunity to feed following intra-AcbSh muscimol infusions prior to the final infusion 
when food was unavailable (Stratford and Kelley, 1999). It would appear therefore that 
expectation at least may not be important although this could depend on the amount of 
experience the animals have of drug followed by food. From the data presented in 
Chapters 4 and 5 there was no significant difference in the amount of freely available 
chow consumed following the first infusion of 660ρmols baclofen or muscimol in naïve 
animals and the infusion given at the end of the study with the 660ρmols. Although this 
does not exclude more subtle effects on learnt associations it certainly indicates that the 
animals were no more or less sensitive to the feeding inducing effect of the drug at the 
end of the experiment. 
 
It is also potentially relevant that animals that were used for experiment 6.1 had a 
different profile of prior experience to those used in experiment 6.2 which could 
complicate the interpretation of direct comparisons between the groups. In experiment 
4.3 using baclofen the animals went through a free feeding test with a dose of 
660ρmols, the 2nd order test following infusions of vehicle, 220 or 660ρmols and a free 
feeding test with vehicle, 220 and 660ρmols. In experiment 5.2 with muscimol animals 
went through a free feeding test with a dose of 660ρmols, the 2nd order test following 
infusions of vehicle, 220, 440 or 660ρmols and a free feeding test with vehicle, 220, 
440 and 660ρmols. Thus the muscimol group experienced more infusions and more 
doses. However the doses were counterbalanced so it would be unlikely that the animals 
had been conditioned to have any particular expectation of effect following a specific 
drug dose and the extra dose given to the muscimol group would not change this 
argument. As mentioned above multiple infusions did not appear to have any effect on 
the efficacy of the drug pre and post 2nd order testing.  
 
2) Induction of Fos synthesis in regions close to the infusion site 
Stratford and Kelley (1999) suggest that infusions in the brain can cause Fos synthesis 
in the neurons surrounding the injection site and it is possible that activation of neurons 
within the VP occurred because of its close proximity to the cannulae tract. However in 
the experiments reported here Fos counts in the VP were deliberately taken in sections 
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that were caudal to both the cannulae tracts and associated areas of gliosis identified in 
the Nissl stained anatomy sections. It is suggested therefore that it is highly unlikely 
that any significant increase in Fos synthesis would be due to the process of infusion 
itself. None of the other brain regions investigated were close enough to the infusion 
site for this to be an issue. 
 
3) Assessing Fos synthesis following unilateral or bilateral infusion of drugs 
Activation in brain regions following unilateral infusions rather than bilateral infusions 
of muscimol has only been reported in one study (Stratford, 2005). Stratford (2005, 
2007) suggests that, when infusions are made bilaterally, it is not possible to be sure 
that the downstream effect is unique to a direct projection or due to indirect pathways or 
even secondary stimulus bound changes. In contrast a unilateral infusion that causes 
unilateral activation is better representative of direct functional as well as temporal links 
in activity. Lateralised Fos induction strongly suggests that the region in question is 
“part of an uninterrupted neural circuit involving the AcbSh” (Stratford, 2005). 
 
Stratford (2005) points out that projections from the AcbSh are almost exclusively 
ipsilateral and he suggests that bilateral activation is more likely to occur as a result of 
secondary systemic changes following AcbSh GABA agonist infusion. He does 
acknowledge however that activation of regions that are a number of synapses removed 
from the AcbSh could themselves give rise to bilateral projections to areas that are 
bilaterally activated. 
 
4) What does increased activity following unilateral infusions mean? 
Stratford (2005) suggests that there are three possible patterns of activity that can be 
recorded following unilateral infusions of a drug. First of all this can result in exclusive 
activation in regions of the brain ipsilateral to the infusion. To be sure that activation is 
exclusively ipsilateral the level of activity in the saline injected side would need to be 
the same as in that recorded if no drug was injected in either side. The experiments 
reported in this chapter did not include a saline only control group thus it is not possible 
to be sure that the level of activation ipsilateral to the saline infusion is the equivalent of 
basal levels. It is not possible therefore to be sure that any of the increases seen 
ipsilateral to the drug infusion in these experiments are exclusively ipsilateral. 
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However where such an effect has previously been reported following muscimol 
infusions it might be possible to infer a similar conclusion if the numbers are very 
similar, particularly if the region in question usually exhibits low constitutive levels of 
Fos expression. Stratford (2005) concludes that the only region of the brain in which 
activation was exclusively ipsilateral to the drug infusion was the LH. The counts from 
experiment 6.2 are compared with the counts reported by Stratford (2005) following 
either unilateral saline and drug infusion or unilateral saline infusion alone in Table 6.2. 
It is interesting to note that there appears to be an effect of dose because, although the 
pattern of activation in experiment 6.2 is very similar to that reported by Stratford 
(2005) the counts are all much lower. 
 
 
Table 6.2. Comparison of number of neurons expressing Fos like immunoreactivity 
(FLI) following unilateral infusions of muscimol and saline (n=9) and unilateral 
infusions of saline only (n=6) in experiments reported by Stratford (2005) with 
numbers following unilateral infusions of muscimol and saline (n=5) in 
Experiment 6.2. The values given are mean counts of cells expressing FLI ± SEM. 
 
Stratford (2005) reported that there was no significant difference between counts of 
cells expressing FLI between the saline infused side in animals that received muscimol 
or no infusion contralaterally. It is clear from Table 6.2 that counts of cells expressing 
FLI in the side of the brain infused with saline in Experiment 6.2 are well within the 
range reported by Stratford (2005) and hence it is highly unlikely that there was any 
effect of muscimol on contralateral cells counts in the LH. It is fairly safe therefore to 
conclude that unilateral muscimol infused into the AcbSh in Experiment 6.2 caused 
exclusively ipsilateral activation of LH neurons. Furthermore, because there was no 
significant difference between levels of Fos synthesis in the LH in saline infused sides 
of the brain in Experiments 6.1 (baclofen) and 6.2 (muscimol) it can also be concluded 
Stratford (2005) 
saline and 880pmols 
muscimol 
Stratford (2005) 
unilateral saline only 
Experiment 6.2 
saline and 220pmols 
muscimol 
 
drug saline nothing saline drug saline 
LH1  857 ± 52.4 170 ± 35.2 151 ± 25.5 148 ± 19.3 521 ± 66.5 135 ± 20.6 
LH2 775 ± 64.0 157 ± 38.5   62 ± 19.7   88 ± 17.6 269 ± 13.4 122 ± 10.5 
LH3 707 ± 41.0 113 ± 28.5   58 ± 12.4   73 ± 10.8 227 ± 29.8 101 ± 10.5 
LH4 445 ± 22.1 114 ± 27.6   66 ± 16.0   85 ± 13.2 184 ± 17.4 118 ± 11.3 
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that intra-AcbSh baclofen induced exclusively ipsilateral activation of the LH. 
Exclusively ipsilateral activation of brain regions following manipulations of AcbSh 
output are highly likely to indicate an uncrossed lateralised pathway connecting regions.   
 
The second pattern of activity that can be measured following unilateral infusions of 
drug is “primarily ipsilateral” activity (Stratford, 2005). Stratford (2005) reported that 
for all regions other than the LH there was some degree of activation in the side 
contralateral to the drug infusion. Primarily ipsilateral activation can be identified when 
there is a significant difference between activity ipsilateral and contralateral to the drug 
infusion but the level of activity in the saline infused side is also significantly elevated 
above basal levels in unilateral saline control animals. Without having this latter control 
group it is not possible to measure effects of drug in the contralateral side but it is 
possible to conclude that any significant ipsilateral induction of activity in areas other 
than the LH is at least primarily ipsilateral if the two sides are different. Small increases 
contralateral to drug infusion could be due to a small number of crossed efferents from 
the AcbSh within monosynaptic pathways or, more likely, bilateral efferents from 
intervening brain regions several synapses removed from the AcbSh. 
 
The final pattern of activity is bilateral activation following unilateral drug infusion.  
Without a unilateral saline control group it is not possible to say whether, when levels 
of Fos synthesis in regions of the brain are the same ipsilateral and contralateral to the 
drug infusion, they are not activated or both equally increased above basal levels. For 
example there was no significant difference between levels of activity in the two sides 
of the Arc following muscimol infusion but activity in both sides was higher than 
following baclofen infusions so the Arc could be bilaterally activated with muscimol. 
As explained above bilateral activation could occur either via secondary systemic 
changes or via a polysynaptic and potentially crossed pathway. Either way however 
such activation cannot be directly attributed to an interaction between the AcbSh and 
the region in question.  
 
With respect to the findings reported in this chapter therefore it can be concluded that a) 
both baclofen and muscimol probably caused increases exclusively ipsilateral to the 
drug infusion in the LH, b) that other areas that appeared to be activated ipsilaterally i.e. 
the Arc, PVN, VP, VTA and CeA with baclofen and the PVN, VP and VTA with 
300 
muscimol may also have been characterised by a small amount of activation 
contralateral to the infusion and c) a lack of divergence between activity in the two 
sides of a brain region could theoretically reflect bilateral activation but this would not 
be due to a direct input from the AcbSh. 
 
Increased neuronal activity in hypothalamic nuclei 
Lateral hypothalamus 
These studies demonstrate that both intra-AcbSh infusions of baclofen and muscimol 
increase Fos synthesis in neurons throughout the rostrocaudal extent of the LH. It has 
been reported by a number of different authors that bilateral and unilateral intra-AcbSh 
infusions of muscimol increases c-fos expression in the LH (Stratford and Kelley, 
1997a, Yoshida et al., 1997, Zheng et al., 2003, Stratford and Kelley, 1999, Stratford, 
2005, Baldo et al., 2004). The effect of baclofen has not been previously investigated.  
 
Bilateral muscimol infusions reportedly increase Fos synthesis predominantly in the 
rostral LH (Stratford and Kelley, 1997a). The densest patches of Fos synthesis 
following both bilateral and unilateral muscimol infusions were seen in the proximity of 
the perifornical area of the LH (Stratford and Kelley, 1999, Stratford, 2005). A role of 
the LH in feeding is well established (see discussion in Chapter 1, Introduction). Both 
electrical or chemical excitation of neurons in the LH induce voracious feeding in 
satiated animals (e.g. Stanley et al., 1993, Miller, 1963, Valenstein and Campbell, 
1966). Increases in firing of cells in the LH in response to food and feeding has also 
been reported (e.g. Anand et al., 1964, Rolls et al., 1976). While activation of various 
nuclei in the hypothalamus is clearly an important part of the mechanism via which the 
AcbSh regulates feeding, particularly because the AcbSh is the only striatal region that 
projects to the LH, hypothalamic mechanisms are predominantly associated with 
homeostatic control of ingestion (Schwartz et al., 2000) which would not explain 
increases in appetitive responding following baclofen infusions. 
 
It was hypothesised by Stratford and Kelley (1999) that blocking GABA receptors in 
the region of the perifornical in the LH would mimic the effects of inhibiting firing of 
GABAergic projection neurons from the AcbSh however GABA receptor antagonist 
infusions into the LH did not significantly increase feeding (Stratford and Kelley, 
1997a, Stratford and Kelley, 1999). Injection of an NMDA antagonist that has 
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previously been shown to attenuate deprivation induced feeding (Stanley et al., 1996) 
also blocked AcbSh muscimol induced feeding suggesting that activity within the LH in 
mediated by glutamatergic connections (Stratford and Kelley, 1997a, Stratford and 
Kelley, 1999).  
 
As Stratford and Kelley (1999) point out it is not possible to ascertain from increases in 
Fos synthesis whether the AcbSh influences neurons in the LH directly through 
monosynaptic connections or via a polysynaptic pathway. A polysynaptic pathway 
could involve one or more additional brain regions between the AcbSh and LH or 
indeed could be controlled by intervening interneurons between the primary efferents of 
the AcbSh and the primary output neurons of the LH. The VP is anatomically 
interposed between the AcbSh and the LH and it has been suggested that the AcbSh 
activates the LH indirectly via a polysynaptic pathway involving this region (see 
below). 
 
However it has since been demonstrated that AcbSh GABAergic projections probably 
do not form synapses with primary feeding related neurons in the LH (Sano and Yokoi, 
2007). These authors showed that GABAergic Acb efferents terminate in a dense patch 
in the LH anterior to the region in which MCH and orexin containing neurons were 
detected (Sano and Yokoi, 2007). They also showed that there were predominantly 
glutamatergic interneurons in the same region where the MSNs terminated and 
suggested that MSNs synapse onto these glutamatergic interneuron, which in turn 
projected to more caudal regions of the LH where MCH and orexin containing neurons 
were found. 
 
Thus Acb projection neurons probably do not directly convey signals to the primary LH 
neurons but instead signals are relayed via excitatory interneurons that stimulate 
neurons in more posterior regions when disinhibited by inhibiting GABA afferents 
(Sano and Yokoi, 2007). This model is consistent with the reports mentioned above that 
show that both deprivation induced and intra-AcbSh muscimol induced feeding is 
attenuated by glutamate rather than GABA antagonists in the LH. Sano and Yokoi 
(2007) also suggest that it could be the MCH neurons in the more posterior levels of the 
LH that are activated and that these in turn send inhibitory projections to the AcbSh that 
further increase activity in the LH.  
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Zheng et al (2003) showed that the percentage of Fos synthesis in orexin neurons in the 
perifornical area of the LH was significantly increased by AcbSh muscimol infusions 
and that there was a net increase in Fos synthesis across the LH. However these authors 
reported that there was no Fos synthesis at all in MCH neurons in the LH. The increase 
in activity specifically in orexin but not MCH neurons has been confirmed elsewhere 
although numerous unidentified neuronal subtypes in the LH were also activated (Baldo 
et al., 2004). It is also important to remember that these counts were all made in the 
absence of access to food and it is not known if this population of MCH neurons would 
be activated during muscimol or baclofen induced feeding. 
 
Baldo and Kelley (2004) suggested that while mild hyperphagia is induced by central 
administration of orexins (e.g. Sakurai et al., 1998, Rodgers et al., 2000) these peptides 
also affect waking and arousal and cause increases in activity in many brain regions that 
could account for the levels seen during feeding (Espana et al., 2001, Espana et al., 
2002).  In addition a wide range of pharmacologically arousing manipulations and 
stressors also activate these neurons so it is difficult to interpret the functional 
significance of activation in orexin neurons following intra-AcbSh muscimol infusions 
(Baldo et al., 2004). 
 
It has been hypothesised that hypothalamic orexin neurons “may be an important 
cellular and molecular link in the integration of sleep and energy homeostasis” (Willie 
et al., 2001). They are anatomically interposed between the AcbSh and feeding related 
neurons in the Arc VMH and neurons of the PVN (Date et al., 1999, Trivedi et al., 
1998, Marcus et al., 2001). Baldo and Kelley (2004) pointed out that arousal effects 
associated with a novel stimuli appeared to be mediated by a medial population of 
orexin neurons in the LH whilst intra-AcbSh muscimol increased activity preferentially 
in a lateral population suggesting that different subpopulations of orexin neurons could 
be differentially involved in mediating arousal versus food motivation. 
 
Activation of LH orexin neurons has since been shown to increase preference for cues 
associated with reward and this activation also reinstates reward seeking post extinction 
(Harris et al., 2005). It has been shown recently that inactivation of neurons in the LH 
prevents context induced reinstatement of food seeking and that neurons in the ventral 
AcbSh that project to the LH were activated during reinstatement (Marchant et al., 
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2009). Furthermore is has been suggested that LH orexin containing neurons constitute 
a key input to the VTA for the modulation of behaviour elicited by reward associated 
stimuli (Aston-Jones et al., 2009).  
 
Both muscimol and baclofen increased Fos synthesis throughout the LH but baclofen 
caused a greater increase in the most caudal region investigated than muscimol did. If 
indeed the Acb MSN terminal region within the LH falls within a small, anterior portion 
of the LH then it is difficult to imagine how the indirect activation of posterior LH 
neurons via glutamatergic interneurons could differ along a rostrocaudal gradient. 
However it is possible that specific groups of MSNs could terminate within distinct 
clusters of interneurons responsible for activating different regions of the LH to 
determine distinct behavioural outputs. Whether or not such a mechanism has any 
functional implication depends on whether there are rostrocaudal gradients in the types 
of neurons found throughout the LH and/or in the topographical organisation of 
projections to other brain regions from the LH. 
 
Because of the complexity of distinguishing between LH neurons and neurons of the 
MFB that are interspersed between them it is very difficult to define specific regions 
within this area of the hypothalamus on either cytoarchitectural or neurochemical 
grounds. However the LH can be broadly divided into anterior, tuberal and mammillary 
levels (Simerly, 2004). At this major level of division there are unique connections with 
other brain regions from each region (Saper et al., 1979). Within the LH neurons 
expressing MCH mRNA extend from β -1.1 to the most caudally detectable cells at β -
4.1 (in the tuberal and mammillary LH) whereas orexin mRNA expressing cells are 
only found between β -1.4 to β -3.8 (tuberal LH) (Broberger et al., 1998). Both cell 
populations form clusters in the perifornical area but at different rostrocaudal levels 
within the LH (Broberger et al., 1998). 
 
Both orexin and MCH positive neurons originating in the LH project widely to most 
regions in the brain (Bittencourt et al., 1992, Peyron et al., 1998). Orexin neurons 
innervate all of the regions that were activated by intra-AcbSh baclofen/muscimol 
infusions but send particularly dense projections to the Arc, slightly less dense 
projections to the PVN, VP, VTA and CeA but avoid many of the nuclei in the 
brainstem involved in motor functions (Peyron et al., 1998). MCH neurons send 
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projections of similar densities to the same regions including the Arc, PVN, substantia 
innominata (that contains the VP), VTA, CeA but also to the BLA and similarly avoid 
nuclei in the brainstem involved in motor functions (Bittencourt et al., 1992). Both 
types of LH neurons do however innervate brainstem structures that influence motor 
behavioural output (Peyron et al., 1998, Bittencourt et al., 1992). 
 
It would seem that robust activation with baclofen of neurons in the caudal limit of the 
LH at β -4.3 could specifically recruit neurons that do not express MCH or orexin and 
muscimol recruits a smaller number of this caudal population of neurons than baclofen. 
However given the proximity of the sections to the most caudal location of MCH 
neurons it is also possible that baclofen but not muscimol stimulates activity in MCH 
neuronal populations of LH. It is clearly important therefore to determine both the 
neurochemical profile and terminal fields of neurons activated by baclofen in this 
posterior region of the LH. 
 
It is certainly conceivable that differential patterns of activation in the LH with baclofen 
and muscimol could mediate different effects on feeding related behaviour via 
connections from this region to other hypothalamic nuclei or beyond. It is also possible 
that baclofen activates different populations of neuronal subtypes that might result in 
different patterns of activation in other regions of the brain. Depending on the profile of 
orexin, MCH and other neuronal subtypes activated by baclofen and muscimol these 
manipulations could act via indirect release of motor pattern generators as hypothesised 
by Kelley et al. (2005b) but equally could mediate control of conditioned responding 
that is dependent on intact LH function and orexin neuron activity. 
 
Arcuate nucleus 
In the experiments reported in this chapter there was no significant difference between 
the amount of Fos synthesis in the drug or saline injected side following intra-AcbSh 
muscimol infusions. However there was a significant increase in the Arc ipsilateral to 
baclofen infusions. When levels of activity were compared between drug treatments it 
emerged that, on the side contralateral to the drug infusion, there was a significantly 
higher level of Fos synthesis with muscimol than with baclofen. The level of activation 
was also higher in the side ipsilateral to muscimol infusion than in the side ipsilateral to 
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baclofen. This could be interpreted as a bilateral increase in activity with muscimol and 
a smaller, unilateral increase with baclofen. 
 
Significant bilateral increases in Fos synthesis in the Arc have been reported following 
bilateral intra-AcbSh muscimol infusions (Baldo et al., 2004). Stratford (2005) reported 
that there appeared to be primarily ipsilateral Fos synthesis in the Arc following 
unilateral muscimol infusions but the effect was less robust than in other regions and no 
statistical verification of this observation was undertaken. There are no direct 
connections between the AcbSh and the Arc but it is innervated by both orexin and 
MCH neurons from the LH and sends reciprocal connections including peptidergic 
efferents (e.g. NPY) to regions containing both neuronal subtypes in the LH (Broberger 
et al., 1998, Elias et al., 1998). The Arc also sends NPY positive projections to the PVN 
(Chronwall, 1985). It is not clear how bilateral activation following muscimol infusion 
could occur unless the LH sends crossed projections to the Arc or activates it via 
polysynaptic pathways including other intervening brain regions. However it is possible 
that if baclofen activates a population of MCH neurons in the LH that are not activated 
by muscimol as was hypothesised above this would explain the unilateral activation in 
the Arc to which they are directly connected. 
 
Zheng et al (2003) reported that, following bilateral intra-AcbSh infusions of muscimol, 
fewer POMC/CART immunoreactive neurons were positive for Fos synthesis in the 
ventrolateral aspect of the Arc but there were more cells showing Fos synthesis in the 
dorsomedial aspect of the Arc where the majority of NPY neurons were found. They 
did not report what the effect of muscimol was on the net total number of FLI cells in 
the whole of the Arc compared to saline infusions. It is possible that activation of NPY 
neurons which co-express GABA might itself be the cause of the reduction in activity in 
POMC/CART neurons to which the former project (Cowley et al., 2001). NPY levels in 
the Arc rise at the onset of the natural feeding cycle in rats and decrease following 
consumption of food and particularly carbohydrates (Akabayashi et al., 1994, Beck et 
al., 1990, Chang et al., 2005, Jhanwar-Uniyal et al., 1990, Wang et al., 1999). Feeding 
increases activity in POMC/CART neurons in the Arc (Johnstone et al., 2006). 
 
Although no attempt was made to distinguish between the ventrolateral and 
dorsomedial portions of the Arc in these experiments a visual inspection of the sections 
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indicates that there was clearly more FLI cells in the dorsomedial portion ipsilateral to 
baclofen and muscimol infusions (See Fig. 6.7. and Fig. 6.13). Baldo and Kelley (2004) 
reported a significant increase in activity in Arc neurons following bilateral infusions of 
muscimol into the AcbSh. Both inhibition of POMC/CART immunoreactive neurons 
and activation of NPY neurons would result in net increases in feeding behaviour but it 
is not clear which other facets of behaviour (e.g. consummatory versus appetitive 
responses) would/could be mediated by the balance between the two systems. It has 
been reported however that intracerebroventricular infusions of NPY antagonists 
suppressed increases in free intake elicited by intra-AcbSh muscimol (Stratford and 
Wirtshafter, 2004). 
 
Paraventricular nucleus 
Both unilateral baclofen and muscimol caused significant increases in Fos synthesis 
ipsilateral to the infusions in the PVN in Experiments 6.1 and 6.2 and there was no 
difference in the magnitude of this effect between treatments. Significant bilateral 
increases in Fos synthesis in this area has been reported following bilateral intra-AcbSh 
infusions of muscimol (Zheng et al., 2003) and significant increases ipsilateral to drug 
following unilateral muscimol infusions have also been shown (Stratford, 2005). 
Stratford (2005) points out that there is no direct connection between the AcbSh and the 
PVN but that there must be an uncrossed polysynaptic neural pathway, perhaps via the 
LH. Zheng et al., (2003) reported that, while muscimol induced significant Fos 
synthesis in neurons of the PVN, there was no significant change in activity in oxytocin 
or CART neurons in the region. 
 
The apparent lack of an effect of intra-AcbSh muscimol infusions on activity in neurons 
expressing anorexigenic peptides in the PVN suggests increased feeding is not caused 
by suppressing the release of satiety factors. However it is possible that these neurons 
were quiescent while animals did not have access to food and suppression might be seen 
during feeding when anorexigenic peptide release should be increased. It is also 
possible that increases in activity in NPY neurons in the Arc increases release of NPY 
in the PVN. NPY injected into the PVN stimulates food intake in satiated animals 
(Stanley and Leibowitz, 1985, Elmquist et al., 1996, Williams et al., 2001). The PVN is 
a key region activated by various acute and chronic stressors (e.g. see Melia et al., 1994) 
but it is always equally activated on both sides of the brain suggesting the robust 
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ipsilateral increases reported here are not due to general increases in arousal or stress 
associated with the procedure.  
 
Section summary 
While intra-AcbSh infusions of both baclofen and muscimol significantly increase 
activity in the LH the former appears to recruit more neurons in the caudal region. 
These neurons activated by baclofen might be MCH neurons, which could in turn cause 
the ipsilateral increases in activity in the Arc, to which they project. There was no 
significant ipsilateral increase in activity in the Arc with muscimol but higher levels in 
this region on both sides relative to activity following baclofen infusions suggest the 
Arc may have been bilaterally activated. If this was due to activation of LH neurons that 
project to the Arc they would have to be part of a crossed pathway or have affects on an 
intervening brain region. While both baclofen and muscimol increased activity 
ipsilaterally in the PVN muscimol reportedly has no effect on activity of anorexigenic 
peptide neurons in the region. Increased activity in the Arc could cause an increase in 
NPY in the PVN that would stimulate feeding. Overall it would appear that the effects 
of baclofen and muscimol on feeding might be mediated by a complex interaction 
between orexigenic and anorexigenic neurons in multiple hypothalamic nuclei. 
Different patterns of Fos expression in the LH and Arc indicate that the organisation of 
these interactions might differ following intra-AcbSh baclofen and muscimol infusions. 
 
Increased neuronal activity in other primary AcbSh efferent target regions 
Both unilateral intra-AcbSh baclofen and muscimol caused significant increases in Fos 
synthesis ipsilateral to the infusions in the VP and the VTA and there was no difference 
in the magnitude of these increases between treatments. Although none of the papers 
that report the effects of intra-AcbSh muscimol infusions on activity in these regions 
have tested the results statistically it has been observed that bilateral infusions increase 
activity bilaterally in these regions (Stratford and Kelley, 1999) and unilateral muscimol 
increases activity ipsilaterally (Yoshida et al., 1997, Stratford, 2005). The AcbSh 
connects monosynaptically with both these brain regions (See Chapter 1). 
 
The VP is involved in the regulation of ingestive behaviour (Johnson et al., 1996, 
Stratford et al., 1999) and it has recently been suggested that it primarily encodes the 
hedonic value of reinforcers (for a review see (Smith et al., 2009). Disinhibiting a 
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population of cells in the VP could be one of the events necessary for the initiation of 
feeding via the AcbSh because the GABAA antagonist bicuculline in the VP suppresses 
the inhibitory effects of AcbSh efferents and causes a robust dose-dependent increase in 
feeding (Stratford, 2007). Although unpublished, Stratford reports that there is evidence 
that fibre-sparing excitotoxic lesions of the VP significantly but not completely (~70%) 
reduced the magnitude of the intra-AcbSh muscimol induced feeding (Stratford, 2007). 
Stratford and Wirtshafter (unpublished data discussed in Stratford, 2007) suggest that an 
element of muscimol induced feeding is mediated via direct connections to the LH.  
 
In the same year it was reported that 1) increases in ‘liking’ by opioid stimulation in 
either the AcbSh or VP hedonic hotspots increased Fos activation in the other hotspot 
and 2) opioid agonist induced hedonic taste reactivity (liking) enhancement in either 
hotspot was blocked by simultaneous antagonist infusions in the other hot spot 
suggesting that the two regions act in unison as a single opioidergic circuit that 
subserves the hedonic impact of food rewards (Smith and Berridge, 2007). However 
while intra-VP naloxone (a µ-opioid antagonist) blocked hedonic orofacial responses 
caused by opioid stimulation in the AcbSh it did not affect the increase in food intake 
(Smith and Berridge, 2007). 
 
These authors suggest that the wanting element of AcbSh opioid induced intake is 
modulated by an independent route that bypasses the VP, possibly the direct AcbSh-LH 
connection (Smith and Berridge, 2007). Thus the VP is a necessary component, along 
with the AcbSh and LH, in a circuit subserving the full and natural expression of 
feeding related behaviours but is not essential for increases in intake alone. This is 
consistent with the report that intra-AcbSh muscimol at least can increase orofacial 
responses to food but infusions that most robustly increase intake do not correlate with 
hedonic increases that might be mediated via the VP (Reynolds and Berridge, 2002). 
 
It is possible that GABAA receptor stimulation releases a greater proportion of 
inhibitory control of the LH via direct monosynaptic connections than intra-AcbSh 
opioid stimulation. There is no data available to indicate what the effect of intra-AcbSh 
baclofen might be on hedonic responses to food. However, given that there was no 
significant difference in activity in the VP between drug treatments in the experiments 
reported here (See Fig. 6.16) muscimol and baclofen probably both have a similar 
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impact on the VP mediated element of the feeding response unless different classes of 
neurons in this region are activated. 
 
The AcbSh sends monosynaptic efferents to the VTA (Heimer et al., 1991b), which is 
one of the major sites from which AcbSh dopaminergic inputs originate (Swanson, 
1982). It has not yet been shown which neurons in the VTA the AcbSh efferents 
synapse onto. However increased activation of the VTA could result in increases in DA 
efflux in target regions in the forebrain including in the Acb. Reverse dialysis of 
muscimol increased firing of mesolimbic DA neurons, particularly in the A10 group 
including neurons in the VTA, which resulted in an increase in DA release and 
metabolism in the Acb (Yoshida et al., 1997). Dopaminergic input from the VTA to the 
Acb is necessary for the control of appetitive behaviours by neurons that are responsive 
to cues predicting reward (Yun et al., 2004b). DA in the Acb has been demonstrated to 
increase the conditioned incentive salience of food reward (Wyvell and Berridge, 2000). 
 
Section summary 
Intra-AcbSh infusions of both baclofen and muscimol caused ipsilateral increases in 
activity in the VP and in the VTA. While the VP might be an essential node in the 
circuit subserving the full expression of AcbSh GABA mediated feeding it would 
appear that blocking activity in this region does not abolish intake suggesting a direct 
connection to the LH is also involved. The VP has been implicated in an AcbSh 
mediated circuit subserving the hedonic control of intake but non-hedonic increases in 
feeding bypass this region. The VTA in contrast is responsible for increases in DA in 
the AcbSh, which in turn increases the incentive salience of reward and is necessary for 
cue induced responding. Measures of activity in these two regions alone without double 
labelling to identify which populations of neurons are activated does not indicate 
divergence in the effects of stimulating GABAA or GABAB receptors at a macrocircuit 
level. It may be relevant however that increased activity in the VTA could cause 
increased DA efflux in other forebrain regions such as the amygdala. 
 
Increased neuronal activity in the central nucleus of the amygdala 
Neither baclofen nor muscimol had any significant effect on activity in the BLA relative 
to vehicle treatment however baclofen significantly increased activity in the CeA on the 
side ipsilateral to the drug infusion. The only report that mentions an effect of muscimol 
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on activity in the CeA demonstrated that Fos synthesis was significantly increased 
bilaterally following unilateral infusions suggesting this was due to a secondary 
systemic effect (Stratford, 2005). The CeA receives direct input from the AcbSh 
(Heimer et al., 1991b) but the CeA only influences the AcbSh via indirect pathways that 
include midbrain dopaminergic neurons (See Chapter 1, Introduction). As mentioned 
above orexin and MCH neurons in the area of the LH that is activated by both intra-
AcbSh GABA receptor agonists also project directly to the CeA and increased activity 
in the VTA can increase DA release in the amygdala (Yoshida et al., 1997).. 
 
It is well established that the CeA is involved in the control of feeding (See Chapter 1). 
Food deprivation has been shown to increase Fos synthesis in both the CeA and BLA 
(Moscarello et al., 2009). There is also a reciprocal relationship between opioid 
mediated effects on feeding in the AcbSh and CeA (Kim et al., 2004). Temporary 
inactivation of the CeA but not the BLA using lidocaine attenuates increases in intake in 
response to palatable food by disrupting the expression of feeding motor responses 
(Ahn and Phillips, 2003). Inactivation of the CeA but not the BLA using muscimol dose 
dependently blocks the expression of AcbSh muscimol induced feeding suggesting this 
region is necessary for the expression of consummatory behaviour (Baldo et al., 2005).  
 
It has also been suggested that the CeA encodes the incentive salience or affective 
properties of stimuli associated with “biologically significant events” (Balleine and 
Killcross, 2006). Cardinal et al., (2003) state that “the CeA acts as a ‘controller of the 
brainstem’, using its widespread projections to the hypothalamus, midbrain reticular 
formation and brainstem to orchestrate behavioural, autonomic, and neuroendocrine 
responses”. The CeA also probably has a modulatory role in attention and arousal 
through its projections to the reticular formation (Cardinal et al., 2003). Thus it is 
possible that activation of the CeA following intra-AcbSh baclofen infusions could 
increase intake via effects on incentive salience or wanting. This would also potentially 
support increases in instrumental responding as was suggested in Chapters 4 and 5. This 
will be discussed in more detail in the general discussion in the final chapter but the 
CeA could be the critical point at which GABAB mediated and GABAA mediated 
feeding circuits differ. 
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Fos activation following food deprivation and in response to food 
It was suggested in Chapter 3 that infusions of baclofen into the AcbSh elicited a 
behavioural profile, in terms of the BSS, similar to that elicited by hunger and it is 
interesting to consider whether a similar pattern of Fos synthesis is seen following food 
deprivation as is reported here following intra-AcbSh baclofen. Food deprivation has 
been shown to induce Fos synthesis in a multitude of brain regions including the AcbC, 
AcbSh, medial preoptic area, dorsomedial caudate nucleus, lateral septum, BLA, Arc, 
dorsomedial hypothalamus, LH and lateral habenula (LHb) but no increase in the VP, 
PVN, CeA (Carr et al., 1998). These authors suggest that this widespread increase in 
activity could be due to the effects of stress associated with food restriction rather than 
hunger per se because the animals had not been fed for between 19-21 hours. 
 
Carr et al., (1998) also acknowledge however that, while the animals were culled at a 
time of day when Fos synthesis associated with circadian cycle would be low in ad lib 
fed animals, the cohort used had been conditioned to expect food during the light cycle 
and Fos synthesis could have been increased because they were expecting a meal. 
Johnstone et al., 2006 showed that animals that were anticipating feeding during a 
restricted period but had not received food had increased levels of Fos synthesis 
(relative to levels in animals not expecting food) in the VMH, LH, dorsomedial portion 
of the Arc, PVN and LHb but levels were similar in the “posterior” hypothalamus. 
These authors do not report any data pertaining to levels of Fos synthesis in the VP, 
amygdala or striatum (Johnstone et al., 2006). 
 
Increases in activity following intra-AcbSh muscimol infusion have been reported for 
all of the areas activated by food restriction/expectation bar the dorsal and ventral 
striatum which could not be assessed because of the location of the guide cannulae (See 
Table 6.1). It is interesting however that food restriction does not activate the VP, PVN 
and CeA while expectation recruits the PVN but does not activate the posterior 
hypothalamus suggesting that intra-AcbSh baclofen and muscimol might both recruit 
additional circuits not active in hungry animals or necessary for the initiation of feeding. 
 
Summary 
The results from experiments reported in this chapter indicate that intra-AcbSh 
infusions of baclofen and muscimol activate neurons in a number of hypothalamic 
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nuclei but that the pattern of activation differs between treatments. While the current 
hypothesis to explain the effects of intra-AcbSh muscimol on food intake suggest that 
disinhibition of neurons in the LH releases patterns of ingestive motor behaviour 
(Kelley et al., 2005b) it would appear that both baclofen and muscimol could recruit 
populations of orexin neurons essential for modulating the effects of external stimuli on 
feeding. However baclofen also recruits a circuit that involves the CeA suggesting that 
this manipulation alone actually modulates a functional circuit known to be involved in 
the response to stimuli and in the affective value of these stimuli. It would not appear 
that circuits essential for the hedonic effects of food and food associated cues is 
important for baclofen or muscimol effects on feeding but circuits subserving wanting 
that include the VTA and CeA are important for the baclofen effect on instrumental 
responding. The recruitment by both intra-AcbSh baclofen and muscimol infusions of 
areas of the brain not apparently involved in circuits activated by hunger and food 
expectation per se further supports this assertion. 
 
Questions raised 
While activation of some neurons in the LH could contribute to the expression of 
conditioned responses the evidence presented in this thesis suggests that intra-AcbSh 
muscimol infusions do not affect instrumental responding. Further studies need to be 
carried out using double labelling techniques to determine the neurochemical subtype of 
neurons that are activated following intra-AcbSh baclofen and muscimol, particularly in 
the LH and other hypothalamic nuclei. Also, while Kelley et al., (2005b) hypothesise 
that disinhibition of the LH results in release of downstream motor components there is 
no functional evidence for this. It remains to be determined whether the subtly different 
patterns of activation in hypothalamus regions with baclofen and muscimol will have 
different effects on motor pattern generation if they have any direct effect at all. The 
evidence presented in this chapter that GABAA and GABAB receptors activate different 
pathways strongly suggests that a different pattern or magnitude of changes in the 
activity of AcbSh MSN output is mediated by stimulation of the two receptor subtypes. 
This leaves us with the question of why the pattern of output would be different. 
Possible local mechanisms to explain these differences will be discussed in the final 
chapter. 
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Chapter 7 
 
General Discussion 
 
Overview 
A specific role for GABA in the AcbSh in the control of feeding behaviour was first 
demonstrated over a decade ago (Stratford and Kelley, 1997b). In the following decade 
a number of papers were published reporting the role of a variety of neurotransmitters 
and neuromodulators in this region in modulating feeding and food motivated 
behaviour. However the nature of the feeding response elicited by intra-AcbSh 
infusions of the GABAA agonist muscimol and the GABAB agonist baclofen has not 
been extensively investigated in the intervening years. In particular the role of baclofen 
has only been tested in terms of the effects on total intake of food, latency to begin 
feeding and meal duration (Lopes et al., 2007, Stratford and Kelley, 1997b) although 
Ward et al., (2000) demonstrated that increased food intake was not due to non-specific 
increases in oral behaviours or increased palatability. 
 
Intra-AcbSh muscimol potentiates orofacial expression of hedonic responses to food but 
increases in feeding appear to be independent of positive taste reactivity (Reynolds and 
Berridge, 2001). Muscimol can elicit both positive and aversive responses along a 
rostrocaudal gradient in the AcbSh and supports the development of place 
preference/avoidance (Reynolds and Berridge, 2002) although preference could be due 
to the reported anxiolytic effects of muscimol (Lopes et al., 2007). Muscimol in the 
AcbSh does not increase instrumental responding on a PR schedule and fails to 
facilitate the acquisition of a Pavlovian association or increase the hedonic value of 
food as hunger does (Zhang et al., 2003, Hanlon et al., 2004, Basso and Kelley, 1999). 
A functional link between the AcbSh and the LH subserves GABA receptor agonist 
induced increases in food intake (Stratford and Kelley, 1997a, Stratford and Kelley, 
1999, Stratford, 2005, Marchant et al., 2009). Kelley and colleagues (2005b) 
hypothesised that inhibition of AcbSh MSN output disinhibits neurons in the LH 
motor/autonomic control columns which in turn releases a subset of motor pattern 
generators in the brainstem that organise ambulation towards and ingestive responses to 
food but does not support expression of more complex goal-directed behaviours. 
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The main aim of this thesis was to further explore the behavioural impact of activating 
GABA receptors subtypes in the AcbSh on both food intake and food seeking 
behaviours. The behavioural paradigms chosen provided measures that dissociated 
between consummatory responses to food and instrumental responding for food 
reinforcement. Comparisons were made with both physiological and pharmacological 
manipulations known to increase these behaviours via specific mechanisms. The 
behavioural paradigms chosen could also provide some insight into whether intra-
AcbSh GABA receptor agonists increase feeding via effects on appetite or satiety.  
 
To reiterate the results briefly; baclofen at all doses tested increased intake of freely 
available food, particularly at the start of the meal and delayed the onset of satiety 
whilst the gross pattern of the BSS remained intact. The pattern of behaviour resembled 
that seen following food deprivation but not that associated with AcbSh µ-opioid 
receptor agonist infusions, or systemic bretazenil. Baclofen at an optimum low dose 
increased instrumental responding during appetitive and consummatory phases of a 2nd 
order operant schedule suggesting that it initiates food seeking rather than attenuating 
satiety signals. At a high dose baclofen disrupted the expression of grooming behaviour 
and elicited grooming and oral stereotypies during the operant schedule and also 
induced non-feeding oral behaviours during the BSS test. 
 
Muscimol also increased feeding at all doses tested but at the expense of the rest of the 
behavioural repertoire that constitutes the BSS. Feeding behaviour was elevated 
throughout the test session. The pattern of behaviour did not resemble those elicited by 
baclofen, hunger, AcbSh µ-opioid receptor agonist infusions or systemic bretazenil. 
Muscimol had no significant effect on instrumental responding but at a high dose 
disrupted the natural expression of grooming behaviour and elicited adjunctive oral 
behaviour. 
 
The dose of baclofen that increased instrumental responding activated neurons in many 
of the same AcbSh efferent target regions that were also activated by an equimolar dose 
of muscimol. In addition intra-AcbSh baclofen activated a subpopulation of neurons in 
the caudal most region of the LH and in the Arc and CeA, areas not activated by 
muscimol. 
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These results suggested that neither baclofen nor muscimol inhibit satiety mechanisms 
but instead were consistent with effects on the initiation and maintenance of feeding 
behaviour. It was hypothesised that, at low doses, baclofen in the AcbSh increases 
intake and appetitive instrumental responding for food via increases in the incentive 
salience (but not the hedonic value) of reward or reward predictive cues that can initiate 
behaviour while muscimol initiates unconditioned motor responses to food but does not 
affect motivation per se. The hypothesised divergence in mechanisms subserving the 
increased feeding elicited by intra-AcbSh GABA receptor subtype agonists is supported 
by the observation that baclofen and muscimol infused into the AcbSh activate 
components of different neuronal pathways within feeding related macrocircuits. 
 
These results raise a number of questions about the mechanisms that might subserve the 
reported effects of intra-AcbSh baclofen and muscimol: 
 
1) Divergence between the effects of intra-AcbSh baclofen and muscimol at the 
behavioural and anatomical level must be subserved by differences in the pattern 
and/or magnitude of activity of the AcbSh MSNs, but how would this arise? 
2) Which functional macrocircuits might be activated and how do these contribute to 
the expression of different behaviours following stimulation of different GABA 
receptor subtypes in the AcbSh? 
3) Increased intake and increases in operant responding can occur as a result of 
increases in hedonic value of the reward or reward associated cues (liking), 
increases in incentive salience of cues (wanting), decreases/blockade of satiety 
mechanisms, changes in attentional processes or because of a decrease in response 
inhibitory control but which of these mechanism might be critical to the results 
reported here? 
4) Why are different effects on behaviour seen across the dose range of baclofen tested 
and, to a lesser extent, across the dose range of muscimol tested and is this related to 
the macrocircuits that subserve the effects? 
5) Although the evidence for a role for GABA in AcbSh mediated feeding is 
compelling is there any evidence that GABA in the AcbSh is part of a biologically 
relevant feeding control mechanism? 
6) How does all of the above contribute to our understanding of the processes involved 
in the control of motivated behaviour in general at the level of the Acb? 
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Differences at the level of GABA receptors - could GABAA or GABAB 
receptors differentially control activity of AcbSh MSNs? 
 
Kelley’s hypothesis to explain the role of GABA in the AcbSh in feeding is dependent 
on the assertion that both GABAA and GABAB receptor agonists inhibit firing of 
GABAergic output neurons (2005b). Kelley et al., (2005b) suggest that baclofen causes 
functional inhibition of MSNs because stimulation of GABAB receptors blocks 
glutamatergic inputs to the MSNs. By contrast muscimol stimulates GABAA receptors 
on the MSNs directly inhibiting firing rates. It is implicit within Kelley’s hypothesis 
that global inactivation of AcbSh inhibitory output neurons increases food intake 
although Stratford (2007) explicitly spells this out. It is possible however that there are 
differences in the effects of stimulating G-protein coupled receptors (GABAB) and 
ionotropic receptors (GABAA) and the location and sensitivity of these receptors may 
ultimately determine the pattern and proportion of MSNs inhibited. Such mechanisms 
are particularly important given that the integrative role of the Acb in motivated 
behaviour requires that a multitude of different types of input that converge on this 
region must be filtered to produce control of different types of behavioural output.  
 
GABA receptor types and location 
Ionotropic GABAA receptors in the Acb are found postsynaptically on MSNs and on 
GABAergic interneurons (Galvan et al., 2006) at GABAergic synapses  which arise 
from inputs from interneurons, local axon collaterals and from minor GABAergic 
innervation from the VP and VTA (Churchill and Kalivas, 1994, Van Bockstaele, 1995, 
Meredith, 1999, Taverna et al., 2004). GABAA receptors are also found postsynaptically 
at non-GABAergic synapses (Fujiyama et al., 2000) that could be dopaminergic or 
cholinergic but not apparently in glutamatergic synapses (Galvan et al., 2006). 
Activation of GABAA receptors results in rapid phasic induction of inhibitory 
postsynaptic potentials (Mody, 1994). 
 
G-protein coupled GABAB receptors are located presynaptically and postsynaptically 
(Kerr and Ong, 1995). The majority of postsynaptic GABAB receptors are extrasynaptic 
but a small number are found in GABAergic synapses and at the edge of glutamatergic 
synapses (Galvan et al., 2006). Postsynaptic GABAB receptors are thought to modulate 
slower hyperpolarisations (Otis et al., 1993, Mody et al., 1994). Presynaptic GABAB 
receptors function as both auto- and heteroreceptors (Bettler et al., 2004). Autoreceptors 
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in GABAergic terminals modulate GABA release (Nisenbaum et al., 1992, Bowery, 
1993, Takahashi et al., 1998, Waldmeier et al., 2008). Heterorecptors are found at 
glutamatergic and possibly dopaminergic terminals and modulate release of 
neurotransmitter (Charara et al., 2000, Calabresi et al., 2000, Smith et al., 2001, Lacey 
et al., 2005). Stimulation of G-protein coupled GABAB receptors may also have other 
secondary effects on activity of Acb neurons via signal transduction cascades (Calver et 
al., 2002, Kerr and Ong, 1995). 
 
Postulated effects of stimulating GABAB receptors 
Baclofen at µM doses reduces glutamate release, which in turn reduces excitation in 
MSNs but there does not appear to be any postsynaptic effect of baclofen in the striatum 
(although there is in other brain regions) (Nisenbaum et al., 1993). Baclofen also 
reduces the small inhibition elicited by excitatory input to MSNs by blocking GABA 
release at autoreceptors from axon collaterals that synapse onto other MSNs(Nisenbaum 
et al., 1993). However, whether autoreceptors are located on the MSN terminals of the 
axon collaterals that innervate other MSNs (feedback inhibition) or on the GABAergic 
interneurons that are also stimulated by glutamatergic inputs (feedforward inhibition) is 
not clear (Nisenbaum et al., 1993). 
 
It has been widely reported that GABAB autoreceptors are activated by much lower 
concentrations of baclofen than are required to activate GABAB postsynaptic receptors 
or presynaptic heteroreceptors on glutamatergic terminals (Calver et al., 2002). 
However Uchimura and North (1991) reported that in the Acb the half maximal 
effective concentration (EC50) of baclofen required for inhibition of MSN activity by 
GABA release is 2µM while the EC50 for glutamatergic excitation was 0.6µM. This 
suggests that GABAB receptor mediated release of GABA in the Acb in vitro is three 
times less sensitive to baclofen than glutamate release and hence the main effect of 
lower doses of baclofen (within a µM concentration range) would be inhibition of 
MSNs via attenuation of excitatory input (Uchimura and North, 1991). 
 
The EC50 for baclofen effects on glutamatergic transmission in the Acb is a thousand 
fold greater than the highest dose of baclofen used in the experiments reported in this 
thesis and it is difficult to predict what effects such low doses of baclofen would have in 
vivo on auto vs. heteroreceptor activation. However it seems highly likely that, at such 
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low doses the ability of baclofen to block glutamatergic transmission in different 
synapses will depend ultimately on the net effect of interactions between multiple 
glutamatergic, dopaminergic, serotonergic, cholinergic and GABAergic inputs to the 
AcbSh MSNS (see Chapter 1, page 31). In addition it is not known to what extent 
excitatory afferents to the Acb synapse onto interneurons and the effect that stimulating 
heteroreceptors in these synapses will have on MSN output. 
 
At the simplest level it is postulated that blocking excitatory input to a subset of 
GABAergic interneurons that receive glutamatergic afferents would reduce their 
inhibitory influence on MSNs and interneurons to which they project. Some local 
neurons could therefore become simultaneously more active as the excitation of others 
is reduced. Excitatory input to MSNs from glutamatergic afferents would be blocked, 
inhibitory inputs from some GABAergic interneurons would be removed but inhibitory 
input from others could be increased. Although it has been postulated that GABAB 
receptors are located presynaptically on DA afferents, it has been shown that baclofen 
does not affect the release of DA in vivo (Santiago et al., 1993). At a behavioural level 
baclofen does not block turning behaviour elicited by unilateral DA receptor agonist 
infusions into the AcbSh suggesting that GABAB receptors do not contribute 
significantly to the modulation of DA input to the Acb (Akiyama et al., 2004). This 
means that baclofen will not prevent dopaminergic inputs from influencing MSN 
output. Blockade of glutamatergic input could actually increase the impact of DA 
modulation of activity in the AcbSh. Which MSNs do and don’t fire will then depend 
on the net influence of blocking neurotransmitter release from heterogeneously 
distributed excitatory afferents, releasing or increasing inhibitory intrinsic inputs from 
different interneurons and favouring the impact of DA afferents. 
 
At higher doses of baclofen the contribution of interneurons to the activity of MSNs 
will be blocked by blocking GABA release via autoreceptors. Instead  stimulation of the 
postsynaptic receptor will inhibit the MSN. This means that, at low doses of baclofen, 
functional pathways intrinsic to the AcbSh could contribute to the net output depending 
on the pattern of innervation of MSNs by glutamatergic afferents and subclasses of 
interneurons but the interneuron contribution will be cancelled out at higher doses (See 
Fig. 7.1). This could explain the dose response effects of baclofen on instrumental 
responding reported in Chapter 4. 
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A) Low dose of baclofen 
 
 
B) High dose of baclofen 
 
 
Figure 7.1. Schematic illustration to show the postulated effects of applying a low 
concentration vs. a high concentration of baclofen to the AcbSh. ❚  B = presynaptic 
GABAB receptor. ✕  = no release of neurotransmitter. At low doses (A) GABAergic 
transmission is not affected but glutamatergic transmission is blocked by 
stimulation of heteroreceptors and the output of the MSN is determined by the net 
effect of inhibitory and excitatory inputs. At high doses (B) both GABAergic and 
glutamatergic transmission is blocked and the output of the MSN is probably 
determined solely by occupation of a postsynaptic GABAB receptor by baclofen 
(not shown for the sake of clarity) which will inhibit MSN firing. 
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Postulated effects of stimulating GABAA receptors 
Because muscimol binds with a much higher affinity to the GABAA receptor than 
endogenous GABA does (Krogsgaard-Larsen and Johnston, 1978) and because GABAA 
receptors are so widely distributed in the Acb (Galvan et al., 2006), the net effect of 
infusions of muscimol into this region could well be complete inhibition of MSN output 
as is generally believed. Although excitatory inputs to MSNs and interneurons will not 
be affected their influence will be negated by high levels of GABA receptor activation 
postsynaptically on MSNs.  
 
Although it has been shown that intra-AcbSh muscimol increase DA efflux in the Acb 
via disinhibition of mesolimbic DA neurons (Yoshida et al., 1997) the hypothesised 
presence of postsynaptic GABAA receptors in dopaminergic synapses (Fujiyama et al., 
2000) could modulate the impact of increased DA. At a behavioural level muscimol can 
block turning behaviour elicited by unilateral DA receptor agonist infusions into the 
AcbSh (Akiyama et al., 2004). This is consistent with the suggestion that GABAA 
receptors are found postsynaptically at DA synapses. 
 
Section summary 
Broadly speaking it is postulated that baclofen at low doses might only inhibit a 
subpopulation of MSNs by decreasing excitatory input and modulating the contribution 
of DA afferents and local interneurons. Which MSNs are ultimately inhibited will 
determine which macrocircuits are activated and which classes of behaviour elicited. In 
contrast stimulation of GABAA receptors with muscimol will result in near global 
inhibition of MSN output by bypassing all of the input neurons and interfering with DA 
transmission. Infusions of muscimol could effectively override the normal functional 
control of feeding via other neurotransmitter systems. The postulated effects of 
muscimol on MSN activity, but not of baclofen, are consistent with a lack of 
motivational effects of GABA stimulation in the Acb reported in this thesis and by other 
investigators (Kelley et al., 2005b). 
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Differences at the level of local signalling systems – could stimulation 
of GABAA or GABAB receptors differentially control activity of AcbSh 
MSNs and hence control of feeding by modulating activity of other 
local neurotransmitters? 
 
As Kelley et al., (2005b) point out, while the effects of individual neurotransmitters and 
the individual firing of separate classes of neurons in the Acb produce apparently 
diverse changes in motivated behaviour, signalling pathways within the Acb are heavily 
interdependent. It is important to take into account the possibility that the different 
effects of AcbSh GABAA and GABAB receptor stimulation on food motivated 
behaviour reported in this thesis could arise because of different interactions with other 
neurotransmitter systems within the Acb at the level of the interneurons and axon 
collaterals from MSNs. However little is known about how the feeding effects of 
stimulation/ blockade of various receptors in the Acb is mediated intra-striatally. Two 
major sources of neurotransmitter in the AcbSh are the local axon collaterals of 
cholinergic interneurons which release ACh within the AcbSh (Zhou et al., 2002) and 
local axon collaterals from both enkephalinergic and dynorphinergic MSNs which are 
responsible for local opioid release. 
 
Cholinergic and opioidergic interneurons 
While the role of opioids in the AcbSh in feeding is well established (e.g. for a review 
see Levine and Billington, 2004) the role of ACh is less well understood but stimulation 
of both GABAA and GABAB receptors in the Acb could modulate the activity of both 
resulting in a complex net effect on feeding. Hoebel and colleagues (Hoebel et al., 
2007) have suggested that increased levels of ACh following activation of cholinergic 
interneurons could mediate satiety mechanisms in downstream targets because 1) ACh 
levels in the Acb peak post maximal food intake (Mark et al., 1992), 2) 
pharmacologically induced hypophagia is associated with increased Acb ACh release 
(Mark et al., 1995) and 3) stimulation of feeding via hypothalamic mechanisms reduces 
Acb ACh release  (Rada et al., 1998, Rada et al., 1999).  
 
Kelley and colleagues (Kelley et al., 2005b) have hypothesised that cholinergic 
interneurons could play a role in potentiating food seeking or consumption, possibly via 
interactions with opioids in the AcbSh because 1) blocking ACh release in the AcbSh 
reduces performance of an operant response for food and acutely reduces free intake of 
322 
food (Pratt and Kelley, 2004), 2) blocking ACh release in the Acb reduces opioid 
induced food intake (Kelley et al., 2005b), 3) blocking ACh release in the AcbSh 
reduces 24 hour food intake and  reduces AcbSh opioid gene expression (Pratt and 
Kelley, 2005) and 4) increased AcbSh opioid gene expression could be associated with 
“energy state signalling” that encourages food intake via hedonic mechanisms (Kelley 
et al., 2005a). Thus they argue that tonic activity in cholinergic interneurons may be 
important for motivational mechanisms via interactions with opioidergic interneurons 
while stimulation of ACh release could also contribute to satiety mechanisms in line 
with the hypothesis put forward by Hoebel and colleagues  (Kelley et al., 2005b). 
 
In in vitro studies it has been shown that stimulation of cholinergic interneurons via 
activation of afferents to the Acb increases inhibition of MSNs, which suppresses the 
inhibitory output of the Acb (de Rover et al., 2002), which in turn would disinhibit 
downstream feeding related circuitry. In addition since there is no direct evidence that 
ACh in the AcbSh reduces feeding via effects on satiety, instead probably quite the 
opposite, it would appear to be more likely that cholinergic interneurons are involved in 
the potentiating of food seeking or consummatory responses, as suggested by Kelley 
and colleagues. The increase in ACh in the Acb during feeding could therefore be part 
of a positive feedback mechanism that involves the hypothalamus which potentiates the 
AcbSh opioidergic hedonic system. The reinforcing role of ACh in the Acb is supported 
by the observation that rats will self administer an ACh agonist into the AcbSh 
(Ikemoto et al., 1998) and the involvement of cholinergic interneurons in the 
synchronised response of the Acb to reward related cues (Reynolds and Wickens, 
2004). 
 
Interestingly it has been demonstrated elsewhere that baclofen and muscimol have 
different effects on both intra-AcbSh opioid and ACh agonist induced behaviours.  
While it has been reported that both baclofen and muscimol reduce extracellular 
concentrations of ACh (Rada et al., 1993) other authors have suggested that only 
activation of GABAA receptors with muscimol tonically regulates release of ACh while 
stimulation of GABAB receptors has a minimal effect (Anderson et al., 1993). At the 
behavioural level however it has been reported that baclofen but not muscimol blocks 
turning behaviour elicited by unilateral ACh receptor agonist infusions (Akiyama et al., 
2004). It has been reported that cholinergic interneurons are connected to each other in 
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part via GABAergic interneurons and stimulation in a small population of cholinergic 
interneurons causes GABAA receptor mediated inhibition of the rest of the population 
(Sullivan et al., 2008). It is difficult to envision how these conflicting reports can be 
reconciled without further investigation, but it would appear that baclofen and 
muscimol in the Acb could well interact differently with cholinergic feeding and reward 
modulatory pathways. 
 
It has also been reported that there is a reciprocal relationship between opioid and 
GABA signalling in the AcbSh modulation of feeding that depends on whether GABAA 
or GABAB receptors are activated.  While blockade of δ-, κ- and µ-opioid receptors 
using a non-selective opioid antagonist or selective antagonists attenuates muscimol 
induced feeding (Khaimova et al., 2004, Znamensky et al., 2001) only δ- and κ- 
antagonists attenuate baclofen induced feeding (Khaimova et al., 2004). Conversely 
feeding induced by a µ-opioid receptor agonist in the AcbSh is increased by blockade of 
GABAA receptors but decreased by blockade of GABAB receptors (Znamensky et al., 
2001). 
 
Once again it is difficult to envision how these different interactions occur and their 
implications for the mechanisms that subserve muscimol or baclofen induced feeding 
without further investigation. For example, what would be the effect of infusing both 
GABA and opioid agonists at the same time? It was noted in Chapter 3 that, based on 
evidence from Will et al., (2007), animals that were on a food restricted diet could have 
higher levels  of striatal enkephalin expression even when fed to satiety that may or may 
not contribute to the BSS recorded following muscimol infusions. It is possible however 
that, given the evidence that blockade of GABAA receptors potentiates µ-opioid 
receptor agonist induced feeding (Znamensky et al., 2001) the two effects are not 
mutually compatible. It seems unlikely that the muscimol induced BSS reported in 
Chapter 3 included a hedonic component modulated by opioid signalling in the AcbSh. 
 
Section summary 
The effects of stimulating GABAB or GABAA receptors on intake and responding for 
food reward do not occur in isolation. It is possible that both baclofen and muscimol 
infused into the AcbSh modulate the interaction of inhibitory amino acid signalling 
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systems and other neurotransmitter systems. It has been shown that the relationship 
between GABAA or GABAB receptors and ACh or opioid systems differs although the 
nature of the interaction is hard to decipher without more evidence. The ACh system 
has been implicated in the control of satiety mechanisms but the evidence is 
circumstantial. In contrast, there is direct evidence for the role of AcbSh Ach signalling 
in response to reward and possible the hedonic value of food via its interactions with the 
opioid signalling system. Given that the BSS with baclofen did not resemble that seen 
with intra-AcbSh opioid stimulation it seems likely that this manipulation might 
eliminate the impact of hedonic modulation of feeding via opioid/Ach mechanisms. 
 
Differences at the level of neuronal macrocircuits - could the regions of 
the brain activated by AcbSh receptor subtype stimulation be part of 
functionally dissociable macrocircuits? 
  
While differences in the BSS recorded following intra-AcbSh baclofen or muscimol 
infusions provided evidence that the effects of stimulation of different GABA receptor 
subtypes could be dissociable it does not really give any clues as to what macrocircuits 
could be involved. However the observation that baclofen, but not muscimol, increased 
instrumental responding during both the appetitive and consummatory phase of a 2nd 
order schedule does provide some insight into which circuits could subserve the effect. 
This evidence will be discussed in the next section. However, the direct anatomical 
evidence from the experiments reported in Chapter 6 that used FLI as a marker of 
increased activity showed that a distinct profile of LH activation was elicited by intra-
AcbSh baclofen infusions compared to muscimol infusions. In addition the CeA was 
uniquely activated by baclofen.  
 
The direct anatomical evidence for potential differences in the effects of GABAA and 
GABAB receptor stimulation on activity in the LH, Arc and PVN was discussed in some 
detail in Chapter 6 but the wider functional implications of the different patterns of 
activation were only briefly considered. The key issue that is raised by these results is 
how they fit into the model of GABA mediated feeding proposed by Kelley et al., 
(2005b) who suggested that the unique projections from the AcbSh to the LH access 
“feeding-selective nodes of the behavioural control column”. The “behavioural control 
column” (BCC) was proposed by Swanson (2000) to be interposed between these brain 
regions and the hierarchically arranged motor system. 
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The BCC consists of a core ventromedial group of hypothalamic nuclei and other 
midbrain nuclei divided into a rostral portion critical for circuits that regulate ingestion, 
reproduction and defensive behaviours, and a caudal portion essential for circuits 
subserving exploratory and foraging behaviour (Swanson, 2000). The rostral portion 
includes the medial preoptic nucleus, the Arc, the PVN, the ventromedial nucleus, the 
tuberal nucleus and the premammillary nuclei and is further subdivided into regions 
involved specifically in ingestive behaviour which is exemplified by the PVN while the 
remainder of the nuclei subserve reproduction and defence (Swanson, 2000). The 
caudal segment encompasses the mammillary body, VTA and SNr (Swanson, 2000). 
The motor system that the BCC accesses can be subdivided into the somatomotor, 
autonomic visceral and neuroendocrine secretomotor systems, and Swanson (2000) 
suggests that the hypothalamus can coordinate responses in all three via connections to 
motor initiator regions which in turn project to motor generator regions.  
 
The results reported in Chapter 6 indicate that both muscimol and baclofen infused into 
the AcbSh activate feeding related circuits via nodes in the ingestion (in particular the 
PVN) and exploratory/foraging related (VTA) portions of the BCC. It is difficult on the 
basis of these results alone then to determine how each receptor agonist would elicit 
different types of behavioural organisation (consummatory vs. appetitive responses). 
However Swanson (2000) points out that ventromedial hypothalamic nodes in the 
rostral portion of the BCC are “interconnected in a massive, highly differentiated way” 
and, as was discussed in Chapter 6, it could be the differing interactions between 
neurons in the LH, Arc and PVN that determine the behavioural output following intra-
AcbSh muscimol or baclofen infusions.  
 
The BCC is also a functional link between the cerebral hemispheres and voluntary 
control of behaviour and Swanson (2000) suggests that the PVN receives cognitive and 
behavioural state input, relayed via the BNST and ventrolateral septal nucleus which 
receive input from the PFC, hippocampus and amygdala. The CeA is suggested to be 
specialised for relaying cortical information to the autonomic motor system (Swanson 
and Petrovich, 1998). Given that the CeA was activated by baclofen, but not muscimol, 
it is likely that feeding induced by GABAB receptor stimulation in the AcbSh is 
mediated by at least two distinct pathways, one direct to the BCC and one indirect 
involving connections between the CeA and the BCC. 
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The functional macrocircuit that links the AcbSh with feeding responsive nodes in the 
LH is probably a cortico-striato-thalamo-cortical loop while the nodes themselves send 
projections both to the motor system and to the thalamus (Swanson, 2000). The 
functional macrocircuit that links the AcbSh and CeA includes indirect projections via 
the PB, the BNST, the ventrolateral septal nucleus and the NTS (Fudge and Haber, 
2000, Fudge et al., 2002, Risold et al., 1997). While activity in these regions was not 
analysed in the experiments reported in Chapter 6, activity in the lateral septum, 
thalamus, BNST and NTS has been reported following unilateral muscimol infusions 
into the AcbSh (Stratford, 2005). Some of the implications of activating these 
macrocircuits will be discussed later in this chapter.  
 
Section summary 
Evidence at the anatomical level presented in this thesis suggests that regions of the 
brain activated by intra-AcbSh GABA receptor subtype agonists probably participate in 
different functional macrocircuits. These macrocircuits could gain access to the motor 
control system via different nodes within the BCC described by Swanson (2000). To 
fully characterise the functional macrocircuits subserving baclofen and muscimol 
induced feeding it will be necessary to analyse activity in other brain regions. Swanson 
(2000) also points out that it is not yet clear how behaviours subserved by different 
subsystems that involve direct inputs to the motor systems as well as inputs elsewhere 
in the hierarchically organised motor control system (e.g. to nodes in the BSS) could be 
integrated and prioritised (Swanson, 2000) 
 
Differences at the level of behavioural output - could different 
behavioural control mechanisms be subserved by intra-AcbSh GABA 
receptor subtype stimulation? 
 
Discussion in the previous section provides some evidence at the anatomical level that 
behaviour elicited by intra-AcbSh infusions of baclofen and muscimol could be 
subserved by different putative macrocircuits.  It is also possible to construct a fuller 
picture of these macrocircuits by considering what is known about regions of the brain 
that subserve the types of behaviour reported specifically for the effects of baclofen but 
not muscimol i.e. increased appetitive and consummatory responses in a 2nd order 
schedule. To this end the evidence for the contribution of different processes that could 
327 
subserve the behaviour recorded with baclofen will first be reviewed and then the brain 
regions that could be involved in these processes will be discussed. 
 
Cue salience (wanting) or hedonic value (liking)? 
Berridge and colleagues have put forward a strong case for the role of both incentive 
salience/appetitive motivation and hedonic value/palatability, which are termed 
‘wanting’ and ‘liking’ respectively, in the expression of motivated behaviours (for a 
review see (Berridge, 2004, Berridge, 2009). While the activation of the VP by both 
intra-AcbSh infusions of muscimol and baclofen reported in Chapter 6 could indicate a 
hedonic component (liking) to the GABA mediated feeding response there is no 
compelling behavioural evidence in the experiments reported here or in the literature 
that this is the case. Previous studies show that muscimol does not increase the hedonic 
value (palatability) of ingesta and positive taste reactivity does not correlate with 
increases in intake (Basso and Kelley, 1999, Reynolds and Berridge, 2002). Secondly 
baclofen does not increase palatability of a liquid meal as indicated by a lack of the 
expected changes in the bout structure (Ward et al., 2000). 
 
In this thesis it has been demonstrated that, while baclofen produces a BSS resembling 
that seen following food deprivation (which can increase both the incentive salience and 
hedonic value of food), the pattern of behaviour is not consistent with increases in 
palatability alone (induced by intra-AcbSh infusions of the µ-opioid DAMGO). The 
BSS with muscimol did not produce a pattern consistent either with combined increases 
in incentive salience/hedonic value associated with hunger or with increases in 
palatability alone. 
 
In the 2nd order schedule muscimol had no significant effect on instrumental responding 
in agreement with previous reports that it does not increase responding on a PR 
schedule (Zhang et al., 2003), and this lack of effect was evident across an extended 
dose range compared to that tested in the PR schedule.  It would appear that, in the case 
of intra-AcbSh muscimol infusion, neither increases in wanting or liking can explain the 
restricted effect on consummatory behaviour. As was concluded in Chapter 5, it is 
highly likely that as Kelley’s hypothesis (2005b) suggests, artificial stimulation of 
postsynaptic GABAA receptors in the AcbSh biases the animals towards expression of 
consummatory responses subserved by increases in subsets of feeding related motor 
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patterns via changes in activity in the hypothalamus. In contrast intra-AcbSh baclofen 
increased instrumental responding during both the appetitive and consummatory phases 
of the 2nd order schedule which suggests some motivational component to the effect. 
From this point forward the discussion will focus solely on the effects of baclofen. 
 
It was concluded in Chapter 4 that the effects of baclofen could not have been as a 
result of hedonic increases in primary reward value (or of the CS itself). First of all, at 
the optimum 220ρmols dose, instrumental responding initially increased before the 
animals gained access to food. Secondly high rates of responding once food became 
available cannot be due to hedonic effects because this would require prior experience 
of the A-O contingency (Dickinson and Balleine, 1994). 
 
In addition total instrumental responding across the session and the rate of responding 
during the appetitive phase was increased at a higher 440ρmols dose of baclofen that 
did not increase responding during the consummatory phase suggesting that the 
instrumental effects of baclofen were independent of the A-O association. In addition 
the experience of consuming pellets under the influence of baclofen did not cause 
animals to re-value their reinforcing properties since because response rates between 
test days did not change as a function of prior drug experience. This did not reflect 
insensitivity of the animals to the hedonic value of the reward per se because, when 
they received pellets their pressing increased above the rates supported by the CS alone 
consistent with the suggestion by Thornton-Jones at al., (2005) that positive feedback 
mechanisms related to feeding can potentiate responding on this schedule. 
 
It was hypothesised that the effects of low doses of baclofen on intake and instrumental 
responding could be due to increased cue saliency both in terms of the discrete cue for 
which animals responded in the 2nd order schedule and possibly to contextual cues 
associated with the test environment in the free feeding test. This was based on the 
assertion that increased instrumental responding is a measure of increased wanting and 
can occur without increases in liking of the reinforcer (Wyvell and Berridge, 2000). In 
addition there was some evidence that baclofen decreased the latency to begin pressing 
again post pellet delivery suggesting decreased reaction times that are associated with 
the increased salience of cues predictive of higher reward magnitude (Giertler et al., 
2003, Blokland, 1998b). 
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There was also a shift to the left in the latency to press the lever post cue presentation, 
the majority of which were not associated with pellet delivery, suggesting animals were 
quicker to perform the instrumental response irrespective of primary reward 
presentation. Evidence was presented in Chapter 4 that neurons in the Acb respond to 
cues that predict reward (e.g. Nicola et al., 2004), DA transmission fluctuates in 
response to cues (Roitman et al., 2004, Carelli, 2004, Cheer et al., 2007). Increased DA 
levels in the AcbSh significantly increases cue-potentiated instrumental responding 
(Wyvell and Berridge, 2000). It has been argued that increased DA transmission 
increases incentive salience (Berridge, 2007b) 
 
Structures subserving motivational control of appetitive responding with baclofen 
The potential role for the AcbSh in basic associations between cues and reward, in 
instrumental learning and the interaction between the two was briefly discussed in 
Chapter 1. However, as was pointed out in Chapter 4, it would appear that the processes 
(and hence underlying macrocircuits) that subserve the ability of cues to control 
behavioural output in different schedules e.g. CRF, PIT or Pavlovian approach are 
mutually exclusive (Holland and Petrovich, 2005, Galarce et al., 2007, Balleine, 2005).  
 
While it has been argued that Pavlovian conditioned cue reinforcement of 
consummatory responses to food is dependent on circuits that involve the BLA and LH, 
but not the AcbSh and CeA (Holland and Petrovich, 2005), it has been clearly 
demonstrated that the expression of Pavlovian approach behaviour and cue-potentiated 
consumption is independent from the expression of conditioned instrumental 
responding (Di Ciano and Everitt, 2004) (Holland and Petrovich, 2005). Furthermore 
Holland and Petrovich (2005) acknowledge that the processes that mediate reward, 
approach and consumption in Pavlovian responding are probably completely separate 
from those that mediate these behaviours in instrumental behaviours. 
 
It is difficult to decipher exactly how animals experience both the process of acquisition 
and consequent performance of the 2nd order schedule with regards to these different 
forms of Pavlovian and instrumental processes. As has been pointed out by other 
authors “the functional role of the second-order stimulus within second-order schedules 
is complex” (Wilson and Bowman, 2004a). The results in all three experiments reported 
in Chapter 4 showed that, in vehicle infused animals, the light cue presented in the 2nd 
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order schedule was able to maintain a low level of instrumental responding despite the 
fact that they were pre-fed, suggesting that the CS functioned as a conditioned 
reinforcer. However Balleine (2005) suggests that, in a 2nd order paradigm, the CS acts 
both  as a conditioned reinforcer, which involves incentive properties associated with 
the CS itself, and also acts as a more general signal that reinforces and maintains S-R 
associations. 
 
Parkinson et al., (1999) demonstrated that, in a conditioned reinforcement paradigm the 
potentiating effects of amphetamine were critically dependent on the intact function of 
the AcbSh. In a similar experiment it was shown that potentiation of conditioned 
reinforcement by infusions of amphetamine into the Acb was blocked by lesions of the 
CeA (Robledo et al., 1996). The direct anatomical evidence from Chapter 6 that intra-
AcbSh infusions of baclofen increased activity in the VTA and the CeA would be 
consistent with an increase in DA in the AcbSh (Wallace et al., 1992). In addition it was 
argued earlier in this discussion that baclofen but not muscimol infused into the AcbSh 
could increase the relative contribution of the DA to behaviour. 
 
In a series of PIT experiments it has been demonstrated that the influence of cues over 
instrumental responding depends on whether the animals are responding on an outcome 
specific or general form of the schedule (e.g. see Holland and Gallagher, 2003, Corbit 
and Balleine, 2005). While outcome specific PIT appears to rely on signalling in the 
BLA (but not the CeA) and on the integrity of the AcbSh (Blundell et al., 2001, Corbit 
et al., 2001, Corbit and Balleine, 2005) generalised PIT procedures rely on the CeA (but 
not the BLA) and on the integrity of the AcbC (Holland and Gallagher, 2003, Hall et al., 
2001, Corbit and Balleine, 2005). In the generalised form of PIT animals probably 
associate the action, pressing on a single lever, with reward but not necessarily with the 
specific properties or value of that reward (Balleine and Killcross, 2006). These authors 
suggest that the BLA is involved in the formation of specific associations between cues 
and the incentive value of rewards whereas the CeA is more involved in the 
development of preparatory responses on the basis of general affective or incentive 
properties. 
 
In an extension of this argument they suggest that the BLA is involved in processing the 
value of a cue in a 2nd order paradigm as an instrumental incentive but the CeA 
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modulates its salience as a reinforcement signal (Balleine and Killcross, 2006). Given 
that intra-AcbSh infusions of baclofen specifically increase activity in the CeA it seems 
likely that an incentive explanation for increased appetitive responding is plausible. 
Thus it could be argued that although the AcbSh might not be directly involved in cue 
potentiated circuit that would specifically increase the general motivating properties and 
excitatory effects of stimuli is activated and would be responsible for the increase in 
goal directed responding.  
 
Although the evidence from studies of PIT suggest that the AcbC but not the AcbSh 
might be involved in the attribution of incentive salience to cues in the 2nd order 
schedule it must be remembered that these studies involved lesions of these regions. It 
is possible that when the integrity of the AcbSh remains intact following baclofen 
infusion it is able to influence cue related processes mediated by the AcbC and 
associated circuits via both the direct and indirect connections between these regions 
discussed in Chapter 1.  
 
Brain substrates subserving disruptions in motor behaviour at high doses of 
baclofen of muscimol  
 
One point that has not been dealt with yet was the observation that high doses of 
baclofen and muscimol disrupted the pattern of motor responses in the 2nd order operant 
schedule. Baclofen produced a breakdown of the normal grooming pattern but elicited 
grooming and oral stereotypies whereas muscimol fragmented grooming behaviour and 
elicited fragmented oral behaviour. It is suggested here however that these effects are 
not incompatible with activity in the proposed circuitry that subserves consummatory 
and/or appetitive behaviour at lower drug doses. 
 
It has been demonstrated that blocking striatal output disrupts the expression of 
syntactic chains of motor responses (Berridge and Fentress, 1987). One possible 
explanation for this is that inactivation of AcbSh output removes the inhibitory 
influence of the direct Acb projections to mesolimbic DA neurons in, for example, the 
VTA. It has been argued that increases in DA transmission via manipulation of VTA 
function enhances the salience of multiple stimuli and behaviour becomes fragmented 
as animals try to respond to each (Badiani et al., 1995). It has also been shown that 
psychostimulants (which increase DA transmission in the brain) can elicit motor 
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stereotypies and that these probably arise as a result of an imbalance in the activity of 
heterogeneous compartments in the striatum (Canales and Graybiel, 2000). Thus 
fragmented behaviour with muscimol could be a direct result of increased DA 
transmission from VTA afferents in the AcbSh while oral stereotypies arise because 
baclofen modulates the contribution of increased DA to different local circuit activity in 
the AcbSh. 
 
Section summary 
 
The macrocircuit subserving the behavioural effects of intra-AcbSh muscimol infusions 
is probably a simple loop involving the direct projections of AcbSh MSNs to the LH 
which artificially biases animals towards consummatory responses by engaging a 
specific subset of motor pattern generators in line with Kelley’s hypothesis. In contrast 
selective stimulation of GABAB receptors in the AcbSh using baclofen engages 1) a 
macrocircuit that produces consummatory responses involving the LH, 2) another 
circuit that involves the CeA which is involved in salience associated with the CS acting 
as a general motivator of response and driving voluntary instrumental responding and 3) 
subcircuits that result in increased DA release in the AcbSh via connections between the 
CeA and VTA which could also increase the salience of the cue acting as a reinforcer 
either directly or via its connections to the AcbC. At high concentrations both agonists 
cause disruption of behavioural output because of excessive levels of DA transmission 
in the same circuits but the behavioural impact depends on which GABA receptor 
subtypes in the AcbSh are stimulated. 
 
Is endogenous AcbSh GABA involved in feeding? 
The evidence discussed above suggests that the use of a GABAA antagonist to inhibit 
AcbSh output might not re-produce the effects of endogenous GABA because it 
bypasses multiple inputs to the MSNs that contribute to motivational control. However 
stimulation of GABAB presynaptic receptors modulates the relative contribution of the 
various inputs to MSNs, which might be more in line with the effects of endogenous 
GABA. Consistent with this hypothesis intra-AcbSh infusions of baclofen produced a 
BSS that resembled to that produced following food deprivation and increased 
instrumental responding for food reward consistent with the effects of hunger which 
potentiates instrumental responding. It was also shown here that, in agreement with 
previous studies, stimulation of GABA receptors in the AcbSh activates regions of the 
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brain that have well established roles in feeding related neural circuitry and are similarly 
activated by hunger and anticipation of feeding (Carr et al., 1998, Stratford, 2005, 
Johnstone et al., 2006) 
 
Elsewhere it has reported that increasing endogenous levels of GABA by blocking the 
activity of the GABA-transaminase inhibitor, gamma-vinyl-GABA induces a large 
increase in feeding (Stratford and Kelley, 1997b). The onset of consummatory 
responses to food is characterised by inhibition of a population of neurons in the Acb 
(Taha and Fields, 2005b, Taha and Fields, 2006). Microdialysis studies show that 
glutamate decreases in the AcbSh during feeding consistent with the possibility that 
endogenous GABA binds to presynaptic GABAB heteroreceptors (Rada et al., 1997, 
Rada et al., 2003). As mentioned previously, it has been reported that feeding initiated 
by food deprivation and feeding initiated by intra-AcbSh muscimol infusions can both 
be attenuated by blocking activity in the LH (Stratford and Kelley, 1999, Stanley et al., 
1996). Intracerebroventricular administration of NPY antagonists also attenuates 
feeding induced by both food deprivation and intra-AcbSh muscimol infusions 
(Stratford and Wirtshafter, 2004) (Chamorro et al., 2002). 
 
Section summary 
Evidence presented in this thesis suggests that GABAB but not GABAA receptor 
stimulation could mimic some of the effects of endogenously released GABA in the 
AcbSh. The observation that this manipulation produces behavioural patterns (delayed 
BSS and increased instrumental responding) consistent with feeding induced by food 
deprivation suggests the manipulation is similar to natural modulators of motivational 
control. When all of this data is taken together with evidence from other studies in the 
literature it provides a strong body of evidence that suggests the AcbSh and GABA 
signalling in this region is a critical region in circuits that control the normal, 
physiological (and possibly cognitive/ voluntary) control of food motivated behaviour. 
  
A modified model to explain the role of inhibitory processes in the 
AcbSh in motivational control systems. 
 
Kelley et al., (2005b) acknowledge that “artificially enhancing GABA tone...bypasses 
the control of feeding behaviour exerted by brain regions sending highly processed, 
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glutamate-coded sensory and motivational information to the ventral striatum”. 
Furthermore inhibiting the AcbSh via indiscriminate postsynaptic binding of muscimol 
short circuits feeding interruption signals (Kelley et al., 2005b). When tonic inhibition 
of feeding nodes in the behavioural control column are artificially released by 
pharmacological blockade of AcbSh output the animals behaviour becomes biased 
towards consummatory behaviour  (Kelley et al., 2005b). 
 
In formulating a model to explain the role of endogenous GABA in the AcbSh in 
modulating food motivated behaviour Kelley et al., (2005b) suggested that feeding is 
initiated by extensive glutamatergic stimulation of the entire striatum which would 
initiate local GABA release from MSN axon collaterals, which inhibits AcbSh output 
control of downstream feeding related circuits. However an animal needs to be able to 
switch from feeding to other behaviours, for example when under threat, and Kelley and 
colleagues suggest that the AcbSh acts as a “sensory sentinel” limiting or gating 
excitatory interruption signals that would stop feeding but allowing particularly strong 
focal glutamatergic input to this region to override this behaviour. They go on to state 
that, while the restricted region of the AcbSh acts a sensory sentinel it only has access 
to a limited portion of the BCC and even less to voluntary motor control systems. Thus 
it is rest of the striatum (AcbC and dorsal striatum) that organises more complex 
environmentally organised motor output. 
 
Taken together, these ideas and observations suggest that the extent to which GABA 
signalling in the AcbSh limits or gates input depends on the degree to which 
endogenous GABA recruits presynaptic GABAB receptors or postsynaptic GABAA 
receptors. GABAB receptors have a high affinity for GABA (Jones et al., 1998) whereas 
GABAA receptors have a much lower affinity for GABA and also desensitize more 
rapidly (Macdonald and Olsen, 1994). Thus when endogenous GABA in the Acb is 
increased it will more likely recruit GABAB receptors before GABAA receptors. 
Widespread glutamatergic input to the entire striatum will increase GABA release but, 
within normal physiological parameters e.g. energy deficit that drives hunger, could 
predominantly activate presynaptic GABAB receptors. This could serve to initiate 
consummatory responses but also modulate the relative impact of DA inputs that 
energise responding and contribute to more complex food seeking strategies based on 
the salience of cues that predict food availability. Thus, while consummatory responses 
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are mediated by inhibitory neurotransmission in this region, this does not exclude a role 
for the AcbSh in the organisation of more complex behaviours. The AcbSh can access 
voluntary behavioural control circuits via indirect pathways involving the LH, CeA and 
reciprocal connections between the AcbSh and AcbC and the associated increases in 
DA transmission drives appetitive responding as a result of increases in cue saliency. 
Increases in hedonic value of reward will be driven predominantly by physiological 
activation of LH circuits which in turn directly recruits the opioid signalling pathway in 
the AcbSh and all of these processes will be in direct competition with the cognitive 
control of responding for food via the glutamatergic interruption signals that Kelley et 
al., (2005b) refer to. 
 
Future directions 
 
As was pointed out at the start of this discussion the nature of the feeding response 
elicited by intra-AcbSh infusions of the GABAA agonist muscimol and the GABAB 
agonist baclofen has not been extensively explored. The results reported in this thesis 
suggest that there is good reason to believe that stimulation of GABAB receptors more 
appropriately reveals the effects of endogenous GABA in the AcbSh than blocking 
GABAA receptors which bypasses much of the normal circuitry involved in the control 
of motivation. 
 
It will be important to determine if intra-AcbSh baclofen will also have different effects 
to those reported for muscimol in paradigms that have already been used to test the role 
of AcbSh GABA in feeding. For example it remains to be determined if baclofen can 
increase instrumental responding for reward on a PR schedule or if it can potentiate the 
acquisition of an instrumental response for food reward. It will also be interesting to 
find out whether baclofen has any effect on taste reactivity, whether there is a similar 
positive/ aversive rostrocaudal gradient as that reported for intra-AcbSh muscimol 
infusions and if it can support the development of place preference and avoidance. It 
would also be interesting to explore whether baclofen or muscimol have any effects on 
long term intake in, for example, a meal patterning experiment. 
 
In addition it will be interesting to use different behavioural paradigms to determine 
whether intra-AcbSh infusions of baclofen increase food intake and food motivated 
instrumental responding via effects on motor pattern generators, on cue salience or on 
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hedonic value of the reinforcer. To this end I suggest that the effects of intra-AcbSh 
baclofen could be tested in a conditioned incentive paradigm whereby the cue is 
presented in the absence of reinforcement. It might also be interesting to set up 
experiments where the impact of discrete and contextual cues is manipulated or test the 
animals in familiar or novel environments that could effect the total amount consumed 
by the animals. The effects of intra-AcbSh baclofen infusions on macronutrient 
selection should also be further explored. The effects of baclofen and muscimol in the 
AcbSh on PIT, conditioned reinforcement and Pavlovian cue-reinforced responding 
could also be investigated. 
 
Finally given the tantalising evidence reported here that intra-AcbSh baclofen activates 
regions of the brain not activated by muscimol it will be important to further explore the 
levels of activity in other regions of the brain such as the SN, thalamus, lateral 
habenula, nucleus of the solitary tract and the bed nucleus of the stria terminalis using 
Fos as a marker. In particular there is a need for double labelling studies to clarify 
whether, in the regions where both baclofen and muscimol exert effects, different 
populations of neurons are activated. It would also be important to determine what areas 
are activated during both baclofen induced consummatory behaviour and instrumental 
behaviour. To determine the functional links between these regions it would then be 
interesting to find out if blockade of activity in any of these regions attenuates or 
changes the baclofen induced feeding response. For example would blockade of activity 
in the CeA decrease feeding and/or decrease the effects of baclofen on instrumental 
responding for food? 
 
Implications of the results reported in this thesis 
 
The results reported in this thesis point to a broader and more complex role of the 
AcbSh in the control of motivated behaviour than one limited to an involvement in the 
release of predetermined behavioural patterns and unconditioned responses to goals. It 
is possible that the nucleus AcbSh modulates cognitive processing systems responsible 
for the assessment of the salience of environmental stimuli, and that it is involved in 
circuits that determine both wanting and liking of reinforcers. The AcbSh may also be a 
critical node in circuits subserving motivational processes through its ability to both 
directly and indirectly influence the activity of the AcbC and the dorsal striatum.  
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The need to understand how the AcbSh contributes to the control of motivated 
behaviours is particularly compelling given its role in addiction to drugs of abuse 
(Leshner and Koob, 1999, Koob, 2000, Berridge, 2004, Cardinal and Everitt, 2004, 
Carelli and Wightman, 2004, Everitt et al., 2008) as well in the pathological functioning 
of feeding related circuits in eating disorders and the development of obesity (Shapira et 
al., 2005, Kelley, 2004, Kelley et al., 2005b, Kelley et al., 2005a, Hetherington and 
Ranson, 1939, Berridge, 2007a, Stratford, 2007). Furthermore the Acb is implicated in a 
number of affective disorders in humans (e.g. Pizzagalli et al., 2009, Sarter et al., 2005, 
Munte et al., 2007, Menzies et al., 2008). The parallel between research in the areas of 
addiction and obesity are becoming increasingly apparent and many investigators 
believe that drugs of abuse ‘hijack’ systems subserving motivation for biologically 
relevant stimuli such as food (Volkow et al., 2008). 
 
There are also broader implications of this work. There has been a recent move towards 
the evaluation of the Acb as a therapeutic target using deep brain stimulation to treat, 
for example, obsessive compulsive disorders (Okun et al., 2007), depression 
(Aouizerate et al., 2009), obesity (Halpern et al., 2008) and addiction (Kuhn et al., 
2009). A better understanding of the role of the AcbSh subregion will be essential for 
developing appropriate strategies for therapies that target this brain region that will not 
have undesirable effects on non-pathological aspects of patient behaviour. 
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